<SEC-DOCUMENT>0001144204-18-043366.txt : 20180809
<SEC-HEADER>0001144204-18-043366.hdr.sgml : 20180809
<ACCEPTANCE-DATETIME>20180809170132
ACCESSION NUMBER:		0001144204-18-043366
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		48
CONFORMED PERIOD OF REPORT:	20180630
FILED AS OF DATE:		20180809
DATE AS OF CHANGE:		20180809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TAPIMMUNE INC.
		CENTRAL INDEX KEY:			0001094038
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880277072
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37939
		FILM NUMBER:		181006174

	BUSINESS ADDRESS:	
		STREET 1:		5 WEST FORSYTH STREET
		STREET 2:		SUITE 200
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32202
		BUSINESS PHONE:		(904) 516-5436

	MAIL ADDRESS:	
		STREET 1:		5 WEST FORSYTH STREET
		STREET 2:		SUITE 200
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TAPIMMUNE INC
		DATE OF NAME CHANGE:	20070628

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENEMAX CORP
		DATE OF NAME CHANGE:	20020718

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EDUVERSE COM
		DATE OF NAME CHANGE:	19990827
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>tv499451_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES SECURITIES AND EXCHANGE
COMMISSION<BR>
Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>FORM 10-Q</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD>
    <TD STYLE="width: 97%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended <B>June 30, 2018</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 97%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _____ to _____.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File Number: <B><U>001-37939</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tv499451_img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 1pt solid"><FONT STYLE="text-transform: uppercase"><B>TAPIMMUNE
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of registrant in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>NEVADA</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>45-4497941</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or other jurisdiction of incorporation or organization)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer Identification No.)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5 West Forsyth Street, Suite 200</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Jacksonville, FL</B></P></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>32202</B></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Zip Code)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>904-516-5436</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Issuer's telephone number)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
(1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past
90 days. Yes&nbsp;<FONT STYLE="font-family: Wingdings">x</FONT>&nbsp;&nbsp;No&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule 405 of Regulation S-T (&sect;232.405 of this chapter) during the preceding 12 months (or for such shorter
period that the registrant was required to submit and post such files). Yes&nbsp;<FONT STYLE="font-family: Wingdings">x</FONT>&nbsp;&nbsp;No&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, non-accelerated filer, a smaller reporting company, or an emerging growth company.
See definition of &ldquo;accelerated filer&rdquo;, &ldquo;large accelerated filer&rdquo;, &ldquo;smaller reporting company&rdquo;,
and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act (check one):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 49%; padding-left: 0.05in"><FONT STYLE="font-size: 10pt">Large accelerated filer</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 48%; padding-left: 0.05in"><FONT STYLE="font-size: 10pt">Accelerated filer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="padding-left: 0.05in"><FONT STYLE="font-size: 10pt">Non-accelerated filer (Do not check</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD>
    <TD STYLE="padding-left: 0.05in"><FONT STYLE="font-size: 10pt">Smaller reporting company</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 10pt">if smaller reporting company)</FONT></TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="padding-left: 0.05in"><FONT STYLE="font-size: 10pt">Emerging growth company</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT>&nbsp;&nbsp;No&nbsp;<FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 2, 2018, the Company had 13,710,544
shares of common stock issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 84%">&nbsp;</TD>
    <TD STYLE="width: 8%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
<TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="vertical-align: top"><A HREF="#s1"><FONT STYLE="font-size: 10pt"><B>PART I &ndash; FINANCIAL INFORMATION</B></FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s1"><FONT STYLE="font-size: 10pt">1</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#s2"><FONT STYLE="font-size: 10pt">Item&nbsp;1.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s2"><FONT STYLE="font-size: 10pt">Financial Statements (Unaudited)</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s2"><FONT STYLE="font-size: 10pt">1</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s3"><FONT STYLE="font-size: 10pt">Condensed Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s3"><FONT STYLE="font-size: 10pt">1</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s4"><FONT STYLE="font-size: 10pt">Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017 </FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s4"><FONT STYLE="font-size: 10pt">2</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s5"><FONT STYLE="font-size: 10pt">Condensed Consolidated Statement of Stockholders' Equity for the six months ended June 30, 2018</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s5"><FONT STYLE="font-size: 10pt">3</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s6"><FONT STYLE="font-size: 10pt">Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s6"><FONT STYLE="font-size: 10pt">4</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s7"><FONT STYLE="font-size: 10pt">Notes to Condensed Consolidated Financial Statements</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s7"><FONT STYLE="font-size: 10pt">5</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#s8"><FONT STYLE="font-size: 10pt">Item&nbsp;2.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s8"><FONT STYLE="font-size: 10pt">Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s8"><FONT STYLE="font-size: 10pt">11</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#s9"><FONT STYLE="font-size: 10pt">Item&nbsp;3.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s9"><FONT STYLE="font-size: 10pt">Quantitative and Qualitative Disclosures About Market Risk.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s9"><FONT STYLE="font-size: 10pt">24</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#s10"><FONT STYLE="font-size: 10pt">Item&nbsp;4.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s10"><FONT STYLE="font-size: 10pt">Controls and Procedures.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s10"><FONT STYLE="font-size: 10pt">24</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="vertical-align: top"><A HREF="#s11"><FONT STYLE="font-size: 10pt"><B>PART II &ndash; OTHER INFORMATION </B></FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s11"><FONT STYLE="font-size: 10pt">24</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#s12"><FONT STYLE="font-size: 10pt">Item&nbsp;1.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s12"><FONT STYLE="font-size: 10pt">Legal Proceedings.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s12"><FONT STYLE="font-size: 10pt">24</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#s13"><FONT STYLE="font-size: 10pt">Item&nbsp;1A.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s13"><FONT STYLE="font-size: 10pt">Risk Factors.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s13"><FONT STYLE="font-size: 10pt">24</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#s14"><FONT STYLE="font-size: 10pt">Item&nbsp;2.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s14"><FONT STYLE="font-size: 10pt">Unregistered Sales of Equity Securities and Use of Proceeds.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s14"><FONT STYLE="font-size: 10pt">34</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#s15"><FONT STYLE="font-size: 10pt">Item&nbsp;3.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s15"><FONT STYLE="font-size: 10pt">Defaults Upon Senior Securities.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s15"><FONT STYLE="font-size: 10pt">35</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#s16"><FONT STYLE="font-size: 10pt">Item&nbsp;4.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s16"><FONT STYLE="font-size: 10pt">Mine Safety Disclosures.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s16"><FONT STYLE="font-size: 10pt">35</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#s17"><FONT STYLE="font-size: 10pt">Item&nbsp;5.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s17"><FONT STYLE="font-size: 10pt">Other Information.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s17"><FONT STYLE="font-size: 10pt">35</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><A HREF="#s18"><FONT STYLE="font-size: 10pt">Item&nbsp;6.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#s18"><FONT STYLE="font-size: 10pt">Exhibits.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s18"><FONT STYLE="font-size: 10pt">35</FONT></A></TD></TR>
<TR STYLE="background-color: White">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="vertical-align: top"><A HREF="#s19"><FONT STYLE="font-size: 10pt">Signatures</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="#s19"><FONT STYLE="font-size: 10pt">36</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11%"><A NAME="s1"></A><FONT STYLE="font-size: 10pt"><B>PART I.</B></FONT></TD>
    <TD STYLE="width: 89%; text-align: justify"><FONT STYLE="font-size: 10pt"><B>FINANCIAL INFORMATION</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11%"><A NAME="s2"></A><FONT STYLE="font-size: 10pt"><B>Item 1.</B></FONT></TD>
    <TD STYLE="width: 89%; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Financial Statements</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in; text-indent: -0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="s3"></A><FONT STYLE="text-transform: uppercase"><B>TAPIMMUNE
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CONDENSED
CONSOLIDATED BALANCE SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">June 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-indent: 20pt">Cash</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">7,782,962</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">5,129,289</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 20pt">Prepaid expenses and deposits</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">108,716</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">51,150</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 40pt">Total current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,891,678</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,180,439</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,891,678</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,180,439</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS' EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 20pt">Accounts payable and accrued liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,595,152</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,508,312</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 20pt">Warrant liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">147,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 20pt">Promissory note</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 40pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,747,152</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,522,312</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,747,152</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,522,312</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">COMMITMENTS AND CONTINGENCIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stockholders' equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Preferred stock - $0.001 par value, 5 million shares authorized at June 30, 2018 and December 31, 2017, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.2in">Series A, $0.001 par value, 1.25 million shares designated, 0 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.2in">Series B, $0.001 par value, 1.5 million shares designated, 0 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.2in">Common stock, $0.001 par value, 41.7 million shares authorized, 13.6 million and 10.6 million shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,624</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,616</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.2in">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">170,287,725</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161,067,538</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.2in">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(166,156,823</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(157,420,027</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total stockholders' equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,144,526</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,658,127</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders' equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,891,678</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,180,439</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>See accompanying notes to these unaudited
condensed consolidated financial statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="s4"></A>TAPIMMUNE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center">For the three months ended</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center">For the six months ended</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="font-weight: bold">Revenues:</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 48%; text-align: left; padding-bottom: 1pt; text-indent: 20pt">Grant income</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: right">205,994</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: right">205,994</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total revenues</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">205,994</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">205,994</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 20pt">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,826,837</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,202,725</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,426,387</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,191,817</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 20pt">General and administrative</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,052,954</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,190,517</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,650,890</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,618,310</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,879,791</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,393,242</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,077,277</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,810,127</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,673,797</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,393,242</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,871,283</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,810,127</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 20pt">Change in fair value of warrant liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(139,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(138,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 20pt">Debt extinguishment gain</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">492,365</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">492,365</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(4,812,797</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(1,893,377</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(8,009,283</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(4,313,262</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss per share, Basic and Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.41</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.22</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.71</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.51</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Weighted average number of common shares outstanding</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,838,371</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,576,634</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,233,755</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,503,521</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>See accompanying notes to these unaudited
condensed consolidated financial statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="s5"></A>TAPIMMUNE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&rsquo;
EQUITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Common Stock</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">Additional Paid-</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">Accumulated</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">Total<BR> Stockholders'</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Par value</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">in Capital</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Deficit</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Equity</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; font-weight: bold">Balance at January 1, 2018</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-weight: bold; text-align: right">10,615,724</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 10%; font-weight: bold; text-align: right">10,616</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 10%; font-weight: bold; text-align: right">161,067,538</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 10%; font-weight: bold; text-align: right">(157,420,027</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">)</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 10%; font-weight: bold; text-align: right">3,658,127</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 10pt">Issuance of common stock in private placement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,300,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,300</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,118,700</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,120,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 10pt">Stock options exercised for cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,416</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,115</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,125</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 10pt">Stock warrants exercised for cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,446,881</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,447</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,259,638</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,261,085</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 10pt">Stock warrants cashless exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">118,425</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">118</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(118</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 10pt">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">132,825</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">133</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,096,339</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,096,472</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: 10pt">Fair value of repriced warrants as inducement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">727,513</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(727,513</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 10pt">Net loss</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(8,009,283</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(8,009,283</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Balance, June 30, 2018</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">13,624,271</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">13,624</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">170,287,725</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(166,156,823</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,144,526</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>See accompanying notes to these unaudited
condensed consolidated financial statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="s6"></A><B>TAPIMMUNE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENTS OF
CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center">For the six months ended</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows from Operating Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; font-weight: bold; text-align: left; text-indent: 10.05pt">Net loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(8,009,283</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(4,313,262</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: 10.05pt">Reconciliation of net loss to net cash used in operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 20pt">Changes in fair value of warrant liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">138,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,500</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 20pt">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,096,472</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">647,387</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 20pt">Debt extinguishment gain</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(492,365</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: 20.1pt">Changes in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 30pt">Prepaid expenses and deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(57,566</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(109,032</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 30pt">Accounts payable and accrued expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,086,840</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">336,135</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 40pt">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(4,745,537</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,935,637</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows from Financing Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 20pt">Proceeds from issuance of common stock and warrants in private placement, net of offering costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,120,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,408,343</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 20pt">Proceeds from exercise of stock warrants, net of offering costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,261,085</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">638,666</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 20pt">Proceeds from exercise of stock options</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">18,125</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 30pt">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,399,210</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,047,009</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net increase in cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,653,673</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,111,372</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Cash at beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,129,289</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,851,243</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Cash at end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,782,962</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9,962,615</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center">For the six months ended</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font-weight: bold; text-align: left"><P>Supplemental schedule of non-cash financing activities:</P>

</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><P>Fair value of repriced warrants as inducement</P>

</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><P>727,513</P>


</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><P>622,042</P>


</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><P>Stock warrants cashless exercised</P>

</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><P>118</P>


</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>See accompanying notes to these unaudited
condensed consolidated financial statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="s7"></A>TAPIMMUNE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>June 30, 2018</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>(Unaudited)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Note 1: Nature of
Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">TapImmune Inc.
(the &ldquo;Company&rdquo; or &ldquo;we&rdquo;), a Nevada corporation incorporated in 1991, is a biotechnology company focusing
on immunotherapy specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment
of oncology. Unlike other vaccine technologies that narrowly address the initiation of an immune response, TapImmune's approach
broadly stimulates the cellular immune system by enhancing the function of killer T-cells and T-helper cells and by restoring antigen
presentation in tumor cells allowing their recognition by the immune system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>NOTE
2: Basis of Presentation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated
financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of
America (&ldquo;U.S. GAAP&rdquo;) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8
of Regulation S-X of the Securities and Exchange Commission (&ldquo;SEC&rdquo;) and on the same basis as the Company prepares its
annual audited consolidated financial statements. In the opinion of management, the accompanying unaudited condensed consolidated
financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation
of such interim results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The results for the condensed consolidated
statement of operations are not necessarily indicative of results to be expected for the year ending December 31, 2018 or for any
future interim period. The condensed consolidated balance sheet at June 30, 2018 has been derived from unaudited financial statements;
however, it does not include all of the information and notes required by U.S. GAAP for complete financial statements. The accompanying
condensed consolidated financial statements should be read in conjunction with the consolidated financial statements for the year
ended December 31, 2017, and notes thereto included in the Company&rsquo;s annual report on Form 10-K filed on March 23, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>NOTE
3: LIQUIDITY AND FINANCIAL CONDITION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s activities since inception
have consisted principally of acquiring product and technology rights, raising capital, and performing research and development.
Successful completion of the Company&rsquo;s development programs and, ultimately, the attainment of profitable operations are
dependent on future events, including, among other things, its ability to access potential markets; secure financing, develop a
customer base; attract, retain and motivate qualified personnel; and develop strategic alliances and collaborations. From inception,
the Company has been funded by a combination of equity and debt financings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expects to continue to incur
substantial losses over the next several years during its development phase. To fully execute its business plan, the Company will
need to complete certain research and development activities and clinical studies. Further, the Company&rsquo;s product candidates
will require regulatory approval prior to commercialization. These activities may span many years and require substantial expenditures
to complete and may ultimately be unsuccessful. Any delays in completing these activities could adversely impact the Company. The
Company plans to meet its capital requirements primarily through issuances of debt and equity securities and, in the longer term,
revenue from product sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2018, the Company had cash
of approximately $7.8 million. Historically, the Company had net losses and negative cash flows from operations. Management intends
to continue its research efforts and to finance operations of the Company through debt and/or equity financings. Management plans
to seek additional debt and/or equity financing through private or public offerings. There can be no assurance that the Company
will be successful in obtaining additional financing on favorable terms, or at all. The Company has no sources of revenue to provide
incoming cash flows to sustain its future operations. The Company&rsquo;s ability to pursue its planned business activities is
dependent upon successful efforts to raise additional capital. These factors raise substantial doubt regarding the Company&rsquo;s
ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome
of these uncertainties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Note 4: SIGNIFICANT
ACCOUNTING POLICIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There have been no material changes in
the Company&rsquo;s significant accounting policies to those previously disclosed in the Company&rsquo;s annual report on Form
10-K, which was filed with the SEC on March 23, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>New Accounting Pronouncement</I>s</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, new accounting pronouncements
are issued by the Financial Accounting Standards Board (&ldquo;FASB&rdquo;) or other standard setting bodies that we adopt as of
the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are
not yet effective will have a material impact on our financial position or results of operations upon adoption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Recent Accounting Pronouncements
Adopted in the Year</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Compensation-Stock Compensation</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2017, the FASB issued Accounting
Standards Update (&ldquo;ASU&rdquo;) No. 2017-09, Compensation&mdash;Stock Compensation (Topic 718): Scope of Modification Accounting,
which clarifies when to account for a change to the terms or conditions of a share-based payment award as a modification. Under
the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of
the award (as equity or liability) changes as a result of the change in terms or conditions. It is effective prospectively for
the annual period beginning after December 15, 2017 and interim periods within that annual period. Early adoption is permitted.
The Company adopted ASU 2017-09 on January 1, 2018; the adoption of ASU 2017-09 did not have a material impact on its financial
condition or results of operations, as the Company has not had any modifications to share-based payment awards. However, if the
Company does have a modification to an award in the future, it will follow the guidance in ASU 2017-09.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Revenue from Contracts with Customers</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2014, the FASB issued ASU No. 2014-09,
 &ldquo;Revenue from Contracts with Customers (Topic 606)&rdquo; (ASU 2014-09) as modified by ASU No. 2015-14, &ldquo;Revenue from
Contracts with Customers (Topic 606): Deferral of the Effective Date,&rdquo; ASU 2016-08, &ldquo;Revenue from Contracts with Customers
(Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net),&rdquo; ASU No. 2016-10, &ldquo;Revenue
from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing,&rdquo; and ASU No. 2016-12, &ldquo;Revenue
from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.&rdquo; The revenue recognition principle
in ASU 2014-09 is that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount
that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition,
new and enhanced disclosures will be required. Companies may adopt the new standard either using the full retrospective approach,
a modified retrospective approach with practical expedients, or a cumulative effect upon adoption approach. The Company adopted
the new standard effective January 1, 2018, using the modified retrospective approach. The only impact of the adoption of ASU 2014-09
was to reclassify the Company's grant income as revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Recent Accounting Pronouncements Not
Yet Adopted</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Accounting for Certain Financial
Instruments with Down Round Features</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 13, 2017, the FASB has issued a
two-part ASU, No. 2017-11, (i). Accounting for Certain Financial Instruments with Down Round Features and (ii) Replacement of the
Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable
Noncontrolling Interests With a Scope Exception.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ASU is effective for public business
entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 and the interim periods
within that annual period. Early adoption is permitted. The Company will be evaluating the impact of adopting this standard on
the consolidated financial statements and disclosures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Improvements to Nonemployee Share-Based
Payment Accounting</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2018, the FASB issued ASU 2018-07
 &ldquo;Improvements to Nonemployee Share-Based Payment Accounting&rdquo;, which simplifies the accounting for share-based payments
granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned
with the requirements for share-based payments granted to employees. The amendments are effective for fiscal years beginning after
December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but
no earlier than an entity&rsquo;s adoption date of Topic 606. The Company is currently evaluating the impact of the new standard
on its consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Note
5: NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic loss per common share is computed
by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted loss per
common share is computed similarly to basic loss per common share except that it reflects the potential dilution that could occur
if dilutive securities or other obligations to issue common stock were exercised or converted into common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the computation
of net loss per share:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center">Six Months Ended</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center">Six Months Ended</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="font-weight: bold">Numerator:</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 48%; text-align: left; padding-bottom: 1pt">Net loss</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: right">(4,812,797</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: right">(1,893,377</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: right">(8,009,283</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 1pt solid; text-align: right">(4,313,262</TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Denominator:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">Weighted average common shares outstanding</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,838,371</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,576,634</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,233,755</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,503,521</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Net loss per share data:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic and Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.41</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.22</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.71</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.51</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following securities, rounded to the
thousand, were not included in the diluted net loss per share calculation because their effect was anti-dilutive for the periods
presented:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center">Six Months Ended</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left">Common stock options</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">439,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">455,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Common stock purchase warrants</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,871,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,544,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Potentially dilutive securities</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,310,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,999,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Note
6: WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A summary of quantitative information with
respect to valuation methodology and significant unobservable inputs used for the Company&rsquo;s common stock purchase warrants
that are categorized within Level 3 of the fair value hierarchy for the six months ended June 30, 2018 and 2017 is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">June 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">June 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%">Stock price</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">9.43</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">3.88</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Exercise price</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8.67</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.20</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Contractual term (years)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.32</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.03</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Volatility (annual)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">83</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">78</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Risk-free rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Dividend yield (per share)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing assumptions are reviewed
quarterly and are subject to change based primarily on management&rsquo;s assessment of the probability of the events described
occurring. Accordingly, changes to these assessments could materially affect the valuations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Financial Liabilities Measured at
Fair Value on a Recurring Basis</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial liabilities measured at fair
value on a recurring basis are summarized below and disclosed on the balance sheet under Warrant liability:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="13" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair value measured at June 30, 2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><B>&nbsp;</B></TD><TD NOWRAP><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>Quoted prices in active</B></TD><TD NOWRAP><B>&nbsp;</B></TD><TD NOWRAP><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>Significant other</B></TD><TD NOWRAP><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>Significant</B></TD><TD NOWRAP><B>&nbsp;</B></TD><TD NOWRAP><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2"><B>&nbsp;</B></TD><TD NOWRAP><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>markets</B></TD><TD><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>observable inputs</B></TD><TD><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>unobservable inputs</B></TD><TD><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>Fair value at</B></TD><TD><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: justify"><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>(Level 1)</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>(Level 2)</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>(Level 3)</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>June 30, 2018</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 49%; text-align: justify">Warrant liability</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD>
    <TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">147,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">147,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="13" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair value measured at December 31, 2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><B>&nbsp;</B></TD><TD NOWRAP><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>Quoted prices in active</B></TD><TD NOWRAP><B>&nbsp;</B></TD><TD NOWRAP><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>Significant other</B></TD><TD NOWRAP><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>Significant</B></TD><TD NOWRAP><B>&nbsp;</B></TD><TD NOWRAP><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2"><B>&nbsp;</B></TD><TD NOWRAP><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><B>&nbsp;</B></TD><TD NOWRAP><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>markets</B></TD><TD NOWRAP><B>&nbsp;</B></TD><TD NOWRAP><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>observable inputs</B></TD><TD NOWRAP><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>unobservable inputs</B></TD><TD NOWRAP><B>&nbsp;</B></TD><TD NOWRAP><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><B>Fair value at</B></TD><TD NOWRAP><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>(Level 1)</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>(Level 2)</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>(Level 3)</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>December 31, 2017</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 49%; text-align: justify">Warrant liability</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD>
    <TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">9,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">9,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value accounting standards define
fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants. As such, fair value is determined based upon assumptions that market participants would use in pricing an
asset or liability. Fair value measurements are rated on a three-tier hierarchy as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Level 1 inputs: Quoted prices (unadjusted) for identical assets or liabilities in active markets;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Level 2 inputs: Inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Level 3 inputs: Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no transfers between Level 1,
2 or 3 during the six months ended June 30, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents changes in
Level 3 liabilities measured at fair value for the six months ended June 30, 2018:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">Warrant</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Liability</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%">Balance - December 31, 2017</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 27%; text-align: right">9,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: 10pt">Change in fair value of warrant liability</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">138,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Balance &ndash; June 30, 2018</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">147,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Note 7: STOCKHOLDERS&rsquo;
EQUITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2018 Common Stock Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Common Stock Purchase Agreement</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 14, 2018, the Company&rsquo;s largest
stockholder Eastern Capital Limited entered into a Common Stock Purchase Agreement with the Company pursuant to which it purchased
1,300,000 shares of common stock at a price per share of $2.40 providing gross proceeds to the Company of $3.12 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Exercise and Repricing of Warrants
Held by Existing Institutional Investors </U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 14, 2018, certain institutional
holders of outstanding warrants entered into Warrant Exercise Agreements with the Company that provide for an amendment to the
exercise price of the warrants being exercised at $2.50 per share. Upon closing of the Warrant Exercise Agreements, such institutional
holders immediately exercised warrants for 782,505 shares of common stock providing aggregate proceeds to the Company of approximately
$2.0 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value relating to the modification
of exercise prices on the repriced and exercised warrants was treated as deemed dividend on the statement of stockholders&rsquo;
equity of $728,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A weighted average summary of quantitative information with
respect to valuation methodology and significant unobservable inputs used for the Company&rsquo;s common stock purchase warrants
that are included in the modification is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center">Weighted Average Inputs</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">Before</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">After</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">Modification</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">Modification</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%">Exercise price</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">9.93</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">2.50</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Contractual term (years)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.37</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.37</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Volatility (annual)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">79</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">79</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Risk-free rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.5</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Dividend yield (per share)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Exercise of Stock Warrants</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During June 2018, shareholders exercised
782,800 shares of common stock pursuant to stock warrants providing aggregate proceeds to the Company of approximately $2.3 million.
118,425 of the stock warrants exercised were exercised on a cashless basis, resulting in a cancellation of 83,130 stock warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Exercise of Stock Options</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2018, 10,416 shares of common
stock were issued pursuant to stock option exercises at an exercise price equal to $1.74 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Consulting Arrangements</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2018,
the Company issued 132,825 shares of common stock as part of consulting agreements. The fair value of the common stock of approximately
$644,000 was recognized as stock-based compensation, $563,000 in general and administrative expenses and $81,000 in research and
development expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I><U>Share Purchase Warrants</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A summary of the Company&rsquo;s share
purchase warrants as of June 30, 2018 and changes during the period is presented below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">Weighted Average</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">Number of</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">Weighted Average</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">Remaining Contractual</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">Total Intrinsic</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Warrants</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Exercise Price</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Life (in years)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Value</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; font-weight: bold">Balance - January 1, 2018</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; font-weight: bold; text-align: right">6,520,000</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 12%; font-weight: bold; text-align: right">6.11</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; font-weight: bold; text-align: right">3.16</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 12%; font-weight: bold; text-align: right">1,739,000</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cashless exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(118,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.01</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Exercised for cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,447,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.95</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Expired or Cancelled</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(84,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.01</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1pt">Balance - June 30, 2018</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">4,871,000</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">5.94</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2.76</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">20,417,000</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>Note
8: STOCK-BASED COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recorded approximately $960,000
and $271,000 of stock-based compensation expense for the three months ended June 30, 2018 and 2017, respectively. The Company recorded
approximately $1,096,000 and $647,000 of stock-based compensation expense for the six months ended June 30, 2018 and 2017, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At June 30, 2018, the total stock-based
compensation cost related to unvested awards not yet recognized was $159,000. The expected weighted average period compensation
costs to be recognized was 0.48 years. Future option grants will impact the compensation expense recognized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">$596,000 and $364,000 of stock-based compensation
expenses for the three months ended June 30, 2018 were included in general and administrative expenses and research and development
expenses, respectively, on the condensed consolidated statements of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">$629,000 and $467,000 of stock-based compensation
expenses for the six months ended June 30, 2018 were included in general and administrative expenses and research and development
expenses, respectively, on the condensed consolidated statements of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>Note 9:&#9;grant
income</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2018,
the Company received $0.2 million of a grant awarded to Mayo Foundation from the U.S. Department of Defense for the Phase II Clinical
Trial of TPIV200. The grant compensated the Company for clinical supplies manufactured and provided by the Company for the clinical
study. In accordance with Accounting Standards Update No. 2014-09, &ldquo;Revenue from Contracts with Customers (Topic 606)&rdquo;
issued by the Financial Accounting Standards Board, the Company recorded the $0.2 million of grant income as revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px; border-bottom: black 1pt solid"></TD>
    <TD STYLE="width: 72px; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><B><A NAME="s8"></A>Item 2.</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This quarterly report on Form 10-Q contains
forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, that involve
risks and uncertainties. All statements other than statements relating to historical matters including statements to the effect
that we &ldquo;believe&rdquo;, &ldquo;expect&rdquo;, &ldquo;anticipate&rdquo;, &ldquo;plan&rdquo;, &ldquo;target&rdquo;, &ldquo;intend&rdquo;
and similar expressions should be considered forward-looking statements. Our actual results could differ materially from those
discussed in the forward-looking statements as a result of a number of important factors, including factors discussed in this section
and elsewhere in this quarterly report on Form 10-Q, and the risks discussed in our other filings with the Securities and Exchange
Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management&rsquo;s
analysis, judgment, belief or expectation only as the date hereof. We assume no obligation to update these forward-looking statements
to reflect events or circumstance that arise after the date hereof.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>As used in this quarterly report: (i)
the terms &ldquo;we&rdquo;, &ldquo;us&rdquo;, &ldquo;our&rdquo;, &ldquo;TapImmune&rdquo; and the &ldquo;Company&rdquo; mean TapImmune
Inc. and its wholly owned subsidiary, GeneMax Pharmaceuticals Inc. which wholly owns GeneMax Pharmaceuticals Canada Inc., unless
the context otherwise requires; (ii) &ldquo;SEC&rdquo; refers to the Securities and Exchange Commission; (iii) &ldquo;Securities
Act&rdquo; refers to the Securities Act of 1933, as amended; (iv) &ldquo;Exchange Act&rdquo; refers to the Securities Exchange
Act of 1934, as amended; and (v) all dollar amounts refer to United States dollars unless otherwise indicated.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The following should be read in conjunction
with our unaudited condensed consolidated interim financial statements and related notes for the three and six months ended June
30, 2018 included in this quarterly report, as well as our Annual Report on Form 10-K for the year ended December 31, 2017 filed
on March 23, 2018.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Company Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a clinical-stage immuno-oncology
company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment
of cancer and metastatic disease. We are actively advancing our clinical programs by expanding our Folate Receptor Alpha program
(TPIV200) for breast and ovarian cancers and our HER2/neu peptide antigen program (TPIV110) in Phase II clinical trials. In parallel,
we are developing a proprietary DNA expression technology named PolyStart&trade; to improve the ability of the cellular immune
system to recognize and destroy diseased cells. We plan to complete the pre-clinical development of our PolyStart&trade; vaccine
and move it into the clinic as an integral component of a prime-boost vaccine methodology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a leader in the development of immunotherapies
for women's cancers, with multiple Phase 2 and Phase 1b/2 clinical studies for the treatment of ovarian and breast cancer. The
company's peptide or nucleic acid-based immunotherapeutic products comprise one or multiple naturally processed epitopes (NPEs)
designed to comprehensively stimulate a patient's killer T-cells and helper T-cells, and to restore or further augment antigen
presentation by using proprietary nucleic acid-based expression systems. Our technologies may be used as stand-alone medications
or in combination with current treatment modalities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Immuno-oncology has become the most rapidly
growing sector in the pharmaceutical and biotech industry. The approval and success of checkpoint inhibitors, including ipilimumab
and nivolumab (Yervoy&reg; and Opdivo&reg;, respectively, Bristol Myers Squibb), pembrolizumab (Keytruda&reg;, Merck &amp; Co.),
avelumab (Bavencio&reg;, EMD Serono), durvalumab (Imfinzi&trade;, AstraZeneca), and atezolizumab (Tecentriq&reg;, Genentech), together
with the development and approval of CAR T-cell therapies sponsored by Novartis, Juno Therapeutics, and Kite Pharma, has provided
much momentum in this sector. In addition, new evidence points to the increasing use of combination immunotherapies for the treatment
of cancer. This has provided greater justification and opportunities for the successful development of T-cell vaccines in combination
with other approaches.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 23, 2017, the U.S. Food and Drug
Administration (&ldquo;FDA&rdquo;) approved expanded use of Keytruda for immunotherapy. The FDA granted accelerated approval to
a treatment for patients whose cancers have a specific genetic feature (biomarker). This is the first time the FDA has approved
a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe the strength of our science
and development approaches is becoming more widely appreciated, particularly as our clinical program has now generated positive
Phase I data using our two products in clinical programs in breast and ovarian cancers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We continue to focus primarily on our Phase
II triple-negative breast cancer trials using TPIV200 (which has achieved Fast Track and Orphan Drug Status), and are planning
for the next Phase II HER2/neu breast cancer trial.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect to continue to prosecute our
PolyStart&trade; patent filings and develop new PolyStart&trade; constructs to facilitate collaborative efforts in our current
clinical indications. We will also evaluate those indications where others have already indicated interest in combination therapies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that these fundamental programs
and corporate activities have positioned our company to capitalize on the acceptance of immunotherapy as a leading therapeutic
strategy in cancer and infectious diseases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are continuously working on improving
our product formulation and supply. TPIV200 and TPIV110 are both off-the-shelf, lyophilized products that only require reconstitution
and mixing with GM-CSF at the clinical site before injection. We believe our off-the-shelf product may provide a significant competitive
advantage over autologous products that require preparation for each patient. We also believe the investments we have made in the
formulation work for both very stable products will result in commercially viable products consistent with typically high pharmaceutical
profit margins.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Phase I data produced for both TPIV200
and TPIV100 in collaboration with the Mayo Clinic are the driving force behind the high-value collaborations we have established
and maintained with organizations such as Mayo Clinic, AstraZeneca, Memorial Sloan Kettering, and the U.S. Department of Defense.
As we move forward into advanced Phase II studies, some of which incorporate collaborations with prestigious third-party organizations,
we believe they will represent further independent validation of the potential of our technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Merger Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 15, 2018, we and our wholly owned
subsidiary, (formed for purposes of the Merger) Timberwolf Merger Sub, Inc., a Delaware corporation (&ldquo;Merger Sub&rdquo;),
and Marker Therapeutics, Inc., a Delaware corporation (&ldquo;Marker&rdquo;), entered into an Agreement and Plan of Merger and
Reorganization (the &ldquo;Merger Agreement&rdquo;). Subject to the terms and conditions set forth in the Merger Agreement, MergerSub
will merge with and into Marker (the &ldquo;Merger&rdquo;), with Marker surviving the Merger as a wholly owned subsidiary of TapImmune
(the &ldquo;Surviving Corporation&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the effective time of the Merger (the
 &ldquo;Effective Time&rdquo;), each outstanding share of Marker&rsquo;s common stock will be converted into the right to receive
(i) shares of TapImmune&rsquo;s common stock, par value $0.001 per share (&ldquo;TapImmune Common Stock&rdquo;), in an amount equal
to the exchange ratio calculated pursuant to the Merger Agreement (the &ldquo;Stock Exchange Ratio&rdquo;), and (ii) warrants to
purchase TapImmune Common Stock, in an amount equal to the exchange ratio calculated pursuant to the Merger Agreement (the &ldquo;Warrant
Exchange Ratio&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Merger Agreement contains customary
representations, warranties and covenants made by us and Marker, including covenants relating to obtaining the requisite approvals
of the stockholders of TapImmune and Marker, indemnification of directors and officers, and TapImmune&rsquo;s and Marker&rsquo;s
conduct of their respective businesses between the date of signing of the Merger Agreement and the closing of the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuance of TapImmune Common Stock
and other transactions contemplated by the Merger Agreement are subject to approval by TapImmune&rsquo;s stockholders. The Merger
is subject to other customary closing conditions, including, among other things, the accuracy of the representations and warranties,
subject generally to an overall material adverse effect qualification, compliance by the parties with their respective covenants
and no existence of any law or order preventing the Merger and related transactions. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Merger Agreement contains certain termination
rights for both us and Marker and provides for the payment of a termination fee of $1,500,000 by us to Marker upon termination
of the Merger Agreement under specified circumstances. In connection with a termination of the Merger Agreement under specified
circumstances involving competing transactions, a willful, intentional and material breach of the non-solicitation obligations
by us, a change in our board of directors&rsquo; recommendation of the Merger to the stockholders or other triggering events, we
may be required to pay Marker reimbursement for certain fees and expenses up to $500,000. In connection with a termination of the
Merger Agreement under specified circumstances involving the failure of Marker stockholders to approve the Merger Agreement within
24 hours of signing the Merger Agreement, intentional and material breach of the non-solicitation obligations by Marker or other
triggering events, Marker may be required to pay our reimbursement for certain fees and expenses up to $500,000. The Merger Agreement
may also be terminated by either us or Marker if the merger has not been consummated by September 15, 2018, subject to an extension
of an additional 60 days if our proxy statement is being reviewed or commented upon by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the Merger, the board of
directors of the Company  will consist of six directors and will be comprised of (i) three
members designated by Marker, and (ii) three members designated by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Common Stock Purchase Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 18, 2018, we closed on the sale
of 1,300,000 shares of common stock for $2.40 per share pursuant to a Common Stock Purchase Agreement with an existing accredited
investor in a private placement under Rule 506 of Regulation D. Aggregate gross proceeds were approximately $3.1 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><U>Exercise of
Warrants Held by Existing Institutional Investors</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Also on May 18,
2018, we and certain existing institutional investors, who are holders of various warrants to purchase shares of TapImmune common
stock, closed on Warrant Exercise Agreements  in which TapImmune agreed
to reduce the exercise price for a portion of the investors&rsquo; previously purchased Series C, Series D, Series E and Series
F warrants from $6.00, $9.00, $15.00 and $7.20, respectively per share to $2.50 per share, provided that the investors exercise
such warrants for cash immediately, which they did, for 782,506 shares and aggregate proceeds of approximately $2.0 million. The
shares of common stock underlying the exercised warrants are registered for resale under the Form S-3 Registration Statement (File
no. 333-220538) declared effective by the SEC on December 29, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Private Placement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On June
8, 2018, in connection with, and in furtherance of, the Merger Agreement, we entered into Securities Purchase Agreements for a private
placement with a select group of institutional and accredited investors (the &ldquo;Purchasers&rdquo;). Pursuant to the
Securities Purchase Agreements, the Purchasers have agreed to purchase 17,500,000 shares of the Company&rsquo;s common stock,
par value $0.001, at $4.00 per share, for gross offering proceeds of $70 million. Each share of common stock will be issued
with a warrant to purchase 0.75 additional shares of the Company&rsquo;s common stock at an exercise price of $5.00 per share
for an aggregate of 13,125,000 Warrants. In accordance with NASDAQ Stock Market Rule 5635, the completion of the issuance and
sale of the common stock and Warrants pursuant to the Securities Purchase Agreements is subject to the approval of the
private placement by the Company&rsquo;s stockholders. The Warrants will be immediately exercisable upon issuance at closing
and will have a term of five years. Subject to obtaining shareholder approval of the private placement, the issuance and sale
of the common stock and Warrants pursuant to the Securities Purchase Agreements is expected to close concurrently with our
merger with Marker.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Intellectual Property Strategies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">A key component
to success is having a comprehensive patent strategy that continually updates and extends patent coverage for key products. It
is highly unlikely that early patents will extend through ultimate product marketing, so extending patent life is an important
strategy for ensuring product protection.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We have three
active patent families that we are supporting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">1. Filed patents
on the PolyStart&trade; expression vector (owned by TapImmune and filed in 2014: this IP covers the use with TAP). We announced
the allowance of this patent in February 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">2. Filed patents
on HER2/neu Class II and Class I antigens: exclusive license from Mayo Foundation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">3. Filed patents
on Folate Receptor Alpha antigens: exclusive license from Mayo Foundation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">While doing the
studies on the path to successful product development takes time, we believe we have put together a team that can deliver the highest
quality data in the least amount of time. The strength of our product pipeline and access to leading scientists and institutions
gives us a unique opportunity to make a major contribution to global health care.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">With respect to
the broader market, a major driver and positive influence on our activities has been the emergence and general acceptance of the
potential of a new generation of immunotherapies that promise to change the standard of care for cancer. The immunotherapy sector
has been greatly stimulated by the approval of Provenge&reg; for prostate cancer and Yervoy&trade; for metastatic melanoma, progression
of the areas of immune checkpoint inhibitors and adoptive T-cell therapy, as well as multiple other approaches reaching Phase II
and Phase III status.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that through our combination
of technologies, we are well positioned to be a leading player in this emerging market. It is important to note that many of the
late-stage immunotherapies currently in development do not represent competition to our programs, but instead offer synergistic
opportunities to partner our antigen-based immunotherapeutics and the PolyStart&trade; expression system. Thus, the use of naturally
processed T-cell antigens discovered using samples derived from cancer patients, plus our PolyStart&trade; expression technology
to improve antigen presentation to T-cells, could not only produce an effective cancer vaccine in its own right, but could also
enhance the efficacy of other immunotherapy approaches such as CAR-T and checkpoint inhibitors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Products and Technology in Development-Clinical</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I><U>TPIV200 </U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Phase I Human Clinical Trials &ndash;
</I>Folate Alpha Breast and Ovarian Cancers &ndash; Mayo Clinic</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Folate Receptor Alpha (&ldquo;FRa&rdquo;)
is overexpressed in over 80% of breast cancers and in addition, over 90% of ovarian cancers, for which the only treatment options
are surgery, radiation therapy and chemotherapy, leaving a very important and urgent clinical need for a new therapeutic. Time
to recurrence is relatively short for ovarian cancer and survival prognosis is extremely poor after recurrence. In the United States
alone, there are approximately 30,000 ovarian cancer patients and 40,000 triple-negative breast cancer patients newly diagnosed
every year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have completed a 21-patient Phase I
clinical trial for the FRa vaccine. Twenty-one patients with breast or ovarian cancer, who had undergone standard surgery and adjuvant
treatment, were treated with one cycle of cyclophosphamide. Following this, patients were vaccinated intradermally with a mixture
of the five FRa peptides adjuvanted with GM-CSF (now called TPIV200) on day one of a 28-day cycle for a maximum of six vaccination
cycles. The vaccine was well-tolerated and safe and 20 out of 21 evaluable patients showed positive immune responses, providing
a strong rationale for progressing to Phase II trials. Further, the data showed that 16 out of 16 patients in the observation stage
still showed immune responses (Source: published online 15Mar2018; DOI: 10.1158/1078-0432.CCR-17-2499). We have developed a commercial
quality lyophilized formulation of the peptides in a single vial for reconstitution and injection. Good Manufacturing Practice
(&ldquo;GMP&rdquo;) manufacturing for the Phase II trials has been completed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 27, 2015, we exercised our option
agreement with Mayo Foundation with the signing of a worldwide exclusive license agreement to commercialize a proprietary Folate
Receptor Alpha vaccine technology for all cancer indications. As part of this agreement, the IND from the Folate Receptor Alpha
Phase I Trial was transferred from Mayo Foundation to us for amendment for Phase II Clinical Trials on our lead product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 15, 2015, we announced that
our collaborators at the Mayo Foundation had been awarded a grant of $13.3 million from the U.S. Department of Defense. This grant,
commencing September 15, 2015, covers the costs for a 280-patient Phase II Clinical Trial of Folate Receptor Alpha Vaccine in patients
with triple-negative breast cancer. We are working closely with Mayo Foundation on this clinical trial by providing clinical and
manufacturing expertise, as well as providing GMP vaccine formulations. These vaccine formulations are being developed for multiple
Phase II clinical programs in triple-negative breast and ovarian cancer in combination with other immunotherapeutics. This Phase
II study of TPIV200 in the treatment of triple-negative breast cancer began enrolling patients in late 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 9, 2015, we announced that
we received Orphan Drug Designation from the U.S. Food &amp; Drug Administration&rsquo;s Office of Orphan Products Development
(&ldquo;OOPD&rdquo;) for our cancer vaccine TPIV200 in the treatment of ovarian cancer. The TPIV200 ovarian cancer clinical program
will now receive benefits including tax credits on clinical research and seven-year market exclusivity upon receiving marketing
approval. TPIV200 is a multi-epitope peptide vaccine that targets Folate Receptor Alpha which is overexpressed in multiple cancers
including over 90% of ovarian cancer cells.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 3, 2016, we announced that
the U.S. FDA designated the investigation of multiple-epitope FRa Vaccine (TPIV200) for maintenance therapy in subjects with platinum-sensitive
advanced ovarian cancer who achieved stable disease or partial response following completion of standard-of-care chemotherapy,
as a Fast Track Development Program. We began enrolling a Phase II study in this indication in 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have opened multiple clinical sites
and have completed enrollment of patients in a Phase II trial of our Folate Receptor Alpha cancer vaccine, TPIV200, in the treatment
of triple-negative breast cancer, one of the most difficult-to-treat cancers representing a clear unmet medical need. The open-label,
80-patient clinical trial is designed to evaluate dosing regimens, efficacy, and immune responses in women with triple-negative
breast cancer and is fully enrolled. Key data from the trial is expected to be included in a future New Drug Application submission
to the FDA for marketing clearance. This trial is sponsored and conducted by TapImmune.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 21, 2016, we announced our participation
in an ovarian cancer study sponsored by Memorial Sloan Kettering Cancer Center in New York City in collaboration with AstraZeneca
Pharmaceuticals in ovarian cancer patients who are not responsive to platinum, a commonly used chemotherapy for ovarian cancer.
This study, a Phase II study of TPIV200 is currently enrolling ovarian cancer patients and is designed to look at the effects of
combination therapy with AstraZeneca&rsquo;s checkpoint inhibitor durvalumab. The study will enroll 40 patients and is open-label.
Because they are unresponsive to platinum, these patients have no real options left. If the combination therapy proves effective,
we believe it would address a critical unmet need. TPIV200 has received Orphan Drug designation for use in the treatment of ovarian
cancer. Although we have no business relationship with AstraZeneca, we are paying for one-half of the costs of the clinical study,
in addition to providing our TPIV200 for the study.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A Company-sponsored Phase II study in platinum-sensitive
ovarian cancer patients was initiated in 2017. This study is designed to evaluate TPIV200 with GM-CSF in a randomized, placebo-controlled
fashion during the first maintenance period after primary surgery and chemotherapy. Patients at this stage of their treatment have
the highest potential for an immunotherapeutic effect and no other approved treatment options. The study will enroll up to 120
patients over the next year and a half, with an interim analysis planned in the first half of 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I><U>TPIV 100/110 </U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Phase I Human Clinical Trials &ndash;
HER2/neu+ Breast Cancer &ndash; Mayo Clinic</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A Phase I study using TPIV 100 (four HER2/neu
peptides adjuvanted with GM-CSF) was completed in 2015. Final safety analysis on all the patients treated is complete and shown
to be safe. In addition, 19 out of 20 evaluable patients showed robust T-cell immune responses to the antigens in the vaccine composition
providing a solid case for advancement to Phase II in 2017. An additional secondary endpoint incorporated into this Phase I Trial
will be a two-year follow on recording time to disease recurrence in the participating breast cancer patients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For Phase I(b)/II studies, we plan to add
a Class I peptide, licensed from the Mayo Clinic (April 16, 2012), to the four Class II peptides, producing TPIV 110 (five peptide
product). Management believes that the combination of Class I and Class II HER2/neu antigens, gives us the leading HER2/neu vaccine
platform. We are amending the IND to incorporate the fifth peptide in the Phase I(b)/II study. Discussions with the FDA have resulted
in a pre-clinical development project that should allow us to file the amended IND in mid-2018. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Products and Technology-Pre-clinical
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Polystart</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 7, 2017, we announced that
we received a Notice of Allowance from the U.S. Patent and Trademark Office of our patent application titled, &ldquo;Chimeric nucleic
acid molecules with non-AUG initiation sequences and uses thereof,&rdquo; which represents our first patent on our Polystart program.
We anticipate additional patent filings in connection with our research and development in this area. We plan to develop Polystart
as both a stand-alone therapy and as a &lsquo;boost strategy&rsquo; to be used synergistically with our peptide-based vaccines
for breast and ovarian cancers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>TapImmune&rsquo;s
Clinical Program Pipeline</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><IMG SRC="tv499451_img02.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>Refer
to the &ldquo;Clinical Program Pipeline Status Updates&rdquo; section below for latest updates on above clinical pipeline chart.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In addition to
the exciting clinical developments, our peptide vaccine technology may be coupled with our recently developed in-house PolyStart&trade;
nucleic acid-based technology, which is designed to make vaccines significantly more effective by producing four times the required
peptides for the immune systems to recognize and act on.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Clinical Program Pipeline Status
Updates</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Completed GMP Manufacturing Scale
Up and Second Clinical Lot of TPIV200; to Supply Additional Phase II Clinical Trials</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We successfully completed a multi-gram
production scale-up as well as GMP manufacturing of a second clinical lot of TPIV200. The vaccine supply will be used in the company&rsquo;s
ongoing Phase II study in platinum-sensitive ovarian cancer, as well as the planned 280-patient Phase II study sponsored by the
Mayo Clinic and funded by the U.S. Department of Defense for treating triple-negative breast cancer. We also made various improvements
to the vaccine manufacturing process, resulting in, what we believe to be, a superior formulation of the vaccine that is more
amenable to large-scale manufacturing and commercialization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Announcement of Publication of Clinical
Trial Results for the TPIV200 Cancer Vaccine in Clinical Cancer Research</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 15, 2018, we announced the publication
of clinical data from a Phase I trial of TPIV200, our multi-epitope T-cell vaccine targeting Folate Receptor Alpha (&ldquo;FRa&rdquo;)
in patients with ovarian and breast cancer. The results show that TPIV200 vaccination was well tolerated by all patients and over
90% developed robust and durable antigen-specific immune responses against FRa without regard for HLA type, which aligns with the
intended mechanism of action of the vaccine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Enrollment Completed: Phase II TPIV200
Trial in Triple-Negative Breast Cancer</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have completed enrollment and are now
treating and following the patients in a Phase II trial of our Folate Receptor Alpha cancer vaccine, TPIV200, in the treatment
of triple-negative breast cancer, one of the most difficult cancers to treat, representing a clear unmet medical need. The open-label,
80-patient clinical trial is designed to evaluate dosing regimens, pre-treatment, efficacy, and immune responses in women with
triple-negative breast cancer. Key data from the trial is expected to be included in a future Biologics License Application submission
to the FDA for marketing clearance. This trial is sponsored and conducted by TapImmune.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An independent Data Safety Monitoring Board
(DSMB) reviews the safety every quarter in this ongoing Phase II study enrolling women with stage I-III triple-negative breast
cancer who have completed initial surgery and chemo/radiation therapy. The randomized four-arm study is evaluating two doses of
TPIV200 (a high dose and a low dose), each of which will be tested both with and without immune priming with cyclophosphamide prior
to vaccination. Safety reviews are conducted quarterly and have shown no safety issues. The study completed enrollment at the end
of 2017, with interim data expected in mid-2018. Details regarding this trial can be found at www.clinicaltrials.gov under identifier
numbers NCT02593227 and FRV-002.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Enrolling Patients: Phase II TPIV200
Trial in Platinum-Sensitive Ovarian Cancer</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have opened multiple clinical sites
and have enrolled half of the patients in a Phase II trial of TPIV200 for a 120-patient study on ovarian cancer patients who are
responsive to platinum. We have received the FDA&rsquo;s Fast Track designation to develop TPIV200 as a maintenance in women with
Stage III and IV ovarian cancer who are in remission following their first round of successful platinum-based chemotherapy. This
multi-center, double-blind efficacy study is sponsored and conducted by TapImmune. We expect to complete enrollment mid-2019. An
interim analysis is planned based upon 50% patient progression, which we anticipate completing in the first half of 2019. Details
regarding this trial can be found at www.clinicaltrials.gov under identifier numbers NCT02978222 and FRV-004. TPIV200 has also
received Orphan Drug designation for use in the treatment of ovarian cancer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Enrolling Patients: Phase II Mayo
Clinic-U.S. DOD Trial of TPIV200 in Triple-Negative Breast Cancer</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patients are being enrolled in this Phase
II study of TPIV200 in the treatment of triple-negative breast cancer, conducted by the Mayo Clinic and sponsored by the U.S. DOD.
The 280-patient study is led by Dr. Keith Knutson of the Mayo Clinic in Jacksonville, Florida. Dr. Knutson is the inventor of the
technology and a member of the Scientific Advisory Board at TapImmune. While we are supplying doses of TPIV200 for the trial and
being reimbursed for the costs associated with manufacturing, the costs associated with conducting this study are being funded
by a $13.3 million grant made by the DOD to the Mayo Clinic.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Enrolling Patients: Phase II Trial
at Memorial Sloan Kettering of TPIV200 in Platinum-Resistant Ovarian Cancer</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A Phase II study of TPIV200 in ovarian
cancer patients who are not responsive to platinum, a commonly used chemotherapy for ovarian cancer, being sponsored by Memorial
Sloan Kettering Cancer Center (&ldquo;MSKCC&rdquo;) in collaboration with AstraZeneca and TapImmune, has begun enrollment for a
40-patient study. The open-label study is designed to evaluate a combination therapy which includes our TPIV200 T-cell vaccine
and AstraZeneca&rsquo;s checkpoint inhibitor, durvalumab. Because they are unresponsive to platinum, these patients have no real
remaining options. If the combination therapy proves effective, we believe it would address a critical unmet need. We successfully
completed enrollment of the first safety cohort. This may enable MSKCC to increase the number of patients that can be enrolled
and will subsequently increase the study&rsquo;s enrollment rate. Currently more than 50% of patients have been enrolled. An interim
analysis is planned in the second half of 2018. Details regarding this trial can be found at www.clinicaltrials.gov under identifier
numbers NCT02764333.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Open IND with FDA for TPIV110 in
2018: Phase II Protocol Now in Preparation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have enhanced the formulation of our
second cancer vaccine product, TPIV110 (the five-peptide product), following very strong safety and immune responses from a Phase
I Mayo Clinic study using TPIV100 (the four-peptide product). TPIV110 targets HER2/neu+, which makes it applicable to breast, ovarian,
and colorectal cancers. The enhanced TPIV product adds a fifth antigen that should produce an even more robust immune response
activating both CD4+ (helper) and CD8+ (killer) T-cells. We have participated in a pre-Investigational New Drug (&ldquo;pre-IND&rdquo;)
meeting with the FDA and will file the amended IND containing the fifth peptide in mid-2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Mayo Clinic to Vaccinate Women With
Ductal Carcinoma In Situ (DCIS) Using TapImmune TPIV100 HER2-targeted T-Cell Vaccine</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 14, 2017, we announced that our
partners at the Mayo Clinic received a grant from the U.S. Department of Defense to conduct a Phase IB study of our HER2-targeted
vaccine candidate TPIV100 in an early form of breast cancer called DCIS. This is the second TapImmune vaccine to be tested in a
fully funded study sponsored by the Mayo Clinic. Our collaborators at Mayo Clinic announced a $3.8 million grant which we believe
would fully fund this trial. If the study is successful, our vaccine may eventually augment or even replace standard surgery and
chemotherapy, and potentially could become part of a routine immunization schedule for preventing breast cancer in healthy women.
The study is expected to enroll 40-45 women with DCIS and begin to commence such enrollment in mid-2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Results of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In this discussion
of the Company&rsquo;s results of operations and financial condition, amounts, other than per-share amounts, have been rounded
to the nearest thousand dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Three Months Ended June 30, 2018 Compared to Three Months
Ended June 30, 2017</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recorded a net loss of $4.8 million
or ($0.41) basic and diluted per share during the three months ended June 30, 2018 compared to a net loss of $1.9 million or ($0.22)
basic and diluted per share during the three months ended June 30, 2017. The change in net loss period over period was due to the
following changes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Revenue</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Grant income</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended June 30,
2018, we received $206,000 of a grant awarded to Mayo Foundation from the US Department of Defense for the Phase II Clinical Trial
of TPIV200. The grant compensated us for clinical supplies manufactured by us and provided for the clinical study.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Operating Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating expenses incurred during the
three months ended June 30, 2018 were $4.9 million compared to $2.4 million in the prior period. Significant changes in operating
expenses are outlined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Research and development costs during the three months ended June 30, 2018 were $1.8 million compared to $1.2 million during the prior year period. The three months ended June 30, 2018 had increased expenses from the prior period relating to our clinical trials.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">General and administrative expenses increased to $3.1 million during the three months ended June 30, 2018 from $1.2 million during the prior year period. This was due to increased expenses relating to:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">o</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">stock-based compensation for employees and outside consultants,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">o</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">compensation expenses resulting from increased headcount,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">o</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">expenses relating to the announced and proposed merger agreement,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">o</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">investor relations expenses, and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-size: 10pt">o</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">increased legal, audit and other professional fees.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Other Expense</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Change in fair value of warrant liabilities</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The change in fair value of warrant liabilities
for the three months ended June 30, 2018 was $139,000 as compared to ($8,000) for the three months ended June 30, 2017. This increase
by $139,000 for the three months ended June 30, 2018 is reflected by a corresponding expense in the condensed consolidated statement
of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Debt extinguishment gain</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In 2003 we entered
into a license agreement with a foreign based third-party for certain adenovirus technology. The license agreement was amended
several times between inception and 2008 at which time it was amended and restated and had a fixed three-year term expiring in
2011. During such time, we did not pursue the technology and have not undertaken further work in the area covered by the technology
license. Neither we nor the third-party took further actions under or pursuant to the license agreement. We carried a historical
accrual of approximately $0.5 million under the amended license agreement related to certain obligations provided for in the license
agreement. The license agreement was governed by the laws of a foreign jurisdiction. We sought and obtained legal advice related
to such accrued obligations under the expired license agreement. We relied upon a judicial conclusion, as opined upon by outside
legal counsel in the applicable foreign jurisdiction, that a court in such foreign jurisdiction would grant relief releasing us
from liability under the license agreement, and in accordance with Accounting Standards Codification 405 &ldquo;Extinguishment
of Liabilities&rdquo;, we recorded a debt extinguishment gain of $0.5 million and reduced the liability amount owed to $0 during
the three months ended June 30, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
<P STYLE="margin: 0"><B><I>Six Months Ended June 30, 2018 Compared to Six Months Ended June 30, 2017</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recorded a net loss of $8.0 million
or ($0.71) basic and diluted per share during the six months ended June 30, 2018 compared to a net loss of $4.3 million or ($0.51)
basic and diluted per share during the six months ended June 30, 2017. The change in net loss period over period was due to the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Revenue</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Grant income</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the six months ended June 30, 2018,
we received $206,000 of a grant awarded to Mayo Foundation from the US Department of Defense for the Phase II Clinical Trial of
TPIV200. The grant compensated us for clinical supplies manufactured by us and provided for the clinical study.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Operating Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating expenses incurred during the
six months ended June 30, 2018 were $8.1 million compared to $4.8 million in the prior period. Significant changes in operating
expenses are outlined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Research and development costs during the six months ended June 30, 2018 were $3.4 million compared to $2.2 million during the prior year period. The six months ended June 30, 2018 had increased expenses from the prior period relating to our clinical trials.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">General and administrative expenses increased to $4.7 million during the six months ended June 30, 2018 from $2.6 million during the prior year period. This was due to increased expenses relating to:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">o</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">stock-based compensation for employees and outside consultants,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">o</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">compensation expenses resulting from increased headcount,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">o</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">expenses relating to the announced and proposed merger agreement,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">o</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">investor relations expenses, and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">o</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">increased legal, audit and other professional fees.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Other Expense</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Change in fair value of warrant liabilities</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The change in fair value of warrant liabilities
for the six months ended June 30, 2018 was $138,000 as compared to ($5,000) for the six months ended June 30, 2017. This increase
by $138,000 for the six months ended June 30, 2018 is reflected by a corresponding expense in the condensed consolidated statement
of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Debt extinguishment gain</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In 2003 we entered
into a license agreement with a foreign based third-party for certain adenovirus technology. The license agreement was amended
several times between inception and 2008 at which time it was amended and restated and had a fixed three-year term expiring in
2011. During such time, we did not pursue the technology and have not undertaken further work in the area covered by the technology
license. Neither we nor the third-party took further actions under or pursuant to the license agreement. We carried a historical
accrual of approximately $0.5 million under the amended license agreement related to certain obligations provided for in the license
agreement. The license agreement was governed by the laws of a foreign jurisdiction. We sought and obtained legal advice related
to such accrued obligations under the expired license agreement. We relied upon a judicial conclusion, as opined upon by outside
legal counsel in the applicable foreign jurisdiction, that a court in such foreign jurisdiction would grant relief releasing us
from liability under the license agreement, and in accordance with Accounting Standards Codification 405 &ldquo;Extinguishment
of Liabilities&rdquo;, we recorded a debt extinguishment gain of $0.5 million and reduced the liability amount owed to $0 during
the six months ended June 30, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Liquidity and Capital Resources</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not generated any revenues since
inception. We have financed our operations primarily through public and private offerings of our stock and debt including warrants
and the exercises thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth our cash
and working capital as of June 30, 2018 and December 31, 2017:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">June&nbsp;30,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center">December&nbsp;31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%">Cash</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">7,782,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">5,129,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Working Capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4,144,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,658,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Cash Flows </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes our cash
flows for the six months ended June 30, 2018 and 2017:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 95%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center">Six&nbsp;Months&nbsp;Ended</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30,</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net Cash provided by (used in):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; text-align: left; padding-left: 0.3in">Operating activities</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(4,746,000</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(3,936,000</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 0.3in">Financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,399,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,047,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 0.3in">Net increase in cash</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,653,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,111,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Financings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Our financing
activities during the six months ended June 30, 2018 were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Common Stock Purchase Agreement</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 14, 2018, the Company&rsquo;s largest
stockholder Eastern Capital Limited entered into a Common Stock Purchase Agreement with the Company pursuant to which it purchased
1,300,000 shares of common stock at a price per share of $2.40 providing gross proceeds to the Company of $3.12 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Exercise and Repricing of Warrants
Held by Existing Institutional Investors </U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 14, 2018, certain institutional
holders of outstanding warrants entered into Warrant Exercise Agreements with the Company that provide for an amendment to the
exercise price of the warrants being exercised at $2.50 per share. Upon closing of the Warrant Exercise Agreements, such institutional
holders immediately exercised warrants for 782,505 shares of common stock providing aggregate proceeds to the Company of approximately
$2.0 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value relating to the modification
of exercise prices on the repriced and exercised warrants was treated as deemed dividend on the statement of stockholders&rsquo;
equity of $728,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Exercise of Stock Warrants</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During June 2018,
shareholders exercised warrants and acquired 782,800 shares of common stock providing aggregate proceeds to the Company of
approximately $2.3 million. 118,425 of the stock warrants exercised were exercised on a cashless basis, resulting in a
cancellation of 83,130 stock warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Exercise of Stock Options</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2018, a former officer exercised
10,416 shares of common stock pursuant to stock options providing proceeds of $18,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Future Capital Requirements </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2018, we had working capital
of $4.1 million, compared to working capital of $3.7 million as of December 31, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The discussion below excludes the
closing of the proposed&nbsp;merger with Marker Therapeutics and the concurrent closing of the $70 million private
placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect our expenses to continue at a
similar pace through 2018 primarily to continue funding our in-process Phase II clinical trials. Two of our clinical studies are
expected to be funded by a total of $17.1 million of grants made by the DOD to the Mayo Clinic. Our collaborators at Mayo Clinic
announced a $3.8 million grant which we expect would fully fund a Phase II clinical trial in DCIS that we had planned for our HER2/neu+
vaccine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our capital requirements for 2018 and beyond
will depend on numerous factors, including the success of our research and development, the resources we devote to develop and
support our technologies and our success in pursuing strategic licensing and funded product development collaborations with external
partners as well as other strategic initiatives we may determine to pursue. Subject to our ability to raise additional capital,
we expect to incur substantial expenditures to further develop our technologies including continued increases in costs related
to research, nonclinical testing and clinical studies and trials, as well as costs associated with our capital raising efforts
and being a public company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe our existing cash will fund
our operations into the first quarter of fiscal 2019. We will require substantial additional capital to conduct research and development,
to fund nonclinical testing and Phase II clinical trials of our licensed, patented technologies, and to begin cultivating collaborative
relationships for the Phase II and future Phase III clinical testing. Our plans could include seeking both equity and debt financing,
alliances or other partnership agreements with entities interested in our technologies, or other business transactions that could
generate sufficient resources to ensure continuation of our operations and research and development programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect to continue to seek additional
funding for our operations. Any such required additional capital may not be available on reasonable terms, if at all. If we were
unable to obtain additional financing, we may be required to reduce the scope of, delay or eliminate some or all of our planned
clinical testing and research and development activities, which could harm our business. The sale of additional equity or debt
securities may result in additional dilution to our shareholders. If we raise additional funds through the issuance of debt securities
or preferred stock, these securities could have rights senior to those holders of our common stock and could contain covenants
that could restrict our operations. We also will require additional capital beyond our currently forecasted amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because of the numerous risks and uncertainties
associated with research, development and commercialization of our product candidates, we are unable to estimate the exact amounts
of our future working capital requirements. Our future funding requirements will depend on many factors, including, but not limited
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">the number and characteristics of the product candidates we pursue;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">the scope, progress, results and costs of researching and developing our product candidates, and conducting pre-clinical and clinical trials including the research and development expenditures we expect to make in connection with our license agreements with Mayo Foundation;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">the amount and timing of transaction expenses
    we incur in connection with the pending Marker merger agreement;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">strategic transactions we may undertake;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">the timing of, and the costs involved in, obtaining regulatory approvals for our product candidates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">our ability to maintain current research and development licensing agreements and to establish new strategic partnerships and collaborations, licensing or other arrangements and the financial terms of such agreements;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">our ability to achieve our milestones under our licensing arrangements and the payment obligations we may have under such agreements;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims, including litigation costs and the outcome of such litigation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">the timing, receipt and amount of sales of, or royalties on, our future products, if any.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have based our estimates on assumptions
that may prove to be wrong. We may need to obtain additional funds sooner or in greater amounts than we currently anticipate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Various conditions outside of our control
may detract from our ability to raise additional capital needed to execute our plan of operations, including overall market conditions
in the international and local economies. We recognize that the United States economy has suffered through a period of uncertainty
during which the capital markets have been impacted, and that there is no certainty that these levels will stabilize or reverse
despite the optics of an improving economy. Any of these factors could have a material impact upon our ability to raise financing
and, as a result, upon our short-term or long-term liquidity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Critical Accounting Policies</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The condensed consolidated financial statements
are prepared in conformity with U.S. GAAP, which require the use of estimates, judgments and assumptions that affect the reported
amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported
amounts of expenses in the periods presented. We believe that the accounting estimates employed are appropriate and resulting balances
are reasonable; however, due to inherent uncertainties in making estimates, actual results could differ from the original estimates,
requiring adjustments to these balances in future periods. The critical accounting estimates that affect the consolidated financial
statements and the judgments and assumptions used are consistent with those described under Part II, Item 7 of our Annual Report
on Form 10-K for the year ended December 31, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Going Concern</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The below excludes the closing of the proposed&nbsp;merger
with Marker Therapeutics and the concurrent closing of the $70 million private placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have no sources of revenue to provide
incoming cash flows to sustain our future operations. As outlined above, our ability to pursue our planned business activities
is dependent upon our successful efforts to raise additional capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These factors raise substantial doubt regarding
our ability to continue as a going concern. Our condensed consolidated financial statements have been prepared on a going concern
basis, which implies that we will continue to realize our assets and discharge our liabilities in the normal course of business.
Our financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and
classification of liabilities that might be necessary should we be unable to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Off-Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not entered into any off-balance
sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes of
financial condition, revenues, expenses, results of operations, liquidity, capital expenditures or capital resources that are material
to investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in; border-bottom: Black 1pt solid"></TD><TD STYLE="width: 0.75in; text-align: left; border-bottom: Black 1pt solid"><A NAME="s9"><B>Item 3.</B></A></TD><TD STYLE="text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Quantitative
and Qualitative Disclosures About Market Risk</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a smaller reporting company as defined
by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in; border-bottom: Black 1pt solid"></TD><TD STYLE="width: 0.75in; text-align: left; border-bottom: Black 1pt solid"><A NAME="s10"><B>Item 4.</B></A></TD><TD STYLE="text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B> Controls
and Procedures</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>(a)</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Evaluation of Disclosure Controls and Procedures</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management, with the participation
of our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and
procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered
by this report. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that
information required to be disclosed in the reports we file or submit under the Exchange Act is accumulated and communicated to
management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding
required disclosure. Based on such evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that,
as of the end of the period covered by this report, our disclosure controls and procedures are not effective in recording, processing,
summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports that we file or submit
under the Exchange Act. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">It should be noted that any system of controls is based in part
upon certain assumptions designed to obtain reasonable (and not absolute) assurance as to its effectiveness, and there can be no
assurance that any design will succeed in achieving its stated goals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>(b)</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Changes in Internal Control Over Financial Reporting</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There have been no changes in our internal
control over financial reporting during the three months ended June 30, 2018 that have materially affected, or are reasonably likely
to materially affect, our internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="s11"></A>PART II &ndash; OTHER INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in; border-bottom: Black 1pt solid"></TD><TD STYLE="width: 0.75in; text-align: left; border-bottom: Black 1pt solid"><A NAME="s12"><B>Item 1.</B></A></TD><TD STYLE="text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B> Legal
Proceedings</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management is not aware of any material
legal proceedings and there are no pending material procedures that would affect the property of the Company. Management is not
aware of any legal proceedings contemplated by any government authority or any other party involving the Company. As of the date
of this Quarterly Report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an
adverse interest to us in any legal proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in; border-bottom: Black 1pt solid"></TD><TD STYLE="width: 0.75in; text-align: left; border-bottom: Black 1pt solid"><A NAME="s13"><B>Item 1A.</B></A></TD><TD STYLE="text-align: justify; border-bottom: Black 1pt solid"> <FONT STYLE="font-size: 10pt"><B>Risk Factors</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the risk factors
set forth in Part I &mdash; Item 1A &mdash; &ldquo;Risk Factors&rdquo; of our Annual Report on Form 10-K for the fiscal
year ended December 31, 2017 (the &ldquo;10-K&rdquo;) and Part II &mdash; Item 1A &mdash; &ldquo;Risk Factors&rdquo; of
our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2018 (the &ldquo;10-Q&rdquo;), investors
should consider the following risk factors arising from our intention to combine with Marker Therapeutics,
Inc. (&ldquo;Marker&rdquo;) through a &ldquo;merger of equals&rdquo; business combination (the &ldquo;merger&rdquo;, and the
Company and Marker following completion of the merger, the &ldquo;Combined Company&rdquo;) as well as the other risk factors
set forth in the preliminary proxy statement we filed with the SEC on July 13, 2018 in connection with the proposed merger,
which also include risks related to Marker, Marker&rsquo;s product candidates, governmental regulation of Marker and
Marker&rsquo;s intellectual property which may affect the Combined Company upon completion of the Merger. On May 15, 2018, we
entered into a definitive merger agreement (the &ldquo;merger agreement&rdquo;) with Marker. Pursuant to the terms of the
merger agreement, Marker will be merged with and into a wholly-owned acquisition subsidiary of the Company formed by the
Company in connection with the merger. Upon completion of the merger, the separate existence of the acquisition subsidiary
will cease and Marker will be a wholly owned subsidiary of the Company and we will continue as the Combined Company in the
merger and renamed Marker Therapeutics, Inc. Following a  vote of the Company&rsquo;s Stockholders, the merger is expected
to close in the third or fourth quarter of 2018, although we cannot assure you that the transaction will close during that
time or at all. The risk factors below related to the proposed merger with Marker and the Combined Company upon completion of
the merger should be read in conjunction with the risk factors set forth in the 10-K and 10-Q and the other information
contained in this report as our business, financial condition or results of operations could be adversely affected if any of
these risks actually occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>RISKS RELATED TO THE PROPOSED MERGER
WITH MARKER </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If the proposed merger with Marker
is not consummated, TapImmune&rsquo;s business could suffer materially and TapImmune&rsquo;s stock price could decline. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The consummation of
the proposed merger with Marker is subject to a number of closing conditions, including the approval of the stock issuance pursuant
to the merger agreement by TapImmune stockholders, and other customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">If the proposed merger
is not consummated, TapImmune may be subject to a number of material risks, and its business and stock price could be adversely
affected, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;TapImmune has incurred, and expects to continue to incur, significant expenses related to the proposed merger with Marker even if the merger
is not consummated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;The market price of TapImmune common stock may decline to the extent that the current market price reflects a market assumption
that the proposed merger will be completed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;The
merger agreement contains covenants relating to TapImmune&rsquo;s solicitation of competing acquisition proposals and the
conduct of TapImmune&rsquo;s business between the date of signing the merger agreement and the closing of the merger. As a
result, significant business decisions and transactions before the closing of the merger require the consent of Marker.
Accordingly, TapImmune may be unable to pursue business opportunities that would otherwise be in its best interest as a
standalone company. If the merger agreement is terminated after TapImmune has invested significant time and resources in the
merger process, TapImmune will have a limited ability to obtain additional financing to fund its operations on a standalone
basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;TapImmune
could be obligated to pay Marker a $1.5 million termination fee in connection with the termination of the merger agreement, depending
on the reason for the termination. Additionally, in connection with the termination of the merger agreement, depending on the
reason for the termination, TapImmune may be obligated to pay up to $500,000 of out-of-pocket costs incurred by Marker in connection
with the transactions and any legal fees incurred by Marker in connection with preparation of the proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;TapImmune
would need to raise additional capital independently of the proposed merger to continue to operate its business on a stand-alone
basis and this capital might not be available on acceptable terms, if at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;The
merger agreement places certain restrictions on the conduct of our business, which may have delayed or prevented us from
undertaking business opportunities that, absent the merger agreement, we may have pursued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;Litigation
related to any failure to complete the merger or related to any enforcement proceeding commenced against us to perform our
obligations under the merger agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;TapImmune&rsquo;s
prospective customers, collaborators and other business partners and investors in general may view the failure to consummate
the merger as a poor reflection on TapImmune&rsquo;s business or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">In addition, if the
merger agreement is terminated and TapImmune&rsquo;s board of directors determines to seek another business combination, it may
not be able to find a third party willing to provide equivalent or more attractive consideration than the consideration to be provided
by each party in the merger. In such circumstances, TapImmune&rsquo;s board of directors may elect to, among other things, divest
all or a portion of TapImmune&rsquo;s business, or take the steps necessary to liquidate all of TapImmune&rsquo;s business and
assets, and in either such case, the consideration that TapImmune receives may be less attractive than the consideration to be
received by TapImmune pursuant to the merger agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Any delay
in completing the merger may reduce or eliminate the benefits expected to be achieved thereunder.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The merger is subject
to a number of conditions beyond our control that may prevent, delay or otherwise materially adversely affect its completion. We
cannot predict whether and when these conditions will be satisfied. Any delay in completing the merger could cause the Combined
Company not to realize some or all of the operational and other benefits that we expect to achieve if the merger is successfully
completed within its expected time frame.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Completion
of the merger is subject to a number of conditions, which, if not satisfied or waived, may result in termination of the merger
agreement.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The merger agreement
contains a number of conditions to completion of the merger, including, among others:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;receipt
of our requisite shareholder approval;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;the
absence of any temporary restraining order, preliminary or permanent injunction or other judgment, order or decree issued by any
court of competent jurisdiction or other legal restraint that prohibits or makes illegal the completion of the merger;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;the
absence of a stop order or proceedings threatened or initiated by the SEC for that purpose;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;the
accuracy of the representations and warranties made in the merger agreement by us, subject to certain materiality thresholds, and
each party having performed, in all material respects, all obligations required to be performed by it under the merger agreement
at or prior to the effective time of the merger; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;the
non-occurrence of any fact, circumstance, development, event, change, occurrence or effect that, individually or in the aggregate,
has had or would reasonably be expected to have a material adverse effect on either party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Many of the
conditions to completion of the merger are not within our control, and we cannot predict when or if these conditions will be
satisfied. If any of these conditions are not satisfied or waived prior to the outside deadline for  consummating the merger,
it is possible that the merger agreement may be terminated. The original deadline for consummating the merger is September
15, 2018, but it will be extended for 60 days to November 14, 2018 since the Company has received notice that the
proxy statement is being reviewed by the SEC. Although we have agreed in the merger agreement to use reasonable best
efforts, subject to certain limitations, to complete the merger in the most expeditious manner practicable, these and other
conditions to completion of the merger may fail to be satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><B><I>The
merger will cause dilution to the Combined Company, which may negatively affect the market price of common stock of the Combined
Company.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">In connection
with the completion of the merger, we expect to issue approximately 13.7 million shares of our common stock exclusive of any
warrants that are expected to be issued and we expect to issue 17.5 million shares in connection with the concurrent private placement, exclusive of
any warrants expected to be issued in connection therewith. The issuance of these new shares of our common stock could have the effect
of depressing the market price of common stock of the Combined Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The announcement and pendency of
the proposed merger with Marker could adversely affect TapImmune&rsquo;s business. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The announcement and
pendency of the proposed merger could adversely affect TapImmune&rsquo;s business for a number of different reasons, many of which
are not within TapImmune&rsquo;s control, including as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;Some
of TapImmune&rsquo;s suppliers, distributors, collaborators, and other business partners may seek to change or terminate their
relationships with TapImmune as a result of the proposed merger;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;As
a result of the proposed merger, current and prospective employees could experience uncertainty about their future roles within
the Combined Company. This uncertainty may adversely affect TapImmune&rsquo;s ability to retain its key employees, who may seek
other employment opportunities; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;TapImmune&rsquo;s
management team may be distracted from day-to-day operations as a result of the proposed merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8203;<B><I>Some of TapImmune&rsquo;s and Marker&rsquo;s officers
and directors have conflicts of interest that may influence them to support or approve the merger. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Certain officers and
directors of TapImmune and Marker participate in arrangements that provide them with interests in the merger that are different
from yours, including, among others, to the extent applicable, their continued service as an officer or director of the Combined
Company, severance benefits, the acceleration of restricted stock and stock option vesting and continued indemnification. These
interests, among others, may influence such officers and directors of TapImmune and Marker to support or approve the merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The merger may be completed even
though material adverse changes may result from the announcement of the merger, industry-wide changes and other causes. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">In general, either party
can refuse to complete the merger if there is a material adverse change affecting the other party between May 15, 2018, the date
of the merger agreement, and the closing. However, some types of changes do not permit either party to refuse to complete the merger,
even if such changes would have a material adverse effect on TapImmune or Marker, to the extent they resulted from the following
(unless, in some cases, they have a materially disproportionate effect on TapImmune or Marker, as the case may be):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;any
rejection by a governmental body of a registration or filing by TapImmune or Marker relating to TapImmune or Marker&rsquo;s intellectual
property rights;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;any
change in the cash position of TapImmune or Marker that results from operations in the ordinary course of business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;conditions
generally affecting the industries in which TapImmune or Marker and its subsidiaries participate or the U.S. or global economy
or capital markets as a whole, to the extent that such conditions do not have a disproportionate impact on Marker and its subsidiaries,
taken as a whole;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;any
failure by TapImmune or Marker or any of its subsidiaries to meet internal projections or forecasts on or after the date of the
merger agreement, provided that any such effect, change, event, circumstance, or development causing or contributing to any such
failure to meet projections or forecasts may constitute a material adverse effect of TapImmune or Marker and may be taken into
account in determining whether a material adverse effect has occurred;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#8203;&#8203;<FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;the
execution, delivery, announcement, or performance of obligations under the merger agreement or the announcement, pendency or anticipated
consummation of the merger;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;any
natural disaster or any acts of terrorism, sabotage, military action, or war or any escalation or worsening thereof; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;any
changes after the date of the merger agreement in U.S. GAAP or applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">If adverse changes occur
but TapImmune and Marker must still complete the merger, the Combined Company&rsquo;s stock price may suffer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>During the pendency of the merger,
TapImmune may not be able to enter into a business combination with another party because of restrictions in the merger agreement.
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Covenants in the merger
agreement impede the ability of TapImmune or Marker to make acquisitions or complete other transactions that are not in the ordinary
course of business pending completion of the merger. As a result, if the merger is not completed, the parties may be at a disadvantage
to their competitors. In addition, while the merger agreement is in effect and subject to limited exceptions, each party is prohibited
from soliciting, initiating, encouraging or taking actions designed to facilitate any inquiries or the making of any proposal or
offer that could lead to the entering into certain extraordinary transactions with any third party, such as a sale of assets, an
acquisition of TapImmune common stock, a tender offer for TapImmune common stock or a merger or other business combination outside
the ordinary course of business, which transactions could be favorable to such party&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The market price of the Combined
Company&rsquo;s common stock may decline as a result of the merger. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The market price of
the Combined Company&rsquo;s common stock may decline as a result of the merger for a number of reasons including if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;the
Combined Company does not achieve the perceived benefits of the merger as rapidly or to the extent anticipated by financial or
industry analysts;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;the
effect of the merger on the Combined Company&rsquo;s business and prospects is not consistent with the expectations of financial
or industry analysts; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;investors
react negatively to the effect on the Combined Company&rsquo;s business and prospects from the merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8203;<B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>TapImmune stockholders may not realize
a benefit from the merger commensurate with the ownership dilution they will experience in connection with the merger. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">If the Combined Company
is unable to realize the strategic and financial benefits currently anticipated from the merger, TapImmune stockholders will have
experienced substantial dilution of their ownership interest without receiving any commensurate benefit. Significant management
attention and resources will be required to integrate and operate the Combined Company. Delays in this process could adversely
affect the Combined Company&rsquo;s business, financial results, financial condition and stock price following the merger. Even
if the Combined Company is able to integrate the business operations successfully, there can be no assurance that this integration
will result in the realization of the full benefits of synergies, innovation, and operational efficiencies that may be possible
from this integration and that these benefits will be achieved within a reasonable period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Because the lack of a public market
for the Marker shares makes it difficult to value Marker, TapImmune may pay consideration in the merger that is greater than the
fair market value of the Marker shares. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The outstanding capital
stock of Marker is privately held and is not traded in any public market. The lack of a public market makes it extremely difficult
to determine the fair market value of Marker. Since the percentage of TapImmune&rsquo;s equity to be issued to Marker stockholders
was determined based on negotiations between the parties, it is possible that the value of the TapImmune common stock to be issued
in connection with the merger will be greater than the fair market value of Marker.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Combined Company
will incur significant transaction costs as a result of the merger, including investment banking, legal, and accounting fees. In
addition, the Combined Company will incur significant consolidation and integration expenses which cannot be accurately estimated
at this time. These costs could include the planned relocation of certain operations from Jacksonville, Florida to Houston, Texas
as well as other transition and start-up costs associated with the clinical programs to be conducted by the Combined Company after
the merger. Actual transaction costs may substantially exceed TapImmune&rsquo;s estimates and may have an adverse effect on the
Combined Company&rsquo;s financial condition and operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Marker&rsquo;s principal stockholders,
executive officers, and directors will own a significant percentage of TapImmune common stock and will be able to exert significant
control over matters submitted to the stockholders for approval. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Immediately following
the effective time of the merger between Marker and TapImmune, and after taking into account the issuance of shares in the private
placement transaction occurring concurrently with the merger, Marker&rsquo;s stockholders are expected to own, on a fully-diluted
basis (assuming the exercise of all outstanding warrants and options), approximately 27.5%, and TapImmune&rsquo;s current stockholders
are expected to own approximately 27.5%, of TapImmune common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">After the merger with
TapImmune, Marker&rsquo;s stockholders will beneficially own a significant percentage of TapImmune common stock. This significant
concentration of share ownership may adversely affect the trading price for TapImmune common stock because investors often perceive
disadvantages in owning stock in companies with large stockholders. These stockholders, if they acted together, could significantly
influence all matters requiring approval by the stockholders following the merger, including the election of directors and the
approval of mergers or other business combination transactions. The interests of these stockholders may not always coincide with
the interests of other stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The merger may limit the use of the
NOL carryforwards and other tax attributes of both TapImmune and Marker to offset future taxable income of the Combined Company.
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Under Section 382 of
the Internal Revenue Code of 1986, as amended, or the Code, if a corporation undergoes an &ldquo;ownership change&rdquo; (generally
defined as a greater than 50% change (by value) in its equity ownership over a three-year period), the corporation&rsquo;s ability
to use its pre-change net operating loss, which is referred to as NOL, carryforwards, and other pre-change tax attributes (such
as research tax credits) to offset its post-change income may be limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">As of December 31, 2017,
TapImmune had federal NOL carryforwards of approximately $41.7 million and state NOL carryforwards of approximately $21.9 million.
The merger may result in an ownership change for TapImmune under Section 382 of the Code and may limit the use of the NOL carryforwards
and other tax attributes of TapImmune to offset future taxable income of the Combined Company for both federal and state income
tax purposes. These tax attributes are subject to expiration at various times in the future to the extent that they have not been
applied to offset the taxable income of the Combined Company. These limitations may affect the Combined Company&rsquo;s effective
tax rate in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>RISKS RELATED TO THE COMBINED COMPANY UPON COMPLETION OF
MERGER </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Risks Related to the Combined Company&rsquo;s
Business and Product Candidates </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Combined Company&rsquo;s future
success will be highly dependent upon its key personnel, and its ability to attract, retain, and motivate additional qualified
personnel. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Combined Company&rsquo;s
ability to compete in the highly competitive biotechnology and pharmaceutical industries depends upon its ability to attract and
retain highly qualified managerial, scientific, and medical personnel. The Combined Company will be highly dependent on its management,
scientific, and medical personnel, including Peter Hoang, its President and Chief Executive Officer, Ann Leen, Ph.D., who is expected
to be its Chief Scientific Officer following completion of the merger, and Juan Vera, M.D., who is expected to be its Chief Development
Officer following completion of the merger. The loss of the services of any of the Combined Company&rsquo;s executive officers,
other key employees, and other scientific and medical advisors, and the Combined Company&rsquo;s inability to find suitable replacements
could result in delays in product development and harm to the Combined Company&rsquo;s business. In particular, Dr. Leen is the
key person who has produced Marker&rsquo;s MultiTAA T cell therapy-based product. A priority of the Combined Company will be to
quickly train additional qualified scientific and medical personnel in the Combined Company to ensure the ability to maintain business
continuity. Any delays in training such personnel could delay the development, manufacture, and clinical trials of the Combined
Company&rsquo;s product candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Combined Company
also anticipates hiring additional scientific and medical personnel to grow its business. The Combined Company will conduct operations
in Houston, Texas. This region is headquarters to many other biopharmaceutical companies and many academic and research institutions.
Competition for skilled personnel in the combined companies market is intense and may limit its ability to hire and retain highly
qualified personnel on acceptable terms or at all. If the Combined Company is not successful in attracting and retaining highly
qualified personnel, it may not be able to successfully implement its business strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Combined Company&rsquo;s strategic
relationship with Baylor College of Medicine, or BCM, is dependent, in part, upon its relationship with key medical and scientific
personnel and advisors. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Marker&rsquo;s therapy
has been developed through its collaboration with the Center for Cell and Gene Therapy at BCM, founded by Malcom K. Brenner, M.D.,
Ph.D., a recognized pioneer in immuno-oncology. In addition to Dr. Brenner, Marker&rsquo;s founders include, Ann Leen, Ph.D., Juan
Vera, M.D., Helen Heslop, M.D., DSc (Hon) and Cliona Rooney, Ph.D., who have significant experience in this field and are all affiliated
with the Center for Cell and Gene Therapy at BCM. Dr. Leen and Dr. Vera are expected to serve as the Combined Company&rsquo;s Chief
Scientific Officer and Chief Development Officer, respectively, following completion of the merger. In addition, Dr. Brenner, Dr.
Heslop and Dr. Rooney have agreed to join the Combined Company&rsquo;s newly formed Scientific Advisory Board that will become
effective in conjunction with the merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Combined Company&rsquo;s
strategic relationship with BCM will be dependent, in part, on its relationship with these key employees and advisors, and in particular
Dr. Leen and Dr. Vera, who are also employed with the Center for Cell and Gene Therapy at BCM. If the Combined Company loses Dr.
Leen or Dr. Vera, or if either leaves their position at BCM, the Combined Company&rsquo;s relationship with BCM may deteriorate,
and its business could be harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Combined Company, and certain
of its key medical and scientific personnel, will need additional agreements in place with BCM to expand its development, manufacture,
and clinical trial efforts. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Although the Combined
Company will have an exclusive license agreement with BCM under which Marker received a worldwide, exclusive license to BCM&rsquo;s
rights in and to three patent families to develop and commercialize the MultiTAA product candidates, the Combined Company will
need to enter into additional agreements with BCM with respect to (i) a strategic alliance to advance pre-clinical research, early
stage clinical trials, and Phase II clinical trials with respect to the Combined Company&rsquo;s product candidates, as well as
continued access to its clinical data, (ii) sponsored research for investigators within the Center for Cell and Gene Therapy at
BCM, and (iii) product manufacturing and support, including personnel and space at the institution for the foreseeable future.
Any delays in entering into new strategic agreements with BCM related to the Combined Company&rsquo;s product candidates could
delay the development, manufacture, and clinical trials of its product candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The multiple roles of certain of
the Combined Company&rsquo;s officers and directors could limit their time and availability to the Combined Company, and create,
or appear to create, conflicts of interest. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">After completion of
the merger, Dr. Leen and Dr. Vera will continue to be employees of BCM, and will be contractually obligated to spend a significant
portion of their time for BCM. In addition, Dr. Leen and Dr. Vera are co-founders and members of ViraCyte, and perform services
from time to time for ViraCyte LLC, or ViraCyte. ViraCyte is owned by the same principal stockholder group as Marker and has technology
which is being developed under a license agreement with BCM by the same research group at BCM. More specifically, ViraCyte is a
clinical stage biopharmaceutical company, which is investigating and developing virus-specific T cell therapy technology for the
prevention and/or treatment of viral infections. Accordingly, Dr. Leen and Dr. Vera may have other commitments that would, at times,
limit their availability to the Combined Company, and other research being conducted by Dr. Leen and Dr. Vera may, at times, receive
higher priority than research on the Combined Company&rsquo;s programs, which may, in turn, delay the development or commercialization
of the Combined Company&rsquo;s product candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">In addition, John Wilson
is a member, director and officer of ViraCyte and will be a director of the Combined Company after the consummation of the merger.
Dr. Leen and Dr. Vera are also co-founders and members of ViraCyte, and perform services for ViraCyte from time to time, and Dr.
Vera will be a director of the Combined Company after the consummation of the merger. All of these individuals will have certain
fiduciary or other obligations to the Combined Company after the consummation of the merger and certain fiduciary or other obligations
to ViraCyte and, in the case of Dr. Leen and Dr. Vera, to BCM. Such multiple obligations may in the future result in a conflict
of interest with respect to presenting other potential business opportunities to the Combined Company or to ViraCyte. A conflict
of interest also may arise concerning the timing of the parties&rsquo; planned and ongoing clinical trials, investigational new
drug application filings and the parties&rsquo; opportunities for marketing their respective product candidates. In addition, they
may be faced with decisions that could have different implications for the Combined Company than for ViraCyte. Consequently, there
is no assurance that these members of the Combined Company&rsquo;s board and management would always act in the Combined Company&rsquo;s
best interests in all situations should a conflict arise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Product development involves a lengthy
and expensive process with an uncertain outcome, and results of earlier pre-clinical and clinical trials may not be predictive
of future clinical trial results. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Clinical testing is
expensive and generally takes many years to complete, and the outcome is inherently uncertain. Failure can occur at any time during
the clinical trial process. The results of pre-clinical testing and early clinical trials of the Combined Company&rsquo;s product
candidates may not be predictive of the results of larger, later-stage controlled clinical trials. Product candidates that have
shown promising results in early-stage clinical trials may still suffer significant setbacks in subsequent clinical trials. Marker&rsquo;s
clinical trials to date have been conducted on a small number of patients in a single clinical site for a limited number of indications.
The Combined Company will have to conduct larger, well-controlled trials in its proposed indications at multiple sites to verify
the results obtained to date and to support any regulatory submissions for further clinical development of Marker&rsquo;s product
candidates. TapImmune&rsquo;s and Marker&rsquo;s assumptions related to Marker&rsquo;s products, such as with respect to lack of
toxicity and manufacturing cost estimates, are based on early limited clinical trials and current manufacturing process at BCM
and may prove to be incorrect. In addition, the initial estimates of the clinical cost of development may prove to be inadequate,
particularly if clinical trial timing or outcome is different than predicted or regulatory agencies require further testing before
approval. A number of companies in the biopharmaceutical industry have suffered significant setbacks in advanced clinical trials
due to lack of efficacy or adverse safety profiles despite promising results in earlier, smaller clinical trials. Moreover, clinical
data are often susceptible to varying interpretations and analyses. The Combined Company does not know whether any Phase II, Phase
III, or other clinical trials it may conduct will demonstrate consistent or adequate efficacy and safety with respect to the proposed
indication for use sufficient to receive regulatory approval or market its product candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Combined Company may not be able
to expand its manufacturing processes to other third-party manufacturing facilities or successfully create its own manufacturing
infrastructure for supply of its requirements of product candidates for use in clinical trials and for commercial sale. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Combined Company
will not own any facility that may be used as its clinical-scale manufacturing and processing facility following the merger. The
Combined Company anticipates it will initially rely solely on the cGMP manufacturing facility within BCM for the manufacturing
of its product candidates. If the cGMP manufacturing facility of BCM, which does manufacturing for itself and other parties, experiences
capacity constraints, disruptions, or delays in manufacturing the Combined Company&rsquo;s products, the Combined Company&rsquo;s
planned clinical trials and necessary manufacturing capabilities will be disrupted or delayed, which will adversely affect the
Combined Company&rsquo;s ability to conduct and further develop its business as currently planned. Further, the cGMP manufacturing
facility is most likely too small to conduct the pivotal clinical studies being planned by the Combined Company, so the Combined
Company will need to develop its own cGMP manufacturing capacity that will be adequate for such clinical trials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">In 2019, the Combined
Company currently intends to begin developing additional cGMP manufacturing capacity of its own that would be capable of supporting
its manufacturing needs with respect to its clinical trials, particularly with respect to pivotal studies. TapImmune and Marker
expect that the Combined Company&rsquo;s manufacturing strategy will involve the use of one or more Contract Manufacturing Organizations,
or CMOs, or the Combined Company will establish its own capabilities and infrastructure, including a manufacturing facility. Establishment
of the Combined Company&rsquo;s own manufacturing facility is subject to many risks. For example, the establishment of a cell-therapy
manufacturing facility is a complex endeavor requiring knowledgeable individuals. Creating an internal manufacturing infrastructure
will rely upon building out a complex facility and finding personnel with an appropriate background and training to staff and operate
the facility. Should it be unable to find these individuals, the Combined Company may need to rely on external contractors or train
additional personnel to fill needed roles. There are a small number of individuals with experience in cell therapy, and the competition
for these individuals is high.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Combined Company
would expect that development of its own manufacturing facility could provide it with enhanced control of material supply for both
clinical trials and the commercial market, enable the more rapid implementation of process changes, and allow for better long-term
margins. However, neither TapImmune nor Marker has any experience as a company in developing a manufacturing facility and may never
be successful in developing the Combined Company&rsquo;s own manufacturing facility or capability. The Combined Company may establish
multiple manufacturing facilities as it expands its commercial footprint to multiple geographies, which may lead to regulatory
delays or prove costly. Even if the Combined Company is successful, its manufacturing capabilities could be affected by cost-overruns,
unexpected delays, equipment failures, labor shortages, natural disasters, power failures, transportation difficulties and numerous
other factors that could prevent the Combined Company from realizing the intended benefits of its manufacturing strategy and have
a material adverse effect on the Combined Company&rsquo;s clinical development and/or commercialization plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">In addition, the manufacturing
process for any products that the Combined Company may develop is subject to the U.S. Food and Drug Administration, or FDA, and
foreign regulatory authority approval process, and the Combined Company will need to contract with manufacturers who can meet all
applicable FDA and foreign regulatory authority requirements on an ongoing basis. If the Combined Company or its CMOs are unable
to reliably produce products to specifications acceptable to the FDA, or other regulatory authorities, the Combined Company may
not obtain or maintain the approvals it needs to commercialize such products. Even if the Combined Company obtains regulatory approval
for any of its product candidates, there is no assurance that either the Combined Company or its CMOs will be able to manufacture
the approved product to specifications acceptable to the FDA or other regulatory authorities, to produce it in sufficient quantities
to meet the requirements for the potential launch of the product, or to meet potential future demand. Any of these challenges could
delay completion of clinical trials, require bridging clinical trials or the repetition of one or more clinical trials, increase
clinical trial costs, delay approval of the Combined Company&rsquo;s product candidate, impair commercialization efforts, increase
its cost of goods, and have an adverse effect on its clinical development and/or commercialization plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Regardless of whether
the Combined Company engages additional CMOs to manufacture its products or establishes its own manufacturing facility, in order
to transfer the Combined Company&rsquo;s manufacturing from or expand its manufacturing capabilities beyond BCM pursuant to its
development plans, whether through additional third parties or by developing its own manufacturing capabilities, the Combined Company
will need access to the Standard Operating Procedures and the specific Batch Production Records that are used to manufacture the
product candidates. If BCM fails to transfer Marker&rsquo;s manufacturing processes, or impedes the Combined Company&rsquo;s ability
to transfer the manufacturing processes of its products to the Combined Company or third-party manufacturers, the Combined Company&rsquo;s
planned clinical trials and additional necessary manufacturing capabilities will be delayed, which will adversely affect the Combined
Company&rsquo;s ability to conduct and further develop its business as currently planned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Combined Company will be dependent
on third-party vendors to design, build, maintain and support its manufacturing and cell processing facilities. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">As a result of the Combined
Company&rsquo;s strategy to outsource its manufacturing, it will rely very heavily on BCM and other third-party manufacturers to
perform the Combined Company&rsquo;s manufacturing of Marker&rsquo;s products for its clinical trials. Marker also licenses a significant
portion of its technology from others and, at this time, does not own any intellectual properties or technologies. The Combined
Company intends to rely on its contract manufacturers to produce large quantities of materials needed for clinical trials and potential
product commercialization. Third-party manufacturers may not be able to meet the Combined Company&rsquo;s needs concerning timing,
quantity, or quality. If the Combined Company is unable to contract for a sufficient supply of needed materials on acceptable terms,
or if it should encounter delays or difficulties in its relationships with manufacturers, its clinical testing may be delayed,
thereby delaying the submission of products for regulatory approval or the market introduction and subsequent sales of its products.
Any such delay may lower the Combined Company&rsquo;s revenues and potential profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">If any third party breaches
or terminates its agreement with the Combined Company,or fails to conduct its activities in a timely manner, the commercialization
of the Combined Company&rsquo;s products under development could be slowed down or blocked completely. It is possible that third
parties relied upon by the Combined Company will change their strategic focus, pursue alternative technologies, or develop alternative
products, either on their own or in collaboration with others, as a means for developing treatments for the diseases targeted by
the Combined Company&rsquo;s collaborative programs, or for other reasons. The effectiveness of these third parties in marketing
their own products may also affect the revenues and earnings of the Combined Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Combined Company
intends to continue to enter into additional third-party agreements in the future. However, the Combined Company may not be able
to negotiate any additional agreements successfully. Even if established, these relationships may not be scientifically or commercially
successful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Combined Company&rsquo;s manufacturing
process is reliant upon the specialized equipment, and other specialty materials, which may not be available to the Combined Company
on acceptable terms or at all. For some of this equipment and materials, the Combined Company relies or may rely on sole source
vendors or a limited number of vendors, which could impair its ability to manufacture and supply its products. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Combined Company
will depend on a limited number of vendors for supply of certain materials and equipment used in the manufacture of its product
candidates. For example, the Combined Company will purchase equipment and reagents critical for the manufacture of its product
candidates from Wilson Wolf Manufacturing Corporation (a company controlled by a Marker stockholder, John Wilson, who will become
a director of the Combined Company), JPT Peptide Technologies and other suppliers. Some of the Combined Company&rsquo;s suppliers
may not have the capacity to support commercial products manufactured under cGMP by biopharmaceutical firms or may otherwise be
ill-equipped to support the Combined Company&rsquo;s needs. The Combined Company also may not have supply contracts with many of
these suppliers,and may not be able to obtain supply contracts with them on acceptable terms or at all. Accordingly, the Combined
Company may not be able to obtain key materials and equipment to support clinical or commercial manufacturing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">For some of this equipment
and materials, the Combined Company will rely, and may in the future rely, on sole-source vendors or a limited number of vendors.
An inability to continue to source product from any of these suppliers, which could be due to regulatory actions or requirements
affecting the supplier, adverse financial, or other strategic developments experienced by a supplier, labor disputes or shortages,
unexpected demands, or quality issues, could adversely affect the Combined Company&rsquo;s ability to satisfy demand for its product
candidates, which could adversely and materially affect the Combined Company&rsquo;s operating results or its ability to conduct
clinical trials, either of which could significantly harm its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">As the Combined Company
continues to develop and scale its manufacturing process, it may need to obtain rights to and supplies of specific materials and
equipment to be used as part of that process. For example, Marker&rsquo;s manufacturing process is based, in part, upon the G-Rex&reg;
cell culture device manufactured by Wilson Wolf Manufacturing Corporation, which is used by many cell therapy developers, both
in commercial and academic settings. The Combined Company will not own any exclusive rights to the G-Rex&reg; that could be used
to prevent third parties from developing similar and competing processes. The Combined Company may not be able to obtain rights
to such materials and equipment on commercially reasonable terms, or at all, and if the Combined Company is unable to alter its
process in a commercially viable manner to avoid the use of such materials or find a suitable substitute, it would have a material
adverse effect on its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Combined Company may enter into
one or more transactions with entities controlled by one of its directors, which could pose a conflict of interest. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">John Wilson, currently
a significant stockholder in Marker and who will be a director of the Combined Company, is also CEO and co-founder of Wilson Wolf
Manufacturing Corporation, which is the sole source vendor that provides Marker with the G-Rex&reg; cell culture device for the
large-scale production of T cells used in Marker&rsquo;s manufacturing process. Marker does not currently have a supply contract
with Wilson Wolf Manufacturing for the G-Rex&reg;. The Combined Company plans to negotiate a supply contract with Wilson Wolf Manufacturing
for the purchase of G-Rex&reg; devices. The Combined Company also plans to engage Wilson Wolf Manufacturing in discussions to customize
the G-Rex&reg; further to optimally match the Combined Company&rsquo;s manufacturing requirements, as well as to develop a scalability
plan to drive efficiencies for a commercial product. There may be conflicts of interest between the Combined Company and Wilson
Wolf Manufacturing. There can be no assurance that Wilson Wolf Manufacturing will agree to enter into any contract with the Combined
Company, or that the terms of any such agreements will be in the best interests of the Combined Company, or will have terms no
less favorable to the Combined Company than could have been obtained from unaffiliated third parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>The future
results of the Combined Company will suffer if the Combined Company does not effectively manage its expanded operations following
the completion of the merger.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Following the completion
of the merger, the size of the business of the Combined Company will increase significantly beyond the current size of either us
or Marker. The Combined Company&rsquo;s future success depends, in part, upon its ability to manage this expanded business, which
will pose substantial challenges for management, including challenges related to the management and monitoring of new operations
and associated increased costs, complexity and allocation of financial resources. If the Combined Company is unsuccessful in managing
its integrated operations, or if it does not realize the expected operating efficiencies, cost savings and other benefits currently
anticipated from the merger, the operations and financial condition of the Combined Company could be adversely affected and the
Combined Company may not be able to take advantage of business development opportunities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>The Combined
Company may be unable to fully realize the competitive synergies that are projected to be achieved through the combination of our
services and Marker&rsquo;s offerings.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Part of the strategic
rationale for the merger is the opportunity for the Combined Company to potentially drive additional value through the utilization
by us of Marker&rsquo;s capabilities. However, the utilization of Marker&rsquo;s offerings is still evolving and subject to a number
of risks and uncertainties, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;government
regulatory agencies and legislative bodies, including agencies and legislatures regulating the use of clinical trials, may impose
new conditions or restrictions which affect the Combined Company&rsquo;s use of Marker&rsquo;s data;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;implementation
of any operational plans to develop new cancer treatments from the Marker offerings will likely be complex and challenging to achieve,
and may be subject to delays and cost overruns and there is no assurance that the research and development can be carried out effectively;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;clinical
research is a complex and evolving area, and creating effective approaches to drive more effective and efficient research outcomes
is difficult and challenging; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;third
parties outside of our control (including suppliers and regulators) may impose restrictions or conditions which affect the projected
timing and successful achievement of our benefits from the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Combined Company
is unable to predict the extent to which these factors will inhibit its business plans and any one of them could result in decreased
or delays in post-closing performance by the Combined Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>We may fail
to realize all of the anticipated benefits of the merger or those benefits may take longer to realize than expected. The Combined
Company may also encounter significant difficulties in integrating the two businesses.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Our ability to realize
the anticipated benefits of the transaction will depend, to a large extent, on the Combined Company&rsquo;s ability to integrate
the two businesses. The combination of two independent businesses is a complex, costly and time-consuming process. As a result,
we and Marker will be required to devote significant management attention and resources to integrating the business practices and
operations. The integration process may disrupt the businesses and, if implemented ineffectively, would restrict the realization
of the full-expected benefits. The failure to meet the challenges involved in integrating the two businesses and to realize the
anticipated benefits of the transaction could cause an interruption of or a loss of momentum in, the activities of the Combined
Company and could adversely affect the results of operations of the Combined Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">In addition, the overall
integration of the businesses may result in material unanticipated problems, expenses, liabilities, competitive responses, and
diversion of management&rsquo;s attention. The difficulties of combining the operations of the companies include, among others:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;difficulties
in achieving successful development of Marker&rsquo;s offerings, business opportunities and growth prospects from the combination;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;difficulties
in the integration of the companies&rsquo; businesses;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;difficulties
in managing the expanded operations of a significantly larger and more complex company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; text-align: justify"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;challenges
in attracting and retaining key personnel; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;potential
unknown liabilities and unforeseen increased expenses or delays associated with the merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Many of these factors
will be outside of the control of the Combined Company and any one of them could result in increased costs, and diversion of management&rsquo;s
time and energy, which could materially impact the business, financial condition and results of operations of the Combined Company.
In addition, even if the operations of the businesses are integrated successfully, the full benefits of the transaction may not
be realized, including growth opportunities that are expected. These benefits may not be achieved within the anticipated time frame,
or at all. Further, additional unanticipated costs may be incurred in the integration of the businesses of ours and Marker. All
of these factors could negatively impact or decrease or delay the expected benefits of the transaction and negatively impact the
price of the Combined Company&rsquo;s shares. As a result, there is no assurance that the combination of us and Marker will result
in the realization of the full benefits anticipated from the merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Risks Related to Combined Company&rsquo;s
Financial Condition and Need for Additional Capital </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Management will have broad discretion
as to the use of the proceeds from the private placement transaction, and the Combined Company may not use the proceeds effectively.
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The Combined Company&rsquo;s
management will have broad discretion as to the application of the net proceeds from the private placement transaction for general
corporate purposes and working capital to advance the development of the Combined Company&rsquo;s product candidates. Management
may spend the proceeds in ways that do not necessarily improve its operating results or enhance the value of its common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Combined Company will require
additional financing before it can generate any revenue from operations. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">After consummation of
the merger and the private placement transaction, the Combined Company anticipates having sufficient cash on hand to fund its operations
for at least the next thirty months. The product candidates of the Combined Company, however, remain in the early stages of development
and the Combined Company anticipates it will be years before it is able to generate any revenue from operations. Accordingly, the
Combined Company will need additional debt or equity financing in the future to execute its business plan, complete its future
clinical trials, and to add manufacturing, sales, marketing, and customer support personnel in the future to advance the commercialization
of its products. The Combined Company will operate in a market that makes its prospects difficult to evaluate, and achievement
of positive cash flow from operations will depend upon revenue resulting from the successful development of its product candidates,
which depend upon regulatory clearance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">In the future, if the
Combined Company fails to satisfy the continued listing standards of NASDAQ, it may not be able to sell shares of its common stock
to raise additional capital. In addition, future market conditions may limit the ability of the Combined Company to raise capital
on favorable terms, or at all, and the terms of any public or private offerings of debt or equity securities likely would be significantly
dilutive to existing stockholders at such time. There is no guarantee that the Combined Company will be able to obtain any of the
additional debt or equity financing that will be required after completion of the merger and the private placement transaction
on commercially reasonable terms or at all. If the Combined Company fails to obtain the necessary debt or equity financing when
needed, it may not be able to execute its planned development and commercialization efforts, which would have a material adverse
effect on the Combined Company&rsquo;s growth strategy, the results of its operations and financial condition and stock price.
If the Combined Company is unable to generate sufficient capital from operations or raise additional funds, it may need to consider
other alternative actions, including one or more of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;delay,
scale-back, or eliminate research and development of some or all of the Combined Company&rsquo;s product candidates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;license
third parties to develop and commercialize products or technologies that TapImmune would otherwise seek to develop and commercialize
ourselves;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;attempt
to sell the company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;cease
operations; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;declare
bankruptcy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8203;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The occurrence of any
of the foregoing events would have a material adverse effect on the Combined Company&rsquo;s growth strategy, the results of its
operations and financial condition, and stock price, and there can be no assurance that it would be able to continue as a going
concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The issuance of additional equity
securities may negatively impact the trading price of the Combined Company&rsquo;s common stock. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">TapImmune has issued
equity securities in the past, will issue equity securities in the merger and private placement transaction, and expects to continue
to issue equity securities to finance the activities of the Combined Company in the future. In addition, outstanding options and
warrants to purchase its common stock may be exercised, and additional options and warrants may be issued, resulting in the issuance
of additional shares of common stock. The issuance by the Combined Company of additional equity securities, including the shares
of common stock issuable upon exercise of the warrants issued by TapImmune in the private placement transaction, would result in
dilution to the Combined Company&rsquo;s stockholders, and even the perception that such an issuance may occur could have a negative
impact on the trading price of the Combined Company&rsquo;s common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Combined Company will have a
significant number of outstanding warrants and options, and future sales of the shares obtained upon exercise of these options
or warrants could adversely affect the market price of the Combined Company&rsquo;s common stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Upon completion of
the merger and private placement transaction, the Combined Company will have outstanding warrants to purchase up to 23,657,372
shares of its common stock at a weighted average exercise price of&thinsp; $4.74 per share, and options exercisable for an aggregate
of 439,467 shares of common stock at a weighted average exercise price of&thinsp; $6.77 per share, in each case calculated as if
the merger had been consummated as of June 29, 2018. TapImmune has committed to register the resale of all the shares issuable
upon exercise of these warrants, and they will be freely tradable by the exercising party upon issuance. Upon such registration,
the holders may sell these shares in the public markets from time to time, without limitations on the timing, amount, or method
of sale. If the Combined Company&rsquo;s stock price rises, the holders may exercise their warrants and options and sell a large
number of shares. This could cause the market price of the Combined Company&rsquo;s common stock to decline and cause existing
stockholders to experience significant further dilution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 72px; font-size: 10pt"><A NAME="s14"></A><FONT STYLE="font-size: 10pt"><B>Item 2.</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Unregistered Sales of Equity Securities and Use of Proceeds</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">We issued the following unrestricted securities during the period covered by this report to the named individual pursuant to exemptions under the Securities Act of 1933 including Section&nbsp;4(2):</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 10, 2018, we issued 15,000 shares of common stock to
Omnicor Media, LLC pursuant to a vendor agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 13, 2018, we issued 33,334 shares of common stock to
Collision Capital, LLC pursuant to a vendor agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 18, 2018, we issued 12,849 shares of common stock to
Richard Kenney, pursuant to a consulting services agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May 31, 2018, we issued 50,000 shares of common stock to
Caro Partners, LLC pursuant to a vendor agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 18, 2018, we issued 11,600 shares of common stock to
Corporate Profile pursuant to a vendor agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px; border-bottom: black 1pt solid"><A NAME="s15"></A></TD>
    <TD STYLE="width: 72px; border-bottom: black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Item 3.</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Defaults Upon Senior Securities</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px; border-bottom: black 1pt solid"><A NAME="s16"></A></TD>
    <TD STYLE="width: 72px; border-bottom: black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Item 4.</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Mine Safety Disclosure</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px; border-bottom: black 1pt solid"><A NAME="s17"></A></TD>
    <TD STYLE="width: 72px; border-bottom: black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Item 5.</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Other Information</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px; border-bottom: black 1pt solid"><A NAME="s18"></A></TD>
    <TD STYLE="width: 72px; border-bottom: black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Item 6.</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Exhibits</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following exhibits are included with
this Quarterly Report on Form 10-Q:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="5" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Incorporated by Reference</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 8%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>number</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 46%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Exhibit description</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 8%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 8%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>File&nbsp;no.</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 8%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 8%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.3pt; text-align: center"><B>Filing</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.3pt; text-align: center"><B>date</B></P></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 8%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.3pt; text-align: center"><B>Filed</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>herewith</B></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028370/tv494002_ex2-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">2.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028370/tv494002_ex2-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Agreement and Plan of Merger and Reorganization, dated as of May 15, 2018, by and among TapImmune Inc., Timberwolf Merger Sub, Inc. and Marker Therapeutics, Inc.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028370/tv494002_ex2-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>&nbsp;8-K</B></FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028370/tv494002_ex2-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>000-27239</B></FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028370/tv494002_ex2-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>2.1</B></FONT></A></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028370/tv494002_ex2-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>5/15/18</B></FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420416131724/v450946_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">3.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420416131724/v450946_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Articles of Incorporation as Amended</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420416131724/v450946_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>10-Q</B></FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420416131724/v450946_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>001-37939</B></FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420416131724/v450946_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>3.1</B></FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420416131724/v450946_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>11/4/16</B></FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000119312516710452/d259737dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">3.2</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000119312516710452/d259737dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Certificate of Change to Articles of Incorporation (reverse split)</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000119312516710452/d259737dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>8-K</B></FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000119312516710452/d259737dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>000-27239</B></FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000119312516710452/d259737dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>3.1</B></FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000119312516710452/d259737dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>9/15/16</B></FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000119312516649467/d226182dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">3.3</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000119312516649467/d226182dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Amended and Restated Bylaws</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000119312516649467/d226182dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>8-K</B></FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000119312516649467/d226182dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>000-27239</B></FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000119312516649467/d226182dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>3.1</B></FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000119312516649467/d226182dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>7/15/16</B></FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Common Stock Purchase Agreement</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10-Q</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">&nbsp;001-37939</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">&nbsp;10.1</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">5/15/18</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.2</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Warrant Exercise Agreement</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10-Q&nbsp;</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">001-37939&nbsp;</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">&nbsp;10.2</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">5/15/18</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.3</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Warrant Exercise Agreement</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">&nbsp;10-Q</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">001-37939</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.3</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">5/15/18</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.4</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Warrant Exercise Agreement</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10-Q&nbsp;</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">001-37939</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.4</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">5/15/18</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.5</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Warrant Exercise Agreement</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">&nbsp;10-Q</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">001-37939</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.5</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B><A HREF="http://www.sec.gov/Archives/edgar/data/1094038/000114420418028862/tv493258_ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">5/15/18</FONT></A></B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><A HREF="tv499451_ex31-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">31.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><A HREF="tv499451_ex31-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1933, as amended.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="tv499451_ex31-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>X</B></FONT></A></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><A HREF="tv499451_ex31-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">31.2</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><A HREF="tv499451_ex31-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Certification of Chief Financial Officer and Chief Accounting Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1933, as amended.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="tv499451_ex31-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>X</B></FONT></A></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><A HREF="tv499451_ex32-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">32.1</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><A HREF="tv499451_ex32-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1933, as amended.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="tv499451_ex32-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>X</B></FONT></A></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><A HREF="tv499451_ex32-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">32.2</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><A HREF="tv499451_ex32-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Certification of Chief Financial Officer and Chief Principal Accounting Officer pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><A HREF="tv499451_ex32-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt"><B>X</B></FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibit 101</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">101.INS - XBRL Instance Document</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">101.SCH - XBRL Taxonomy Extension Schema
Document</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">101.CAL - XBRL Taxonomy Extension Calculation
Linkbase Document</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">101.DEF - XBRL Taxonomy Extension Definition
Linkbase Document</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">101.LAB - XBRL Taxonomy Extension Label
Linkbase Document</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">101.PRE - XBRL Taxonomy Extension Presentation
Linkbase Document</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="s19"></A><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the requirements of
the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date:&#9;August 9, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>TAPIMMUNE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 30%; border-bottom: black 1pt solid; padding-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-size: 10pt"><I>/s/ Peter L. Hoang</I></FONT></TD>
    <TD STYLE="width: 65%; padding-bottom: 1pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>Peter L. Hoang</B></FONT><BR>
<FONT STYLE="font-size: 10pt">President and Chief Executive Officer and Principal Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-left: 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-size: 10pt"><I>/s/ Michael J. Loiacono</I></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>Michael J. Loiacono</B></FONT><BR>
<FONT STYLE="font-size: 10pt">Chief Financial Officer and Principal Accounting Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>tv499451_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Peter L. Hoang, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this Report on Form 10-Q for the quarterly period ended June 30, 2018 of TapImmune Inc.;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Report;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurances regarding the reliability of financial reporting in the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this Report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:&#9;August 9, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Peter L. Hoang &nbsp;</FONT></TD>
    <TD STYLE="width: 67%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">By: &nbsp;&nbsp;&nbsp;<B>Peter L. Hoang</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>tv499451_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Michael J. Loiacono, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">I have reviewed this Report on Form 10-Q for the quarterly period ended June 30, 2018 of TapImmune Inc.;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Report;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurances regarding the reliability of financial reporting in the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Disclosed in this Report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:&#9;August 9, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Michael J. Loiacono &nbsp;</FONT></TD>
    <TD STYLE="width: 67%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">By: &nbsp;&nbsp;&nbsp;<B>Michael J. Loiacono</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Title: Chief Financial Officer and Chief Accounting Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>tv499451_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned, Peter L. Hoang, the Chief
Executive Officer of TapImmune Inc. (the &ldquo;Company&rdquo;) hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Report on Form 10-Q of TapImmune Inc., for the quarterly period
ended June 30, 2018, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and
that the information contained in the Report on Form 10-Q fairly presents in all material respects the financial condition and
results of operations of TapImmune Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:&#9;August 9, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 28%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Peter L. Hoang</I></FONT></TD>
    <TD STYLE="width: 67%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>Peter L. Hoang</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.4in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>tv499451_ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL ACCOUNTING
OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned, Michael J. Loiacono, the
Chief Financial Officer and Chief Accounting Officer of TapImmune Inc. (the &ldquo;Company&rdquo;) hereby certifies, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Report on Form 10-Q of TapImmune
Inc., for the quarterly period ended June 30, 2018, fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, and that the information contained in the Report on Form 10-Q fairly presents in all material respects the
financial condition and results of operations of TapImmune Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:&#9;August 9, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 26%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><I>/s/ Michael J. Loiacono</I></FONT></TD>
    <TD STYLE="width: 69%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>Michael J. Loiacono</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Chief Financial Officer and Chief Accounting Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>tpiv-20180630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DataTracks version 3.0 on 09-August-2018 [11:07:37] {AM} EST - www.datatracks.com-->
<xbrli:xbrl xmlns:tpiv="http://www.tapimmune.com/20180630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2018-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2018-01-31">
<link:schemaRef xlink:type="simple" xlink:href="tpiv-20180630.xsd" />
<xbrli:context id="P01_01_2018To06_30_2018">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2017To06_30_2017">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2017-01-01</xbrli:startDate>
<xbrli:endDate>2017-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P04_01_2018To06_30_2018">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-04-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P04_01_2017To06_30_2017">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2017-04-01</xbrli:startDate>
<xbrli:endDate>2017-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn08_02_2018">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-08-02</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2017To12_31_2017">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2017-01-01</xbrli:startDate>
<xbrli:endDate>2017-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P05_01_2018To05_14_2018">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-05-01</xbrli:startDate>
<xbrli:endDate>2018-05-14</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn05_14_2018">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-05-14</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2016">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2016-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2017">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To06_30_2018_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To06_30_2018_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To06_30_2018_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To06_30_2018_SellingGeneralAndAdministrativeExpensesMemberusgaapIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To06_30_2018_GrantMembersrtProductOrServiceAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To06_30_2018_WarrantMemberusgaapFinancialInstrumentAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To06_30_2018_ConsultingArrangementsMemberTPIVArrangementsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="tpiv:ArrangementsAxis">tpiv:ConsultingArrangementsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To06_30_2018_AccountingStandardsUpdate201409MemberusgaapAdjustmentsForNewAccountingPronouncementsAxis_GrantMembersrtProductOrServiceAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_FairValueHedgingMemberusgaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsBeforeModificationMemberusgaapClassOfWarrantOrRightAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tpiv:WeightedAverageInputsBeforeModificationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsBeforeModificationMemberusgaapClassOfWarrantOrRightAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tpiv:WeightedAverageInputsBeforeModificationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsBeforeModificationMemberusgaapClassOfWarrantOrRightAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tpiv:WeightedAverageInputsBeforeModificationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsBeforeModificationMemberusgaapClassOfWarrantOrRightAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tpiv:WeightedAverageInputsBeforeModificationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsBeforeModificationMemberusgaapClassOfWarrantOrRightAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tpiv:WeightedAverageInputsBeforeModificationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_FairValueHedgingMemberusgaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P04_01_2017To06_30_2017_GrantMembersrtProductOrServiceAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2017-04-01</xbrli:startDate>
<xbrli:endDate>2017-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P04_01_2018To06_30_2018_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-04-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P04_01_2018To06_30_2018_SellingGeneralAndAdministrativeExpensesMemberusgaapIncomeStatementLocationAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-04-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P04_01_2018To06_30_2018_GrantMembersrtProductOrServiceAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-04-01</xbrli:startDate>
<xbrli:endDate>2018-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2017To06_30_2017_GrantMembersrtProductOrServiceAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2017-01-01</xbrli:startDate>
<xbrli:endDate>2017-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2017_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2017_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsAfterModificationMemberusgaapClassOfWarrantOrRightAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tpiv:WeightedAverageInputsAfterModificationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2017_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsAfterModificationMemberusgaapClassOfWarrantOrRightAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tpiv:WeightedAverageInputsAfterModificationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2017_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsAfterModificationMemberusgaapClassOfWarrantOrRightAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tpiv:WeightedAverageInputsAfterModificationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2017_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsAfterModificationMemberusgaapClassOfWarrantOrRightAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tpiv:WeightedAverageInputsAfterModificationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2017_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsAfterModificationMemberusgaapClassOfWarrantOrRightAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tpiv:WeightedAverageInputsAfterModificationMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2017_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2017_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2017_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2017_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2017_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">tpiv:SharePurchaseWarrantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn05_14_2018_EasternCapitalLimitedMemberdeiLegalEntityAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">tpiv:EasternCapitalLimitedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-05-14</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="P01_01_2018To01_31_2018_CommonStockMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2018-01-01</xbrli:startDate>
<xbrli:endDate>2018-01-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_CommonStockMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn12_31_2017_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2017-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="PAsOn06_30_2018_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001094038</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2018-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<tpiv:ValuationMethodology id="Factid_1276128" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company&amp;#8217;s common stock purchase warrants that are categorized within Level 3 of the fair value hierarchy for the six months ended June 30, 2018 and 2017 is as follows:&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table style="font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 80%; border-spacing: 0px; margin: 0in auto 0in 0px;;text-align:left;"&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June 30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June 30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2017&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="width: 1255px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;Stock price&lt;/td&gt;&lt;td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="width: 216px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;9.43&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 17px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="width: 215px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;3.88&lt;/td&gt;&lt;td style="width: 17px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:white"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;Exercise price&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;8.67&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;1.20&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;Contractual term (years)&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;1.32&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;1.03&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:white"&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;Volatility (annual)&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;83&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;%&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;78&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;Risk-free rate&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;1&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;%&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;1&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:white"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;Dividend yield (per share)&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;0&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;%&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;0&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</tpiv:ValuationMethodology>
<us-gaap:SignificantAccountingPoliciesTextBlock id="Factid_1153169" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 4: SIGNIFICANT ACCOUNTING POLICIES&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;There have been no material changes in the Company&amp;#8217;s significant accounting policies to those previously disclosed in the Company&amp;#8217;s annual report on Form 10-K, which was filed with the SEC on March 23, 2018.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;New Accounting Pronouncement&lt;/div&gt;&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;s&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Recent Accounting Pronouncements Adopted in the Year&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Compensation-Stock Compensation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;In May 2017, the FASB issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) No. 2017-09, Compensation&amp;#8212;Stock Compensation (Topic 718): Scope of Modification Accounting, which clarifies when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions. It is effective prospectively for the annual period beginning after December 15, 2017 and interim periods within that annual period. Early adoption is permitted. The Company adopted ASU 2017-09 on January 1, 2018; the adoption of ASU 2017-09 did not have a material impact on its financial condition or results of operations, as the Company has not had any modifications to share-based payment awards. However, if the Company does have a modification to an award in the future, it will follow the guidance in ASU 2017-09.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Revenue from Contracts with Customers&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;In May 2014, the FASB issued ASU No. 2014-09, &amp;#8220;Revenue from Contracts with Customers (Topic 606)&amp;#8221; (ASU 2014-09) as modified by ASU No. 2015-14, &amp;#8220;Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date,&amp;#8221; ASU 2016-08, &amp;#8220;Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net),&amp;#8221; ASU No. 2016-10, &amp;#8220;Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing,&amp;#8221; and ASU No. 2016-12, &amp;#8220;Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.&amp;#8221; The revenue recognition principle in ASU 2014-09 is that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, new and enhanced disclosures will be required. Companies may adopt the new standard either using the full retrospective approach, a modified retrospective approach with practical expedients, or a cumulative effect upon adoption approach. The Company adopted the new standard effective January 1, 2018, using the modified retrospective approach. The only impact of the adoption of ASU 2014-09 was to reclassify the Company's grant income as revenue.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Accounting for Certain Financial Instruments with Down Round Features&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;On July 13, 2017, the FASB has issued a two-part ASU, No. 2017-11, (i). Accounting for Certain Financial Instruments with Down Round Features and (ii) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests With a Scope Exception.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The ASU is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 and the interim periods within that annual period. Early adoption is permitted. The Company will be evaluating the impact of adopting this standard on the consolidated financial statements and disclosures.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Improvements to Nonemployee Share-Based Payment Accounting&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;In June 2018, the FASB issued ASU 2018-07 &amp;#8220;Improvements to Nonemployee Share-Based Payment Accounting&amp;#8221;, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than an entity&amp;#8217;s adoption date of Topic 606. The Company is currently evaluating the impact of the new standard on its consolidated financial statements.&lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:MinorityInterestDisclosureTextBlock id="Factid_1153154" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 5: NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basic loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted loss per common share is computed similarly to basic loss per common share except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table sets forth the computation of net loss per share:&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align:left;"&gt;&lt;table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%;"&gt;&lt;tr&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June 30,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June 30,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2017&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2017&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Numerator:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 48%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net loss&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(4,812,797&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(1,893,377&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(8,009,283&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(4,313,262&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Denominator:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average common shares outstanding&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;11,838,371&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;8,576,634&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;11,233,755&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;8,503,521&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net loss per share data:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basic and Diluted&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(0.41&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(0.22&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(0.71&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(0.51&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following securities, rounded to the thousand, were not included in the diluted net loss per share calculation because their effect was anti-dilutive for the periods presented:&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align:left;"&gt;&lt;table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in auto 0in 0px; width: 96%;;text-align:left;"&gt;&lt;tr&gt;&lt;td style="border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June 30,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: 0px none; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: 0px none; padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2017&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Common stock options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;439,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;455,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Common stock purchase warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;4,871,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;6,544,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Potentially dilutive securities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;5,310,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 2.5pt; background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;6,999,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
<us-gaap:DerivativesAndFairValueTextBlock id="Factid_1276125" contextRef="P01_01_2018To06_30_2018">&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"&gt;&lt;div style="text-transform: uppercase; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;NOTE 6: WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company&amp;#8217;s common stock purchase warrants that are categorized within Level 3 of the fair value hierarchy for the six months ended June 30, 2018 and 2017 is as follows:&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table style="font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 80%; border-spacing: 0px; margin: 0in auto 0in 0px;;text-align:left;"&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June 30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June 30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2017&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="width: 1255px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;Stock price&lt;/td&gt;&lt;td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="width: 216px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;9.43&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 17px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="width: 215px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;3.88&lt;/td&gt;&lt;td style="width: 17px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:white"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;Exercise price&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;8.67&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;1.20&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;Contractual term (years)&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;1.32&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;1.03&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:white"&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;Volatility (annual)&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;83&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;%&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;78&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;Risk-free rate&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;1&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;%&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;1&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:white"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;Dividend yield (per share)&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;0&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;%&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;0&lt;/td&gt;&lt;td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management&amp;#8217;s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuations.&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Financial Liabilities Measured at Fair Value on a Recurring Basis&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Warrant liability:&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table style="font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 99%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="14" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value measured at June 30, 2018&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Quoted prices in active&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;markets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;observable inputs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;unobservable inputs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value at&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Level 1)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Level 2)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Level 3)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June 30, 2018&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="width: 755px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;Warrant liability&lt;/td&gt;&lt;td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;-&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;-&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;147,000&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 226px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;147,000&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; background: none;"&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table style="font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 99%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="14" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value measured at December 31, 2017&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Quoted prices in active&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;markets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;observable inputs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;unobservable inputs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value at&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Level 1)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Level 2)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Level 3)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December 31, 2017&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="width: 755px; text-align: justify; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;Warrant liability&lt;/td&gt;&lt;td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;-&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;-&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;9,000&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 226px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;9,000&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value accounting standards define fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is determined based upon assumptions that market participants would use in pricing an asset or liability. Fair value measurements are rated on a three-tier hierarchy as follows:&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table style="font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"&gt;&lt;tr style="vertical-align:top"&gt;&lt;td style="width: 24px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 24px; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-family: symbol; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#183;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level 1 inputs: Quoted prices (unadjusted) for identical assets or liabilities in active markets;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; background: none;"&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table style="font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"&gt;&lt;tr style="vertical-align:top"&gt;&lt;td style="width: 24px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 24px; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-family: symbol; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#183;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level 2 inputs: Inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly; and&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; background: none;"&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table style="font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"&gt;&lt;tr style="vertical-align:top"&gt;&lt;td style="width: 24px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 24px; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-family: symbol; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#183;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-size: 10pt; font-family: &amp;quot;times new roman&amp;quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level 3 inputs: Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; background: none;"&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;There were no transfers between Level 1, 2 or 3 during the six months ended June 30, 2018.&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table presents changes in Level 3 liabilities measured at fair value for the six months ended June 30, 2018:&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table style="font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 69%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Warrant&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liability&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="width: 1083px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;Balance - December 31, 2017&lt;/td&gt;&lt;td style="width: 40px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 158px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;9,000&lt;/td&gt;&lt;td style="width: 26px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:white"&gt;&lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt; padding-top: 0px;"&gt;Change in fair value of warrant liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: 1pt solid black; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: 1pt solid black; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;138,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="padding-bottom: 2.5pt; padding-left: 0px; padding-top: 0px;"&gt;Balance &amp;#8211; June 30, 2018&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: 2.5pt double black; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="border-bottom: 2.5pt double black; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;147,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DerivativesAndFairValueTextBlock>
<us-gaap:StockholdersEquityNoteDisclosureTextBlock id="Factid_1275267" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 7: STOCKHOLDERS&amp;#8217; EQUITY&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018 Common Stock Transactions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Common Stock Purchase Agreement&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;On May 14, 2018, the Company&amp;#8217;s largest stockholder Eastern Capital Limited entered into a Common Stock Purchase Agreement with the Company pursuant to which it purchased 1,300,000 shares of common stock at a price per share of $2.40 providing gross proceeds to the Company of $3.12 million.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Exercise and Repricing of Warrants Held by Existing Institutional Investors &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;On May 14, 2018, certain institutional holders of outstanding warrants entered into Warrant Exercise Agreements with the Company that provide for an amendment to the exercise price of the warrants being exercised at $2.50 per share. Upon closing of the Warrant Exercise Agreements, such institutional holders immediately exercised warrants for 782,505 shares of common stock providing aggregate proceeds to the Company of approximately $2.0 million.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value relating to the modification of exercise prices on the repriced and exercised warrants was treated as deemed dividend on the statement of stockholders&amp;#8217; equity of $728,000.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;A weighted average summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company&amp;#8217;s common stock purchase warrants that are included in the modification is as follows:&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align:left;"&gt;&lt;table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in auto 0in 0px; width: 60%;;text-align:left;"&gt;&lt;tr&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted Average Inputs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Before&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;After&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Modification&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Modification&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 64%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Exercise price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 15%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;9.93&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 15%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.50&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Contractual term (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.37&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.37&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Volatility (annual)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;79&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;79&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Risk-free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;1.5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;1.5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield (per share)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;0&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;0&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Exercise of Stock Warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;During June 2018, shareholders exercised 782,800 shares of common stock pursuant to stock warrants providing aggregate proceeds to the Company of approximately $2.3 million. &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;118,425&lt;/div&gt; of the stock warrants exercised were exercised on a cashless basis, resulting in a cancellation of 83,130 stock warrants.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Exercise of Stock Options&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;In January 2018, 10,416 shares of common stock were issued pursuant to stock option exercises at an exercise price equal to $1.74 per share.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Consulting Arrangements&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;During the six months ended June 30, 2018, the Company issued 132,825 shares of common stock as part of consulting agreements. The fair value of the common stock of approximately $644,000 was recognized as stock-based compensation, $563,000 in general and administrative expenses and $81,000 in research and development expenses.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Share Purchase Warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;A summary of the Company&amp;#8217;s share purchase warrants as of June 30, 2018 and changes during the period is presented below:&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align:left;"&gt;&lt;table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%;;text-align:left;"&gt;&lt;tr&gt;&lt;td style="border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted Average&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number of&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted Average&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Remaining Contractual&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total Intrinsic&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Exercise Price&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Life (in years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Balance - January 1, 2018&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,520,000&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6.11&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3.16&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,739,000&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Issued&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cashless exercised&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(118,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.01&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Exercised for cash&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(1,447,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.95&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Expired or Cancelled&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(84,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.01&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Balance - June 30, 2018&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,871,000&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 2.5pt; background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.94&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 2.5pt; background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2.76&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 2.5pt; background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20,417,000&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock id="Factid_1153094" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 8: STOCK-BASED COMPENSATION&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company recorded approximately $960,000 and $271,000 of stock-based compensation expense for the three months ended June 30, 2018 and 2017, respectively. The Company recorded approximately $1,096,000 and $647,000 of stock-based compensation expense for the six months ended June 30, 2018 and 2017, respectively.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;At June 30, 2018, the total stock-based compensation cost related to unvested awards not yet recognized was $159,000. The expected weighted average period compensation costs to be recognized was 0.48 years. Future option grants will impact the compensation expense recognized.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$596,000 and $364,000 of stock-based compensation expenses for the three months ended June 30, 2018 were included in general and administrative expenses and research and development expenses, respectively, on the condensed consolidated statements of operations.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$629,000 and $467,000 of stock-based compensation expenses for the six months ended June 30, 2018 were included in general and administrative expenses and research and development expenses, respectively, on the condensed consolidated statements of operations.&lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="Factid_1153170" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;New Accounting Pronouncement&lt;/div&gt;&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;s&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Recent Accounting Pronouncements Adopted in the Year&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Compensation-Stock Compensation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;In May 2017, the FASB issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) No. 2017-09, Compensation&amp;#8212;Stock Compensation (Topic 718): Scope of Modification Accounting, which clarifies when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions. It is effective prospectively for the annual period beginning after December 15, 2017 and interim periods within that annual period. Early adoption is permitted. The Company adopted ASU 2017-09 on January 1, 2018; the adoption of ASU 2017-09 did not have a material impact on its financial condition or results of operations, as the Company has not had any modifications to share-based payment awards. However, if the Company does have a modification to an award in the future, it will follow the guidance in ASU 2017-09.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Revenue from Contracts with Customers&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;In May 2014, the FASB issued ASU No. 2014-09, &amp;#8220;Revenue from Contracts with Customers (Topic 606)&amp;#8221; (ASU 2014-09) as modified by ASU No. 2015-14, &amp;#8220;Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date,&amp;#8221; ASU 2016-08, &amp;#8220;Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net),&amp;#8221; ASU No. 2016-10, &amp;#8220;Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing,&amp;#8221; and ASU No. 2016-12, &amp;#8220;Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.&amp;#8221; The revenue recognition principle in ASU 2014-09 is that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, new and enhanced disclosures will be required. Companies may adopt the new standard either using the full retrospective approach, a modified retrospective approach with practical expedients, or a cumulative effect upon adoption approach. The Company adopted the new standard effective January 1, 2018, using the modified retrospective approach. The only impact of the adoption of ASU 2014-09 was to reclassify the Company's grant income as revenue.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Accounting for Certain Financial Instruments with Down Round Features&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;On July 13, 2017, the FASB has issued a two-part ASU, No. 2017-11, (i). Accounting for Certain Financial Instruments with Down Round Features and (ii) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests With a Scope Exception.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The ASU is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 and the interim periods within that annual period. Early adoption is permitted. The Company will be evaluating the impact of adopting this standard on the consolidated financial statements and disclosures.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Improvements to Nonemployee Share-Based Payment Accounting&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;In June 2018, the FASB issued ASU 2018-07 &amp;#8220;Improvements to Nonemployee Share-Based Payment Accounting&amp;#8221;, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than an entity&amp;#8217;s adoption date of Topic 606. The Company is currently evaluating the impact of the new standard on its consolidated financial statements.&lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock id="Factid_1153155" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table sets forth the computation of net loss per share:&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align:left;"&gt;&lt;table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%;"&gt;&lt;tr&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June 30,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June 30,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2017&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2017&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Numerator:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 48%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net loss&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(4,812,797&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(1,893,377&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(8,009,283&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(4,313,262&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Denominator:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted average common shares outstanding&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;11,838,371&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;8,576,634&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;11,233,755&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;8,503,521&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net loss per share data:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basic and Diluted&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(0.41&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(0.22&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(0.71&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(0.51&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
<us-gaap:NatureOfOperations id="Factid_1153171" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 1: Nature of Operations&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="background: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="background: rgb(255, 255, 255); font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;TapImmune Inc. (the &amp;#8220;Company&amp;#8221; or &amp;#8220;we&amp;#8221;), a Nevada corporation incorporated in 1991, is a biotechnology company focusing on immunotherapy specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology. Unlike other vaccine technologies that narrowly address the initiation of an immune response, TapImmune's approach broadly stimulates the cellular immune system by enhancing the function of killer T-cells and T-helper cells and by restoring antigen presentation in tumor cells allowing their recognition&amp;#160;by the immune system.&lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NatureOfOperations>
<us-gaap:BasisOfAccounting id="Factid_1153172" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;NOTE 2: Basis of Presentation&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of America (&amp;#8220;U.S. GAAP&amp;#8221;) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) and on the same basis as the Company prepares its annual audited consolidated financial statements. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of such interim results.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The results for the condensed consolidated statement of operations are not necessarily indicative of results to be expected for the year ending December 31, 2018 or for any future interim period. The condensed consolidated balance sheet at June 30, 2018 has been derived from unaudited financial statements; however, it does not include all of the information and notes required by U.S. GAAP for complete financial statements. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2017, and notes thereto included in the Company&amp;#8217;s annual report on Form 10-K filed on March 23, 2018.&lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BasisOfAccounting>
<tpiv:LiquidityAndFinancialConditionTextBlock id="Factid_1153173" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;NOTE 3: LIQUIDITY AND FINANCIAL CONDITION&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&amp;#8217;s activities since inception have consisted principally of acquiring product and technology rights, raising capital, and performing research and development. Successful completion of the Company&amp;#8217;s development programs and, ultimately, the attainment of profitable operations are dependent on future events, including, among other things, its ability to access potential markets; secure financing, develop a customer base; attract, retain and motivate qualified personnel; and develop strategic alliances and collaborations. From inception, the Company has been funded by a combination of equity and debt financings.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company expects to continue to incur substantial losses over the next several years during its development phase. To fully execute its business plan, the Company will need to complete certain research and development activities and clinical studies. Further, the Company&amp;#8217;s product candidates will require regulatory approval prior to commercialization. These activities may span many years and require substantial expenditures to complete and may ultimately be unsuccessful. Any delays in completing these activities could adversely impact the Company. The Company plans to meet its capital requirements primarily through issuances of debt and equity securities and, in the longer term, revenue from product sales.&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of June 30, 2018, the Company had cash of approximately $7.8 million. Historically, the Company had net losses and negative cash flows from operations. Management intends to continue its research efforts and to finance operations of the Company through debt and/or equity financings. Management plans to seek additional debt and/or equity financing through private or public offerings. There can be no assurance that the Company will be successful in obtaining additional financing on favorable terms, or at all. The Company has no sources of revenue to provide incoming cash flows to sustain its future operations. The Company&amp;#8217;s ability to pursue its planned business activities is dependent upon successful efforts to raise additional capital. These factors raise substantial doubt regarding the Company&amp;#8217;s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.&lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</tpiv:LiquidityAndFinancialConditionTextBlock>
<tpiv:NetLossPerShareTableTextBlock id="Factid_1153369" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following securities, rounded to the thousand, were not included in the diluted net loss per share calculation because their effect was anti-dilutive for the periods presented:&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align:left;"&gt;&lt;table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in auto 0in 0px; width: 96%;;text-align:left;"&gt;&lt;tr&gt;&lt;td style="border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June 30,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2018&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: 0px none; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: 0px none; padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2017&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Common stock options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;439,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;455,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Common stock purchase warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;4,871,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;6,544,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Potentially dilutive securities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;5,310,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 2.5pt; background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;6,999,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</tpiv:NetLossPerShareTableTextBlock>
<tpiv:FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis id="Factid_1276129" contextRef="P01_01_2018To06_30_2018">&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Warrant liability:&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table style="font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 99%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="14" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value measured at June 30, 2018&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Quoted prices in active&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;markets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;observable inputs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;unobservable inputs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value at&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Level 1)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Level 2)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Level 3)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June 30, 2018&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="width: 755px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;Warrant liability&lt;/td&gt;&lt;td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;-&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;-&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;147,000&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 226px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;147,000&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; background: none;"&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table style="font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 99%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="14" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value measured at December 31, 2017&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Quoted prices in active&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;markets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;observable inputs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;unobservable inputs&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value at&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Level 1)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Level 2)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(Level 3)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December 31, 2017&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="width: 755px; text-align: justify; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;Warrant liability&lt;/td&gt;&lt;td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;-&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;-&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;9,000&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 226px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;9,000&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</tpiv:FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis>
<tpiv:MeasuredAtFairValue id="Factid_1276130" contextRef="P01_01_2018To06_30_2018">&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table presents changes in Level 3 liabilities measured at fair value for the six months ended June 30, 2018:&lt;/div&gt;&lt;/div&gt;&lt;div style="color: rgb(0, 0, 0); font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"&gt;&lt;div style="text-decoration: none; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;table style="font: 10pt &amp;quot;times new roman&amp;quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 69%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Warrant&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom"&gt;&lt;td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liability&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="width: 1083px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;Balance - December 31, 2017&lt;/td&gt;&lt;td style="width: 40px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 13px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="width: 158px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;9,000&lt;/td&gt;&lt;td style="width: 26px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:white"&gt;&lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt; padding-top: 0px;"&gt;Change in fair value of warrant liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: 1pt solid black; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: 1pt solid black; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;138,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:bottom; background-color:#cceeff"&gt;&lt;td style="padding-bottom: 2.5pt; padding-left: 0px; padding-top: 0px;"&gt;Balance &amp;#8211; June 30, 2018&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: 2.5pt double black; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;$&lt;/td&gt;&lt;td style="border-bottom: 2.5pt double black; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"&gt;147,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0px; padding-top: 0px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</tpiv:MeasuredAtFairValue>
<us-gaap:CashEquivalentsAtCarryingValue id="Factid_1153050" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="-5">7800000</us-gaap:CashEquivalentsAtCarryingValue>
<us-gaap:OptionIndexedToIssuersEquityShares id="Factid_1153062" contextRef="P01_01_2018To06_30_2018" unitRef="shares" decimals="0">439000</us-gaap:OptionIndexedToIssuersEquityShares>
<us-gaap:OptionIndexedToIssuersEquityShares id="Factid_1153063" contextRef="P01_01_2017To06_30_2017" unitRef="shares" decimals="0">455000</us-gaap:OptionIndexedToIssuersEquityShares>
<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="Factid_1153080" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">9000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease id="Factid_1153081" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">138000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
<us-gaap:ResearchAndDevelopmentExpense id="Factid_1153141" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">3426387</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense id="Factid_1153142" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">2191817</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense id="Factid_1152976" contextRef="P04_01_2018To06_30_2018" unitRef="USD" decimals="0">1826837</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense id="Factid_1152977" contextRef="P04_01_2017To06_30_2017" unitRef="USD" decimals="0">1202725</us-gaap:ResearchAndDevelopmentExpense>
<tpiv:CommonStockWarrantsEquityTreatment id="Factid_1153064" contextRef="P01_01_2018To06_30_2018" unitRef="shares" decimals="0">4871000</tpiv:CommonStockWarrantsEquityTreatment>
<tpiv:CommonStockWarrantsEquityTreatment id="Factid_1153065" contextRef="P01_01_2017To06_30_2017" unitRef="shares" decimals="0">6544000</tpiv:CommonStockWarrantsEquityTreatment>
<us-gaap:NetIncomeLoss id="Factid_1153157" contextRef="P04_01_2018To06_30_2018" unitRef="USD" decimals="0">-4812797</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss id="Factid_1153158" contextRef="P04_01_2017To06_30_2017" unitRef="USD" decimals="0">-1893377</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss id="Factid_1153159" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">-8009283</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss id="Factid_1153160" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">-4313262</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss id="Factid_1153028" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">-4313262</us-gaap:NetIncomeLoss>
<dei:DocumentType id="Factid_1276094" contextRef="P01_01_2018To06_30_2018">10-Q</dei:DocumentType>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Factid_1153066" contextRef="P01_01_2018To06_30_2018" unitRef="shares" decimals="0">5310000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="Factid_1153067" contextRef="P01_01_2017To06_30_2017" unitRef="shares" decimals="0">6999000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:GeneralAndAdministrativeExpense id="Factid_1152978" contextRef="P04_01_2018To06_30_2018" unitRef="USD" decimals="0">3052954</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense id="Factid_1152979" contextRef="P04_01_2017To06_30_2017" unitRef="USD" decimals="0">1190517</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense id="Factid_1153143" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">4650890</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense id="Factid_1153144" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">2618310</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="Factid_1153082" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">147000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
<us-gaap:PreferredStockParOrStatedValuePerShare id="Factid_1153091" contextRef="PAsOn06_30_2018" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare id="Factid_1153097" contextRef="PAsOn06_30_2018_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare id="Factid_1153095" contextRef="PAsOn12_31_2017" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare id="Factid_1153105" contextRef="PAsOn12_31_2017_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare id="Factid_1153113" contextRef="PAsOn12_31_2017_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare id="Factid_1153110" contextRef="PAsOn06_30_2018_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesAuthorized id="Factid_1153111" contextRef="PAsOn06_30_2018_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="shares" decimals="-5">1500000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized id="Factid_1153114" contextRef="PAsOn12_31_2017_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="shares" decimals="-5">1500000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized id="Factid_1153106" contextRef="PAsOn12_31_2017_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="shares" decimals="-4">1250000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized id="Factid_1153096" contextRef="PAsOn12_31_2017" unitRef="shares" decimals="-6">5000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized id="Factid_1153098" contextRef="PAsOn06_30_2018_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="shares" decimals="-4">1250000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized id="Factid_1153092" contextRef="PAsOn06_30_2018" unitRef="shares" decimals="-6">5000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:OperatingExpenses id="Factid_1152980" contextRef="P04_01_2018To06_30_2018" unitRef="USD" decimals="0">4879791</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses id="Factid_1152981" contextRef="P04_01_2017To06_30_2017" unitRef="USD" decimals="0">2393242</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses id="Factid_1152992" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">8077277</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses id="Factid_1152993" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">4810127</us-gaap:OperatingExpenses>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="Factid_1153161" contextRef="P04_01_2018To06_30_2018" unitRef="shares" decimals="0">11838371</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="Factid_1153162" contextRef="P04_01_2017To06_30_2017" unitRef="shares" decimals="0">8576634</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="Factid_1153163" contextRef="P01_01_2018To06_30_2018" unitRef="shares" decimals="0">11233755</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="Factid_1153164" contextRef="P01_01_2017To06_30_2017" unitRef="shares" decimals="0">8503521</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<dei:AmendmentFlag id="Factid_1276095" contextRef="P01_01_2018To06_30_2018">false</dei:AmendmentFlag>
<us-gaap:IncreaseDecreaseInDerivativeLiabilities id="Factid_1153030" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">-4500</us-gaap:IncreaseDecreaseInDerivativeLiabilities>
<us-gaap:IncreaseDecreaseInDerivativeLiabilities id="Factid_1153031" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">138000</us-gaap:IncreaseDecreaseInDerivativeLiabilities>
<us-gaap:StockholdersEquity id="Factid_1153004" contextRef="PAsOn12_31_2017_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">10616</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity id="Factid_1153005" contextRef="PAsOn12_31_2017_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">161067538</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity id="Factid_1153006" contextRef="PAsOn12_31_2017_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">-157420027</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity id="Factid_1153007" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">3658127</us-gaap:StockholdersEquity>
<us-gaap:SharesIssued id="Factid_1153008" contextRef="PAsOn12_31_2017_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="shares" decimals="0">10615724</us-gaap:SharesIssued>
<us-gaap:ShareBasedCompensation id="Factid_1153032" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">647387</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation id="Factid_1153033" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">1096472</us-gaap:ShareBasedCompensation>
<dei:DocumentPeriodEndDate id="Factid_1276096" contextRef="P01_01_2018To06_30_2018">2018-06-30</dei:DocumentPeriodEndDate>
<us-gaap:Cash id="Factid_1152942" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">7782962</us-gaap:Cash>
<us-gaap:Cash id="Factid_1152943" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">5129289</us-gaap:Cash>
<us-gaap:OperatingIncomeLoss id="Factid_1152994" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">-7871283</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss id="Factid_1152995" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">-4810127</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss id="Factid_1152982" contextRef="P04_01_2018To06_30_2018" unitRef="USD" decimals="0">-4673797</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss id="Factid_1152983" contextRef="P04_01_2017To06_30_2017" unitRef="USD" decimals="0">-2393242</us-gaap:OperatingIncomeLoss>
<us-gaap:PreferredStockSharesIssued id="Factid_1153101" contextRef="PAsOn06_30_2018_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="shares" decimals="0">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesIssued id="Factid_1153107" contextRef="PAsOn12_31_2017_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="shares" decimals="0">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesIssued id="Factid_1153115" contextRef="PAsOn12_31_2017_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="shares" decimals="0">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesIssued id="Factid_1153112" contextRef="PAsOn06_30_2018_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="shares" decimals="0">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesOutstanding id="Factid_1153117" contextRef="PAsOn06_30_2018_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="shares" decimals="0">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding id="Factid_1153118" contextRef="PAsOn12_31_2017_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="shares" decimals="0">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding id="Factid_1153108" contextRef="PAsOn06_30_2018_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="shares" decimals="0">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding id="Factid_1153109" contextRef="PAsOn12_31_2017_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="shares" decimals="0">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PrepaidExpenseCurrent id="Factid_1152944" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">108716</us-gaap:PrepaidExpenseCurrent>
<us-gaap:PrepaidExpenseCurrent id="Factid_1152945" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">51150</us-gaap:PrepaidExpenseCurrent>
<us-gaap:EarningsPerShareBasicAndDiluted id="Factid_1153165" contextRef="P04_01_2018To06_30_2018" unitRef="USD_per_Share" decimals="2">-0.41</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted id="Factid_1153166" contextRef="P04_01_2017To06_30_2017" unitRef="USD_per_Share" decimals="2">-0.22</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted id="Factid_1153167" contextRef="P01_01_2018To06_30_2018" unitRef="USD_per_Share" decimals="2">-0.71</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted id="Factid_1153168" contextRef="P01_01_2017To06_30_2017" unitRef="USD_per_Share" decimals="2">-0.51</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:SharePrice id="Factid_1161744" contextRef="PAsOn06_30_2018_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis" unitRef="USD_per_Share" decimals="2">9.43</us-gaap:SharePrice>
<us-gaap:SharePrice id="Factid_1161745" contextRef="PAsOn06_30_2017_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis" unitRef="USD_per_Share" decimals="2">3.88</us-gaap:SharePrice>
<dei:DocumentFiscalYearFocus id="Factid_1276097" contextRef="P01_01_2018To06_30_2018">2018</dei:DocumentFiscalYearFocus>
<tpiv:PrivatePlacementAmount id="Factid_1153216" contextRef="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">1300</tpiv:PrivatePlacementAmount>
<tpiv:PrivatePlacementAmount id="Factid_1153217" contextRef="P01_01_2018To06_30_2018_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">3118700</tpiv:PrivatePlacementAmount>
<tpiv:PrivatePlacementAmount id="Factid_1153218" contextRef="P01_01_2018To06_30_2018_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">0</tpiv:PrivatePlacementAmount>
<tpiv:PrivatePlacementAmount id="Factid_1153219" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">3120000</tpiv:PrivatePlacementAmount>
<tpiv:PrivatePlacementShare id="Factid_1153215" contextRef="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="shares" decimals="0">1300000</tpiv:PrivatePlacementShare>
<dei:DocumentFiscalPeriodFocus id="Factid_1276098" contextRef="P01_01_2018To06_30_2018">Q2</dei:DocumentFiscalPeriodFocus>
<us-gaap:IncreaseDecreaseInPrepaidExpense id="Factid_1153034" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">109032</us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInPrepaidExpense id="Factid_1153035" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">57566</us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:DerivativeFairValueOfDerivativeLiability id="Factid_1153146" contextRef="PAsOn06_30_2018_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="USD" decimals="0">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
<us-gaap:DerivativeFairValueOfDerivativeLiability id="Factid_1153147" contextRef="PAsOn06_30_2018_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="USD" decimals="0">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
<us-gaap:DerivativeFairValueOfDerivativeLiability id="Factid_1153148" contextRef="PAsOn06_30_2018_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="USD" decimals="0">147000</us-gaap:DerivativeFairValueOfDerivativeLiability>
<us-gaap:DerivativeFairValueOfDerivativeLiability id="Factid_1153149" contextRef="PAsOn06_30_2018_FairValueHedgingMemberusgaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis" unitRef="USD" decimals="0">147000</us-gaap:DerivativeFairValueOfDerivativeLiability>
<us-gaap:DerivativeFairValueOfDerivativeLiability id="Factid_1153150" contextRef="PAsOn12_31_2017_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="USD" decimals="0">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
<us-gaap:DerivativeFairValueOfDerivativeLiability id="Factid_1153151" contextRef="PAsOn12_31_2017_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="USD" decimals="0">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
<us-gaap:DerivativeFairValueOfDerivativeLiability id="Factid_1153152" contextRef="PAsOn12_31_2017_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="USD" decimals="0">9000</us-gaap:DerivativeFairValueOfDerivativeLiability>
<us-gaap:DerivativeFairValueOfDerivativeLiability id="Factid_1153153" contextRef="PAsOn12_31_2017_FairValueHedgingMemberusgaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis" unitRef="USD" decimals="0">9000</us-gaap:DerivativeFairValueOfDerivativeLiability>
<us-gaap:AssetsCurrent id="Factid_1152946" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">7891678</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent id="Factid_1152947" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">5180439</us-gaap:AssetsCurrent>
<us-gaap:CommonStockParOrStatedValuePerShare id="Factid_1153121" contextRef="PAsOn12_31_2017" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare id="Factid_1153119" contextRef="PAsOn06_30_2018" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:DerivativeGainLossOnDerivativeNet id="Factid_1152984" contextRef="P04_01_2018To06_30_2018" unitRef="USD" decimals="0">-139000</us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet id="Factid_1152985" contextRef="P04_01_2017To06_30_2017" unitRef="USD" decimals="0">7500</us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet id="Factid_1152996" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">-138000</us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet id="Factid_1152997" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">4500</us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:CommonStockSharesAuthorized id="Factid_1153120" contextRef="PAsOn06_30_2018" unitRef="shares" decimals="-5">41700000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized id="Factid_1153122" contextRef="PAsOn12_31_2017" unitRef="shares" decimals="-5">41700000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:Assets id="Factid_1152948" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">7891678</us-gaap:Assets>
<us-gaap:Assets id="Factid_1152949" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">5180439</us-gaap:Assets>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="Factid_1153036" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">336135</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities id="Factid_1153037" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">2086840</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Factid_1153009" contextRef="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">10</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Factid_1153010" contextRef="P01_01_2018To06_30_2018_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">18115</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Factid_1153011" contextRef="P01_01_2018To06_30_2018_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Factid_1153012" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">18125</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<dei:EntityRegistrantName id="Factid_1276099" contextRef="P01_01_2018To06_30_2018">TAPIMMUNE INC.</dei:EntityRegistrantName>
<us-gaap:GainsLossesOnExtinguishmentOfDebt id="Factid_1153265" contextRef="P04_01_2018To06_30_2018" unitRef="USD" decimals="0">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
<us-gaap:GainsLossesOnExtinguishmentOfDebt id="Factid_1153266" contextRef="P04_01_2017To06_30_2017" unitRef="USD" decimals="0">492365</us-gaap:GainsLossesOnExtinguishmentOfDebt>
<us-gaap:GainsLossesOnExtinguishmentOfDebt id="Factid_1153267" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
<us-gaap:GainsLossesOnExtinguishmentOfDebt id="Factid_1153268" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">492365</us-gaap:GainsLossesOnExtinguishmentOfDebt>
<dei:EntityCentralIndexKey id="Factid_1276100" contextRef="P01_01_2018To06_30_2018">0001094038</dei:EntityCentralIndexKey>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Factid_1153013" contextRef="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="shares" decimals="0">10416</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:NetCashProvidedByUsedInOperatingActivities id="Factid_1153038" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">-3935637</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities id="Factid_1153039" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">-4745537</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:CommonStockSharesIssued id="Factid_1153123" contextRef="PAsOn06_30_2018" unitRef="shares" decimals="-5">13600000</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued id="Factid_1153263" contextRef="PAsOn12_31_2017" unitRef="shares" decimals="-5">10600000</us-gaap:CommonStockSharesIssued>
<us-gaap:ShareBasedCompensation id="Factid_1153087" contextRef="P01_01_2018To06_30_2018_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis" unitRef="USD" decimals="0">629000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation id="Factid_1153088" contextRef="P01_01_2018To06_30_2018_SellingGeneralAndAdministrativeExpensesMemberusgaapIncomeStatementLocationAxis" unitRef="USD" decimals="0">467000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation id="Factid_1153099" contextRef="P04_01_2018To06_30_2018_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis" unitRef="USD" decimals="0">596000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation id="Factid_1153100" contextRef="P04_01_2018To06_30_2018_SellingGeneralAndAdministrativeExpensesMemberusgaapIncomeStatementLocationAxis" unitRef="USD" decimals="0">364000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation id="Factid_1153083" contextRef="P04_01_2018To06_30_2018" unitRef="USD" decimals="0">960000</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation id="Factid_1153084" contextRef="P04_01_2017To06_30_2017" unitRef="USD" decimals="0">271000</us-gaap:ShareBasedCompensation>
<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized id="Factid_1153085" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">159000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
<us-gaap:EarningsPerShareBasicAndDiluted id="Factid_1152989" contextRef="P04_01_2017To06_30_2017" unitRef="USD_per_Share" decimals="2">-0.22</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted id="Factid_1153001" contextRef="P01_01_2017To06_30_2017" unitRef="USD_per_Share" decimals="2">-0.51</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:CommonStockSharesOutstanding id="Factid_1153264" contextRef="PAsOn06_30_2018" unitRef="shares" decimals="-5">13600000</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding id="Factid_1153126" contextRef="PAsOn12_31_2017" unitRef="shares" decimals="-5">10600000</us-gaap:CommonStockSharesOutstanding>
<dei:CurrentFiscalYearEndDate id="Factid_1276101" contextRef="P01_01_2018To06_30_2018">--12-31</dei:CurrentFiscalYearEndDate>
<dei:EntityFilerCategory id="Factid_1276102" contextRef="P01_01_2018To06_30_2018">Smaller Reporting Company</dei:EntityFilerCategory>
<tpiv:ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement id="Factid_1153207" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">3120000</tpiv:ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement>
<tpiv:ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement id="Factid_1153208" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">5408343</tpiv:ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement>
<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="Factid_1153086" contextRef="P01_01_2018To06_30_2018">P5M23D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="Factid_1152950" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">3595152</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="Factid_1152951" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">1508312</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
<us-gaap:DerivativeLiabilitiesCurrent id="Factid_1152952" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">147000</us-gaap:DerivativeLiabilitiesCurrent>
<us-gaap:DerivativeLiabilitiesCurrent id="Factid_1152953" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">9000</us-gaap:DerivativeLiabilitiesCurrent>
<us-gaap:ProceedsFromWarrantExercises id="Factid_1153209" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">4261085</us-gaap:ProceedsFromWarrantExercises>
<us-gaap:ProceedsFromWarrantExercises id="Factid_1153210" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">638666</us-gaap:ProceedsFromWarrantExercises>
<dei:TradingSymbol id="Factid_1276103" contextRef="P01_01_2018To06_30_2018">TPIV</dei:TradingSymbol>
<dei:EntityCommonStockSharesOutstanding id="Factid_1276104" contextRef="PAsOn08_02_2018" unitRef="shares" decimals="0">13710544</dei:EntityCommonStockSharesOutstanding>
<us-gaap:CashPeriodIncreaseDecrease id="Factid_1153044" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">2111372</us-gaap:CashPeriodIncreaseDecrease>
<us-gaap:CashPeriodIncreaseDecrease id="Factid_1153045" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">2653673</us-gaap:CashPeriodIncreaseDecrease>
<us-gaap:NotesPayableCurrent id="Factid_1152954" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">5000</us-gaap:NotesPayableCurrent>
<us-gaap:NotesPayableCurrent id="Factid_1152955" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">5000</us-gaap:NotesPayableCurrent>
<us-gaap:LiabilitiesCurrent id="Factid_1152956" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">3747152</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent id="Factid_1152957" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">1522312</us-gaap:LiabilitiesCurrent>
<us-gaap:Cash id="Factid_1153046" contextRef="PAsOn12_31_2016" unitRef="USD" decimals="0">7851243</us-gaap:Cash>
<us-gaap:Cash id="Factid_1153048" contextRef="PAsOn06_30_2017" unitRef="USD" decimals="0">9962615</us-gaap:Cash>
<us-gaap:Liabilities id="Factid_1152958" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">3747152</us-gaap:Liabilities>
<us-gaap:Liabilities id="Factid_1152959" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">1522312</us-gaap:Liabilities>
<us-gaap:CommitmentsAndContingencies id="Factid_1152960" contextRef="PAsOn06_30_2018" unitRef="USD" xsi:nil="true" />
<us-gaap:CommitmentsAndContingencies id="Factid_1152961" contextRef="PAsOn12_31_2017" unitRef="USD" xsi:nil="true" />
<us-gaap:PreferredStockValue id="Factid_1152966" contextRef="PAsOn06_30_2018_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
<us-gaap:PreferredStockValue id="Factid_1152967" contextRef="PAsOn12_31_2017_SeriesAPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
<us-gaap:PreferredStockValue id="Factid_1152968" contextRef="PAsOn06_30_2018_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
<us-gaap:PreferredStockValue id="Factid_1152969" contextRef="PAsOn12_31_2017_SeriesBPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="USD" decimals="0">0</us-gaap:PreferredStockValue>
<us-gaap:CommonStockValue id="Factid_1152970" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">13624</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue id="Factid_1152971" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">10616</us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapital id="Factid_1152972" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">170287725</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital id="Factid_1152973" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">161067538</us-gaap:AdditionalPaidInCapital>
<us-gaap:RetainedEarningsAccumulatedDeficit id="Factid_1152974" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">-166156823</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit id="Factid_1152975" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">-157420027</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Factid_1153243" contextRef="P01_01_2018To01_31_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="shares" decimals="0">10416</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="Factid_1153244" contextRef="P01_01_2018To01_31_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="USD_per_Share" decimals="2">1.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
<us-gaap:StockholdersEquity id="Factid_1152962" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">4144526</us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity id="Factid_1152964" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">7891678</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity id="Factid_1152965" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">5180439</us-gaap:LiabilitiesAndStockholdersEquity>
<tpiv:GrantIncomeTextBlock id="Factid_1153093" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-size: 10pt; text-transform: uppercase; font-family: &amp;quot;times new roman&amp;quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 9:&amp;#160;&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;grant income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;During the six months ended June 30, 2018, the Company received $0.2 million of a grant awarded to Mayo Foundation from the U.S. Department of Defense for the Phase II Clinical Trial of TPIV200. The grant compensated the Company for clinical supplies manufactured and provided by the Company for the clinical study. In accordance with Accounting Standards Update No. 2014-09, &amp;#8220;Revenue from Contracts with Customers (Topic 606)&amp;#8221; issued by the Financial Accounting Standards Board, the Company recorded the $0.2 million of grant income as revenue.&lt;/div&gt;&lt;/div&gt; &lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</tpiv:GrantIncomeTextBlock>
<tpiv:ValuationMethodologyTableTextBlock id="Factid_1153128" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;A weighted average summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company&amp;#8217;s common stock purchase warrants that are included in the modification is as follows:&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align:left;"&gt;&lt;table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in auto 0in 0px; width: 60%;;text-align:left;"&gt;&lt;tr&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted Average Inputs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Before&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;After&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Modification&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Modification&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 64%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Exercise price&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 15%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;9.93&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 15%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.50&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Contractual term (years)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.37&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.37&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Volatility (annual)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;79&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;79&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Risk-free rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;1.5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;1.5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield (per share)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;0&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;0&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</tpiv:ValuationMethodologyTableTextBlock>
<tpiv:SharePurchaseWarrantsTableTextBlock id="Factid_1153127" contextRef="P01_01_2018To06_30_2018">&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;A summary of the Company&amp;#8217;s share purchase warrants as of June 30, 2018 and changes during the period is presented below:&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"&gt;&lt;div style="white-space: pre-line; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align:left;"&gt;&lt;table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%;;text-align:left;"&gt;&lt;tr&gt;&lt;td style="border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted Average&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number of&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted Average&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Remaining Contractual&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total Intrinsic&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="white-space: pre-wrap; font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Exercise Price&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Life (in years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal;"&gt;&lt;div style="background: none;;font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Balance - January 1, 2018&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,520,000&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6.11&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3.16&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,739,000&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Issued&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cashless exercised&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(118,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.01&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Exercised for cash&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(1,447,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.95&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;Expired or Cancelled&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;(84,000&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.01&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;-&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Balance - June 30, 2018&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,871,000&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 2.5pt; background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.94&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 2.5pt; background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2.76&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0in 0in 2.5pt; background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom;"&gt;&lt;div style="font-size: 10pt; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20,417,000&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"&gt;&lt;div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"&gt;&lt;div style="font-family: &amp;quot;times new roman&amp;quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</tpiv:SharePurchaseWarrantsTableTextBlock>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Factid_1153002" contextRef="P01_01_2018To06_30_2018" unitRef="shares" decimals="0">11233755</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Factid_1153003" contextRef="P01_01_2017To06_30_2017" unitRef="shares" decimals="0">8503521</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Factid_1152990" contextRef="P04_01_2018To06_30_2018" unitRef="shares" decimals="0">11838371</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Factid_1152991" contextRef="P04_01_2017To06_30_2017" unitRef="shares" decimals="0">8576634</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax id="Factid_1161776" contextRef="P04_01_2018To06_30_2018_GrantMembersrtProductOrServiceAxis" unitRef="USD" decimals="0">205994</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax id="Factid_1161777" contextRef="P04_01_2017To06_30_2017_GrantMembersrtProductOrServiceAxis" unitRef="USD" decimals="0">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax id="Factid_1161778" contextRef="P01_01_2018To06_30_2018_GrantMembersrtProductOrServiceAxis" unitRef="USD" decimals="0">205994</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
<us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax id="Factid_1161779" contextRef="P01_01_2017To06_30_2017_GrantMembersrtProductOrServiceAxis" unitRef="USD" decimals="0">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
<us-gaap:Revenues id="Factid_1153134" contextRef="P04_01_2018To06_30_2018" unitRef="USD" decimals="0">205994</us-gaap:Revenues>
<us-gaap:Revenues id="Factid_1153135" contextRef="P04_01_2017To06_30_2017" unitRef="USD" decimals="0">0</us-gaap:Revenues>
<us-gaap:Revenues id="Factid_1153136" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">205994</us-gaap:Revenues>
<us-gaap:Revenues id="Factid_1153137" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">0</us-gaap:Revenues>
<tpiv:ExerciseOfWarrantsAmount id="Factid_1157948" contextRef="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">1447</tpiv:ExerciseOfWarrantsAmount>
<tpiv:ExerciseOfWarrantsAmount id="Factid_1157949" contextRef="P01_01_2018To06_30_2018_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">4259638</tpiv:ExerciseOfWarrantsAmount>
<tpiv:ExerciseOfWarrantsAmount id="Factid_1157950" contextRef="P01_01_2018To06_30_2018_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">0</tpiv:ExerciseOfWarrantsAmount>
<tpiv:ExerciseOfWarrantsAmount id="Factid_1157951" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">4261085</tpiv:ExerciseOfWarrantsAmount>
<tpiv:ExerciseOfWarrantsShare id="Factid_1157945" contextRef="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="shares" decimals="0">1446881</tpiv:ExerciseOfWarrantsShare>
<tpiv:WarrantOfCashlessExercised id="Factid_1273429" contextRef="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">118</tpiv:WarrantOfCashlessExercised>
<tpiv:WarrantOfCashlessExercised id="Factid_1273430" contextRef="P01_01_2018To06_30_2018_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">-118</tpiv:WarrantOfCashlessExercised>
<tpiv:WarrantOfCashlessExercised id="Factid_1273431" contextRef="P01_01_2018To06_30_2018_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">0</tpiv:WarrantOfCashlessExercised>
<tpiv:WarrantOfCashlessExercised id="Factid_1273432" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">0</tpiv:WarrantOfCashlessExercised>
<tpiv:WarrantOfCashlessExercisedSharesIssued id="Factid_1273428" contextRef="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="shares" decimals="0">118425</tpiv:WarrantOfCashlessExercisedSharesIssued>
<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="Factid_1273434" contextRef="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">133</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="Factid_1273435" contextRef="P01_01_2018To06_30_2018_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">1096339</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="Factid_1273436" contextRef="P01_01_2018To06_30_2018_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="Factid_1273437" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">1096472</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
<us-gaap:GainsLossesOnExtinguishmentOfDebt id="Factid_1153206" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">492365</us-gaap:GainsLossesOnExtinguishmentOfDebt>
<us-gaap:ProceedsFromStockOptionsExercised id="Factid_1153040" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromStockOptionsExercised>
<us-gaap:ProceedsFromStockOptionsExercised id="Factid_1153041" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">18125</us-gaap:ProceedsFromStockOptionsExercised>
<us-gaap:ClassOfWarrantOrRightOutstanding id="Factid_1153225" contextRef="PAsOn12_31_2017" unitRef="shares" decimals="0">6520000</us-gaap:ClassOfWarrantOrRightOutstanding>
<tpiv:NumberOfWarrantIssued id="Factid_1153228" contextRef="P01_01_2018To06_30_2018" unitRef="shares" decimals="0">0</tpiv:NumberOfWarrantIssued>
<us-gaap:NetCashProvidedByUsedInFinancingActivities id="Factid_1153042" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">6047009</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities id="Factid_1153043" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">7399210</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<tpiv:NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement id="Factid_1153211" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">727513</tpiv:NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement>
<tpiv:NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement id="Factid_1153212" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">622042</tpiv:NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement>
<tpiv:NumberOfWarrantsCashlessExercised id="Factid_1161738" contextRef="P01_01_2018To06_30_2018" unitRef="shares" decimals="0">-118000</tpiv:NumberOfWarrantsCashlessExercised>
<tpiv:NumberOfWarrantExercisedForCash id="Factid_1153233" contextRef="P01_01_2018To06_30_2018" unitRef="shares" decimals="0">-1447000</tpiv:NumberOfWarrantExercisedForCash>
<tpiv:NumberOfWarrantExpiredOrCancelled id="Factid_1153235" contextRef="P01_01_2018To06_30_2018" unitRef="shares" decimals="0">-84000</tpiv:NumberOfWarrantExpiredOrCancelled>
<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross id="Factid_1273433" contextRef="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="shares" decimals="0">132825</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
<us-gaap:ClassOfWarrantOrRightOutstanding id="Factid_1153237" contextRef="PAsOn06_30_2018" unitRef="shares" decimals="0">4871000</us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="Factid_1153201" contextRef="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="Factid_1153202" contextRef="P01_01_2018To06_30_2018_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">727513</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="Factid_1153203" contextRef="P01_01_2018To06_30_2018_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">-727513</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="Factid_1153204" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<tpiv:ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice id="Factid_1154836" contextRef="PAsOn12_31_2017" unitRef="USD_per_Share" decimals="2">6.11</tpiv:ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice>
<tpiv:ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice id="Factid_1153229" contextRef="P01_01_2018To06_30_2018" unitRef="USD_per_Share" decimals="0">0</tpiv:ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice>
<tpiv:ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice id="Factid_1153232" contextRef="P01_01_2018To06_30_2018" unitRef="USD_per_Share" decimals="2">4.01</tpiv:ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice>
<tpiv:ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash id="Factid_1153234" contextRef="P01_01_2018To06_30_2018" unitRef="USD_per_Share" decimals="2">2.95</tpiv:ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash>
<tpiv:ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice id="Factid_1153236" contextRef="P01_01_2018To06_30_2018" unitRef="USD_per_Share" decimals="2">4.01</tpiv:ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice>
<tpiv:ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice id="Factid_1154837" contextRef="PAsOn06_30_2018" unitRef="USD_per_Share" decimals="2">5.94</tpiv:ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice>
<tpiv:ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife id="Factid_1153239" contextRef="P01_01_2018To06_30_2018">P2Y9M4D</tpiv:ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife>
<tpiv:ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife id="Factid_1153262" contextRef="P01_01_2017To12_31_2017">P3Y1M28D</tpiv:ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Factid_1153259" contextRef="P05_01_2018To05_14_2018" unitRef="shares" decimals="0">1300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:SharesIssuedPricePerShare id="Factid_1153247" contextRef="PAsOn05_14_2018_EasternCapitalLimitedMemberdeiLegalEntityAxis" unitRef="USD_per_Share" decimals="2">2.40</us-gaap:SharesIssuedPricePerShare>
<us-gaap:SharesIssuedPricePerShare id="Factid_1153248" contextRef="PAsOn05_14_2018" unitRef="USD_per_Share" decimals="2">2.50</us-gaap:SharesIssuedPricePerShare>
<us-gaap:StockIssuedDuringPeriodValueNewIssues id="Factid_1153260" contextRef="P05_01_2018To05_14_2018" unitRef="USD" decimals="-4">3120000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="Factid_1153249" contextRef="PAsOn05_14_2018" unitRef="shares" decimals="0">782505</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights id="Factid_1153251" contextRef="PAsOn06_30_2018" unitRef="shares" decimals="0">782800</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:ProceedsFromWarrantExercises id="Factid_1153261" contextRef="P05_01_2018To05_14_2018" unitRef="USD" decimals="-5">2000000</us-gaap:ProceedsFromWarrantExercises>
<tpiv:ExerciseOfWarrantsAmount id="Factid_1153250" contextRef="P01_01_2018To06_30_2018_WarrantMemberusgaapFinancialInstrumentAxis" unitRef="USD" decimals="0">728000</tpiv:ExerciseOfWarrantsAmount>
<us-gaap:AllocatedShareBasedCompensationExpense id="Factid_1153255" contextRef="P01_01_2018To06_30_2018_ConsultingArrangementsMemberTPIVArrangementsAxis" unitRef="USD" decimals="0">132825</us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense id="Factid_1153256" contextRef="P01_01_2018To06_30_2018_ConsultingArrangementsMemberTPIVArrangementsAxis" unitRef="USD" decimals="0">644000</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:ResearchAndDevelopmentExpense id="Factid_1153257" contextRef="P01_01_2018To06_30_2018_ConsultingArrangementsMemberTPIVArrangementsAxis" unitRef="USD" decimals="0">563000</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="Factid_1153258" contextRef="P01_01_2018To06_30_2018_ConsultingArrangementsMemberTPIVArrangementsAxis" unitRef="shares" decimals="0">81000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:NetIncomeLoss id="Factid_1152987" contextRef="P04_01_2017To06_30_2017" unitRef="USD" decimals="0">-1893377</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss id="Factid_1153019" contextRef="P01_01_2018To06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss id="Factid_1153020" contextRef="P01_01_2018To06_30_2018_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">0</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss id="Factid_1153021" contextRef="P01_01_2018To06_30_2018_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">-8009283</us-gaap:NetIncomeLoss>
<tpiv:ClassOfWarrantOrRightOutStandingIntrinsicValue id="Factid_1154840" contextRef="PAsOn12_31_2017" unitRef="USD" decimals="0">1739000</tpiv:ClassOfWarrantOrRightOutStandingIntrinsicValue>
<tpiv:ClassOfWarrantOrRightOutStandingIntrinsicValue id="Factid_1154841" contextRef="PAsOn06_30_2018" unitRef="USD" decimals="0">20417000</tpiv:ClassOfWarrantOrRightOutStandingIntrinsicValue>
<us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax id="Factid_1161774" contextRef="P01_01_2018To06_30_2018_AccountingStandardsUpdate201409MemberusgaapAdjustmentsForNewAccountingPronouncementsAxis_GrantMembersrtProductOrServiceAxis" unitRef="USD" decimals="-5">200000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
<us-gaap:StockholdersEquity id="Factid_1153023" contextRef="PAsOn06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">13624</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity id="Factid_1153024" contextRef="PAsOn06_30_2018_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">170287725</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity id="Factid_1153025" contextRef="PAsOn06_30_2018_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="USD" decimals="0">-166156823</us-gaap:StockholdersEquity>
<us-gaap:SharesIssued id="Factid_1153027" contextRef="PAsOn06_30_2018_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="shares" decimals="0">13624271</us-gaap:SharesIssued>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161712" contextRef="PAsOn06_30_2018_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsBeforeModificationMemberusgaapClassOfWarrantOrRightAxis" unitRef="pure" decimals="2">9.93</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161713" contextRef="PAsOn06_30_2017_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsAfterModificationMemberusgaapClassOfWarrantOrRightAxis" unitRef="pure" decimals="2">2.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161716" contextRef="PAsOn06_30_2018_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsBeforeModificationMemberusgaapClassOfWarrantOrRightAxis" unitRef="pure" decimals="0">79</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161717" contextRef="PAsOn06_30_2017_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsAfterModificationMemberusgaapClassOfWarrantOrRightAxis" unitRef="pure" decimals="0">79</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161718" contextRef="PAsOn06_30_2018_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsBeforeModificationMemberusgaapClassOfWarrantOrRightAxis" unitRef="pure" decimals="1">1.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161719" contextRef="PAsOn06_30_2017_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsAfterModificationMemberusgaapClassOfWarrantOrRightAxis" unitRef="pure" decimals="1">1.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161720" contextRef="PAsOn06_30_2018_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsBeforeModificationMemberusgaapClassOfWarrantOrRightAxis" unitRef="pure" decimals="0">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161721" contextRef="PAsOn06_30_2017_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsAfterModificationMemberusgaapClassOfWarrantOrRightAxis" unitRef="pure" decimals="0">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingTerm id="Factid_1161714" contextRef="PAsOn06_30_2018_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsBeforeModificationMemberusgaapClassOfWarrantOrRightAxis">P2Y4M13D</us-gaap:WarrantsAndRightsOutstandingTerm>
<us-gaap:WarrantsAndRightsOutstandingTerm id="Factid_1161715" contextRef="PAsOn06_30_2017_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis_WeightedAverageInputsAfterModificationMemberusgaapClassOfWarrantOrRightAxis">P2Y4M13D</us-gaap:WarrantsAndRightsOutstandingTerm>
<tpiv:NonCashExcerciseOfWarrantsAmount id="Factid_1161709" contextRef="P01_01_2018To06_30_2018" unitRef="USD" decimals="0">118</tpiv:NonCashExcerciseOfWarrantsAmount>
<tpiv:NonCashExcerciseOfWarrantsAmount id="Factid_1161710" contextRef="P01_01_2017To06_30_2017" unitRef="USD" decimals="0">0</tpiv:NonCashExcerciseOfWarrantsAmount>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161746" contextRef="PAsOn06_30_2018_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis" unitRef="pure" decimals="2">8.67</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161747" contextRef="PAsOn06_30_2017_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis" unitRef="pure" decimals="2">1.20</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161750" contextRef="PAsOn06_30_2018_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis" unitRef="pure" decimals="0">83</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161751" contextRef="PAsOn06_30_2017_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis" unitRef="pure" decimals="0">78</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161752" contextRef="PAsOn06_30_2018_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis" unitRef="pure" decimals="0">1</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161753" contextRef="PAsOn06_30_2017_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis" unitRef="pure" decimals="0">1</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161754" contextRef="PAsOn06_30_2018_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis" unitRef="pure" decimals="0">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingMeasurementInput id="Factid_1161755" contextRef="PAsOn06_30_2017_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis" unitRef="pure" decimals="0">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
<us-gaap:WarrantsAndRightsOutstandingTerm id="Factid_1161748" contextRef="PAsOn06_30_2018_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">P1Y3M25D</us-gaap:WarrantsAndRightsOutstandingTerm>
<us-gaap:WarrantsAndRightsOutstandingTerm id="Factid_1161749" contextRef="PAsOn06_30_2017_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_SharePurchaseWarrantsMemberusgaapStatementEquityComponentsAxis">P1Y0M11D</us-gaap:WarrantsAndRightsOutstandingTerm>
<xbrli:unit id="USD">
<xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="shares">
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="pure">
<xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="USD_per_Share">
<xbrli:divide>
<xbrli:unitNumerator>
<xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unitNumerator>
<xbrli:unitDenominator>
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unitDenominator>
</xbrli:divide>
</xbrli:unit>
<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended" />
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>tpiv-20180630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DataTracks version 3.0 on 09-August-2018 [11:07:37] {AM} EST - www.datatracks.com-->
<schema targetNamespace="http://www.tapimmune.com/20180630" elementFormDefault="qualified" xmlns:tpiv="http://www.tapimmune.com/20180630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2018-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:srt="http://fasb.org/srt/2018-01-31">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.tapimmune.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
<link:definition>1001 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
<link:definition>1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
<link:definition>1003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfOperations" id="CondensedConsolidatedStatementsOfOperations">
<link:definition>1004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/CondensedConsolidatedStatementOfStockholdersEquity" id="CondensedConsolidatedStatementOfStockholdersEquity">
<link:definition>1005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfCashFlows" id="CondensedConsolidatedStatementsOfCashFlows">
<link:definition>1006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/NatureOfOperations" id="NatureOfOperations">
<link:definition>1007 - Disclosure - NATURE OF OPERATIONS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/BasisOfPresentation" id="BasisOfPresentation">
<link:definition>1008 - Disclosure - BASIS OF PRESENTATION</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/LiquidityAndFinancialCondition" id="LiquidityAndFinancialCondition">
<link:definition>1009 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
<link:definition>1010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholder" id="NetLossPerShareApplicableToCommonShareholder">
<link:definition>1011 - Disclosure - NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurements" id="WarrantLiabilityAndFairValueMeasurements">
<link:definition>1012 - Disclosure - WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/StockholdersEquity" id="StockholdersEquity">
<link:definition>1013 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/StockBasedCompensation" id="StockBasedCompensation">
<link:definition>1014 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/GrantIncome" id="GrantIncome">
<link:definition>1015 - Disclosure - GRANT INCOME</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
<link:definition>1016 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderTables" id="NetLossPerShareApplicableToCommonShareholderTables">
<link:definition>1017 - Disclosure - NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsTables" id="WarrantLiabilityAndFairValueMeasurementsTables">
<link:definition>1018 - Disclosure - WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
<link:definition>1019 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/LiquidityAndFinancialConditionAdditionalInformationDetail" id="LiquidityAndFinancialConditionAdditionalInformationDetail">
<link:definition>1020 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderComputationOfIncomeLossPerShareDetail" id="NetLossPerShareApplicableToCommonShareholderComputationOfIncomeLossPerShareDetail">
<link:definition>1021 - Disclosure - NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER - Computation of income (loss) per share (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderPotentiallyDilutiveSecuritiesDetail" id="NetLossPerShareApplicableToCommonShareholderPotentiallyDilutiveSecuritiesDetail">
<link:definition>1022 - Disclosure - NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER - Potentially Dilutive Securities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionValuationMethodologyDetail" id="WarrantLiabilityAndFairValueMeasurementsConversionOptionValuationMethodologyDetail">
<link:definition>1023 - Disclosure - WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS - Conversion Option - Valuation Methodology (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" id="WarrantLiabilityAndFairValueMeasurementsConversionOptionFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail">
<link:definition>1024 - Disclosure - WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS - Conversion Option - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionScheduleOfChangesInLevel3LiabilitiesMeasuredAtFairValueDetail" id="WarrantLiabilityAndFairValueMeasurementsConversionOptionScheduleOfChangesInLevel3LiabilitiesMeasuredAtFairValueDetail">
<link:definition>1025 - Disclosure - WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS - Conversion Option - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/StockholdersEquityWeightedAverageSummaryOfQuantitativeInformationDetail" id="StockholdersEquityWeightedAverageSummaryOfQuantitativeInformationDetail">
<link:definition>1026 - Disclosure - STOCKHOLDERS' EQUITY -  Weighted average summary of quantitative information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/StockholdersEquitySummaryOfTheCompanySSharePurchaseWarrantsDetail" id="StockholdersEquitySummaryOfTheCompanySSharePurchaseWarrantsDetail">
<link:definition>1027 - Disclosure - STOCKHOLDERS' EQUITY- Summary of the Company's share purchase warrants (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/StockholdersEquityAdditionalInformationDetail" id="StockholdersEquityAdditionalInformationDetail">
<link:definition>1028 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/StockBasedCompensationAdditionalInformationDetail" id="StockBasedCompensationAdditionalInformationDetail">
<link:definition>1029 - Disclosure - STOCK-BASED COMPENSATION - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.tapimmune.com/role/GrantIncomeAdditionalInformationDetail" id="GrantIncomeAdditionalInformationDetail">
<link:definition>1030 - Disclosure - GRANT INCOME - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="tpiv-20180630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="tpiv-20180630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="tpiv-20180630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="tpiv-20180630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://fasb.org/us-gaap/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/exch/2018-01-31" schemaLocation="https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2018-01-31" schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
<import namespace="http://fasb.org/us-types/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd" />
<import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd" />
<element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_DocumentAndEntityInformationAbstract" substitutionGroup="xbrli:item" />
<element name="ExerciseOfWarrantsAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_ExerciseOfWarrantsAmount" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="PrivatePlacementAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_PrivatePlacementAmount" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="PrivatePlacementShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_PrivatePlacementShare" substitutionGroup="xbrli:item" />
<element name="WarrantOfCashlessExercised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_WarrantOfCashlessExercised" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="WarrantOfCashlessExercisedSharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_WarrantOfCashlessExercisedSharesIssued" substitutionGroup="xbrli:item" />
<element name="ExerciseOfWarrantsShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_ExerciseOfWarrantsShare" substitutionGroup="xbrli:item" />
<element name="ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="NonCashExcerciseOfWarrantsAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_NonCashExcerciseOfWarrantsAmount" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="LiquidityAndFinancialConditionTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_LiquidityAndFinancialConditionTextBlock" substitutionGroup="xbrli:item" />
<element name="DerivativesAndFairValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_DerivativesAndFairValueAbstract" substitutionGroup="xbrli:item" />
<element name="GrantIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_GrantIncomeAbstract" substitutionGroup="xbrli:item" />
<element name="GrantIncomeTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_GrantIncomeTextBlock" substitutionGroup="xbrli:item" />
<element name="NetLossPerShareTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_NetLossPerShareTableTextBlock" substitutionGroup="xbrli:item" />
<element name="ValuationMethodology" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_ValuationMethodology" substitutionGroup="xbrli:item" />
<element name="FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis" substitutionGroup="xbrli:item" />
<element name="MeasuredAtFairValue" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_MeasuredAtFairValue" substitutionGroup="xbrli:item" />
<element name="SharePurchaseWarrantsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_SharePurchaseWarrantsTableTextBlock" substitutionGroup="xbrli:item" />
<element name="ValuationMethodologyTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_ValuationMethodologyTableTextBlock" substitutionGroup="xbrli:item" />
<element name="CommonStockWarrantsEquityTreatment" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_CommonStockWarrantsEquityTreatment" substitutionGroup="xbrli:item" />
<element name="SharePurchaseWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_SharePurchaseWarrantsMember" substitutionGroup="xbrli:item" />
<element name="WeightedAverageInputsBeforeModificationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_WeightedAverageInputsBeforeModificationMember" substitutionGroup="xbrli:item" />
<element name="WeightedAverageInputsAfterModificationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_WeightedAverageInputsAfterModificationMember" substitutionGroup="xbrli:item" />
<element name="NumberOfWarrantsCashlessExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_NumberOfWarrantsCashlessExercised" substitutionGroup="xbrli:item" />
<element name="NumberOfWarrantIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_NumberOfWarrantIssued" substitutionGroup="xbrli:item" />
<element name="NumberOfWarrantExercisedForCash" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_NumberOfWarrantExercisedForCash" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife" substitutionGroup="xbrli:item" />
<element name="NumberOfWarrantExpiredOrCancelled" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_NumberOfWarrantExpiredOrCancelled" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightOutStandingIntrinsicValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" substitutionGroup="xbrli:item" />
<element name="CommonStockCapitalSharesReservedForFutureIssuanceTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="ClassOfWarrantOrRightExerciseAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_ClassOfWarrantOrRightExerciseAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="ClassOfWarrantOrRightExerciseDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_ClassOfWarrantOrRightExerciseDomain" substitutionGroup="xbrli:item" />
<element name="CommonStockCapitalSharesReservedForFutureIssuanceLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems" substitutionGroup="xbrli:item" />
<element name="EasternCapitalLimitedMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_EasternCapitalLimitedMember" substitutionGroup="xbrli:item" />
<element name="ArrangementsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_ArrangementsAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="ArrangementsDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_ArrangementsDomain" substitutionGroup="xbrli:item" />
<element name="ConsultingArrangementsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="tpiv_ConsultingArrangementsMember" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>tpiv-20180630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DataTracks version 3.0 on 09-August-2018 [11:07:37] {AM} EST - www.datatracks.com-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfOperations" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#NetLossPerShareApplicableToCommonShareholderPotentiallyDilutiveSecuritiesDetail" roleURI="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderPotentiallyDilutiveSecuritiesDetail" />
<calculationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_Cash" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseCurrent" use="optional" order="20" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_Liabilities" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LiabilitiesCurrent" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_NotesPayableCurrent" use="optional" order="30" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquity" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_CommonStockValue" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AdditionalPaidInCapital" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" order="30" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderPotentiallyDilutiveSecuritiesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityShares" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityShares" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityShares" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_CommonStockWarrantsEquityTreatment" xlink:label="loc_tpiv_CommonStockWarrantsEquityTreatment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="loc_tpiv_CommonStockWarrantsEquityTreatment" use="optional" order="20" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_OperatingIncomeLoss" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_OperatingExpenses" use="optional" order="10" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_Revenues" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" use="optional" order="30" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashPeriodIncreaseDecrease" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_NetIncomeLoss" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ShareBasedCompensation" use="optional" order="30" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" use="optional" order="40" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" use="optional" order="50" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" use="optional" order="60" weight="-1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" xlink:label="loc_TPIV_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_TPIV_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises" use="optional" order="30" weight="1" />
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>tpiv-20180630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DataTracks version 3.0 on 09-August-2018 [11:07:37] {AM} EST - www.datatracks.com-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#DocumentAndEntityInformation" roleURI="http://www.tapimmune.com/role/DocumentAndEntityInformation" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheetsParenthetical" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfOperations" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedStatementOfStockholdersEquity" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedStatementOfStockholdersEquity" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#StockholdersEquityTables" roleURI="http://www.tapimmune.com/role/StockholdersEquityTables" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#LiquidityAndFinancialConditionAdditionalInformationDetail" roleURI="http://www.tapimmune.com/role/LiquidityAndFinancialConditionAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#NetLossPerShareApplicableToCommonShareholderComputationOfIncomeLossPerShareDetail" roleURI="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderComputationOfIncomeLossPerShareDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#NetLossPerShareApplicableToCommonShareholderPotentiallyDilutiveSecuritiesDetail" roleURI="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderPotentiallyDilutiveSecuritiesDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#WarrantLiabilityAndFairValueMeasurementsConversionOptionValuationMethodologyDetail" roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionValuationMethodologyDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#WarrantLiabilityAndFairValueMeasurementsConversionOptionFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#WarrantLiabilityAndFairValueMeasurementsConversionOptionScheduleOfChangesInLevel3LiabilitiesMeasuredAtFairValueDetail" roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionScheduleOfChangesInLevel3LiabilitiesMeasuredAtFairValueDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#StockholdersEquityWeightedAverageSummaryOfQuantitativeInformationDetail" roleURI="http://www.tapimmune.com/role/StockholdersEquityWeightedAverageSummaryOfQuantitativeInformationDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#StockholdersEquitySummaryOfTheCompanySSharePurchaseWarrantsDetail" roleURI="http://www.tapimmune.com/role/StockholdersEquitySummaryOfTheCompanySSharePurchaseWarrantsDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#StockholdersEquityAdditionalInformationDetail" roleURI="http://www.tapimmune.com/role/StockholdersEquityAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#StockBasedCompensationAdditionalInformationDetail" roleURI="http://www.tapimmune.com/role/StockBasedCompensationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#GrantIncomeAdditionalInformationDetail" roleURI="http://www.tapimmune.com/role/GrantIncomeAdditionalInformationDetail" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/DocumentAndEntityInformation">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_187555" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_187558" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_DocumentInformationTable_187558" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_187557" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_187558" xlink:to="loc_us-gaap_StatementClassOfStockAxis_187557" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_187556" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_187557" xlink:to="loc_us-gaap_ClassOfStockDomain_187556" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_187556_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_187557" xlink:to="loc_us-gaap_ClassOfStockDomain_187556_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_187411" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_DocumentType_187411" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_187412" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_AmendmentFlag_187412" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_187421" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_DocumentPeriodEndDate_187421" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_187422" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_DocumentFiscalYearFocus_187422" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_187423" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_DocumentFiscalPeriodFocus_187423" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_187436" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_EntityRegistrantName_187436" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_187437" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_EntityCentralIndexKey_187437" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_187453" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_CurrentFiscalYearEndDate_187453" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_187458" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_EntityFilerCategory_187458" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_187540" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_TradingSymbol_187540" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_187547" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_187547" use="optional" order="15" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_36" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_33" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_36" xlink:to="loc_us-gaap_StatementTable_33" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_34" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_33" xlink:to="loc_us-gaap_StatementClassOfStockAxis_34" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_35" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_34" xlink:to="loc_us-gaap_ClassOfStockDomain_35" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_35_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_34" xlink:to="loc_us-gaap_ClassOfStockDomain_35_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_42" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_35" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_42" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_43" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_35" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_43" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_37" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_36" xlink:to="loc_us-gaap_AssetsAbstract_37" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_38" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_37" xlink:to="loc_us-gaap_AssetsCurrentAbstract_38" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_44" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_38" xlink:to="loc_us-gaap_Cash_44" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_45" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_38" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_45" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_46" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_38" xlink:to="loc_us-gaap_AssetsCurrent_46" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_47" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_38" xlink:to="loc_us-gaap_Assets_47" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_36" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_40" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_40" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_48" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_48" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_49" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_49" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_50" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40" xlink:to="loc_us-gaap_NotesPayableCurrent_50" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_51" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40" xlink:to="loc_us-gaap_LiabilitiesCurrent_51" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_52" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40" xlink:to="loc_us-gaap_Liabilities_52" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_53" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40" xlink:to="loc_us-gaap_CommitmentsAndContingencies_53" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_59" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_59" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_41" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39" xlink:to="loc_us-gaap_StockholdersEquityAbstract_41" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_58" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41" xlink:to="loc_us-gaap_StockholdersEquity_58" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_54" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41" xlink:to="loc_us-gaap_PreferredStockValue_54" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_55" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41" xlink:to="loc_us-gaap_CommonStockValue_55" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_56" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41" xlink:to="loc_us-gaap_AdditionalPaidInCapital_56" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_57" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_57" use="optional" order="27" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_132" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_PreferredStockSharesIssued_137" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_138" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_138" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_139" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_139" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_140" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_CommonStockSharesIssued_141" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_142" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_142" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_135" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_135" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_136" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_136" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_129" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_StatementTable_129" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_130" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_129" xlink:to="loc_us-gaap_StatementClassOfStockAxis_130" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_130" xlink:to="loc_us-gaap_ClassOfStockDomain_131" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_131_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_130" xlink:to="loc_us-gaap_ClassOfStockDomain_131_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_133" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_131" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_133" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_134" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_131" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_134" use="optional" order="14" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_192" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_190" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_192" xlink:to="loc_us-gaap_StatementTable_190" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_191" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_190" xlink:to="loc_us-gaap_StatementClassOfStockAxis_191" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_195" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_191" xlink:to="loc_us-gaap_ClassOfStockDomain_195" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_195_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_191" xlink:to="loc_us-gaap_ClassOfStockDomain_195_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_221030" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_190" xlink:to="loc_srt_ProductOrServiceAxis_221030" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_221031" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_221030" xlink:to="loc_srt_ProductsAndServicesDomain_221031" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_221031_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_221030" xlink:to="loc_srt_ProductsAndServicesDomain_221031_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantMember" xlink:label="loc_us-gaap_GrantMember_221032" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_221031" xlink:to="loc_us-gaap_GrantMember_221032" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_193" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_192" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_193" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_196" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_193" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_196" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_197" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_193" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_197" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_198" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_193" xlink:to="loc_us-gaap_OperatingExpenses_198" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_199" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_193" xlink:to="loc_us-gaap_OperatingIncomeLoss_199" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_194" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_192" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_194" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_200" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_194" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_200" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_201" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_194" xlink:to="loc_us-gaap_NetIncomeLoss_201" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_220801" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_194" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_220801" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_202" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_192" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_202" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_203" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_192" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_203" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_220163" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_192" xlink:to="loc_us-gaap_RevenuesAbstract_220163" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_220164" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_220163" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_220164" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_220165" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_220163" xlink:to="loc_us-gaap_Revenues_220165" use="optional" order="22" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedStatementOfStockholdersEquity">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_209" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ExerciseOfWarrantsAmount" xlink:label="loc_tpiv_ExerciseOfWarrantsAmount_220912" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_tpiv_ExerciseOfWarrantsAmount_220912" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_206" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_StatementTable_206" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_207" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_206" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_207" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_208" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_207" xlink:to="loc_us-gaap_EquityComponentDomain_208" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_208_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_207" xlink:to="loc_us-gaap_EquityComponentDomain_208_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_210" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_208" xlink:to="loc_us-gaap_CommonStockMember_210" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_211" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_208" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_211" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_212" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_208" xlink:to="loc_us-gaap_RetainedEarningsMember_212" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_213" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_StockholdersEquity_213" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_214" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_SharesIssued_214" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_215" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_215" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_216" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_216" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_217" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_217" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_218" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_218" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_219" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_NetIncomeLoss_219" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_PrivatePlacementAmount" xlink:label="loc_tpiv_PrivatePlacementAmount_220213" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_tpiv_PrivatePlacementAmount_220213" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_PrivatePlacementShare" xlink:label="loc_tpiv_PrivatePlacementShare_220220" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_tpiv_PrivatePlacementShare_220220" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_WarrantOfCashlessExercised" xlink:label="loc_tpiv_WarrantOfCashlessExercised_220238" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_tpiv_WarrantOfCashlessExercised_220238" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_WarrantOfCashlessExercisedSharesIssued" xlink:label="loc_tpiv_WarrantOfCashlessExercisedSharesIssued_220251" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_tpiv_WarrantOfCashlessExercisedSharesIssued_220251" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_220257" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_220257" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ExerciseOfWarrantsShare" xlink:label="loc_tpiv_ExerciseOfWarrantsShare_220826" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_tpiv_ExerciseOfWarrantsShare_220826" use="optional" order="21" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_226" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_224" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_226" xlink:to="loc_us-gaap_StatementTable_224" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_225" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_224" xlink:to="loc_us-gaap_StatementClassOfStockAxis_225" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_233" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_225" xlink:to="loc_us-gaap_ClassOfStockDomain_233" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_233_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_225" xlink:to="loc_us-gaap_ClassOfStockDomain_233_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_227" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_226" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_227" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_234" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_227" xlink:to="loc_us-gaap_NetIncomeLoss_234" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_228" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_227" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_228" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities_235" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_228" xlink:to="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities_235" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_236" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_228" xlink:to="loc_us-gaap_ShareBasedCompensation_236" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_220301" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_228" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_220301" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_229" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_227" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_229" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_237" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_229" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_237" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_238" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_229" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_238" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_239" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_227" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_239" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_230" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_226" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_230" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_240" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_230" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_240" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_241" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_230" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_241" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" xlink:label="loc_tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement_220303" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_230" xlink:to="loc_tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement_220303" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_220307" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_230" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_220307" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashPeriodIncreaseDecrease_242" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_226" xlink:to="loc_us-gaap_CashPeriodIncreaseDecrease_242" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_243" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_226" xlink:to="loc_us-gaap_Cash_243" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_231" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_226" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_231" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_232" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_231" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_232" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NonCashExcerciseOfWarrantsAmount" xlink:label="loc_tpiv_NonCashExcerciseOfWarrantsAmount_220997" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_232" xlink:to="loc_tpiv_NonCashExcerciseOfWarrantsAmount_220997" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement" xlink:label="loc_tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement_220309" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_232" xlink:to="loc_tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement_220309" use="optional" order="25" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/StockholdersEquityTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_220156" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_220153" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_220156" xlink:to="loc_us-gaap_StatementTable_220153" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_220154" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_220153" xlink:to="loc_us-gaap_StatementClassOfStockAxis_220154" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_220155" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_220154" xlink:to="loc_us-gaap_ClassOfStockDomain_220155" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_220155_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_220154" xlink:to="loc_us-gaap_ClassOfStockDomain_220155_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_220157" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_220153" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_220157" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_220158" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_220157" xlink:to="loc_us-gaap_EquityComponentDomain_220158" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_220158_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_220157" xlink:to="loc_us-gaap_EquityComponentDomain_220158_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_SharePurchaseWarrantsTableTextBlock" xlink:label="loc_tpiv_SharePurchaseWarrantsTableTextBlock_220161" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220156" xlink:to="loc_tpiv_SharePurchaseWarrantsTableTextBlock_220161" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ValuationMethodologyTableTextBlock" xlink:label="loc_tpiv_ValuationMethodologyTableTextBlock_220162" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220156" xlink:to="loc_tpiv_ValuationMethodologyTableTextBlock_220162" use="optional" order="9" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/LiquidityAndFinancialConditionAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_64" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_66" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_64" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_66" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_62" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_64" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_62" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_63" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_62" xlink:to="loc_us-gaap_StatementClassOfStockAxis_63" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_65" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_63" xlink:to="loc_us-gaap_ClassOfStockDomain_65" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_65_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_63" xlink:to="loc_us-gaap_ClassOfStockDomain_65_default" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderComputationOfIncomeLossPerShareDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_71" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAttributableToParentDilutedAbstract" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract_72" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_71" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract_72" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_76" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract_72" xlink:to="loc_us-gaap_NetIncomeLoss_76" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_73" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_71" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_73" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_77" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_73" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_77" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_74" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_71" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_74" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_78" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_74" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_78" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_69" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_71" xlink:to="loc_us-gaap_StatementTable_69" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_70" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_69" xlink:to="loc_us-gaap_StatementClassOfStockAxis_70" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_75" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_70" xlink:to="loc_us-gaap_ClassOfStockDomain_75" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_75_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_70" xlink:to="loc_us-gaap_ClassOfStockDomain_75_default" use="optional" order="10" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderPotentiallyDilutiveSecuritiesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_83" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_81" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_83" xlink:to="loc_us-gaap_StatementTable_81" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_82" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_81" xlink:to="loc_us-gaap_StatementClassOfStockAxis_82" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_84" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_82" xlink:to="loc_us-gaap_ClassOfStockDomain_84" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_84_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_82" xlink:to="loc_us-gaap_ClassOfStockDomain_84_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityShares" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityShares_85" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityShares_85" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_CommonStockWarrantsEquityTreatment" xlink:label="loc_tpiv_CommonStockWarrantsEquityTreatment_86" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83" xlink:to="loc_tpiv_CommonStockWarrantsEquityTreatment_86" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_87" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_87" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionValuationMethodologyDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_95" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_221001" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_95" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_221001" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_221002" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_95" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_221002" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_99" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_95" xlink:to="loc_us-gaap_SharePrice_99" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_90" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_95" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_90" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_220955" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_90" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_220955" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_220956" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_220955" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_220956" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_220956_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_220955" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_220956_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_220957" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220956" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_220957" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_220958" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220956" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_220958" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_220959" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220956" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_220959" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_220960" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220956" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_220960" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_220961" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220956" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_220961" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_220962" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220956" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_220962" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_91" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_90" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_91" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_92" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_91" xlink:to="loc_us-gaap_EquityComponentDomain_92" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_92_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_91" xlink:to="loc_us-gaap_EquityComponentDomain_92_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_SharePurchaseWarrantsMember" xlink:label="loc_tpiv_SharePurchaseWarrantsMember_96" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_92" xlink:to="loc_tpiv_SharePurchaseWarrantsMember_96" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_112" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_107" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_112" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_107" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_108" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_107" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_108" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_109" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_108" xlink:to="loc_us-gaap_HedgingRelationshipDomain_109" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_109_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_108" xlink:to="loc_us-gaap_HedgingRelationshipDomain_109_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_113" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_109" xlink:to="loc_us-gaap_FairValueHedgingMember_113" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_110" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_107" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_110" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_111" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_110" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_111" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_111_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_110" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_111_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_114" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_111" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_114" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_115" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_111" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_115" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_116" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_111" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_116" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_117" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_112" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_117" use="optional" order="12" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionScheduleOfChangesInLevel3LiabilitiesMeasuredAtFairValueDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_122" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_120" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_122" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_120" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_121" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_120" xlink:to="loc_us-gaap_StatementClassOfStockAxis_121" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_123" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_121" xlink:to="loc_us-gaap_ClassOfStockDomain_123" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_123_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_121" xlink:to="loc_us-gaap_ClassOfStockDomain_123_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_124" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_122" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_124" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_125" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_122" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_125" use="optional" order="6" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/StockholdersEquityWeightedAverageSummaryOfQuantitativeInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_220250" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_220938" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_220250" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_220938" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_220939" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_220250" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_220939" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_220246" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_220250" xlink:to="loc_us-gaap_StatementTable_220246" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_220940" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_220246" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_220940" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_220941" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_220940" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_220941" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_220941_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_220940" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_220941_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_220942" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220941" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_220942" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_220943" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220941" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_220943" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_220944" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220941" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_220944" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_220945" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220941" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_220945" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_220946" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220941" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_220946" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_220255" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_220246" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_220255" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_220256" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_220255" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_220256" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_220256_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_220255" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_220256_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_WeightedAverageInputsBeforeModificationMember" xlink:label="loc_tpiv_WeightedAverageInputsBeforeModificationMember_220260" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_220256" xlink:to="loc_tpiv_WeightedAverageInputsBeforeModificationMember_220260" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_WeightedAverageInputsAfterModificationMember" xlink:label="loc_tpiv_WeightedAverageInputsAfterModificationMember_220290" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_220256" xlink:to="loc_tpiv_WeightedAverageInputsAfterModificationMember_220290" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_220262" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_220246" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_220262" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_220263" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_220262" xlink:to="loc_us-gaap_EquityComponentDomain_220263" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_220263_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_220262" xlink:to="loc_us-gaap_EquityComponentDomain_220263_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_SharePurchaseWarrantsMember" xlink:label="loc_tpiv_SharePurchaseWarrantsMember_220292" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_220263" xlink:to="loc_tpiv_SharePurchaseWarrantsMember_220292" use="optional" order="20" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/StockholdersEquitySummaryOfTheCompanySSharePurchaseWarrantsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_220300" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantsCashlessExercised" xlink:label="loc_tpiv_NumberOfWarrantsCashlessExercised_221012" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_NumberOfWarrantsCashlessExercised_221012" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_220297" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_us-gaap_StatementTable_220297" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_220298" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_220297" xlink:to="loc_us-gaap_StatementClassOfStockAxis_220298" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_220299" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_220298" xlink:to="loc_us-gaap_ClassOfStockDomain_220299" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_220299_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_220298" xlink:to="loc_us-gaap_ClassOfStockDomain_220299_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_220304" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_220304" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantIssued" xlink:label="loc_tpiv_NumberOfWarrantIssued_220306" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_NumberOfWarrantIssued_220306" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantExercisedForCash" xlink:label="loc_tpiv_NumberOfWarrantExercisedForCash_220308" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_NumberOfWarrantExercisedForCash_220308" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice_220319" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice_220319" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash_220327" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash_220327" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife_220343" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife_220343" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantExpiredOrCancelled" xlink:label="loc_tpiv_NumberOfWarrantExpiredOrCancelled_220386" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_NumberOfWarrantExpiredOrCancelled_220386" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice_220388" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice_220388" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice_220390" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice_220390" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue" xlink:label="loc_tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue_220392" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue_220392" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice_220894" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice_220894" use="optional" order="16" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/StockholdersEquityAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems" xlink:label="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NonCashExcerciseOfWarrantsAmount" xlink:label="loc_tpiv_NonCashExcerciseOfWarrantsAmount_220447" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_tpiv_NonCashExcerciseOfWarrantsAmount_220447" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable" xlink:label="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_146" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_TitleOfIndividualAxis_146" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_158" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_146" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_158" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_158_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_146" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_158_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_147" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_TypeOfArrangementAxis_147" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_148" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_147" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_148" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_148_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_147" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_148_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_149" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_149" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_160" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_149" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_160" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_160_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_149" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_160_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_150" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_150" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_161" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_150" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_161" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_161_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_150" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_161_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_151" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_151" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_152" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_151" xlink:to="loc_us-gaap_EquityComponentDomain_152" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_152_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_151" xlink:to="loc_us-gaap_EquityComponentDomain_152_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_162" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_152" xlink:to="loc_us-gaap_CommonStockMember_162" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_153" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_153" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_163" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_153" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_163" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_163_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_153" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_163_default" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_154" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_StatementClassOfStockAxis_154" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_164" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_154" xlink:to="loc_us-gaap_ClassOfStockDomain_164" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_164_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_154" xlink:to="loc_us-gaap_ClassOfStockDomain_164_default" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_155" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_155" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_165" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_155" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_165" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_165_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_155" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_165_default" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightExerciseAxis" xlink:label="loc_tpiv_ClassOfWarrantOrRightExerciseAxis_156" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_tpiv_ClassOfWarrantOrRightExerciseAxis_156" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightExerciseDomain" xlink:label="loc_tpiv_ClassOfWarrantOrRightExerciseDomain_166" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_tpiv_ClassOfWarrantOrRightExerciseAxis_156" xlink:to="loc_tpiv_ClassOfWarrantOrRightExerciseDomain_166" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightExerciseDomain" xlink:label="loc_tpiv_ClassOfWarrantOrRightExerciseDomain_166_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_tpiv_ClassOfWarrantOrRightExerciseAxis_156" xlink:to="loc_tpiv_ClassOfWarrantOrRightExerciseDomain_166_default" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_220428" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_220428" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_220429" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_220428" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_220429" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_220429_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_220428" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_220429_default" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_220437" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_dei_LegalEntityAxis_220437" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_220438" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_220437" xlink:to="loc_dei_EntityDomain_220438" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_220438_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_220437" xlink:to="loc_dei_EntityDomain_220438_default" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_EasternCapitalLimitedMember" xlink:label="loc_tpiv_EasternCapitalLimitedMember_220439" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_220438" xlink:to="loc_tpiv_EasternCapitalLimitedMember_220439" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_220442" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_FinancialInstrumentAxis_220442" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_220443" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_220442" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_220443" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_220443_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_220442" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_220443_default" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_220445" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_220443" xlink:to="loc_us-gaap_WarrantMember_220445" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ArrangementsAxis" xlink:label="loc_tpiv_ArrangementsAxis_220454" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_tpiv_ArrangementsAxis_220454" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ArrangementsDomain" xlink:label="loc_tpiv_ArrangementsDomain_220455" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_tpiv_ArrangementsAxis_220454" xlink:to="loc_tpiv_ArrangementsDomain_220455" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ArrangementsDomain" xlink:label="loc_tpiv_ArrangementsDomain_220455_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_tpiv_ArrangementsAxis_220454" xlink:to="loc_tpiv_ArrangementsDomain_220455_default" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ConsultingArrangementsMember" xlink:label="loc_tpiv_ConsultingArrangementsMember_220457" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_ArrangementsDomain_220455" xlink:to="loc_tpiv_ConsultingArrangementsMember_220457" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_220453" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_220453" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_220422" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_220422" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_220423" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_220423" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_220424" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_220424" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_169" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_169" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_170" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_170" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_220434" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_220434" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_220435" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_220435" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ExerciseOfWarrantsAmount" xlink:label="loc_tpiv_ExerciseOfWarrantsAmount_220441" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_tpiv_ExerciseOfWarrantsAmount_220441" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantExpiredOrCancelled" xlink:label="loc_tpiv_NumberOfWarrantExpiredOrCancelled_220449" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_tpiv_NumberOfWarrantExpiredOrCancelled_220449" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_220450" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_220450" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_220451" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_220451" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_220452" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_220452" use="optional" order="58" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/StockBasedCompensationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_179" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_173" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_179" xlink:to="loc_us-gaap_StatementTable_173" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_174" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_173" xlink:to="loc_us-gaap_StatementClassOfStockAxis_174" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_180" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_174" xlink:to="loc_us-gaap_ClassOfStockDomain_180" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_180_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_174" xlink:to="loc_us-gaap_ClassOfStockDomain_180_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_175" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_173" xlink:to="loc_us-gaap_AwardTypeAxis_175" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_181" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_181" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_181_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_181_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_176" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_173" xlink:to="loc_us-gaap_PlanNameAxis_176" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_182" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_176" xlink:to="loc_us-gaap_PlanNameDomain_182" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_182_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_176" xlink:to="loc_us-gaap_PlanNameDomain_182_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_177" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_173" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_177" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_178" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_177" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_178" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_178_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_177" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_178_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_183" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_178" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_183" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_184" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_178" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_184" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_185" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_179" xlink:to="loc_us-gaap_ShareBasedCompensation_185" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_186" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_179" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_186" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_187" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_179" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_187" use="optional" order="18" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/GrantIncomeAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_220138" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_220135" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_220138" xlink:to="loc_us-gaap_StatementTable_220135" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_221027" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_220135" xlink:to="loc_srt_ProductOrServiceAxis_221027" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_221028" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_221027" xlink:to="loc_srt_ProductsAndServicesDomain_221028" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_221028_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_221027" xlink:to="loc_srt_ProductsAndServicesDomain_221028_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantMember" xlink:label="loc_us-gaap_GrantMember_221029" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_221028" xlink:to="loc_us-gaap_GrantMember_221029" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_220136" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_220135" xlink:to="loc_us-gaap_StatementClassOfStockAxis_220136" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_220137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_220136" xlink:to="loc_us-gaap_ClassOfStockDomain_220137" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_220137_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_220136" xlink:to="loc_us-gaap_ClassOfStockDomain_220137_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_220897" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_220135" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_220897" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_220898" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_220897" xlink:to="loc_us-gaap_TypeOfAdoptionMember_220898" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_220898_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_220897" xlink:to="loc_us-gaap_TypeOfAdoptionMember_220898_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_220899" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_220898" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_220899" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_220901" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_220138" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_220901" use="optional" order="13" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>tpiv-20180630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DataTracks version 3.0 on 09-August-2018 [11:07:37] {AM} EST - www.datatracks.com-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_DocumentAndEntityInformationAbstract" xlink:label="loc_tpiv_DocumentAndEntityInformationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document And Entity Information [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_DocumentAndEntityInformationAbstract" xlink:to="lab_tpiv_DocumentAndEntityInformationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document And Entity Information [Abstract]</label>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationTable" xml:lang="en-US">Document Information [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationLineItems" xml:lang="en-US">Document Information [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType" xml:lang="en-US">Document Type</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol" xml:lang="en-US">Trading Symbol</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xml:lang="en-US">Series A Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xml:lang="en-US">Series A Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xml:lang="en-US">Series B Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xml:lang="en-US">Series B Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">Assets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">ASSETS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Assets, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Current assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Cash" xml:lang="en-US">Cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Cash" xml:lang="en-US">Cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_Cash" xml:lang="en-US">Cash at beginning of period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_Cash" xml:lang="en-US">Cash at end of period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Prepaid Expense, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Prepaid expenses and deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Total current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Total assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Liabilities, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Current liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xml:lang="en-US">Accounts payable and accrued liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xml:lang="en-US">Derivative Liability, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xml:lang="en-US">Warrant liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NotesPayableCurrent" xml:lang="en-US">Notes Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NotesPayableCurrent" xml:lang="en-US">Promissory note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Total liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and Contingencies</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total liabilities and stockholders' equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders' equity:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Total stockholders' equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Balance, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Balance, Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Common stock, $0.001 par value, 41.7 million shares authorized, 13.6 million and 10.6 million shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional Paid in Capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional paid-in capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred Stock, Shares Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred stock issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred stock outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common stock shares par value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common stock shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common stock shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common stock shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred stock par value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred stock shares authorized/designated</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xml:lang="en-US">Costs and Expenses [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xml:lang="en-US">Operating expenses:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and Development Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and Administrative Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and administrative</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpenses" xml:lang="en-US">Operating Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingExpenses" xml:lang="en-US">Total operating expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Operating Income (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Loss from operations</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Other income (expense):</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xml:lang="en-US">Change in fair value of warrant liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/presentationGuidance" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xml:lang="en-US">Debt extinguishment gain</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xml:lang="en-US">Debt extinguishment gain</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Earnings Per Share, Basic and Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Net loss per share, Basic and Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Basic and Diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted average number of common shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenuesAbstract" xml:lang="en-US">Revenues [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RevenuesAbstract" xml:lang="en-US">Revenues:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xml:lang="en-US">Grant income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Revenues" xml:lang="en-US">Revenues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_Revenues" xml:lang="en-US">Total revenues</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProductOrServiceAxis" xml:lang="en-US">Product and Service [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProductsAndServicesDomain" xml:lang="en-US">Product and Service [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantMember" xlink:label="loc_us-gaap_GrantMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GrantMember" xml:lang="en-US">Grant [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrantMember" xlink:to="lab_us-gaap_GrantMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid In Capital [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember" xml:lang="en-US">Retained Earnings [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsMember" xml:lang="en-US">Accumulated Deficit [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ExerciseOfWarrantsAmount" xlink:label="loc_tpiv_ExerciseOfWarrantsAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ExerciseOfWarrantsAmount" xml:lang="en-US">Exercise Of Warrants Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_tpiv_ExerciseOfWarrantsAmount" xml:lang="en-US">Stock warrants exercised for cash, Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ExerciseOfWarrantsAmount" xlink:to="lab_tpiv_ExerciseOfWarrantsAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ExerciseOfWarrantsAmount" xml:lang="en-US">Exercise of warrants amount.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssued" xml:lang="en-US">Shares, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharesIssued" xml:lang="en-US">Balance, Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharesIssued" xml:lang="en-US">Balance, Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xml:lang="en-US">Stock options exercised for cash, Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Stock options exercised for cash, Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xml:lang="en-US">Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xml:lang="en-US">Stock-based compensation, Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xml:lang="en-US">Stock Issued During Period, Shares, Share-based Compensation, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xml:lang="en-US">Stock-based compensation, Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_PrivatePlacementAmount" xlink:label="loc_tpiv_PrivatePlacementAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_PrivatePlacementAmount" xml:lang="en-US">Private Placement Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_PrivatePlacementAmount" xml:lang="en-US">Issuance of common stock in private placement, Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_PrivatePlacementAmount" xlink:to="lab_tpiv_PrivatePlacementAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_PrivatePlacementAmount" xml:lang="en-US">Private placement amount.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_PrivatePlacementShare" xlink:label="loc_tpiv_PrivatePlacementShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_PrivatePlacementShare" xml:lang="en-US">Private Placement Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_PrivatePlacementShare" xml:lang="en-US">Issuance of common stock in private placement, Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_PrivatePlacementShare" xlink:to="lab_tpiv_PrivatePlacementShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_PrivatePlacementShare" xml:lang="en-US">Private placement share.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_WarrantOfCashlessExercised" xlink:label="loc_tpiv_WarrantOfCashlessExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_WarrantOfCashlessExercised" xml:lang="en-US">Warrant of Cashless Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_tpiv_WarrantOfCashlessExercised" xml:lang="en-US">Stock warrants cashless exercised, Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_WarrantOfCashlessExercised" xlink:to="lab_tpiv_WarrantOfCashlessExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_WarrantOfCashlessExercised" xml:lang="en-US">The value of warrant exercised of non cash transaction amount.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_WarrantOfCashlessExercisedSharesIssued" xlink:label="loc_tpiv_WarrantOfCashlessExercisedSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_WarrantOfCashlessExercisedSharesIssued" xml:lang="en-US">Warrant of Cashless Exercised shares issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_tpiv_WarrantOfCashlessExercisedSharesIssued" xml:lang="en-US">Stock warrants cashless exercised, Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_WarrantOfCashlessExercisedSharesIssued" xlink:to="lab_tpiv_WarrantOfCashlessExercisedSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_WarrantOfCashlessExercisedSharesIssued" xml:lang="en-US">The warrant exercised of non cash transaction shares issued.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Fair value of repriced warrants as inducement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ExerciseOfWarrantsShare" xlink:label="loc_tpiv_ExerciseOfWarrantsShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ExerciseOfWarrantsShare" xml:lang="en-US">Exercise Of Warrants Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_tpiv_ExerciseOfWarrantsShare" xml:lang="en-US">Stock warrants exercised for cash, Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ExerciseOfWarrantsShare" xlink:to="lab_tpiv_ExerciseOfWarrantsShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ExerciseOfWarrantsShare" xml:lang="en-US">Exercise of warrants share.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Cash Flows from Operating Activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Reconciliation of net loss to net cash used in operating activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInDerivativeLiabilities" xml:lang="en-US">Increase (Decrease) in Derivative Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInDerivativeLiabilities" xml:lang="en-US">Changes in fair value of warrant liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInDerivativeLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensation" xml:lang="en-US">Share-based Compensation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation" xml:lang="en-US">Stock-based compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Changes in operating assets and liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Prepaid expenses and deposits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Accounts payable and accrued expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net cash used in operating activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Cash Flows from Financing Activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xml:lang="en-US">Proceeds from exercise of stock options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net cash provided by financing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" xlink:label="loc_tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" xml:lang="en-US">Proceeds From Issuance Of Common Stock And WarrantsIn Private Placement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" xml:lang="en-US">Proceeds from issuance of common stock and warrants in private placement, net of offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" xlink:to="lab_tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" xml:lang="en-US">The cash inflow from the additional capital contribution to the entity due to issue of common stock and warrants in a private placement.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xml:lang="en-US">Proceeds from Warrant Exercises</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xml:lang="en-US">Proceeds from exercise of stock warrants, net of offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashPeriodIncreaseDecrease" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashPeriodIncreaseDecrease" xml:lang="en-US">Cash, Period Increase (Decrease)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashPeriodIncreaseDecrease" xml:lang="en-US">Net increase in cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashPeriodIncreaseDecrease" xlink:to="lab_us-gaap_CashPeriodIncreaseDecrease" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental disclosure of cash flow information</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US">Supplemental schedule of non-cash financing activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NonCashExcerciseOfWarrantsAmount" xlink:label="loc_tpiv_NonCashExcerciseOfWarrantsAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_NonCashExcerciseOfWarrantsAmount" xml:lang="en-US">Non Cash Excercise Of Warrants Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_NonCashExcerciseOfWarrantsAmount" xml:lang="en-US">Stock warrants cashless exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_NonCashExcerciseOfWarrantsAmount" xlink:to="lab_tpiv_NonCashExcerciseOfWarrantsAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_NonCashExcerciseOfWarrantsAmount" xml:lang="en-US">The value of warrant exercised of non cash amount transaction.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement" xlink:label="loc_tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement" xml:lang="en-US">Noncash or Part Noncash Transaction Fair Value Of Repriced Warrants As Inducement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement" xml:lang="en-US">Fair value of repriced warrants as inducement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement" xlink:to="lab_tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement" xml:lang="en-US">Fair value of repriced warrants as inducement which classified as non financing and investing activities.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NatureOfOperations" xml:lang="en-US">Nature of Operations [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NatureOfOperations" xml:lang="en-US">NATURE OF OPERATIONS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccounting" xlink:label="loc_us-gaap_BasisOfAccounting" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfAccounting" xml:lang="en-US">Basis of Accounting [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BasisOfAccounting" xml:lang="en-US">BASIS OF PRESENTATION</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccounting" xlink:to="lab_us-gaap_BasisOfAccounting" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="loc_us-gaap_TextBlockAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TextBlockAbstract" xml:lang="en-US">Text Block [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TextBlockAbstract" xlink:to="lab_us-gaap_TextBlockAbstract" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_LiquidityAndFinancialConditionTextBlock" xlink:label="loc_tpiv_LiquidityAndFinancialConditionTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_LiquidityAndFinancialConditionTextBlock" xml:lang="en-US">Liquidity And Financial Condition [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_tpiv_LiquidityAndFinancialConditionTextBlock" xml:lang="en-US">LIQUIDITY AND FINANCIAL CONDITION</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_LiquidityAndFinancialConditionTextBlock" xlink:to="lab_tpiv_LiquidityAndFinancialConditionTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_LiquidityAndFinancialConditionTextBlock" xml:lang="en-US">Liquidity and financial condition text block.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Accounting Policies [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xml:lang="en-US">Noncontrolling Interest [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xml:lang="en-US">NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_DerivativesAndFairValueAbstract" xlink:label="loc_tpiv_DerivativesAndFairValueAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_DerivativesAndFairValueAbstract" xml:lang="en-US">Derivatives and Fair Value [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_DerivativesAndFairValueAbstract" xlink:to="lab_tpiv_DerivativesAndFairValueAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xml:lang="en-US">Derivatives and Fair Value [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xml:lang="en-US">WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US">Stockholders' Equity Note [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">STOCKHOLDERS' EQUITY</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">STOCK-BASED COMPENSATION</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_GrantIncomeAbstract" xlink:label="loc_tpiv_GrantIncomeAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_GrantIncomeAbstract" xml:lang="en-US">Grant Income [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_GrantIncomeAbstract" xlink:to="lab_tpiv_GrantIncomeAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_GrantIncomeAbstract" xml:lang="en-US">Grant Income (Abstract)</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_GrantIncomeTextBlock" xlink:label="loc_tpiv_GrantIncomeTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_GrantIncomeTextBlock" xml:lang="en-US">Grant Income [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_GrantIncomeTextBlock" xml:lang="en-US">GRANT INCOME</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_GrantIncomeTextBlock" xlink:to="lab_tpiv_GrantIncomeTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_GrantIncomeTextBlock" xml:lang="en-US">The entire disclosure of grant income.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NetLossPerShareTableTextBlock" xlink:label="loc_tpiv_NetLossPerShareTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_NetLossPerShareTableTextBlock" xml:lang="en-US">Net Loss Per Share [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_NetLossPerShareTableTextBlock" xml:lang="en-US">Net Loss Per Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_NetLossPerShareTableTextBlock" xlink:to="lab_tpiv_NetLossPerShareTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_NetLossPerShareTableTextBlock" xml:lang="en-US">Net Loss Per Share</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ValuationMethodology" xlink:label="loc_tpiv_ValuationMethodology" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ValuationMethodology" xml:lang="en-US">Valuation Methodology</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_tpiv_ValuationMethodology" xml:lang="en-US">Valuation Methodology</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ValuationMethodology" xlink:to="lab_tpiv_ValuationMethodology" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ValuationMethodology" xml:lang="en-US">Valuation methodology.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis" xlink:label="loc_tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis" xml:lang="en-US">Financial Assets And Liabilities Measured At Fair Value On Recurring Basis</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis" xml:lang="en-US">Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis" xlink:to="lab_tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis" xml:lang="en-US">Financial assets and liabilities measured at fair value on recurring basis.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_MeasuredAtFairValue" xlink:label="loc_tpiv_MeasuredAtFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_MeasuredAtFairValue" xml:lang="en-US">Measured At Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_tpiv_MeasuredAtFairValue" xml:lang="en-US">Schedule of Changes in Level 3 Liabilities Measured at Fair Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_MeasuredAtFairValue" xlink:to="lab_tpiv_MeasuredAtFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_MeasuredAtFairValue" xml:lang="en-US">Measured at fair value.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_SharePurchaseWarrantsTableTextBlock" xlink:label="loc_tpiv_SharePurchaseWarrantsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_SharePurchaseWarrantsTableTextBlock" xml:lang="en-US">Share Purchase Warrants [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_SharePurchaseWarrantsTableTextBlock" xml:lang="en-US">Schedule of share purchase warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_SharePurchaseWarrantsTableTextBlock" xlink:to="lab_tpiv_SharePurchaseWarrantsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_SharePurchaseWarrantsTableTextBlock" xml:lang="en-US">Tabular disclosure of share purchase warrants.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ValuationMethodologyTableTextBlock" xlink:label="loc_tpiv_ValuationMethodologyTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ValuationMethodologyTableTextBlock" xml:lang="en-US">Valuation Methodology [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_ValuationMethodologyTableTextBlock" xml:lang="en-US">Schedule of weighted average valuation methodology</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ValuationMethodologyTableTextBlock" xlink:to="lab_tpiv_ValuationMethodologyTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ValuationMethodologyTableTextBlock" xml:lang="en-US">Tabular disclosure of valuation methodology.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:to="lab_us-gaap_CashAndCashEquivalentsLineItems" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xml:lang="en-US">Cash Equivalents, at Carrying Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xml:lang="en-US">Earnings Per Share [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAttributableToParentDilutedAbstract" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract" xml:lang="en-US">Net Income (Loss) Attributable to Parent, Diluted [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract" xml:lang="en-US">Numerator:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xml:lang="en-US">Denominator:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted average common shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xml:lang="en-US">Net loss per share data:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityShares" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityShares" xml:lang="en-US">Option Indexed to Issuer's Equity, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityShares" xml:lang="en-US">Common stock options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityShares" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityShares" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_CommonStockWarrantsEquityTreatment" xlink:label="loc_tpiv_CommonStockWarrantsEquityTreatment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_CommonStockWarrantsEquityTreatment" xml:lang="en-US">Common Stock Warrants Equity Treatment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_CommonStockWarrantsEquityTreatment" xml:lang="en-US">Common stock purchase warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_CommonStockWarrantsEquityTreatment" xlink:to="lab_tpiv_CommonStockWarrantsEquityTreatment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_CommonStockWarrantsEquityTreatment" xml:lang="en-US">Common stock warrants - equity treatment.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Potentially dilutive securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xml:lang="en-US">Measurement Input Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xml:lang="en-US">Measurement Input Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xml:lang="en-US">Measurement Input, Share Price [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExercisePriceMember" xml:lang="en-US">Measurement Input, Exercise Price [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExercisePriceMember" xlink:to="lab_us-gaap_MeasurementInputExercisePriceMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xml:lang="en-US">Measurement Input, Expected Term [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xml:lang="en-US">Measurement Input, Price Volatility [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xml:lang="en-US">Warrants and Rights Outstanding, Term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharePrice" xml:lang="en-US">Share Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharePrice" xml:lang="en-US">Stock price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_SharePurchaseWarrantsMember" xlink:label="loc_tpiv_SharePurchaseWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_SharePurchaseWarrantsMember" xml:lang="en-US">Share Purchase Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_tpiv_SharePurchaseWarrantsMember" xml:lang="en-US">Share Purchase Warrants [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_SharePurchaseWarrantsMember" xlink:to="lab_tpiv_SharePurchaseWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_SharePurchaseWarrantsMember" xml:lang="en-US">Share Purchase Warrants [Member]</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xml:lang="en-US">Derivative, Fair Value, Net [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xml:lang="en-US">Hedging Relationship [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xml:lang="en-US">Hedging Relationship [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xml:lang="en-US">Hedging Relationship [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xml:lang="en-US">Hedging Relationship [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueHedgingMember" xml:lang="en-US">Fair Value Hedging [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueHedgingMember" xml:lang="en-US">Fair Value [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US">Fair Value, Hierarchy [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US">Fair Value, Hierarchy [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US">Fair Value Hierarchy [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US">Fair Value Hierarchy [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US">Quoted prices in active markets (Level 1)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US">Significant other observable inputs (Level 2)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Significant other unobservable inputs (Level 3)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xml:lang="en-US">Derivatives, Fair Value [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xml:lang="en-US">Derivatives, Fair Value [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xml:lang="en-US">Warrant liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xml:lang="en-US">Class of Warrant or Right [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xml:lang="en-US">Class of Warrant or Right [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xml:lang="en-US">Change in fair value of warrant liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_WeightedAverageInputsBeforeModificationMember" xlink:label="loc_tpiv_WeightedAverageInputsBeforeModificationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_WeightedAverageInputsBeforeModificationMember" xml:lang="en-US">Weighted Average Inputs Before Modification [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_WeightedAverageInputsBeforeModificationMember" xml:lang="en-US">Weighted Average Inputs Before Modification [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_WeightedAverageInputsBeforeModificationMember" xlink:to="lab_tpiv_WeightedAverageInputsBeforeModificationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_WeightedAverageInputsBeforeModificationMember" xml:lang="en-US">Weighted average inputs before modification.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_WeightedAverageInputsAfterModificationMember" xlink:label="loc_tpiv_WeightedAverageInputsAfterModificationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_WeightedAverageInputsAfterModificationMember" xml:lang="en-US">Weighted Average Inputs After Modification [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_WeightedAverageInputsAfterModificationMember" xml:lang="en-US">Weighted Average Inputs After Modification [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_WeightedAverageInputsAfterModificationMember" xlink:to="lab_tpiv_WeightedAverageInputsAfterModificationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_WeightedAverageInputsAfterModificationMember" xml:lang="en-US">Weighted average inputs after modification.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantsCashlessExercised" xlink:label="loc_tpiv_NumberOfWarrantsCashlessExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_NumberOfWarrantsCashlessExercised" xml:lang="en-US">Number Of Warrants Cashless Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_NumberOfWarrantsCashlessExercised" xml:lang="en-US">Number of Warrant of Cashless exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_NumberOfWarrantsCashlessExercised" xlink:to="lab_tpiv_NumberOfWarrantsCashlessExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_NumberOfWarrantsCashlessExercised" xml:lang="en-US">Number of warrants cashless exercised.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Number of Warrants, Beginning balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Number of Warrants, Ending balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantIssued" xlink:label="loc_tpiv_NumberOfWarrantIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_NumberOfWarrantIssued" xml:lang="en-US">Number Of Warrant Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_NumberOfWarrantIssued" xml:lang="en-US">Number of Warrants, Issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_NumberOfWarrantIssued" xlink:to="lab_tpiv_NumberOfWarrantIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_NumberOfWarrantIssued" xml:lang="en-US">Number of warrants issued.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantExercisedForCash" xlink:label="loc_tpiv_NumberOfWarrantExercisedForCash" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_NumberOfWarrantExercisedForCash" xml:lang="en-US">Number Of Warrant Exercised for cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_NumberOfWarrantExercisedForCash" xml:lang="en-US">Number of Warrant Exercised for cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_NumberOfWarrantExercisedForCash" xlink:to="lab_tpiv_NumberOfWarrantExercisedForCash" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_NumberOfWarrantExercisedForCash" xml:lang="en-US">Number of warrants exercised.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice" xml:lang="en-US">Class Of Warrant Or Rights Out standing Issued Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price, Issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice" xlink:to="lab_tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice" xml:lang="en-US">Class of warrant or rights outstanding issued weighted average exercise price.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash" xml:lang="en-US">Class Of Warrant Or Rights Outstanding Exercised Weighted Average Exercised for cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash" xml:lang="en-US">Weighted Average Exercise Price, Exercised for cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash" xlink:to="lab_tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash" xml:lang="en-US">Class of warrant or rights outstanding exercised weighted average exercise price.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife" xml:lang="en-US">Class Of Warrant Or Rights Out standing Weighted Average Remaining Contractual Life</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife" xml:lang="en-US">Weighted Average Remaining Contractual Life, Outstanding (in years)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife" xlink:to="lab_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife" xml:lang="en-US">Class of warrant or right outstanding issued weighted average remaining life.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantExpiredOrCancelled" xlink:label="loc_tpiv_NumberOfWarrantExpiredOrCancelled" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_NumberOfWarrantExpiredOrCancelled" xml:lang="en-US">Number Of Warrant Expired or Cancelled</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_NumberOfWarrantExpiredOrCancelled" xml:lang="en-US">Number of Warrant Expired or Cancelled</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_NumberOfWarrantExpiredOrCancelled" xlink:to="lab_tpiv_NumberOfWarrantExpiredOrCancelled" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_NumberOfWarrantExpiredOrCancelled" xml:lang="en-US">Number of warrants expired or cancelled.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice" xml:lang="en-US">Class Of Warrant Or Rights Outstanding Cashless Exercised Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average	Exercise Price Cashless exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice" xlink:to="lab_tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice" xml:lang="en-US">Class of warrant or rights outstanding cashless exercised weighted average exercise price.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice" xml:lang="en-US">Class Of Warrant or Rights Outstanding Expired or Cancelled Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average	Exercise Price Expired or Cancelled</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice" xlink:to="lab_tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice" xml:lang="en-US">Class of warrant or rights outstanding expired or Cancelled weighted average exercise price.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue" xlink:label="loc_tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue" xml:lang="en-US">Class Of Warrant Or Right Out standing Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue" xml:lang="en-US">Total Intrinsic Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue" xlink:to="lab_tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue" xml:lang="en-US">Intrinsic value of outstanding class of warrant or right.</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" xml:lang="en-US">Class Of Warrant Or Rights Out Standing Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price, Beginning Balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price, Ending Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" xlink:to="lab_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" xml:lang="en-US">Class Of Warrant Or Rights Outstanding Weighted Average Exercise Price.</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityAbstract" xml:lang="en-US">Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable" xlink:label="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable" xml:lang="en-US">Common Stock Capital Shares Reserved For Future Issuance [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable" xml:lang="en-US">Common Stock Capital Shares Reserved For Future Issuance [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable" xlink:to="lab_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable" xml:lang="en-US">Common Stock Capital Shares Reserved For Future Issuance [Table]</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TitleOfIndividualAxis" xml:lang="en-US">Title of Individual [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TitleOfIndividualAxis" xml:lang="en-US">Title of Individual [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TitleOfIndividualAxis" xlink:to="lab_us-gaap_TitleOfIndividualAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Relationship to Entity [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Relationship to Entity [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xml:lang="en-US">Arrangements and Non-arrangement Transactions [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xml:lang="en-US">Arrangements and Non-arrangement Transactions [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Sale of Stock [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Sale of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xml:lang="en-US">Sale of Stock [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xml:lang="en-US">Sale of Stock [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xml:lang="en-US">Income Statement Location [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xml:lang="en-US">Income Statement Location [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xml:lang="en-US">Long-term Debt, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xml:lang="en-US">Long-term Debt, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightExerciseAxis" xlink:label="loc_tpiv_ClassOfWarrantOrRightExerciseAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ClassOfWarrantOrRightExerciseAxis" xml:lang="en-US">Class of Warrant or Right, Exercise [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ClassOfWarrantOrRightExerciseAxis" xlink:to="lab_tpiv_ClassOfWarrantOrRightExerciseAxis" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightExerciseDomain" xlink:label="loc_tpiv_ClassOfWarrantOrRightExerciseDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ClassOfWarrantOrRightExerciseDomain" xml:lang="en-US">Class of Warrant or Right, Exercise [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ClassOfWarrantOrRightExerciseDomain" xlink:to="lab_tpiv_ClassOfWarrantOrRightExerciseDomain" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems" xlink:label="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems" xml:lang="en-US">Common Stock Capital Shares Reserved For Future Issuance [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems" xml:lang="en-US">Common Stock Capital Shares Reserved For Future Issuance [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems" xlink:to="lab_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems" xml:lang="en-US">Common Stock Capital Shares Reserved For Future Issuance [Line Items]</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Shares Issued, Price Per Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Allocated Share-based Compensation Expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xml:lang="en-US">Selling, General and Administrative Expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US">Subsequent Event Type [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US">Eastern Capital Limited [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US">Subsequent Event Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_EasternCapitalLimitedMember" xlink:label="loc_tpiv_EasternCapitalLimitedMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_EasternCapitalLimitedMember" xml:lang="en-US">Eastern Capital Limited [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_EasternCapitalLimitedMember" xlink:to="lab_tpiv_EasternCapitalLimitedMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_EasternCapitalLimitedMember" xml:lang="en-US">EasternCapitalLimitedMember</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xml:lang="en-US">Financial Instrument [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xml:lang="en-US">Financial Instruments [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantMember" xml:lang="en-US">Warrant [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ArrangementsAxis" xlink:label="loc_tpiv_ArrangementsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ArrangementsAxis" xml:lang="en-US">Arrangements [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ArrangementsAxis" xlink:to="lab_tpiv_ArrangementsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ArrangementsAxis" xml:lang="en-US">Arrangements Axis</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ArrangementsDomain" xlink:label="loc_tpiv_ArrangementsDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ArrangementsDomain" xml:lang="en-US">Arrangements [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ArrangementsDomain" xlink:to="lab_tpiv_ArrangementsDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ArrangementsDomain" xml:lang="en-US">Arrangements</label>
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ConsultingArrangementsMember" xlink:label="loc_tpiv_ConsultingArrangementsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_tpiv_ConsultingArrangementsMember" xml:lang="en-US">Consulting Arrangements [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tpiv_ConsultingArrangementsMember" xlink:to="lab_tpiv_ConsultingArrangementsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_tpiv_ConsultingArrangementsMember" xml:lang="en-US">Consulting Arrangements</label>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AwardTypeAxis" xml:lang="en-US">Award Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US">Equity Award [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameAxis" xml:lang="en-US">Plan Name [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameDomain" xml:lang="en-US">Plan Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xml:lang="en-US">Research and Development Expense [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xml:lang="en-US">Type of Adoption [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" />
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>tpiv-20180630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DataTracks version 3.0 on 09-August-2018 [11:07:37] {AM} EST - www.datatracks.com-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#DocumentAndEntityInformation" roleURI="http://www.tapimmune.com/role/DocumentAndEntityInformation" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheetsParenthetical" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfOperations" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedStatementOfStockholdersEquity" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedStatementOfStockholdersEquity" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#NatureOfOperations" roleURI="http://www.tapimmune.com/role/NatureOfOperations" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#BasisOfPresentation" roleURI="http://www.tapimmune.com/role/BasisOfPresentation" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#LiquidityAndFinancialCondition" roleURI="http://www.tapimmune.com/role/LiquidityAndFinancialCondition" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#SignificantAccountingPolicies" roleURI="http://www.tapimmune.com/role/SignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#NetLossPerShareApplicableToCommonShareholder" roleURI="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholder" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#WarrantLiabilityAndFairValueMeasurements" roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurements" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#StockholdersEquity" roleURI="http://www.tapimmune.com/role/StockholdersEquity" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#StockBasedCompensation" roleURI="http://www.tapimmune.com/role/StockBasedCompensation" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#GrantIncome" roleURI="http://www.tapimmune.com/role/GrantIncome" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://www.tapimmune.com/role/SignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#NetLossPerShareApplicableToCommonShareholderTables" roleURI="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderTables" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#WarrantLiabilityAndFairValueMeasurementsTables" roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsTables" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#StockholdersEquityTables" roleURI="http://www.tapimmune.com/role/StockholdersEquityTables" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#LiquidityAndFinancialConditionAdditionalInformationDetail" roleURI="http://www.tapimmune.com/role/LiquidityAndFinancialConditionAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#NetLossPerShareApplicableToCommonShareholderComputationOfIncomeLossPerShareDetail" roleURI="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderComputationOfIncomeLossPerShareDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#NetLossPerShareApplicableToCommonShareholderPotentiallyDilutiveSecuritiesDetail" roleURI="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderPotentiallyDilutiveSecuritiesDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#WarrantLiabilityAndFairValueMeasurementsConversionOptionValuationMethodologyDetail" roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionValuationMethodologyDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#WarrantLiabilityAndFairValueMeasurementsConversionOptionFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#WarrantLiabilityAndFairValueMeasurementsConversionOptionScheduleOfChangesInLevel3LiabilitiesMeasuredAtFairValueDetail" roleURI="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionScheduleOfChangesInLevel3LiabilitiesMeasuredAtFairValueDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#StockholdersEquityWeightedAverageSummaryOfQuantitativeInformationDetail" roleURI="http://www.tapimmune.com/role/StockholdersEquityWeightedAverageSummaryOfQuantitativeInformationDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#StockholdersEquitySummaryOfTheCompanySSharePurchaseWarrantsDetail" roleURI="http://www.tapimmune.com/role/StockholdersEquitySummaryOfTheCompanySSharePurchaseWarrantsDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#StockholdersEquityAdditionalInformationDetail" roleURI="http://www.tapimmune.com/role/StockholdersEquityAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#StockBasedCompensationAdditionalInformationDetail" roleURI="http://www.tapimmune.com/role/StockBasedCompensationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="tpiv-20180630.xsd#GrantIncomeAdditionalInformationDetail" roleURI="http://www.tapimmune.com/role/GrantIncomeAdditionalInformationDetail" />
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/DocumentAndEntityInformation">
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_DocumentAndEntityInformationAbstract" xlink:label="loc_tpiv_DocumentAndEntityInformationAbstract_187559" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_187558" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_DocumentAndEntityInformationAbstract_187559" xlink:to="loc_dei_DocumentInformationTable_187558" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_187557" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_187558" xlink:to="loc_us-gaap_StatementClassOfStockAxis_187557" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_187556" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_187557" xlink:to="loc_us-gaap_ClassOfStockDomain_187556" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_187555" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_187558" xlink:to="loc_dei_DocumentInformationLineItems_187555" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_187411" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_DocumentType_187411" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_187412" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_AmendmentFlag_187412" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_187421" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_DocumentPeriodEndDate_187421" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_187422" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_DocumentFiscalYearFocus_187422" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_187423" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_DocumentFiscalPeriodFocus_187423" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_187436" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_EntityRegistrantName_187436" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_187437" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_EntityCentralIndexKey_187437" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_187453" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_CurrentFiscalYearEndDate_187453" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_187458" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_EntityFilerCategory_187458" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_187540" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_TradingSymbol_187540" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_187547" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_187555" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_187547" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_32" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_33" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_32" xlink:to="loc_us-gaap_StatementTable_33" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_34" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_33" xlink:to="loc_us-gaap_StatementClassOfStockAxis_34" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_35" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_34" xlink:to="loc_us-gaap_ClassOfStockDomain_35" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_42" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_35" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_42" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_43" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_35" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_43" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_36" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_33" xlink:to="loc_us-gaap_StatementLineItems_36" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_37" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_36" xlink:to="loc_us-gaap_AssetsAbstract_37" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_38" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_37" xlink:to="loc_us-gaap_AssetsCurrentAbstract_38" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_44" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_38" xlink:to="loc_us-gaap_Cash_44" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_45" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_38" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_45" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_46" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_38" xlink:to="loc_us-gaap_AssetsCurrent_46" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_47" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_38" xlink:to="loc_us-gaap_Assets_47" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_36" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_40" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_40" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_48" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_48" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_49" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_49" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_50" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40" xlink:to="loc_us-gaap_NotesPayableCurrent_50" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_51" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40" xlink:to="loc_us-gaap_LiabilitiesCurrent_51" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_52" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40" xlink:to="loc_us-gaap_Liabilities_52" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_53" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40" xlink:to="loc_us-gaap_CommitmentsAndContingencies_53" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_41" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39" xlink:to="loc_us-gaap_StockholdersEquityAbstract_41" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_54" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41" xlink:to="loc_us-gaap_PreferredStockValue_54" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_55" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41" xlink:to="loc_us-gaap_CommonStockValue_55" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_56" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41" xlink:to="loc_us-gaap_AdditionalPaidInCapital_56" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_57" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_57" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_58" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41" xlink:to="loc_us-gaap_StockholdersEquity_58" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_59" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_59" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_128" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_129" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_128" xlink:to="loc_us-gaap_StatementTable_129" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_130" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_129" xlink:to="loc_us-gaap_StatementClassOfStockAxis_130" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_130" xlink:to="loc_us-gaap_ClassOfStockDomain_131" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_133" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_131" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_133" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_134" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_131" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_134" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_132" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_129" xlink:to="loc_us-gaap_StatementLineItems_132" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_135" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_136" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_PreferredStockSharesIssued_137" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_138" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_139" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_139" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_140" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_CommonStockSharesIssued_141" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_142" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_132" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_142" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_189" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_190" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_189" xlink:to="loc_us-gaap_StatementTable_190" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_191" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_190" xlink:to="loc_us-gaap_StatementClassOfStockAxis_191" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_195" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_191" xlink:to="loc_us-gaap_ClassOfStockDomain_195" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_221030" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_190" xlink:to="loc_srt_ProductOrServiceAxis_221030" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_221031" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_221030" xlink:to="loc_srt_ProductsAndServicesDomain_221031" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantMember" xlink:label="loc_us-gaap_GrantMember_221032" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_221031" xlink:to="loc_us-gaap_GrantMember_221032" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_192" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_190" xlink:to="loc_us-gaap_StatementLineItems_192" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_220163" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_192" xlink:to="loc_us-gaap_RevenuesAbstract_220163" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_220164" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_220163" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_220164" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_220165" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_220163" xlink:to="loc_us-gaap_Revenues_220165" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_193" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_192" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_193" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_196" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_193" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_196" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_197" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_193" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_197" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_198" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_193" xlink:to="loc_us-gaap_OperatingExpenses_198" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_199" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_193" xlink:to="loc_us-gaap_OperatingIncomeLoss_199" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_194" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_192" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_194" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_200" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_194" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_200" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_220801" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_194" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_220801" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_201" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_194" xlink:to="loc_us-gaap_NetIncomeLoss_201" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_202" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_192" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_202" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_203" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_192" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_203" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedStatementOfStockholdersEquity">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_205" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_206" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_205" xlink:to="loc_us-gaap_StatementTable_206" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_207" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_206" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_207" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_208" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_207" xlink:to="loc_us-gaap_EquityComponentDomain_208" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_210" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_208" xlink:to="loc_us-gaap_CommonStockMember_210" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_211" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_208" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_211" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_212" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_208" xlink:to="loc_us-gaap_RetainedEarningsMember_212" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_209" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_206" xlink:to="loc_us-gaap_StatementLineItems_209" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_213" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_StockholdersEquity_213" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_214" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_SharesIssued_214" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_PrivatePlacementAmount" xlink:label="loc_tpiv_PrivatePlacementAmount_220213" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_tpiv_PrivatePlacementAmount_220213" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_PrivatePlacementShare" xlink:label="loc_tpiv_PrivatePlacementShare_220220" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_tpiv_PrivatePlacementShare_220220" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_215" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_215" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_216" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_216" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ExerciseOfWarrantsAmount" xlink:label="loc_tpiv_ExerciseOfWarrantsAmount_220912" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_tpiv_ExerciseOfWarrantsAmount_220912" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ExerciseOfWarrantsShare" xlink:label="loc_tpiv_ExerciseOfWarrantsShare_220826" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_tpiv_ExerciseOfWarrantsShare_220826" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_WarrantOfCashlessExercised" xlink:label="loc_tpiv_WarrantOfCashlessExercised_220238" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_tpiv_WarrantOfCashlessExercised_220238" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_WarrantOfCashlessExercisedSharesIssued" xlink:label="loc_tpiv_WarrantOfCashlessExercisedSharesIssued_220251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_tpiv_WarrantOfCashlessExercisedSharesIssued_220251" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_217" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_218" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_218" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_220257" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_220257" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_219" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_NetIncomeLoss_219" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_220" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_StockholdersEquity_220" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_221" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_209" xlink:to="loc_us-gaap_SharesIssued_221" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_223" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_224" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_223" xlink:to="loc_us-gaap_StatementTable_224" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_225" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_224" xlink:to="loc_us-gaap_StatementClassOfStockAxis_225" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_233" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_225" xlink:to="loc_us-gaap_ClassOfStockDomain_233" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_226" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_224" xlink:to="loc_us-gaap_StatementLineItems_226" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_227" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_226" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_227" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_234" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_227" xlink:to="loc_us-gaap_NetIncomeLoss_234" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/presentationGuidance" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_228" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_227" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_228" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities_235" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_228" xlink:to="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities_235" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_236" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_228" xlink:to="loc_us-gaap_ShareBasedCompensation_236" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_220301" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_228" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_220301" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_229" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_227" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_229" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_237" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_229" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_237" use="optional" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_238" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_229" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_238" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_239" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_227" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_239" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_230" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_226" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_230" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement" xlink:label="loc_tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement_220303" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_230" xlink:to="loc_tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement_220303" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_220307" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_230" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_220307" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_240" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_230" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_240" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_241" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_230" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_241" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashPeriodIncreaseDecrease_242" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_226" xlink:to="loc_us-gaap_CashPeriodIncreaseDecrease_242" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_243" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_226" xlink:to="loc_us-gaap_Cash_243" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_244" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_226" xlink:to="loc_us-gaap_Cash_244" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_231" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_226" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_231" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_232" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_231" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_232" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement" xlink:label="loc_tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement_220309" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_232" xlink:to="loc_tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement_220309" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NonCashExcerciseOfWarrantsAmount" xlink:label="loc_tpiv_NonCashExcerciseOfWarrantsAmount_220997" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_232" xlink:to="loc_tpiv_NonCashExcerciseOfWarrantsAmount_220997" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/NatureOfOperations">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_247" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_248" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_247" xlink:to="loc_us-gaap_NatureOfOperations_248" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/BasisOfPresentation">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_250" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccounting" xlink:label="loc_us-gaap_BasisOfAccounting_251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_250" xlink:to="loc_us-gaap_BasisOfAccounting_251" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/LiquidityAndFinancialCondition">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="loc_us-gaap_TextBlockAbstract_253" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_LiquidityAndFinancialConditionTextBlock" xlink:label="loc_tpiv_LiquidityAndFinancialConditionTextBlock_254" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_253" xlink:to="loc_tpiv_LiquidityAndFinancialConditionTextBlock_254" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/SignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_3" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_3" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholder">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_5" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_6" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_5" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_6" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurements">
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_DerivativesAndFairValueAbstract" xlink:label="loc_tpiv_DerivativesAndFairValueAbstract_8" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_9" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_DerivativesAndFairValueAbstract_8" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_9" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/StockholdersEquity">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_11" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_12" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_11" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_12" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/StockBasedCompensation">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_15" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_14" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_15" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/GrantIncome">
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_GrantIncomeAbstract" xlink:label="loc_tpiv_GrantIncomeAbstract_220126" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_GrantIncomeTextBlock" xlink:label="loc_tpiv_GrantIncomeTextBlock_220131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_GrantIncomeAbstract_220126" xlink:to="loc_tpiv_GrantIncomeTextBlock_220131" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/SignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_20" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_21" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_20" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_21" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_23" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_24" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_23" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_24" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NetLossPerShareTableTextBlock" xlink:label="loc_tpiv_NetLossPerShareTableTextBlock_25" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_23" xlink:to="loc_tpiv_NetLossPerShareTableTextBlock_25" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsTables">
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_DerivativesAndFairValueAbstract" xlink:label="loc_tpiv_DerivativesAndFairValueAbstract_27" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ValuationMethodology" xlink:label="loc_tpiv_ValuationMethodology_28" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_DerivativesAndFairValueAbstract_27" xlink:to="loc_tpiv_ValuationMethodology_28" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis" xlink:label="loc_tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis_29" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_DerivativesAndFairValueAbstract_27" xlink:to="loc_tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis_29" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_MeasuredAtFairValue" xlink:label="loc_tpiv_MeasuredAtFairValue_30" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_DerivativesAndFairValueAbstract_27" xlink:to="loc_tpiv_MeasuredAtFairValue_30" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/StockholdersEquityTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_220147" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_220153" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_220147" xlink:to="loc_us-gaap_StatementTable_220153" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_220154" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220153" xlink:to="loc_us-gaap_StatementClassOfStockAxis_220154" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_220155" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_220154" xlink:to="loc_us-gaap_ClassOfStockDomain_220155" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_220157" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220153" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_220157" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_220158" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_220157" xlink:to="loc_us-gaap_EquityComponentDomain_220158" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_220156" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220153" xlink:to="loc_us-gaap_StatementLineItems_220156" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ValuationMethodologyTableTextBlock" xlink:label="loc_tpiv_ValuationMethodologyTableTextBlock_220162" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220156" xlink:to="loc_tpiv_ValuationMethodologyTableTextBlock_220162" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_SharePurchaseWarrantsTableTextBlock" xlink:label="loc_tpiv_SharePurchaseWarrantsTableTextBlock_220161" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220156" xlink:to="loc_tpiv_SharePurchaseWarrantsTableTextBlock_220161" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/LiquidityAndFinancialConditionAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_61" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_62" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_61" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_62" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_63" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_62" xlink:to="loc_us-gaap_StatementClassOfStockAxis_63" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_65" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_63" xlink:to="loc_us-gaap_ClassOfStockDomain_65" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_64" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_62" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_64" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_66" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_64" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_66" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderComputationOfIncomeLossPerShareDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_68" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_69" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_68" xlink:to="loc_us-gaap_StatementTable_69" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_70" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_69" xlink:to="loc_us-gaap_StatementClassOfStockAxis_70" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_75" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_70" xlink:to="loc_us-gaap_ClassOfStockDomain_75" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_71" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_69" xlink:to="loc_us-gaap_StatementLineItems_71" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAttributableToParentDilutedAbstract" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract_72" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_71" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract_72" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_76" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract_72" xlink:to="loc_us-gaap_NetIncomeLoss_76" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_73" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_71" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_73" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_77" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_73" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_77" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_74" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_71" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_74" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_78" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_74" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_78" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderPotentiallyDilutiveSecuritiesDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_80" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_81" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_80" xlink:to="loc_us-gaap_StatementTable_81" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_82" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_81" xlink:to="loc_us-gaap_StatementClassOfStockAxis_82" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_84" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_82" xlink:to="loc_us-gaap_ClassOfStockDomain_84" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_83" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_81" xlink:to="loc_us-gaap_StatementLineItems_83" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityShares" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityShares_85" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityShares_85" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_CommonStockWarrantsEquityTreatment" xlink:label="loc_tpiv_CommonStockWarrantsEquityTreatment_86" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83" xlink:to="loc_tpiv_CommonStockWarrantsEquityTreatment_86" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_87" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_87" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionValuationMethodologyDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_89" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_90" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_89" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_90" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_91" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_90" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_91" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_92" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_91" xlink:to="loc_us-gaap_EquityComponentDomain_92" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_SharePurchaseWarrantsMember" xlink:label="loc_tpiv_SharePurchaseWarrantsMember_96" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_92" xlink:to="loc_tpiv_SharePurchaseWarrantsMember_96" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_220955" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_90" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_220955" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_220956" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_220955" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_220956" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_220957" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220956" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_220957" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_220958" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220956" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_220958" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_220959" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220956" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_220959" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_220960" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220956" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_220960" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_220961" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220956" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_220961" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_220962" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220956" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_220962" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_95" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_90" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_95" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_99" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_95" xlink:to="loc_us-gaap_SharePrice_99" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_221001" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_95" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_221001" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_221002" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_95" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_221002" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_106" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_107" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_106" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_107" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_108" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_107" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_108" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_109" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_108" xlink:to="loc_us-gaap_HedgingRelationshipDomain_109" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_113" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_109" xlink:to="loc_us-gaap_FairValueHedgingMember_113" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_110" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_107" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_110" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_111" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_110" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_111" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_114" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_111" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_114" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_115" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_111" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_115" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_116" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_111" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_116" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_112" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_107" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_112" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_117" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_112" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_117" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionScheduleOfChangesInLevel3LiabilitiesMeasuredAtFairValueDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_119" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_120" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_119" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_120" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_121" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_120" xlink:to="loc_us-gaap_StatementClassOfStockAxis_121" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_123" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_121" xlink:to="loc_us-gaap_ClassOfStockDomain_123" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_122" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_120" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_122" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_124" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_122" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_124" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_125" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_122" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_125" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_126" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_122" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_126" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/StockholdersEquityWeightedAverageSummaryOfQuantitativeInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_220244" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_220246" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_220244" xlink:to="loc_us-gaap_StatementTable_220246" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_220255" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220246" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_220255" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_220256" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_220255" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_220256" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_WeightedAverageInputsBeforeModificationMember" xlink:label="loc_tpiv_WeightedAverageInputsBeforeModificationMember_220260" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_220256" xlink:to="loc_tpiv_WeightedAverageInputsBeforeModificationMember_220260" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_WeightedAverageInputsAfterModificationMember" xlink:label="loc_tpiv_WeightedAverageInputsAfterModificationMember_220290" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_220256" xlink:to="loc_tpiv_WeightedAverageInputsAfterModificationMember_220290" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_220262" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220246" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_220262" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_220263" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_220262" xlink:to="loc_us-gaap_EquityComponentDomain_220263" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_SharePurchaseWarrantsMember" xlink:label="loc_tpiv_SharePurchaseWarrantsMember_220292" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_220263" xlink:to="loc_tpiv_SharePurchaseWarrantsMember_220292" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_220940" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220246" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_220940" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_220941" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_220940" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_220941" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_220942" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220941" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_220942" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_220943" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220941" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_220943" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_220944" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220941" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_220944" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_220946" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220941" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_220946" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_220945" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_220941" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_220945" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_220250" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220246" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_220250" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_220938" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_220250" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_220938" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_220939" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_220250" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_220939" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/StockholdersEquitySummaryOfTheCompanySSharePurchaseWarrantsDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_220295" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_220297" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_220295" xlink:to="loc_us-gaap_StatementTable_220297" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_220298" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220297" xlink:to="loc_us-gaap_StatementClassOfStockAxis_220298" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_220299" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_220298" xlink:to="loc_us-gaap_ClassOfStockDomain_220299" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_220300" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220297" xlink:to="loc_us-gaap_StatementLineItems_220300" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_220304" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_220304" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantIssued" xlink:label="loc_tpiv_NumberOfWarrantIssued_220306" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_NumberOfWarrantIssued_220306" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantsCashlessExercised" xlink:label="loc_tpiv_NumberOfWarrantsCashlessExercised_221012" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_NumberOfWarrantsCashlessExercised_221012" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantExercisedForCash" xlink:label="loc_tpiv_NumberOfWarrantExercisedForCash_220308" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_NumberOfWarrantExercisedForCash_220308" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantExpiredOrCancelled" xlink:label="loc_tpiv_NumberOfWarrantExpiredOrCancelled_220386" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_NumberOfWarrantExpiredOrCancelled_220386" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_220310" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_220310" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice_220894" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice_220894" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice_220319" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice_220319" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice_220388" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice_220388" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash_220327" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash_220327" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice_220390" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice_220390" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice_220895" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice_220895" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife" xlink:label="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife_220343" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife_220343" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue" xlink:label="loc_tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue_220392" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220300" xlink:to="loc_tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue_220392" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/StockholdersEquityAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_144" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable" xlink:label="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_144" xlink:to="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_146" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_TitleOfIndividualAxis_146" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_158" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_146" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_158" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_147" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_TypeOfArrangementAxis_147" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_148" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_147" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_148" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_149" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_149" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_160" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_149" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_160" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_150" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_150" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_161" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_150" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_161" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_151" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_151" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_152" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_151" xlink:to="loc_us-gaap_EquityComponentDomain_152" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_162" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_152" xlink:to="loc_us-gaap_CommonStockMember_162" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_153" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_153" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_163" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_153" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_163" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_154" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_StatementClassOfStockAxis_154" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_164" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_154" xlink:to="loc_us-gaap_ClassOfStockDomain_164" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_155" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_155" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_165" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_155" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_165" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightExerciseAxis" xlink:label="loc_tpiv_ClassOfWarrantOrRightExerciseAxis_156" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_tpiv_ClassOfWarrantOrRightExerciseAxis_156" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ClassOfWarrantOrRightExerciseDomain" xlink:label="loc_tpiv_ClassOfWarrantOrRightExerciseDomain_166" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_ClassOfWarrantOrRightExerciseAxis_156" xlink:to="loc_tpiv_ClassOfWarrantOrRightExerciseDomain_166" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_220428" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_220428" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_220429" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_220428" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_220429" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_220437" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_dei_LegalEntityAxis_220437" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_220438" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_220437" xlink:to="loc_dei_EntityDomain_220438" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_EasternCapitalLimitedMember" xlink:label="loc_tpiv_EasternCapitalLimitedMember_220439" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_220438" xlink:to="loc_tpiv_EasternCapitalLimitedMember_220439" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_220442" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_us-gaap_FinancialInstrumentAxis_220442" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_220443" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_220442" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_220443" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_220445" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_220443" xlink:to="loc_us-gaap_WarrantMember_220445" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ArrangementsAxis" xlink:label="loc_tpiv_ArrangementsAxis_220454" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_tpiv_ArrangementsAxis_220454" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ArrangementsDomain" xlink:label="loc_tpiv_ArrangementsDomain_220455" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_ArrangementsAxis_220454" xlink:to="loc_tpiv_ArrangementsDomain_220455" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ConsultingArrangementsMember" xlink:label="loc_tpiv_ConsultingArrangementsMember_220457" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_ArrangementsDomain_220455" xlink:to="loc_tpiv_ConsultingArrangementsMember_220457" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems" xlink:label="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceTable_145" xlink:to="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_169" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_169" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_170" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_170" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_220422" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_220422" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_220423" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_220423" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_220424" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_220424" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_220434" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_220434" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_220435" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_220435" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_ExerciseOfWarrantsAmount" xlink:label="loc_tpiv_ExerciseOfWarrantsAmount_220441" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_tpiv_ExerciseOfWarrantsAmount_220441" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NonCashExcerciseOfWarrantsAmount" xlink:label="loc_tpiv_NonCashExcerciseOfWarrantsAmount_220447" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_tpiv_NonCashExcerciseOfWarrantsAmount_220447" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_NumberOfWarrantExpiredOrCancelled" xlink:label="loc_tpiv_NumberOfWarrantExpiredOrCancelled_220449" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_tpiv_NumberOfWarrantExpiredOrCancelled_220449" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_220450" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_220450" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_220451" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_220451" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_220452" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_220452" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_220453" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems_157" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_220453" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/StockBasedCompensationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_172" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_173" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_172" xlink:to="loc_us-gaap_StatementTable_173" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_174" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_173" xlink:to="loc_us-gaap_StatementClassOfStockAxis_174" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_180" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_174" xlink:to="loc_us-gaap_ClassOfStockDomain_180" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_175" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_173" xlink:to="loc_us-gaap_AwardTypeAxis_175" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_181" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_175" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_181" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_176" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_173" xlink:to="loc_us-gaap_PlanNameAxis_176" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_182" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_176" xlink:to="loc_us-gaap_PlanNameDomain_182" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_177" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_173" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_177" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_178" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_177" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_178" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_183" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_178" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_183" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_184" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_178" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_184" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_179" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_173" xlink:to="loc_us-gaap_StatementLineItems_179" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_185" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_179" xlink:to="loc_us-gaap_ShareBasedCompensation_185" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_186" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_179" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_186" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_187" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_179" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_187" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.tapimmune.com/role/GrantIncomeAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="tpiv-20180630.xsd#tpiv_GrantIncomeAbstract" xlink:label="loc_tpiv_GrantIncomeAbstract_220133" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_220135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tpiv_GrantIncomeAbstract_220133" xlink:to="loc_us-gaap_StatementTable_220135" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_220136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220135" xlink:to="loc_us-gaap_StatementClassOfStockAxis_220136" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_220137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_220136" xlink:to="loc_us-gaap_ClassOfStockDomain_220137" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_220897" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220135" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_220897" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_220898" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_220897" xlink:to="loc_us-gaap_TypeOfAdoptionMember_220898" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_220899" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_220898" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_220899" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_221027" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220135" xlink:to="loc_srt_ProductOrServiceAxis_221027" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_221028" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_221027" xlink:to="loc_srt_ProductsAndServicesDomain_221028" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrantMember" xlink:label="loc_us-gaap_GrantMember_221029" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_221028" xlink:to="loc_us-gaap_GrantMember_221029" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_220138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220135" xlink:to="loc_us-gaap_StatementLineItems_220138" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_220901" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_220138" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_220901" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tv499451_img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv499451_img01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 5 "G P$1  (1 0,1 ?_$ +L   $#!0$!
M       '" D"! 4&"@,! 0 !!0$! 0               P0%!@<" 0@0   %
M @,&! ,%!P('      $" P0%$08 $@<A$Q05" DQ(A8705$8,D(C&0IA<8&1
M,T,DL5+1-$0E)C8:$0 ! @0$ P4$!P4%!@<    ! @, $00%(3$2!D%1$V%Q
M(C(4@146!Y&AL<'10A?P4K(C,^%B<R0T\7*"PM)3@[-T)28V)__:  P# 0 "
M$0,1 #\ [^,$$&""#!!!@@@P008((^#A)9QE'HBD2UQP4J.(CT&48YXX*V*H
M8ZQ$4TTRJJ*B)0*DD4QMXHL*@E331*4-IA'9A2GF'@V<R(2J1JIU+X"&&7]=
MHWO>LTZTWU,"7BXU(D=()6O*(.FD9)$\RK1R=/.F#D2^:@".S"5W8<!02"/]
ML.+,\WTU)F#&"19Z@' "FO"XCF%+R%5=D*B0<@B*QQ*2HF(.P _;CJINBK<V
MRPD EU)X Y0UTDOK=_(@PZ73+5"QI-9MIV>^864U&@X9DYG;86EVI;D20=&6
M*T>N(M10CH6[G<FR&*40'*.'2&ZI;/J"D@9Y0FJ\L.*Z0EK/#"%P:"4QU#E.
M(@)2@)<PB4@@([ *( )1^>$$5"G5EM22"GG'K+&@EZ<PL1?X4AQ!@@@P008(
M(,$$&""#!!!@@@P008((,$$&""#!!!@@B@1\U/F'_'#=9DN.@/#.,1+/T(\B
MCATX%JW1:.5UES'(D@D@W3,NX444..1,R2)!.!AH&4HX>M(G(2XPT?=T".:[
MK:ZZ[QUOD9&Q=&Y:4;:6%D'3"-5BGKB->7ZHQ/PR]P7+*('(ZB[*([(8L<@W
M,"DCD$5*E,&+OMG;GO%X/D3*3*7U\HI6X]Q>[J<LSQ4)_MC"A=JR*DM/[MOS
M3*ZWA ]R6;:[X<YD-TQ3FV*()N64>DM55 [E'S'(81,(X6WK810)#FG#]NR$
M]EWXUY*)XG]N<3CA9R!! ZK<A$T$B*J5$1,HJEF,LD! \=A@'^&,]2S3U!0Z
M^)EHX9??&@JDA"T<5_=$&7=^[;FINKB-K=7W2+<UP:<]5ND+0$U'MFRJS"3U
M M!@!GR;$6J9T4)B784'=).,Y3$,8M/ ,7*RW6W.K-$\$%!D$X)^@_=%#NM(
M]2*]6DF8QC/=G?NSS_5<:7Z:>J&-3LOJJT]8?BG=@>+1U0A8XHM'$VPCEBH<
M+/(F2HY;I@("H F#8./-T[>:M#3%93F;#VH8RG,8\ ,)=\.]K;C3>77J3 K9
M2#["9<S]T= K<Q3'S%S!O$4S@!Q,(F+X -##Y#$K0P4VCBG1<HO,$$&""#!!
M!@@@P008((,$$&""#!!!@@@P008((,$$)MJ5J?:NE4*-PW<Y=(1YU2M4"L&2
MSYVLY,43@FDBE]HQ@#9CQ24Z9R\4<I*NH1^640*]R'N<C<&@UZ:4:)Z4ZY)W
M)?AV5M.KR+9<LA%(6LY> WND[=XQ27=IN0BMX >4 $#;!Q+V)+:ZM*W@%(!R
M/.(>^]04I#4PLC,0POIEB(YZRCDGR"K=UNFH*-)=FK&+D2:)D19(I)NB@N!6
MJ! *0*%I3PKC:*6MI*-(32)2V2)^'#&,;K*&KK%%54I;@!D-6.$2]V;8H(1D
M1.6JY3B+JMIR2:MZ1+OE3D=ERF=1JR:VU5.:3+N@$/*!QQ6]RNNW)HA:RKVS
MBR;;::MKH4V@)$^4HD^TBU1AM5+93FFAC-9QDL9G=-OJ GQ]OS"1=TY;ND!\
MQ0-E$0, 4,4<90NE=HRL.S(6<.Z--74HJRV63Y1C[85HZ2.43'*02"2N>@"4
M=@ 0XEIY1ILV>(8C6)L/:T"1AXNG:J&M#R0M)YB<,*UGZ%NF:_\ 5^R=?'%B
M(6IK384HE/PNHEBN36Y.NU6Q"E5C)1>+!%218R*103524J!@\=N)ZHNE76TK
M=,^ZM;+1.D$SE/E$336:@M=0NIHV4-+=P44@#5+'&4*;>6O5R6N@N=M%1RZJ
M1555MZ*J:@*& #%(8AZER$(7:(?>PP$2S<SGSAQ=AW*:[K6A;A,F5$\FP175
M2*<3$35$ S@0!^%1QZ844 !&XX\CB#!!!@@@P008((,$$&""#!!!@@@P008(
M(,$$-4ZKT!7M*VP*%1)=#4X?L,"0T&GA4,=!.H2$>3D9PG6GC<>%:@=)%02A
M7\5N@I7*8X  @=,VP .(" [!KMQTV]Z<SR'&.'6!4#2865YH[IE>R!$KBL&W
M)%=0-X9XA&,V4BW./_4$7:)MU!$#?,1VXDD7AX)ULJ(2,)9_;$2Y8V4JTD#'
M&$DO'IWD[3:+R.G3E:5;HESKP+Y<>*W"(BH 1RXT$5D?ND\1Q(TE^#BPEV(^
MJL9;05M0Q.7U&N33&\5+[L9ZWBKO:K;BX8E[O&T1<J!355BYQH<0X5Z $$I7
MNTQ?VUQ9DVA%\;UM_DP^G'C$$FX*M2BEPXJ^Z'J:)]?NB&JR[:W)Z=9:=W_4
M&B]K7*X*RWKH"@4W(GZHE:2C+>@.52H#00J&*U<]J5E"E;JDZFA*1F/;A.<3
M-#NAAY:6R9'EC#L)XX/V8.F1@7343H15L!'::HE#,"A5VHG3\Q1^!L5;TY8)
M)XQ9E52:D)T\##)-525:R ' P"":I#$/O<U1 1,8=Z%?-^_'HA=OAWP\_0W;
MI590C2O)DMM KL4.'^@8].4*KA6L>0G!@@@P008((,$$&""#!!!@@@P008((
M,$$&""$*UWM.:NZ!B6<(S%XX;3*#HY<X% I"EH)AK\,>]5#:#/S'*$_$7,?)
M"6MHE73V">7!>($A("(2%S*R0U<!',P$17<N@((<*W03 Q]X8#AL\,-4=2I7
M(XIG#MQZGIDZDX*A9M-[\L;4*&1FK"NN!NZ!4$$TI:W)5K*$ Y J=!TNU,(H
M*E-4,IRD_GAVY0:4GIG2!B1VPP3=&G7)*Q.0/9"G-B[WSF$@B4P>42 4R8TV
M5(:IB&$/C4:X:-LN-.=D/%.(<1SB,WN#=/[N2L2:U:T^CO\ R.VD59&Y(MH4
MV:X(4B=7;A-$*E&0CDP$Y,H )@ :UQHNTK\Y0O>F*Y-N$3RX>R>49YNRT]9D
M/M)\:0?VSCF#N9\ZO-X@*H;UX?** D%1-9D(&$:J*IB55J]!/*90"B7:.WPQ
M]&4U'9;C;>I4-A:Y<U#[)1\\OU]^HK@6VG2EO5^ZG+Z(=7IG=/4CI[:3"/L7
M5'4-K.77.1%J6%;JDVY>LG,W+/$FX.&T>_,Y.NW9-#'54R4 "D"NS&/;LLEE
MIU!2&@,3Q5^,;#M>ZW9Y.E;A) $\!^$35V!T:]5T@[,OJ[U5#.P[T[==&%BK
M/CFSAN@5))-RBX?NVZAU53J@:H!E'S5 :!C%Z[^6]I8P1&QT1FP%OB:S$H%F
M6ZUM"W8BV6;A9RWAV9&B2[D"E76!/:*I@* !YC&^6._RB><<E:BZ4_EC:\<Q
MW!@@@P008((,$$&""#!!!@@@P008((,$$&""/,Q0$U?CL'^6S#5YI15K&4 (
MU2XQ@IJ(C9N/?1$HS2D(N09KL)-@Z2!=H\9.R&361<(G 2J%,41 :^ ".%:)
M?25(YSAI7,+=;DG*.;'77I)UUZ!];U=?ND.9EXRQIF3/(W-IV5P\>Z>W'%BJ
M=P\M^X(HAE"QKQ<AC;A\4H4,(%^&+W2N4-70*2]+JA4Y3D8H[E/64M:$)\I$
M3@]-74I:_4'I1#:C0:1HQ5T'#S]L.5BJ/[;FVX 1[&N%"CYDDE2B*(A3,G2N
M*G5)"7",SSB[404&Q/ 2A>G<K'2K=>.>)HN4'3=1%TDK045&3DADUBB4:E$Y
MDSB%!\0PV0MQMY"D8&<+5+:'6%)7RCG>U<Z8=,]$-4KU=RTBF$5)R3B2M:VV
MB R%RRI9=QOT8Z+C4 .HNYS@)"G.&4"B #L ,;):MU.4]"$+,E2QC(+AM=-3
M6E;8QU0^GH\Z395W?+'J"U>M\EO+1#')HQIPZ 3O;2B%T2HGN&;2_H$N-^F%
M"[,R(> ABF[DW'[PDT@Y$S/?%UL.WO13<<&8$2PHI%*8!H(B8N8QS&$3 (4
M"T^&SQQ2EI#AF8N*)H3I&47!4RE'-M$=NT1$1 !^ "/@&.YF4N$<Z1JU<8KQ
MY'4&""#!!!@@@P008((\<QP$*B40'Y .$7ZEEDA/YC"2$U!/B*9=T59QK39A
M8D!&LY2A;2J4\)QX@HJ&\S"38;R4#X?MVX;TJGUJ47Q)N?APEA O2I(2R9N<
M8]"*9J!4!&FVF'!*9R$&A:437YHJSC\R_P :X\*7)^&4H22ZC2-7FCZ!AV^
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MO2;N#Z)];VJS]ZVT>[E%SWU:$7%N0>%8V[$QTTJQL%PJBX5X9DV=QZ)5R&*
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M1;UI=2\1TL]-VINMLT"7$6O '3MF-*.=U-7A+$!C;$0Q0^TZ>N9)P2B90$1
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MPP@.&USN%)8MLVVRV\ 5SBT.+D,CJYSPF8G'&%7ZC76.B8 ('?\ 5D(1_M@
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K[M]6WU_ZG]/6-?FQ\L_+CRC3-K^__0W+WEJ]X^B=Z7D\^DZ,L/-+/"/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tv499451_img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv499451_img02.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!X0+E P$1  (1 0,1 ?_$ 0L  0  !@,!
M       !!08'" D" P0* 0$  @(# 0$              @,!! 4&!P@)$
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M[^&U'2[T)[R-4;RGYS;G!_/A(_B_5/Y#T]UGA[^&U'2[T)[R-4;RAO.;\XC
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M_P"O,7.:J_BZK_IM#_5E+&\W>.NX'LM^8W^J%PS^UT? N.HJ*:(FB*(%$1
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MLY*NYAJ*)P40!K*+NU'[4$#E 2 FH0""&X;#N.H9?IO3\G+*C+)=*QE*0X8
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MRECS,L/=Z0E$XDQG&X44A,KTZYFB6R#"R6O)[QFW<NUF+I(ZJA^O8 .)-C
M%'PO2>DM5T&<4U$R5.IZ-KB)I<^,IS2]Q> T$CK P:"! C%9%>D9CJ+)'T6-
MDQCIIEP  MCL*UO,N=&7F66:-F=.$HIK90L0_$M%M5(Z7-#.ZI\'.8H7<D@$
MP5VI-"V=";QJ:J:7C _L8AV:]RE^&TNFTU4Z>XAX-562Y\87<-^(-^*.Y>0.
MUM74N;&9+'[(2W-Z1#I6&JZQW"[APH!2G<+JKF H;% ZQQ4.!"[>Q)UF'8.T
M0#PCWZ]/DT<O+,L;32M@759D]]76&HGWE>?45A9(5G_X3LN_^>&&O_53)^NI
MS_\ ^Q,L_P"EUO\ 7E+FV_\ ;#_^K4W^SFK'=LL=LLBX3 @G0716)U@)B@=%
M0BI=P*)3" B38=A =A[PUV5U.RLR.KHG_OI3&#G+%QDF<ZGKY\YM[:R8?Z15
MX\_YSM?([(2F2[Q'P,=/JP,'710KC5VSC@80+ (]FH9)X]?K'<&1$1.(GV$P
MB( 4-@#KFD=+RM/:==DCW%Q,Q[K1 P<Z/FN7)ZGSF?G;)6$6RRT_1@O=DGD-
M?,GQ^%V,N2)B#8(J#"G4>0KZ3UG)&913U&28R$DX=/7@*2R;Y$# =($D@*&P
MD'<=:FG-!4>2U&85#WXA6O<ZT7!PAAY1RJC/-45V;2:.2!;2P\QC$J\>1N=V
M2LHU2P0=IQO@@UJML"2O6?+3#&C)ODZ:9>(3;+K.9Y1VL@C(NT$2D.NDB0P!
MW;#VZZEE'A%3Y97&I,Z;P 3AE1@T$[[;1#]4V#8NRYIX@UE?+#0!& B>80_0
MKHL'.K*UOQPTH-KI^(K%*,J>WH3?*4K1D'F4B59H=,S>+)95W0D1(5-,"&4(
M@54Q1,.X&,(ZMD^$M!*S5]=Q7MD/MX8,&%QC$WW6]F$(VJ!UY6S*1D@@8F[=
ML/TVKHG><N7;#;<P7)[#49.3S;B:+P];46T=,E8,ZY$-4F39]"-U)Q0[:84;
MHE\8HH91,3!V$#6QE_@Y0T\RF<V<29%1Q(P$7").$B-UL(\B@_7-:<1A8YL/
M@\]B\\?S;RQ%Y#P=DMM#THT[@'' XQIK=:/E#1LA!"P>QPN9Y$LJ"J\@9N_4
M]DD=,G5MV:L9X89?.I<PIW/,)\PO)W&(,!S06N-;5@<UX BT0_TJU-JSK8K=
MBV,Q0^K=+9P\5>K#?TI^.@_$6YW*V5PZ<O8Y_,BX/Y1#MU'8BD04_&!TE QQ
M  US62Z%I<MJAF<N8XE\AC<'ZK<))Q#E,;;%IU6>FKDACH1B776Q(MB;]E@V
M;+U2>(__ !;Q7_YCTG_UDC-=EU"7?ENM:;A2S/ZA6CDKL6>RC_(=\(7;F'_Q
M=RI_YCWC_P!9I35&G 795+ O]FT?^QEJ&;0]LS8W6JH,!9QMG'3)T3E6DLH5
M_88>/FXQLVL+=T[BE&\]&KQCPRS=D[8+F6316W3,"I0*;O =:6L=,R-8Y5[+
M<_ \D6B\0,?B@I9)G53D59WF2.J"J=Q[DR?QKE&N9<@&D4O9:Q:PN+%G)(+J
MPZTH5TL[!%VW071<J,A66'<H*E/T_P!=OVZOS/(6YUH\:7>88&!L=T!A!\RE
M2Y[/E:@[R1:3BZ3%7C;\OLI,HS.$6Q;5IJ7/>1(7)=ID"1[TS^%L%>GOOAC/
MO=$\D9%NT*^ .M-P#D#$#;<.T==5J_##+ZYM'BF6TE.91$.W$0MW0O7+R-:U
M]/,G"2V+'38QW$;NE79OGG',SY"J&0ZC)T;"T1\:T0TB\AV:MT=:*M=J78&:
MF9R\I*EE5?*Y!$K7Q9/'$50(F80!/?MUP-#X,9=E^82ZLSGF6V8<+3<&N:6X
M;]A,8W[+ERM9XBYE4TW <V$2TD\H,8JE;YSORS<Z#*8^BZ?B/&3*QRM;FKA/
MXMI2=3LEQE:HX;/(5Y./$GCA 56SYHFL(HI)&$0$H"!1'6]0>$674.HS43IS
MYK2#A#SV0001&]U]YM5==X@UE32MD,$#9&&V'P+MR!SMR5DRK6&$M..L&*VF
MVU\E;L^6FN-F*.49MAXE-JLHO/B\,V;O%FR)2BLF@50NWL1*/;JG+/"6CR?-
MV5\B?,,AD(2XV1&TF\C^3<HS]:SZ^B=33VMQ.!MY_P!+U83!F87>"KH2\1]%
MQUD"019"U9QV2JZI8XB-=@Y8NF\U'-TWS%9M.,5&8^*7!01*!Q\/;KO>K]&S
MM89,R@II_"<UUPOLV<Q7#:7SIV0U[IX'4,?.JTY*<GK1R@GXZUW.B8PJMC:*
M/E)"9H%;<PLG93O2-$P4L\B]DY-W,*LB- *@8QB^+(.VP]^N'T1H"IT/)FRI
M]09PF0 !_4 V"&Q;&IM1'/ZD3(0@8\Y.U8RJ_P!C4_8'_:CKOS>T.==6=V3S
M+)CEG_XVR?\ L+AW_P!T=)UTW0G_ &+*_P 97?[68N=U7_S',?\ T/\ 4E*P
M]:G7=6L=?LT>1%1]7)N*G61')3F;'=Q+Y!^W(N5)1)4R)E4  P%,41#N$-=H
MS.F%=E55E;[JAH'2T!:4BKFT^;4U:V.&F])5=YOR[9,]Y4M&7+@RAV%EM[QJ
M]E6\"W7;Q:*K-BA'H^1HO'#QR!?$MB&$%%#;FW]+;A-,:9I=*Y#+HV.CPFN8
M2;_VEWP+<S?-W9IJ!^<O-C@/->K\_ET9?#,">:0AJ)]]*6(BX6!D:-EAA#U,
ML::,%V9N283>%G#H" ^-!8$0-_\ 5;=FNM#PNH!E;\@F3BV=WCO,8 F&/%AO
MNV1W+DYVM:R742YTL1:UL.3LX8]"K?'GG(<W8Y@*'#,J=AVQ26-ZPO2ZI=+3
M2EI"[LJBOU@:N%G&TJQ.A&] E*;Q)4U% *'68W;OUNI\$\OJ*U]0V:YC'VP%
MP=$'%?;$ ##=M7,#Q!K6TP&$$C;R6_I&]4C2^=F4<?4L]6JM%PW'SH0%DK#/
M*(41(^3X^#M+U\]DXY"R>7%2<(;R2Q"F7;J' HDW$1( ZY"?X14-9GLIT^=,
M[D0"9<;"1"!!C$ 0'5%E^\KC_>#7R97[%O[6%_(1://>N=,YX91J]&JE'G*%
MA7*):#'FB*%:\HX_;VJX5&,Z_'-V$5**O$$S-6"X]215DU1 0#P   K_  <R
M\YYWFDGS)<O%%[6&&+R@Q;':1>L2M?U]9(<VK:,;;&Q&S;SK'[%&8['B/+<#
MF:'BZW.6FOS,A8&;&QQIW%?5EI CLIG"T<Q<,#I@U5>&50!)1/Q1RE$NVP:[
MIGNE)>;Y),TX^>::3.#09E^'"0[SPAY5PF7Y[44&=2\S:"2PGS@CXU>S.O,F
M=S]"3D99L)<?ZW-6.79S,O?J71G<7D!V[9N$5S"I974T^75(^\5T+@<IA,EL
M4![-]=7TOX:-TS6"=)SV:)(; -$0!RV+FM1:K.>TG F@8]I6'/;L&X[B ;".
MVVX]NX[;CMOKUF1VYEN+J&W?9?Y;UT.9_#,^>LCLN?\ A/Q6_P#+J\_^]*S:
M\VTC_&5W^-=_4EKMV?\ \/3_ .'9\:QQ'N^1KT>?V@NK2?JUQU080.+LPMYE
M9"-F]9:<,..C#DQF/[T+!,.J_1ZK6)R_WZ6CO%_"Z%7K::1W#>(%4BJ1'S]R
MNFB!Q(;Q9#&, ;@&O/\ Q'UE^5<AIWZ?894VH>&MC9:5VW2>F*74%:ZEG&#9
M +CS"WXE5%U8\8,SOHG&W%3"N6:UE69O<=!5-Y8[VVM$+=(=R9RBZ7DV3H <
M5EVD4A'"8D.HF1,3"<X=@:XC+*KQ&R"@;G^J*RA.1/87X?WT+_5Z+=RY3.:?
M3>8O[CE,MSLW:<+G6&ZP7 7+NREP+REC2@VZ_M;WB#)3#'+EFTR?!8SN)K#8
ML?.'+A-L"=ECS,&@HE;NC"FL9(Y_%[";YD-]6T/BQD&9YBVGDT];(>YCB)DZ
M(E3.J>K+ZQZVVX6+7K= 54G*>\39C7SL;8M!B6B-Y^"*SK=<6,!!GVZ5)+&D
M*2N1/F_29>91/E$N=NAD4T"F[^^E-09,RQY$7!P-TB(H#M\QKRBDUKFK<HET
M_$<9$W/V-= "V69O8YH0Y5W&LTU2NSDO A-9D[W-Y'"43'I6".,^!^2,JT:(
MM%2R3A!S9INH/[I#8F4OR)LF24%'(F766^ V[)=!DX\0B(^*77(8G8!^D1UZ
M9G/C!DM#F,K)#)>"UX:3AZL2=EMO.! +J=+H#.*ZA&8MF-A"-_E62S#@I%9@
MXM\2K'CY]B[&N0[R\R!&W&=R!9WD(_OLXWF_(ZS6XEB'PD=]*( T5 "-VZ8$
M*'LS;F !ZT[Q.HLHU7GS,^IYM7E3Z=K9+&@$2QA!B8P@+3'G7/3-$T\W(,LF
MES37NK3B)VF[X@L6:3P:R[9GF3/OKF\>8@K^);8-$N%SRG:"P%73N GZ48*,
M>HMGBDDX<)B50IDR>+\6<@B.Y@#7=,T\5<KH9672Y4E\^DJ*(/;*8,3I89"\
M; 8W\BZA2Z)JC0U59,>)395>Y@+K(X_] 4^8>;RST^S'8<)"ZHS2R0N.394C
MIQ>P*C3K7316;(MY*OSZ+)1$Z;@SC?J7*B1("&%02[=NH?&'2\_3S<Z933N^
M3)_!;@ Q@WV6BVS?'<N2?X?YE)S9^2.F#ARY'&-MD##TKWU3S?\ :;C./8**
MY"<8/*0L"%4K9U,G>,&\6%5@U>J1U4:-HQ9Z[.@H\*W$RB:93K 8"=0%$=5Y
MGXPY+3]WJ*B1FS>J#;$6 POQ[P>6"S3>'F85<[N]/-:;86&]7 H7F^H^6P-G
M2YY!RM1<=Y2Q3D U*-$6"X-&5:KSB)>*MI-E>%"0SY=.1LG0!H(45BE<D.43
M; /;J9MXOS*+4='2Y9(>_+JN4V8Z(B\\0 MV[(Q?YEO4/AY,J<AK*ZNG-;-I
M9SY8C_()%OQ*W..O-YYAR%5:985+IA^BRN3&;F2Q=0KW=0A;OD.,0$X)2%>B
M$V+DIF[X2@*(JG()RF =@#6QFWB_E]!F+J:7)F.I&G#/<UL6M?N)NC#9>N-R
MW069/9+S&?-:*HRSP03:61V<D5(L?<$LKWFGW:\2=JQIC.#QO?Y3&]Y4R59%
MZZ:O6&*9IN3^.5\@<-W3=ZZ73:M@1.=5994HE+T#U:V:_P 4,ARJ=*R^BIYD
M[O3&S!A;'%;8!;>(1,8 !1RW1.9&159CF$T-<QV&T[[%Y97A#D6OX=9YAL5]
MP_7TIBI2%[K- F+GY'?[93XY004FZ[&*L@8R)%V^RR:)7'CS)F+[$#" :A1^
M+^0U6IY=!.I)A<'!I(;8#R[55.T!F5'D$W,),T871(M6& #N&X=P]H>#L'TA
M[0UZW$.ZPN-JZ2 0(&]-865W-_[,E_;$_P"Z$UIYG_RJJ_P[U?2?QDG_ %K?
MA7WC_P#L)_\ U1?_ *'Z_.[_ .8/^)']8K[._P#XS_Z7_P "O+KC5S*@/Z@_
MJ:P[LE-B^<7S[?\ I5QO_P!G\D?P^J:^D/\ +C_\A_JV?"5X3XT_W/R_&M!&
MOJ!>#IHB:(FB)HB:(FB)HB@;YDWJ#^EK(O6#<>99)\H?].Z1_P"06 __ '9P
M6NH:&_[9J?\ K5?_ %YBYS57\75?]-H?ZLI8WF[QUW ]EOS&_P!4+AG]KH^!
M<=144T1-$4=QU@@%[9GZ[;EDN)>V8>TP6)N.I/)F<3%^]86.Y6F$8;KKQ:L3
MCQPX38$.A'9==<F^K&SIC!+#3]5)X3>1@A8=YL%IM1W6#6F$&7)OJG".)Q?U
MU!TMK^T$WU$2V@EPC$G>5DM:X0(L3<=62R99BTF)"LE/,AV.78Z$-]B;CJ,L
M<,.#8P=?M536-:7%HM<8E-]88T,DF0TD2S?:?A6<(-X3<=9(B(&*D8.=B($4
MW'472VN:&NB0TQ%IO4G/<\Q="/,FK7N,QX>[M 0\B@H:BLIHB:(N1?U?U!U9
M3_Q!_P //_V95<WZL\RR-MW_ ,+>$_\ S0S3_!,>ZZ3EG_>F9_X:E_\ R+LU
M7_R*1S_$L<-=R775'?6("]!8F^I$ES@\DXFB \JRTX"2V$2F^DHF27&62"Z^
MTK#NL8F$4U(3)H,<;X\Y6<1(AL3?T0 0] 0 0^7_ /+JMHPAP$>N8F-OPW+$
MTF= /V;K/@01WWW[0'?L$1$.T>H?FA$1]GV]OA#?4W$.EF66MPET;A&-U]^R
MZY0#(61=#G*;CZ/JCX1]7U=3=.>YH:;A<IQL@FXZBY[GB#KEDG%88*&H+"R0
MK/\ \)^7/_/##/\ ZJY/UU4@/\2<M:Z[V76_UI2YMO\ VP__ *K3?[.:L<>[
M?U==IDB$L@?JF61SX"N&+B)]41MJYO\ 6*AN.I3/VLSBO[<%F7,=+M;"WDBF
MXZ/_ &C6M=<VY1EGAN<Y@$77V)N.INF/?VBJVRVL$ $W'5<P<0 .N"D  8A-
M]3ES'RNP38LIN.JVM#0X",'WJ.$;DW'66#AM#&]D""QPVQBKA8B_\6\5?^8]
M)_\ 62,UQNH23IVNC]VF?U"N2R/_ )Y*^8?A"[<Q?^+F5/\ S(N__K-*:KTP
M2W+91%_LRC_V,M0SC_F\WG5N-]<HQC9<SBL[?Z;%J8C##9!-QU:Q[I<PS6]L
MW_Z% M:9W>(?M80_0)OJD2VM<7".(F)M-ZG+=P@0R$'&)B(V^5-QUE[!, #H
MP!!OVA9<XNOAT!-QT>QKYPGNCQ +XJL,:#$"U-]2A9#8LF!,3>F^JY<ILF:9
M\LN$P\IAT7(X!S<)N35CHN>9CB2X\I^!8:T-$!<NM7^QJ?L#_M1U)O:'.CNR
M>99,<L__ !MD_P#87#O_ +HZ3KINA/\ L65_C*[_ &LQ<[JO_F.8_P#H?ZDI
M8V"(@.NZ3;9C7_K-:(= 7%/F. ?*$,#K_P#2H;CJJ<T3V/9-B6S"TG9:V,.:
M_9>J/U!+_4$8>5-]8G,$^L-?,CWDR\$8P&'= 6>6]9%C2W]4IOJ=L(6P4L9P
M8+,*;CHXESVS#VVB YE!H#3$)N.DN,I[IC8XW&)C;\*R\\0@NA$#99\";ZE,
M<9IC,@><!2#RVZ'0FXZK+)1$"R7]$>A5.EM<<1O4? ']7A-K:D=N9\P_ J9G
M\.SYZR.RY_X3\5O_ "ZO/_O2LVO-M(_QE=_C7?U):[=G_P##T_\ AV?&L<1[
MOD:]'G]H+JTGZM<=4WV*RT77K++AGR,9<9,PC<YR#=66EV6KSE#O,''+)HRC
MNM6(B)7"L:*QB)*/&CENF<$S&(!R@(=1>_7GOB9IBOU=ETNDD%H?3N#I4
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M"3YQTF_R.28.E<B\FPF1:38:O6F<C+I*0"8F:1,G$OG0>0"Y5Z!,=01(4HB
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M^V4.+O)&1QIQNC6."LGNW]>HMQ83K)K4Y)=S$/'>2;"]:MY!(B0BV669KD4
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ML3M>:1F,BW,J45&^-GI3\EYV*1].*:9C<XF/.@\.^57]'K+/XFR_U#69^O\
M2D^E;)=F5+Q@8XHV+#=&9^)3)9IYD&M@H?D=\JOZ/>6?Q-E_J&ISM?Z1FB7'
M,J7$P0-ODL^52;H[4##%E/,'D3\COE5_1[RS^)LO]0'6/S[HY@C*S&F#]\5,
M:1U"_P"NIYA"A^1URK_H]Y9_$V7][ZK_ #SHXWYE31YUG\HY_P#=G]"?D=<J
M_P"CWEG\39?WOI^>=&_B5/TI^4M0?=G]"YI\/N5":J1C\?,L%+XU(!$:=*E
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M Y-E OF/LY5+VA/C" CS*(YHR$'?)H>X6GM=2&1Y46X@Z86C;$P6#F,YMC@
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MR21U2F4\68"[CKL>2S)T]ADON?\ Z5QV:&EE$3''JA5@.W8(&*<IBE.4Y1W
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M"LIA#SC=8@[G(*KAKXXG4&YDU0-W"&O#,Y;,DYC-E@PE1L"]LR:9+J,MENG
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M>*@@VL;./EF$:ZDH%1<Y2"[;D50(<Y ,8.LN^NRIQS R$(K,R26L)61X@8
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MUY]CC^J+AS+A9SQ-8!)(^="_R;.E/*_U_P O_@U,80;%DO>YC6/,8)Y9^O\
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M04P(4HTG P&,8 ,4ACQT64#J%[!,'6;?<>S;TM=,R.NET.1:-J,!:ZGS&O\
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M 6#^G2J2UMHFB)HB:(G]7Z>D"2"-BBZ8R6TXS"-RDLL@"[J)V#M3<'-N&X"
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M6(F1[/1YJB7B3C\:Q329O[":A#UXLE;Y=!P61D)6+CE3>2"51-%%4YCB0>P
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ME4VH4IF[7?LZ?5:]5&KYT0B;E\VKT0TB47;E-+]R(NX(UZSE+[$#&';LUM0
MN454FB)HB> ='?5NYDVJK'W^AM<_C:P_M8[6I1=J9S!9V*D];:PFB+%3FQ2L
MY9"XV7VK\=9-Y'Y-=.JJ\29QEK5H,U:JE&6:-D;U1J[?DD5QHUCNE5;.HYE+
M"  S67 W44=C%IGDB42+U=*#3VEA[B_DM2<7<<+HEB%:RXTO-)S1'XYNF*N?
M^2\@35CPO=K+"L)@U2;/HPV1LA928S$<8CZ 90CI^63([460731*8B>I(>XR
MG1)B%:6B-P6*N6,Z99YQT[@<@:IX0&H6;F/F7&.:*5993+I*#>K!@BEY"?,9
M5@T8)5JX.: X9UXTPUCY-)%ZG+IM"+E,D"@@QO.TH&M%ZO5B_P Y;DW-)*8Q
MQAC_ !T2OYIKN68_%2;6+S<[L&'EJ/6+'(8^M&;IQ6HM*0]JEP2K0I=,(]!Q
M'.UVQ#*N=U#:=[>+(+.!L(P$54?%;ESR,J?'SS?5OY2+8QL]1Y*M!JEKR_"2
M%M+9Z[,/<</+?CR;NRDT1.'7D+C*5R2:2*R)4&J#@S4B._6;>V7,,T8G!4S
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MH:"EK4A<#3&6YJ5P/6370[]6;2@:"HW3%-AXZ4<G:LW+MRS9'7,*"28@3IL
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M+=(]H>-/N;]'7RMI2HIWTDYM-2.$HU&V,9,,76/P6[U]KU#)\N;*;/JQQ>[
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M6;F^K3\B[?=5NH)0<MM^D52E'<5$QWV!8@=H>CKSKQ&T'(U;0EV#]N1>RP_
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M*W=*[)3CQ-DXC%TFR;!?R91!4J9!!W=]T0L\1NY7DK'$N1C.1^'^2]MS'/Y
MNV+N,EUXY2HRU4KT*>_*WB_UN_/[Z_-7C,HRONF*]=*T;QS1F*!43E$5!,3<
MV6R)@()A!1QB$%F5K;5::(FM>HN"*8K?8ME_A;_^YLM:TOZT<X12[7(HG]0=
MW8/@'M 0'8=$6.#G!DDXYBUSD]]\$:6%@^.-BP8I4!8NC2BTE-Y)@KT2PIR(
MJ^1ECTVL.9N= 2@IXQ0# (E 0&F;+<\@B"FT@"U8T<?."5GPMDK!U\DLC5V>
M:XD'FYY?&Q\)+,W$V7EEEF.R1!E8N';E8C,:4T9F:NQ5ZP<K& Z)2E 0&G@3
M(;%(S"+6=I4E7O-OOTL4\.L3V_(L)+PG')SR:;WM6)AY5BM>(#D/1,HT4[*L
M&7=*##/H-ID;QAU'7613R<P$ @F P#3OWA8X\_D77P?\WK8>*=KJ;FS1?$.=
MBL78[=8YH62,:83MM1S]8F!V\=$H2M[L\]<9VMP[U[!1:999&$:II2CL14,*
M9"E)K(IW\BR9@-JR1S)@#*5EY1<<^2^)[M08)YBJI9&Q1D.J9#KM@F6MHQ?E
M"<I-@G75.D*Y)QKB%OL8[I*1&:CP%H\2+F%5,PE !=W?O"8PL4J#YN[-=6C<
M3X F\ZXXEN&6".1#7D-CNN1^/+*TY!33B R!-92H^.;U<W=G<4E2MUFZSRJB
MTBR8$D)!H@DB8$Q%0PRERGL?BL@L%P(L6W0QA.8QA[S&,8>W<=SF$YMQV#<
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M%F!7BDGI8R/DGXMW+]2,8/9!2,C4@>2SHK-JHX!HR8D.551XZ$@$2(.W6<P
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MVGS%K);GGKO83$N -I Q0C"Y5WYP//+,OG)^.\9;\@.K'QYQY6N-5CFZ@QL
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MLMM;629*Z;JFGIIK9K)?Y0+BXM<!Q(-)9&$,5O9OY%J2\Q%9ETQX=*#1FCB
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M+V[CA6"'?TOOFLWIAVZ^Q? %\MF1SC--A,/@7S%XP69LP+24^:M)$ !T"AP
MO1TE5.0HE$0-[+I.&X[AKVZHD2)KH@P7ETFQN+: O $+&% X$*J J)F3.<5S
M@H*8AMXOQA3@;Q0_.@(:K[I)]:WRJ??)VY<QB8[I0(4IP(W* $)XS8F_?OT
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M7LC4'\N^;QL8W5>OG:A4FZ"(;F,81[3''?I22(':8P^Q#7'YYG&5Y+0<>J<
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M=Y,8^R'?K(\>1T)6*^A:SOG\A',5Y-^Q!9Y6VC!L[:,&QU%$UEDS% NVW4(
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M*DU74\;0%B?U^;O:,8[C)&>A*Y!.6@$=%D#D= 8@J%**9]]7=]9#LA4EDR,
M2JQ?\L:#6KEDH+%=*S)4:M0.!Y"HQ=,J]UG\AS<GG).7-46+4C9!W"WAU>E&
M11A6<*4SA!))078=O460FM-N],$PB\JKLL<@X>A<<+QG>.BII-:&K,F:M5BX
M5^7JMAD+XZ>C5:E49.MS"#:6:R,S=GK1GXKH(!BGZR&,!@'6'/C<K& W&TJ[
MU$2N#>E5!'(;M@_OI*Q!%NKV)9DCXIU;1C&REA6C&":JP,HT),ZA$$Q-N!"
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MQ0-.2T-ERFFH':;BL'EA;8GEOIA\G_@TF539+2^:YP:>QU>UOYH*9IY?=W3
MP<9@$6XKH\JB#P!]/N^9]D/;Z!=@W']'5??FS&M%.7.G.,(%L!T[E::60R3+
MG/:.N8$ W<V]=9I-$ICE\87<FXF*)RE-TB4.@0W >HPG\&P=@]@[@.DFM86N
M[U,9+=+CC%AP[KX+$NEE3<6"4^'[N_K[^:')%1+(HFWZ5"#L!=R@HGU>R[0$
M W 1#I'?;8-_!JWC33,E!KF.DS6AP<-QY% 2Z.93OF2VNXS"1 V"(Y5V"\V
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MD3MT$;1.FMXDF4#*&W%\BB#STP^3_P &J&5=5AC,;A/,LMD41EXG"#MNY/+
MV$=^P.\=PV#TQ$=@VUM2IKJJ+*5[3.:(N#^J .0VQ,=BUCW5IZTMQ;<(6DGT
M+B#],X *9P-OX $/!W]H;AJH3:@NP-+'$7P(/.KI-,UX+ILHL;LB3;YER\M#
M];\G_P!'0O<;0Z!YAZ59W6F]4]*>7>F7Z(?:ZME3^')?)<,1?M@+%6*.4*AD
M\$P9<% 7N_A#Z+?Y'L=:TH.9+$ISBYH-E@$(^57SI,F9/=/EMP.<!';<GEOI
ME^3_ .CJ1NZA+7;#"[SI+E-8\.=U@#=O7>WEEFJQ%T% 34(("4P".^^X=_8&
MY1#O#7%Y_D^7ZAH.Y5K>MZ\ 3T'TK?R6NJLDK^^TSR6Q[%PZ5F!@+/4S1)EK
M)QSLZ(%,F5^Q X^R3$X=2J*8FZ13$/#MOKX6\0] YAI*OG3Z8.G43IKBV+<,
M&DF%T=B^L]#ZRH]2R&RZC#)J&L (!Q1(%M\%]"N$,XUW*U=9.FCM('XI "C<
MYR%5ZR@ &ZB[[]^NA4]1*F,&$];:-Q7>2'![@1U ;#O&]7^W[=OU=;V 8,45
MB":K1=9_F#?L3?JZ2OJ'<Y656,W]@J9_%<E_GMSK4H^P[YY^ +!_3I5):VT3
M1$T1-$5E,O85C,O3>%)>5EU(]##F54<GEBPCD9!K:^BG6RFKUN0,LX1%BR=M
M+6HH=8@*'W2 O3L81"J=*XK0V,(%28[ 8K$S#WFXJ?AJ(QO&065+K)N<=9YM
MN96<]*L6"T\O!R>-[/BC'V,&;\7!QBJ_B&DSZ#2&7 JQ]F)1.GNH<=:W<OY9
MZ%9QS&,%2=9\W'"4=AE&>MES?9B>V?BW?< 2D1'TMO!6W(S::D?OJ;V^TV24
MMMC>67+LG--2%.] S)DHN)52-V_0("[G_+/0I=X.Y3+CEPNR#0\,\5+8[R,X
MJ_*S&47?;9D*XW&KMK\PMMKS^PCG&68*[UYG8:R=TY9KQ<:BU<L9)N+5:+#I
M\8B<R8V"F($,1Z%!TT$Q@KW?D9UE/ 5?PXUO-@:VZKY17S]"YA+%PZL\TSX[
MNTID1[?@K*R9X$8A[9)IVBK#=B!XE<S7QO4/CM8=)P[8JI\T@B#0JDEL WR]
M6/#UNREEV+L4SAW*#O)$0UJF-$:=!O2.<>6FA*0AFSRWVJ70,N:TJ/U7)WJY
M?&(E2212(<XC@2P2 ;E%LTXH%MG.K>8YX/Q..ZLTK#?)$K*I-.)MIXJ%=K5U
MFT4/'6BUSEH4NXI)22A0D61ILR!674*)@3 _C $=@L[M+5QF _JA4R'F_P"-
M9!'2<)E>2C[=5HCB82B3CFG1TA&P=HXF0M@@8&<F8 9AL6P1EVCK*Y3?L"N&
M9VX" H. ,'5K'=]SBG$&X05V,E8GRODB?XT5BW2\/;J52<C/<P9FLK2)CZM&
MV*>H315YB"F1E*6EII^E$EN<DW?G4.Z>>+"%3\H6.=4FILDX1",5$N!N$%EP
M(B8PF$>H3"(B81W$1$=Q$1\.^IAL#%14-31-$31%S)\T7]D7]L&H3/JW<R@[
M9SA;(/\ 5O\ [#_ZAKS[^^?S_C78_P!WY/B6)W.ZQ8'A^+V:(_D3-GB\:SU)
MFH^<:1;AD6WOVXD;[*4R-<.F[B8GXYT9-=))$#FZBEW#;7.Z,I\[S74TFFTT
MR;[2EO!XC6N@(1):2 3 B() (@8 Q*ZCKB=DDC3=1*SZ;)%/-;!N-[6PC99B
M(N-MBT#6CC;2L<09\L\A/.3*9<X^7RU81D+CC6I0=<=96R8E!OX:/QC#WE",
ML;EV*< @J@G(F;H 9-$ASF#J+OKZ,.H,ZS#,)65Y)IR919E14M2V+VO+,4PA
MTR;C<P0$0["VP0@T'"OD6GT1I_)9DO/LPU+3U.GZJKD$TS7AQ);' W"TF,+0
M;X%?09GP2^-J/0( G\'O013#<0*D!F()] C_ %IB[#Z.OF_3\QTR3-G5 PDU
MA8#?$G$0#",+ ;3 <J^U6=RD5<ZG$L3F&A'"C <&#F]<1A&RR#8FVY8]:[6M
M)-$31$T1-$31$T1-$3P#Z@ZP[LGF/P(JIMWV28_[/5S_ #0UUK9;_"'YSE*H
M[7D5+ZNE?5CR_"J9?8"AJQ6*("(" AW@/IA\L.T-#"%MRBXX6DG8%8E_QBP#
M*TR_8YD\7UUY1\I9%'+>0:XH$B+"V9(^'H2S%MLH9.23<_"IIVML7(F1,BB4
M[4I?%B B!HB6#<%0V:YUK555PQ/0[C::_D>4J\:]R71J??Z?0+>\,Y%_6(S)
M,<U86IDU\2J#;R2:"-:"Y$Z"RG2W*!-MQ#5+Y Q&S:MUDV6& .,'06#_  9\
MVI@KBSCS TK:\3XLEN3N*:(VK\UEVLM9A=F[LHINV4A9Z\PDUFD>QFWT4L1N
MM*ECT)54A1*94P"(#'@#8%"=-+X"7:-JRHFN)G&NQX^N&*;!ANESF.[_ )"G
M<L7"K235T[:R^3++*_#<M>DGBSP)*(LRTR<SDCUBLV6;J"84NC?;6.!9<J Z
M:#&"J+"W'W#''.MOJEA+'\-C^"E9(TS+MHUS+R;R7E3) W*^EYNP2$K.2CA)
ML4$T_'N502)[$FP"(:VI$MC!UKUF,PF)"JEIC*AL<D3&8&E9C4,GV&I0E!FK
MH0702TA3*[(R$U"UUP!G!FA&,;*22ZI!(EXSJ4]D80[ KFRVS(\.TK ,QW9"
MM9'<1N,<17LT5.-P7CMO5N1%J=7C-M:/!D=P.1K?((-T7EBG8AZHNQ+)G\G(
M?J;IM^A8/&D$JH=8PE4_#!#Q DQ6.+,!M)B%BCF[S:>*'/'VW8EXNT3&.,Y*
MV7K%MUN,3? MUNI>88/&5L8V8<19'EI23LUR;4"TIM#-5BM%#)MP4$P-S )B
MFA5R2^062Q%\0K9,W]H,5@A\2D_'?S?Y8').:[WF7$G%W&V/LPX;C,*3'%OC
M=$3;G"UDCD)UU/2=^R&%@@:DRG[JL#DK!CY/$-_(6)3;K**&*)->5(FM%H6V
MZ:T[8K+/#G#'BYQ_L;^Y8=PK5:5;9>H&H,M9DG,_-3TS2C2*,J%9FY.S3<V[
ME(M%\T2.FFN97Q90\4GXM+J(.SP1N6L9LPV;%T4?A+Q0QK$PT#1,'5*LPE<R
MK%9PKT0P<3YXZ"RO",7\?#W"$9.I=9I#N8EC(+)-FK<B<>D"@@#?81U<R6 V
M'*L&;;UKX*Y3? F&&>;I/DFUQQ6T,]3%&:XSD\J)-UBVEY0F+X'S2LK+>.%J
M+1-PF0XJ%2*L;I @G,0H%##Y32+K4$R-C2K73'!?B#8<L&SE+X H;C*:LZUM
M3VTD)+LDI>U,11,TLTW6(^4;U.>L2)D$Q\N>L%G)S)E$Q]R%'5?!$8PM4N),
MA#8LK1$3&$QA$QC#N8PCN(B/:(B/>/;K96%#1$\ Z.^K=S)M56/O]#:Y_&UA
M_:QVM2B[4SF"SL5)ZVUA<B[ (;@ AZ8]GI;[=NV^BCC:+"5;U7%E+5RU'9Q%
MDY^,>*QZ_P 7LI89%V#,M,D; RM#N/4B2J Q.[/-QR2H+B43@4.D! !'5,UF
M,BQ5OF&$&W*VU!XJX3QK8:5::E7Y:.F<?#F,U7<.;)+OR,_C\LZ5TR?XYNN[
M.B\-,6%NF=#QFXLR )4A HZJX W+'%>ZS>NJ XE8(K4/AB C*N]&&X_R5^D\
M91S^>DY)M'KY/C+)#79.8!ZNH-A:S<9:'B1DG8*$3!8!+TB7?3@<BR733>%+
ML(\0</\ 'F9^%,:/,J(L6<,[K=:I5GS+D>ZXXHD [=)NE(J@T6RV"0KU79$,
MD5-'Q*(G;H!XI$4TO8ZS*EO:;18MA[L30!? *LLC\>L;92R#BK*MB);(S(&&
M7LHYI5FIEUL=+?#'3BT:[G*I9/@!^T2M-,G7D*T4>1;TBS98Z!!$ [=[)DL/
M,2+8+$E[9;2UY@28JT]:X&<9ZADMGE&$K-K(]B+S+92K&/G>2KU(X7I^3)\S
MM>6R!3<..YPU#KUD7>/7*Y5T6@ @Z=**)D*H<QM8ER@QT0%LMJ)(-KA<LQ0[
M.SL .\ +OTAU>R,!0$1$" 81Z0$1$ [QWU>N,!'&+MA31;*JEK_H;,_[00O\
M E]<;/![R3LP'XE*5]:WG7S3^=L,(<BZAN([?%3$%'M_KOOAL6WRM?97@A.9
M*T\ 6XBXP')=:OF3Q=!EZ@>^9+QLP76=*K;S76,T[[C?FE/P&#,>Y[RQ1J10
MG6)*CD6,CI*'=V:3=V?Q\<8\J\CVC))ZDQ3%0PKHF$" '6&^P]/\=,^SG*\U
MH:67F,VCR^<YW$+2Z#6C#$D-!)L-@ *SX79?EV9R*E_=&S:AK"6M,+7;!:0+
M;K3!6IG^//('E'S2J7'')&'L*\0,C$Q;.SR%:QY!-T:Q(1K-I,6!C*V)*!L,
MPT6DWA6QFY5B+%%!(FZA>P 'FL@USEVA-'OU#*S"=G%!,GAC'%CQ!Q@W"W&U
MM@[1CY%Q=;IZLS_48R*93BBKA++BP.:>J+28L<X>=4?F+@V&.,!RV?:)R Q;
MG&$HE^AL9Y=B<>)RIQQY;IERC'E9EF':AFUE092;E-)19)))$W7U$$P%';L^
MGO%[,LWS^7D.;T#J:;4T_'IFDM/$E0,7=4G#V7$!T#8M*L\/:2CRR9GV65G>
M*>7-X4YT'#!,L&&#@";Q:T$<JGG(O@ ZX[-JY"/\]XVN.8L@2.-D,8X.A&KX
ME[N45D)9A'A.+)+.U4X1G$2SQ1'94@^4)(F6ZR@ %'4T[XTUF>5TZN;EKG:8
MH'O;-FN+ V6X;""8F+1'J@[%9FGAI*RSA4,VJ SJN8'-E=8ES+PX$ M%L1 N
M!58R7FSUE)+(&,J5RCP_>.4.):<[NE^X\Q,3:6DK'MHV-:R4M&Q=R=IA 3D[
M'HNR=3=(A>@Y@Z^@!UI4_CC4/JAFE9ELRFT97SN[R:P@80\F$2UL7@61C#R+
MDV^&4HTQD4D\3\]HVF8:<&!):(X8N@V/EAO68N"(*N/(?S&ZRT#"B-BO6<OA
MTB\0Q,K*F;#(B@A+=3<_E_DQ@#;QHG IP]CMMKSG4]96S9FOJB74N[M+F4PE
MG$1B:X. PB\6<R[3IF12%FC),ZE:*JIE5)FM(:8%D#UKP?.L-\DXRN-BXX9Q
MD8Q'$D11YWSDTMC%.26HSA7+$;+3%A.U8$C+@VD4V;*GLB+%ZV!6@G$ $ .7
M?;7/9)G6<93J>BD=XJ*BKD9#+J'R<7[(2B&N#B"X S(0A $P,([%P]9DU)79
M+/G-IV2*>97.D-F0$3,B1"R)Z;%4MH\U3,5^9S#CJ/Y-X:L6<<45*6R"GA:+
M;3/WT3=#BV19!.8D'GCS,JQ(R*1A*1B<'"I0Z3F$"F ==AI_\P,V=*IL]J*"
M9*T;4U+:=U00"!/<8!A:TEYA<788!<5/\))TH3*1M4'Z@I9>/@Q,0PC%&/9M
M C#%%6PP%P&:9>K&!)6Z\AJ-ART\HE)T<#427J-FM$O=65=4%N_=/'\0+2/K
MPG<)'\2FNH850$/F1[N9UGXQU.GLUJ\MR^@-119>QCJPXF 2Q, P0!=%YBYL
M<(,(\A56G/# YF953F]1PJF87"4TQ)? &-T0+ ;X+"B\5Z#I.;+9BZ(M+&_Q
M=)OR--<6R-C9"(C)YPQF&S";!&*EO%R#4K5X19J)#B4=P$P")>D1[=3ZJK,T
MT4*^73&DF5%.9K0<,2R!,>J3NN72F:8-)J1]#WF+&N(VKZ7;G@K$]UY>9+XM
M6?A1C>J\::Y@]K;R\CZU4Y>HS5.GOO52EE'"]T162K\FHWDSF*1,/W4ARAXP
M#E P:^/<OU;J3+Z++]4R\]FU6I^^.#:0XW$-#R ;L,"("$;%]%U.1Y-451H7
MY>R11R:=KGS>J(' "77Q,;[B3SK EGQXQQFOS<W#Q6QYWQA@*NQ^=<O1Q,B7
M>.5>2=S6>662@J7#Q#6(!O(3:DFIXM=4QEB(($'K-L40V[Q)UGJW+_$BMKJ*
MEFU>8S*67/FRL31A#6XGGK.#8@&V$2=D5U2KTQD-1IAC:NK9)HI]:]DE^%W6
M<<(#8!I=>#"( "PGM'$J&Q/R*RM@3D)R"QQA9IBR,B9I2_2\58K C<8RQ(-7
ME</3*M"-U)>4D7C.2(JLAU;-BE/U&$"]6O:V^+U9GFF*?.\DHC/S6JF\&6PN
MERQC ZX<Z8YK1"Z\Q-P*\W]WHRW.':?S"JX=()9F8C$W0A" -\57<SYO:ZK9
MEXU8SQOE&DY)J?*VMR-NQ/E9M'3-;B5H&OM3/[(ZFJ_*%/+,W,<P+XPK<HF.
MN!P*'2<-:E%XV27:,S'VC($O/LLFADZ6"U^%Q,&X7-):X$V1!LVKDZWPMJJ6
M=3RI,\.;5",LQAB&_>.8JWTMQ-8V+/N/>.V ,SP.<;S<[!8JO.MS46X8R<8_
MDZHN4TH\LD;:DCKJP7D15W"3IN8?'$0$  -PWVLI\6*N9I>IU/J2B-/(IS#&
M"V8QQ-P:99=;& ((%IO7'UFC9M'GLC3F53S.,\6  BS;'% 6<ZF^8>'+&CX?
MO^:L59PJ><ZGAZZ-*#F!"&J-NISRFS4BY%@U?1IK.FDC;*^:2(*7E;<Q2"&P
MEWWUQ6E_'-^<9VW*\PI'2IDU@>SLN#F$1!BPN .$@D$Q&VY<UG/ARW+<IXM"
M]L\,>0XQ@0^)Q"#H& ((B+.E64P%G2I82E9RRS/'NC<B+#+1D?'4B(R$YDSU
M6MRBDB!G4FX@H]%56>>O&A@001'<"G. ]NP /==?9+F>I=/S*K**MV5LI&F?
M,F"PO8!AX=EL,1!/,NM:7S*ER'-94JOI!5.GOX0:8'"3;BOAL@LW_.V4?$./
M+#Q3E*/C6LX:RUE'$QKEFO%%/.#>%JZ[]"&5@U5(M(?$1C_RY=^CMT)F53;!
MU%W 3#X[X$9WJ*?45PK9\RJRJ7,,MDYQ)Q$V&$;2!9;!>@^+N1Y?+D4M31AM
M-/<&N<P=,+(WCE6JKQH#W^Q]3?7TEQCO7B]J=9?GA_XVG%.]+4ZR_/#_ ,;3
MBG>EJ=9?GA_XVG%.]+4ZR_/#_P ;3BG>EJ]3.4<L'*3IN<Q%43% A@W, EW^
M8,7^N*;PAKC\WRS+=49=,HZYK0]K2T&%\%MY=F.8Y+7,J<N+G-)!= PAOO(N
M6;''W/L[2Y5I+1+A9!-%=).29"(BF =8"H9,1,!0ZR]NW@U\-:^T14:2S7]B
MS_A)P+XQ;L,+HQ\R^O-%ZE9J/+<6*-1*(:X0(@2([1 ^2*^AC!^;8'*T U=-
MW*9'X(@"C<RA04W   1$HCOWAKIM.YTQA<+6"]=T=*>P1<(*_NKE6NL_S!OV
M)OU=)7U#N<K*K&;^P5,_BN2_SVYUJ4?8=\\_ %@_ITJDM;:)HB:(FB)HB:(G
M@$/ /]7R=$6'F:<AYI_*,PY@C$UPH]";W[$V9LB2UCMN/ELAK?"^.Y*BQT!&
M(,$;=42,8MXM:ECNU/&*K&(0 ( =FM*9-(F%O*I"$(E45BWG1 6:D0B5KHUQ
MF,ULU\MQN0<:86K[J]*0!<&7:1Q[=[ZD:2>1!FM%D)QBF>**NL>0=&< @FDN
MHBKK#9H,<5BDU@?>I&MR)S!F/*5PC.,60,2GQ[!<6L6\A:"I:Z'-V!+)K^^3
ME]2^!):Q-;17I6GPCN/II$"*HL';MFZ7,91,XIBD-K'M+P!>LF4P-Q;5EY@;
M+4=GG"F*\T146ZA&.3Z/ W).&>*E<.(9>7:%4>Q"K@A2)N!C7Q%4@.  !R@!
MM@ 0*&RJE=C1$]+T=$31$T1-$31%S)\T7]D7]L&H3/JW<R@[9SA;(/\ 5O\
M[#_ZAKS[^^?S_C78_P!WY/B6OSSE/'/C#FK =JN?)\)2(KV&J]9K3"7V!,NM
M8:(HZ:-"R4E Q0+$C9>1?),TD$T'9%$S','8&^^N]>&.KM;Z9U,T:5?(EU$]
MS6-Q8>M&P1+P0T DDFQ>3>+^D-#:LTXY^M&U#:6FZP,LN!,+; T@.W0*T0XS
MR)YIJKW:E*P7FZ^2,A9H:QT>.96RVP,BFU^^"P+,R56:L#.4N!8EJO/K%*\:
MH*I@DN/:B4Q0#7U3GV7>/F8LJ:BJU/DYDSJ9[C*E&4)CY;!^U:TM8#U8P,#&
M-]J^4,ASKP'HWTM'(TQG/"I:AC&5,PS#+XCG#"YQ+X&T1 (L"^D//QDQ6J'0
M4Q %E(CT*!LH3=1CN!R[FZ1 >S;?8!#7QIIC&WO$V6X2Z%T[ 6NO=-B3U8[2
M 3S+[RK'2)@D22TOKVR@^+?U)< .MR1(O6/6NV+531$T1-$31$T1-$31$\ ^
MH.L.[)YC\"*J;=]DF/\ L]7/\T-=:V6_PA^<Y2J.UY%2^KI7U8\OPJF7V H:
ML5B:R!$P47"+2.1:_P#DQR#Y'U7DSA3C5QUAN/ RN3\1Y5RI,6OD+*WZ-@XQ
M+',Y689O#1H410%Q5E3V(#G56*8B14Q'N[]2KJ#377J=-3MA$WJ18F\XWB]Q
MQ1JW);DZYK^ FDCE^U8"F'3=[,VF@2&1ZG:K+4R2-(L;:+\KE*/;G-7<.(MX
MX23 4Q!,YC* '5"75%[ \WD*3Z?KF"N1,^<*XJ0%3Q];9*YW+Q>3H>=LM2JC
M##N7I7)2M4K,@O%6"W36+H^DN,AU:IQ3YN)#R4I&LVAQ$O0<W441GWA1$HLL
M4WR'SQXM8SJ^/[G-9#D[)7,H51:]TA]BW'V1<O*35(;EV<V\S7&U4LKB+KS%
M8Q2+N78($2.!BC[,IRE<= (KWW#F]QDIE3Q7='.15;-#9O@G%IQ.ACFHW/)U
M@O%78LFSV4LL-5J! 6*QF@89)T0'CE5JFFU44*FKT*;EUGCK.&*LWD+SDF(<
M=<L,1<7Y2K9+?&RSB9SDUE=(O&&4Y,D:X>R-;9U.#4AHJBR!%6LJWGCJ23\S
MM)& 4;^*? B=0H:HEU!#^6*Q('5<=@5SN6_)^QX'<8;QKBG';/*_(CDC>']$
MPU1IFP'J]00^]^%6LEVON0+*BR>O(JE46OI>4.P;H'=.E#D01#K-U%VIM1:.
M90ER^)B.P%2R#S[FC"E0NEEYXUC$M"A:^O74JMD/CY(Y(R)7;\_L+EVS^]*-
MQQ(5EUE!E;XYVV I$DT'B+\J@&3,00Z=5B>5)U,YUDJ_R*:,.?7$U]A6_<@U
M,GJPV+\4V.,J&4)"U4V[5&R8ZLDS)PT5%Q]UH=CKT==*[Y<O8&BI%'#$B0M%
M@<]?B"F.#O"CW.IWV*?8?YJ\9\\2=\AL:Y,2>26-H%.WVQM9ZU:Z$HA15@<B
MWR+$%O4+6RV''3D&B@IS;(RT<?IV\< B :=X5A:1>J;QUYP'B7E-E<IFJY0<
M-:O1*B]R#-W2Y47(5 HSNA1[@&SJX5>ZW2KP59N5=(L8I2.XMPZ26\8F)-_&
M%W=X6#)+C%=E2Y]<5+G5\F6^+R)*QT7B'';K+EZ8V['N0Z-9F.+FK9R[-D.)
MJ=RJ\'8[+3UT&A_%/F#9PB<X=&_4)0%WA.$66JX^ >4&$>4,/8;%@RVOKM6J
MU),8QW9_O1M\!6Y523CS23%]49VQP<3%W:&4;E,!WL4J[:)JIG3,IUAMK(G@
MF"$0O5_];*PFB)X!T=]6[F3:JL??Z&US^-K#^UCM:E%VIG,%G8L6.0/(_'G&
MN$I,YD)G<Y(F1+_%XPJ$50ZG(W2PS%VG8R7DX2&:045N_<*2H0RB"0IE-LN<
M@& I!,<FVL 15@GOG',#1U+C+5(5;.3.P2&;G'')SA]3%C]3-4+F@E76N,=1
MY>AH22ID7=@@")+L'"3E9HN1RD<52I]9RZSI\'%NXIP";=Z]=^\X7A?&\I+Q
MM@H^?G;6BPM2F\W6.O8DDIRK\<D+E'-I>-9YRF&DEXJKRD?#NB/))NR+)J1K
M7=58 3V..#40613D[O,N[)/G!,,XXN_WDITO-N1R(9*QKAZ5NV+:$SLV/8/)
MV6H^.EJ529.S/K)"I#,O8F7:.5O$)K(MB.DB'."IRICCO!6#3/(ZMCMB]3?S
M@&"%GF<S.(O+,94^.<U:ZGE3)DAC:4+CF,O=3F(Z%7H$%8$'"R]KN4VZEVWP
M:R8MU#.@63*)B*J%2!W@P4>YU.]>1WYP;"L2QGT;+4\TU#($';L8TE'"MFQU
MY!ENPS>9RR!\7FK$$G-+0DM'6XL0]\4Y/(MT4#,5RN#(G(!#9XZF&PZI-H5=
MO>7=/9W:AXQ3Q;GF4R?<Z2CDB6QU&8\15MF,Z*O:?O-)8LFL5Y]JE!LOAY-8
M@@R4DEP10.L"0I!U"-0G"Q]96X0YH5.EDR&G;)6X9;LYN3>0<%8QQGB7#SOX
MQ964I<%"S4G4X: 3M+Q*XHU*-<.'SVR.EHAHHW.(&124*7KQWCE3NY\W(HK>
M<6P*%8QG.L:[FV;L&5;[?L2U_%4%BF9DLMQ>6\9Q9IBW8UME**Z2<5VRQ[ @
MJ 9946!DQ!3RD$A XY[PG=S^D%DQ@_-5+Y!8XBLG4()UO"2$A/0;^(M4(YKE
MKJ]GJLR[KUGJEI@71E%HFP0,U'KMW"0F.0#)[D.<@@<=I8(@8%9"-/\ 0V9_
MC^&_@$OK0G_7>0_$IR?KF_."^9CSOJ_BN2%,#N V)8D1[1#<WWPV'7UYX+$#
M3["?67S3XR1]ND-]56SX6<CN.N+L1\O<.<A;=D*D1?(NE4^IPMGQU55+1-Q!
M8=U/N)%TD@1TW!%P0T@ET=0@!NWTM<#XV:6SG.LUR^NR^1WELJ:(RX@8NLTM
M%MA!(@1;>M+PWS[+\HHZJ14OX9F27#$/U;#;SB\0VJ><8<[<(>)W,B@Y1H&6
M,QY#Q@WQAD*)N-DO>/7$;98NSV"!DH2 B8R+;O7KF3B5_*"',KN!$C'$!#;5
M.=TFK=2^&L_)9V42Z%U/7L+6LA @.:7&QK8&TB[985MTT_)M-:VH\WDU3JGO
M%&1$VFUIY3'9TJT&,N4.)ZGP#Y.\?I1U,$R-EW.5%O--CT8-ZO'.*_ V-C(N
MUY"1V\FC7*#-H8?$G]EU  !Z7,5.C\YH]8Y+G+6G@RLI=+<Z-Q@X-$+[<14&
M:FI*C):S*<.%]56": +H F/P""K+E'S/Q]D#S@&-.4V'R2=GK^,:I@A0J$Y&
M.(1:0G<;@@I,QA6[XIC>(4%(Q$UMA*=7I$1Z0U/P[T+6'2.8:7S/]A+S6IJ'
M%_JX ,!B-ALCT*6HM6R:G.J'.9(Q2Z>4V62=F$"/G)66"O-3@=B'.^<N<^*;
M9FBZ9XS/4[>QKN#Y>@H0\+3+O=HN/83+^=NRSLZ#V#8KL2JD31 YNCK -_8@
M'2J;3WB#GFFZ+P\FT3?ROE^9%QJVQZT";!$ G$"8;ESDC/=)9;4S]4&J(S"8
MQV&63>YP(A?;>K<X?YZ8 IT3YJYC8Y>R(O>)]FRM/9G%O5I%9O%-;DI(N(T\
M.8O4>:.JN[ .A( ,4@[CW:NS/0>I:]FHI-)*);F'!=+ZPZYE@Q%]D#"TJNFU
M3E=%59+4/[- )@,+P)L(^6"H:2YMX,7XWW/&B4I8?OHL/G&VW):+:C6Y K<^
M*TK C(*22[T0\2E)E9@8?(Q_=!,'2&^N4HM*YXS5+,PFL@TZ;93DQ';#6C##
MR7K7FY[2'+WY8V]F8.J .0DF/G5TJ[S_ ..3+SD'+/D^[F;&7%.4\166FU&4
M+5I,TJ^FY2B0$,U27A2E!RU;+/(X2^-/['8 $0#7&R=#:B9X5T6G)=,7EF9,
MJIEW4A. -O,8V7E2I]=TE9K6IK&D\.?1S -_5;@:#NO$5L#P0VF:MQ9\WKB.
M'E,R8]OV1:!..JK>\68 K?(" H\E=+"^%6T2N2;"S57Q1)KQ\D0%V[)0A&K<
MP@)A%+</+-63)SM;ZAS','RYDALR6Q\HS72B[ UH:,(B'EL(NQ6%>B99*%7I
M[+I]-$5+G3,)A&\/!@=GZ;U\XF5:@3"?(G*.-']P:WYSC;+#]G,W9D<RY+0X
MC9])[*S!A\<N8\@X65.9=(%#B#@#D P[ .OKC3\YFH=%9>VB;@!R=UFZQPV+
MY^S.GJ,KU+,?4&)#S$[[5F!YQ;GK8N56=+JTPUF[+*7&V2K%+C6M"5?S53@'
M,HPA&B5E3>USRA(5T'<B'L@5\:FJ)1W*(".O/_"KP\RC3V444_5<AGM:95/+
M2X N[9P];FNML!79=6:OJ*W,:T9:]W=FTDL&W=+$51&1N2N));AEPHP#$O99
M;(&#<VW2[WMDK#.&\8PKDU( \9N&4D<09R"ZS8=A(F)3%$3;;=FMFDT=F--X
MG9SF9;"BFTCF2C&\83$0V0$%3/U'15NELBHVVS&5A>[GBWY5GK)^<"X?6_F!
MRFRX>Q3=/')&$<;4G!N>9+$3>_R&*[O5JZG'6&42HDUXU=0'I@*1)R0.H_DQ
MBE$OC '7GD[P\U@?#W*Y-')#WFNJ9SI3GM:',8ZPXRX"R,81C;R+M=5JG3%=
MG5=/K7-:V53A@>=CK/E"M3R,YN<>,Z6S@RWC^0N>X%? %>R?%7K/J&/&43D=
MG;7:D*:GW%E5HYPG%.&4H_B^M=HW/N@Q6\6;<X#KE-':/U?IO(\W#\IH:EN:
M!@:U\QI%Q!@[$3&)O)O$;EQVI,^RK,,WR1E'4$,9+)B#NMNW05S;/YT/!]5Y
M"\-,G0[R?Y$W7"3"]0^?,^'Q?'XLGLC5BZ1BT/&QT77TE_&R+ZMMUA=$.X,4
M%52& H[J".N*ROPXUH[2F=Z?KW5%-*;,8YM.PF;)#FDDESFXF@&RX[(FU<KF
MFL-.4N9Y+G_5<Z:",5T8PC\=JQPYF<MZ5D'%=\KM(YY\C<V)WZQLW4;A:S8A
M@J156<#]\19DT9<;*W3;K/EZ\V1(1L#8NZJR0"?L$0UM: T9G>5:BDS:C+6R
M729(ZXG<0'$T#J@%P!?>8PPW0BN)U7G^6YC(G.IJB$F9,)P 0VF_R\ZH;S=^
M8>'^#\G/<G\K@LKM>IQ3)WB-G"U%>XQ+2[F763/8YJ'2502<*5Y-,BC)-4?%
M"L85!]D4NWI_BX->9OIJ5DVFY+\4R;"=@.%QE839&RPNA&U=4T"W2]%GIK,[
MG!P+(2L5H$S$#&!_DQ5L>8E[X[9)ORN6<:Y\S9GO+-]M3]U?Y'*^.F5%C8F#
M!L<\4E6BLG3E$C)@H";1%B3I32;D 0[=Q'C/!QN?Y713-/UU *=LH XL0<7&
M)Q1 %D!;&)BMO7C:3,\VXK*ETR6 2&F(NM$#$QCY%BSY3Z8_1!Z^O<5Y_P!W
M;RJ'E7IC]$'KZ)W=O*GE7IC]$'KZ)W=O*GE7IC]$'KZ)W=O*GE7IC]$'KZ)W
M=O*JCKL*_L3P&[<#I-D@*=X],!O$MTQ$-B@8>PZY@[@#74-4ZVH=$T$Q]9#B
M3 2WRW+F,CTE7ZCS!C:*.!C@'>2]9%1<4UC6B,>Q1'H 2IIB  "K@^X&.LH;
MO,<YO1[O!KXAU7K"NU/6OFS'$RK0WYI,5]>Z<TW3Y%2RY$D 3' %^_$+%LSX
M18_R(M84)])1TR@TQ3%0BO61)1(AQWZ-^P0'PCK@J&5/DC"_LE<S53OVPE["
MMVB)!(D0AAW, #N/H[CN&WI;:Y)5(?Y@W[$WZNDKZAW.5E5C-_8*F?Q7)?Y[
M<ZU*/L.^>?@"P?TZ526MM$T1-$31$T1-$31%C9EG 4]?LJXYS+2<M26++KCF
ME9"H3)9&CUN]Q\A"9&=UE]*+G8V)TU(QEHUU5D3M5B"H0!.8#IG+['53I0<8
MK(*ME&\(X2@N:S-8-RG;,3W"+H%VQM:[<XKU9R'(9$A,@W1[DFR3=C9V%)FQ
M;7@V0)5[*-I)L4J:!WBB/DYT03(2/!"BZ9A4LA^"S*A/DTL-9INF*ZLXP'1.
M.LW"M*Q6;5//*31I*T2*<O"W.=/Y77+C-GN+_P H>@T=%345!1)(IBE ,MDA
MK@X+ G8K"LQJ!1:MC"BT[&](BR0E/H=:AZE6(I-118K"#@F23"/;BLL8ZRZH
M))=2BAQ$ZJIC'$=S:N4E5NB)HB:(FB)HB:(N9/FB_LB_M@U"9]6[F4';.<+9
M!_JW_P!A_P#4->??WS^?\:['^[\GQ+6/YPKD;PP>X\S/Q&SER.J>(;K?:.@T
M!&4;RDA(UY23$DG6Y]1DT9JH.6XO&1%/$^,*91,AB]F^O2M!:5UVZOH-595D
ME3692VJ<UKQA+)L.J0 ;R#$ ;"%XCXJZOT-,RO--)9MG-/2YI,H@S X.+I3K
M7!PAM((NM@M26<+SQIS->(=A3/.98?J])RI6./\ 4.2596I-D6EKQ9,*/6HP
M%EQVZ^#%"520EU1\68%5">)'I$3'+V![+097JO*\AG2,^TG63:BGGU+Y$XS'
M,=)9.@7-.![8W6AP=9=:3'P#/,UT?F%?23\@UA(HZ1TFBE39#*;BLG3)&,8B
M'RI@:[K0B,),>L3 0^@+.I")EI1""8Z81KXB:AS <ZR8"P\6L8X=@BJ0N^W@
MWU\Y9)44QJZBGF3G2YMA;*X8+7.MN<6G"0">L"#LBOMB9B#F.E.X[74@!F0#
M3#JF) A$'=""Q_UV):B:(FB)HB:(FB)HB:(G@'U!UAW9/,?@153;OLDQ_P!G
MJY_FAKK6RW^$/SG*51VO(J7U=*^K'E^%4R^P%#5BL32$; D86[EIM\X%AF%N
MW,CC%D;*?#+)?,#!=1P1G:I6*%Q_CZ*R(6M7JS6.G/:NXD8J3M%7!$74;&.P
M*H14^Y1Z1#8V^M&JDDGK6K<IYK;[(K'^G\2,_M./.$*4OA.W0.-(KSKF,LX8
MBX[VEY$7&>XX\2H9_-/V<;;3%EI>+8Q5?E!6D"Q:;EZ,,5VFAN(AL6#)!P!0
MFSAQ3!7OY9X1RW6^=,WR>80G-*W8SR+QVJ.(3.>$-RJT;DZFVFBV^>FU8JY5
MBRKLEYZC6MC-E<).6C@"-Y% P+EZ3$U&9(((O27-8X0<+513G&7(+"5<X\8:
MQ/C?G/3N(Z&#,@JC3\(VW%4UR28YYLV1)"P,(7/N1Y5=9&MTQ2(F571%XDPQ
M[9TNJBZ.8$@#57 <-ZF)DHDQ BK04_ V8\8<'.$46OQ[YK57F%AK$V5X?'V3
MN.3ZAR-QQ/;;-<9UZCC;-D):+&UKMAQW;BIQCJ0.Y:NXXZ27644E! =9X#N6
M*<2638!!9HST7RCIG)+@)R%R9ABWY5FVO%S(6#>0I\#-H.;1QYE[(4CC297L
M,C'R$[7T@QP=Y!OQ=OF:BZ34R725,Q1*)IRI)Q<JU]^&Z,?(KF<W,69C0S'Q
M$Y<X/HSK,,[Q:M>3&5YPY$2,1$VV\XIR[4"UFTR6.GLXLQAW-WJ[QHV=M6*Z
MR)9%$%$B*%,)1-M3I#HB&Y6R6,<PXC"U6\S9G_FME3%"EAP;Q:Y&X'@8K*&*
MVUH=S;7%Q>5=AQ8XDI <N+X;Q2[G;37H:<@69&96SR0?^5N2JKJ-$?&$*8*'
MR3ALBK<$N7UHQ*U_/^,'(ZZ83\Z,R;X4Y-/U,^9KX163$T9R+EZS;<PY(J6/
MI7'Y;O,S2L0\&,3)!-89P"\>N/E3)LB5)4#' 0"D27<J<9L8 K.'F9Q9S'GO
MD;F!E0X)Q%5S(GFKLM<=Z]D5R8C.GL<H6'*S65K](D'R"I5V?EL2@)C@"?BT
M61S&[@Z=;/ /E6H)H%D!"*M]F&'Y*\RN 5MXH0_$C+V KC3,-8L9JJY+F:#3
MZO;+SB>=I;UWBW$4A"3]@^&("V,:PZ\EL"J#2+;_ -Y@L01WZ:9DET;(J]DU
MH BK;V?C[9,R8NY9V^.PCYR!;.RO!G.6#*2OR^OM#F8]\]R#',7@XTQK#5Z2
M.[LCU_8(5$Z$@)4F)"I>Q, N"AJ+99:8F*Q->T@!N^*W;X/K[FH81PW3W<06
MO.:KBK'U=>5U-L@R2@WL/4XJ/?Q)6+4 :M?(G:"B9B)@! , [:Y"4UN&X+7=
M:5<_5RPFB)X!T=]6[F3:JL??Z'5S^-K#^UCM:E$(NF#> L.[!YEK-\X!5,KV
ML>'Y<,%;-[O7^85#LB$[+U&7N=3K+)A1LAI+2UVBX5PR>-ZNLJX3:KN@<("W
M,X*8IC' I#0GRWC:5FGY;H*CZ5P<R8C?:UFC(V1*&_RQ*\Q6/*C++2H0ECCZ
M)\'P.#I+!M;Q]CE&:<OI\HQL*9JX5>R9R"X6%<>@GL-1;(<6@F]7&< 2W<O/
MEKA?R"G['RSK>*,OXIKF$><;EK)YH3O5,M=BRMCZ6?4."Q?<W.)7T5-,ZJ^1
ML=-@D1;HRY 3C7XG5)XT@^+&1D.A8H\<1$;EKCE,<YJQUR_R*O#4"XW^IPW+
M+#<YCCC)-U?-R4!D.,H-,H%%JN>FV0*A%M,#M3TV)C74HDK,.A5,XC^E]UN
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M.[M\7X-39FDF5*X,JH:V3&.$$!L=\!9'E51R_$07R7.@;(MC\2Y"F<P[F;'
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MQYPC:(M(<9+K+1U;CO'*@)&#;I;J (=P@@H&WH=O1V!JMM?2,<7LFRFO-Y$
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MS!?7F2[7#6"+R#1IRM"NWN#ORIC(-6C9^WZ>@5#D,8HP-'+.URSQG<BJ')'
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M&^]]L"TF_5+L4[KHZ@;MP'QBRFQ=NG<=?2FF]1T.0:(94OFM$^6TP@8Q/(O
MM19'79QJQ\F2R-,XC'$P@-BJ[D?@>D<=H>JXSH+)8&D<U*H_E71"A*V.54$
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MMC]T#F9<=#R>.F/C#%  #<>D UV_5'C?X;:FHYO"T?3/JG26RI4QLS%P0P$
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M+4RG',@20?2DPR6;HGC99@B#1-%@00ZB=0G$VO;?"[PI?KG)75]1.,N<Q\#
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M%QAE/)N,K/2K1;I*;Q9FNC'K-Y=PC6R1E@0ET'D286(/#KMWBOC$TS# AKA
MB(0N>T=2]7=XL<1D<2<O>"#JHX@S&UPYA/S=F>:?6KAGJ'@96]XYO%[SO6+4
MTJ]LG(-M][M=R#)UM^^4*S8]"R48(H=)0()=88R42-\5 SIQVB"WF@ !V[%
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MKZ/7.55^;TF42I=4V?6R&3F.+0&"6^XN=& -MK1$I4Z=KZ&GFS9TRF(DDM<
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M"^*@8N>7$ 1W*/CS?/%^5JM[63&EC^R;UE<17/TB '#MVW[>GL =P$#!N(&
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M!%MP0LAM60W,*V9#2PYC[$%?=JTC-?)W(E,PG'/*)+O)5W0VTNHXL.6K77+
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M\=>:ODK#KDCNHY 1KK[X7KS@HG(9)_&+@LS=M5U$1]B?<*IC V7B  =%2$[
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MB/> !Z.N?-/-[,Z9A:=\%Q5&Z,9K6Q<VZ]9(8EQ2I,"VM-F1%*)#I5C8Q0#
M:0.4=TG+@H])BLQ$-P[NH>[L => ^*'BK29;+=D= Z%6+,0M](7LN@_#>JJI
M@SRO&.C-N$W0OV0*S)A(-U-/6T7%H'56.=-NW01)OM[("  %3+TE*4.SL#8
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MP 3RB'_"2N_=5O[75>+,OL7]"QPI'V@3RB'_  DKOW5;^UTQ9E]B_H3A2/M
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M%--$31$T1-$31$T1=9_F#?L3?JZ2OJ'<Y656,W]@J9_%<E_GMSK4H^P[YY^
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M6K+KF#B;%E1R:3C;3^(]XXS7Y?+$/5<?YIR1EF2D<;Y!I"SA:.D+-8G5B;?
MD0+X@$<('9*KE0 1\9T"(%UXWX?:N\0*W*JG653G5-6T\N2Y[I+8/J00(_5
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MEV*5X5YI)JV4N<-ER9KIC6G]HPD8Q$$0<;.54EYPSB-'\,\OHUNNWVM6FBV
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MEY*XASKCW*:6:8ZLMS4JNH2![;C\M5J,9$.'-J.X3*U2*^?) 1)$.E0# 81
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M'ZAZ]_1ZM^K?MT(!L(B$O43JJJ!LHHHH'H'.8P?\81T@!< D2H&44,  8YS
M4-@ QA$ #;IV !'L#I[/4T  M  *S$[TZS]($ZS=!?F2]0])>[N+OL'=H6M-
MI )6(E<![A]3](-OTM'=@CD/P+$%5-N^R3'_ &>KG^:&NM;+?X0_.<IU':\B
MI<=72OJQY?A5,OL!<_&J]/1XQ3H .D"=9ND WWVZ=]MM]3@%8N(&, @(&, @
M.X" B @/H@/@'3"-P2)7(553&$XJ*"8Q1()A.83"0WS11$1W$IO"'<.@ %R1
M*@"AP3\4!S@E_P F!A\7Z/S&_3WZ0!M@D2H 8Q3 <IC%. ]0& 1 P#Z("':
MZS (N1E53B G44,)0V*)CF,)0W$VP"(CL&X[^KK$!N2)7 1$3"81$3"83"81
M$3"8>\PCWB8=^_64B5S,JJ<W4910QN[J,<PFV#M -Q$1[]8@-P6$%50Q@.90
MXG*(B4PG,)@$=MQ PCN CTA\C2 W!9NN4!.<3=8G,)Q[SB81,/\ \X1WT@-P
M2)OC:H&,8XB8YA,8WS0F$3";U1'<1UDVWHHF44.!0.H<P%#8H&.8P%#NV* B
M.P;#K$!N2)43*JG^;54/\S\T<QOF $"=XC\P!AV]#?3"W<$B5QZC#U")C")]
MP..X^S 1W$#?/;CV]NLW7)$J/C#]/1UGZ/G>H>GOW^9WV[]()$IXQ02 F*AQ
M('2($ZC= "4=RB!=]O8CW>AK$!N"1*@)C&$!$PB(!L B(CL'H!OX-9%ER+CX
M!T=]6[F3:JL??Z&US^-K#^UCM:E%VIG,%G8J3UMK"UK\WZGE2X<B_-ZM,17A
M?%UG89+Y!+FR0&.V63(ZL-%,"RZ2A)6NR;V,BA+,>-!L@JY=)D(L<.@IC;EU
MJ/DXG$[RLC#"U6"L_!+'D-GO@O@ZS.<BY-IBJ/-O)N6[0[EIBJ*9,R-D9&F6
M:Q2-[>4!6";1L59+&^540AD%D&IB-44@\9T'$U$R0Z(A&'(KY<QK02>18=66
MRR3_ (QX(Q!E^G6%[%QL/S%8U#)N6YWDF[@XA]C/+$W5L54"*KV'W+>X73,[
M^I@@XKCV9< BE'LS>3F54$0"OA/WNZ5;C:3 "WR*MXZYR;&>X!Y1R0E<,\9:
MG./W%ZJ.N/=ZK>=8.WLYJ7L2)9W-^'K]66WWBFO$(BIX^[1MI(4ZC2/2*HN@
M"@D6<)_\KI2 ML7HQ!&Y(G.7<>CDC*\?C_D]!<RL@2LXU>T7DW*9&OF#FU@L
M:-<HC"1:+_$&3!L_BTT<9D[322:L54A5$?*P,8UDJ6\F$3%:\X ",+(>=;:N
M>EYQO0N*^9'^0G#-J,YCC(E2HAEJ])61^O?[%CZT1T!'02$)$RKQI-21CJH)
M. (D7902BH '[=M[,%CKX*JD$9HVVK6-FO)M%MG&GS3-[@\QWW%51HV8JE 7
M/,-$I<JXL^,Y: XOWNLS"+F&L] LJ;4$YQ4L<LHZBEFXBOTD.!C%,&O.:#+L
MOBMN994V;BLR/-;(33/$F;&1W5INF/C\G<HSV*<XWJK/J;>>0M9MRD78I7*5
MMAG[&',^DU+2\?QY))%A'M9!LS3.@W3(4-[*>03=<%H3R086K9EK;4U5+7_0
MR9_V@A?X!+ZXNH_C&_-/Q*[]T.?TK5_YU(PDX<6\P>"XT/LW !^S!N[?O'7L
MOA6X,U)+=MX1A])J\S\26EVG'0V/']4KY8CJE73\6<$S$'K 2F$O:4QC )3
M;MV$!VU]>SIK75.$]@LNV1A?#?YU\OTL@BC+OUL?QKRI-62!_&)-FY#=XB04
MR]0_KA\.VM6$K8Y;)?4.AB!(%T=G-N7$6;'J,;R9N)C#U&.(D QA]$1 =]PW
MTA*Q%Q=US>8F)YRLF;5$AQQ8A<=HYCL7'R"/[-FK8O3\STB0-O4V[M8#9 $
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M!9=Q"3HUHJEV77,W756F6R,T<?)1%1%0$P$5  P#JP3.$PMVE6]VEMM#A8L
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MOK/OBUAZE'_Y;_\ >*OW3:>]:J^FW^PH_D@ROX'3OTU_[?3WQ:O]2C_\M_\
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MSI?4].&WD3C34^ (3[6LO<Z7U/3AMY$XTU3*%KL&:;AMXQGV2L?W-TOKQO\
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M40ASB*BK<IM]CB(CMWZ^-]::'S_1N>37\-PH"XP,-B^J=+:TRW/<GE\-P-;
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M!.8P/FP<"(PF %W2+(*#9LMLP.D%@;_(B!'R[5'RH? (?*U4)SYAX4P-%/N
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M69JIFG*BSJ5E9B;Y"3<SBNK6&3?(2$[.0-(!LW3?I2*Q5!29K&%NF*FXE]B
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M0;L]B?LV$.P=]P'<!WVWW =6\>@,\U/>6\<MABC;#=>L2J',)#'2Y,HM8_M
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11-$31$T1-$31$T1-$31%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6764031088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Aug. 02, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TAPIMMUNE INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001094038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TPIV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,710,544<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6764425808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 7,782,962<span></span>
</td>
<td class="nump">$ 5,129,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and deposits</a></td>
<td class="nump">108,716<span></span>
</td>
<td class="nump">51,150<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">7,891,678<span></span>
</td>
<td class="nump">5,180,439<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">7,891,678<span></span>
</td>
<td class="nump">5,180,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">3,595,152<span></span>
</td>
<td class="nump">1,508,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Warrant liability</a></td>
<td class="nump">147,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Promissory note</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,747,152<span></span>
</td>
<td class="nump">1,522,312<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,747,152<span></span>
</td>
<td class="nump">1,522,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 41.7 million shares authorized, 13.6 million and 10.6 million shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively</a></td>
<td class="nump">13,624<span></span>
</td>
<td class="nump">10,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">170,287,725<span></span>
</td>
<td class="nump">161,067,538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(166,156,823)<span></span>
</td>
<td class="num">(157,420,027)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">4,144,526<span></span>
</td>
<td class="nump">3,658,127<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">7,891,678<span></span>
</td>
<td class="nump">5,180,439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6764534144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized/designated</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock shares par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="nump">41,700,000<span></span>
</td>
<td class="nump">41,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="nump">13,600,000<span></span>
</td>
<td class="nump">10,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="nump">13,600,000<span></span>
</td>
<td class="nump">10,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized/designated</a></td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized/designated</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6763997152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 205,994<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 205,994<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,826,837<span></span>
</td>
<td class="nump">1,202,725<span></span>
</td>
<td class="nump">3,426,387<span></span>
</td>
<td class="nump">2,191,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3,052,954<span></span>
</td>
<td class="nump">1,190,517<span></span>
</td>
<td class="nump">4,650,890<span></span>
</td>
<td class="nump">2,618,310<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">4,879,791<span></span>
</td>
<td class="nump">2,393,242<span></span>
</td>
<td class="nump">8,077,277<span></span>
</td>
<td class="nump">4,810,127<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(4,673,797)<span></span>
</td>
<td class="num">(2,393,242)<span></span>
</td>
<td class="num">(7,871,283)<span></span>
</td>
<td class="num">(4,810,127)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(139,000)<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="num">(138,000)<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">492,365<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">492,365<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (4,812,797)<span></span>
</td>
<td class="num">$ (1,893,377)<span></span>
</td>
<td class="num">$ (8,009,283)<span></span>
</td>
<td class="num">$ (4,313,262)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, Basic and Diluted</a></td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (0.71)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of common shares outstanding</a></td>
<td class="nump">11,838,371<span></span>
</td>
<td class="nump">8,576,634<span></span>
</td>
<td class="nump">11,233,755<span></span>
</td>
<td class="nump">8,503,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GrantMember', window );">Grant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Grant income</a></td>
<td class="nump">$ 205,994<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 205,994<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6754160112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - 6 months ended Jun. 30, 2018 - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid In Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Amount at Dec. 31, 2017</a></td>
<td class="nump">$ 3,658,127<span></span>
</td>
<td class="nump">$ 10,616<span></span>
</td>
<td class="nump">$ 161,067,538<span></span>
</td>
<td class="num">$ (157,420,027)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Share at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,615,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_PrivatePlacementAmount', window );">Issuance of common stock in private placement, Amount</a></td>
<td class="nump">3,120,000<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">3,118,700<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_PrivatePlacementShare', window );">Issuance of common stock in private placement, Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised for cash, Amount</a></td>
<td class="nump">18,125<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">18,115<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised for cash, Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ExerciseOfWarrantsAmount', window );">Stock warrants exercised for cash, Amount</a></td>
<td class="nump">4,261,085<span></span>
</td>
<td class="nump">$ 1,447<span></span>
</td>
<td class="nump">4,259,638<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ExerciseOfWarrantsShare', window );">Stock warrants exercised for cash, Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,446,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_WarrantOfCashlessExercised', window );">Stock warrants cashless exercised, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_WarrantOfCashlessExercisedSharesIssued', window );">Stock warrants cashless exercised, Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation, Amount</a></td>
<td class="nump">1,096,472<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
<td class="nump">1,096,339<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Stock-based compensation, Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Fair value of repriced warrants as inducement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">727,513<span></span>
</td>
<td class="num">(727,513)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(8,009,283)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,009,283)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, Amount at Jun. 30, 2018</a></td>
<td class="nump">$ 4,144,526<span></span>
</td>
<td class="nump">$ 13,624<span></span>
</td>
<td class="nump">$ 170,287,725<span></span>
</td>
<td class="num">$ (166,156,823)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Share at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,624,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ExerciseOfWarrantsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of warrants amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ExerciseOfWarrantsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ExerciseOfWarrantsShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of warrants share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ExerciseOfWarrantsShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_PrivatePlacementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Private placement amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_PrivatePlacementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_PrivatePlacementShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Private placement share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_PrivatePlacementShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_WarrantOfCashlessExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of warrant exercised of non cash transaction amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_WarrantOfCashlessExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_WarrantOfCashlessExercisedSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The warrant exercised of non cash transaction shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_WarrantOfCashlessExercisedSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6764383616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (8,009,283)<span></span>
</td>
<td class="num">$ (4,313,262)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Reconciliation of net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeLiabilities', window );">Changes in fair value of warrant liabilities</a></td>
<td class="nump">138,000<span></span>
</td>
<td class="num">(4,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,096,472<span></span>
</td>
<td class="nump">647,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(492,365)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and deposits</a></td>
<td class="num">(57,566)<span></span>
</td>
<td class="num">(109,032)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">2,086,840<span></span>
</td>
<td class="nump">336,135<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(4,745,537)<span></span>
</td>
<td class="num">(3,935,637)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement', window );">Proceeds from issuance of common stock and warrants in private placement, net of offering costs</a></td>
<td class="nump">3,120,000<span></span>
</td>
<td class="nump">5,408,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of stock warrants, net of offering costs</a></td>
<td class="nump">4,261,085<span></span>
</td>
<td class="nump">638,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">18,125<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">7,399,210<span></span>
</td>
<td class="nump">6,047,009<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashPeriodIncreaseDecrease', window );">Net increase in cash</a></td>
<td class="nump">2,653,673<span></span>
</td>
<td class="nump">2,111,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash at beginning of period</a></td>
<td class="nump">5,129,289<span></span>
</td>
<td class="nump">7,851,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash at end of period</a></td>
<td class="nump">7,782,962<span></span>
</td>
<td class="nump">9,962,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental schedule of non-cash financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement', window );">Fair value of repriced warrants as inducement</a></td>
<td class="nump">727,513<span></span>
</td>
<td class="nump">622,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_NonCashExcerciseOfWarrantsAmount', window );">Stock warrants cashless exercised</a></td>
<td class="nump">$ 118<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_NonCashExcerciseOfWarrantsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of warrant exercised of non cash amount transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_NonCashExcerciseOfWarrantsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of repriced warrants as inducement which classified as non financing and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_NoncashOrPartNoncashTransactionFairValueOfRepricedWarrantsAsInducement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity due to issue of common stock and warrants in a private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ProceedsFromIssuanceOfCommonStockAndWarrantsInPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753972800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">NATURE OF OPERATIONS</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 1: Nature of Operations</div></div></div><div style="background: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="background: rgb(255, 255, 255); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">TapImmune Inc. (the &#8220;Company&#8221; or &#8220;we&#8221;), a Nevada corporation incorporated in 1991, is a biotechnology company focusing on immunotherapy specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology. Unlike other vaccine technologies that narrowly address the initiation of an immune response, TapImmune's approach broadly stimulates the cellular immune system by enhancing the function of killer T-cells and T-helper cells and by restoring antigen presentation in tumor cells allowing their recognition&#160;by the immune system.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753904944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">BASIS OF PRESENTATION</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 2: Basis of Presentation</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (&#8220;SEC&#8221;) and on the same basis as the Company prepares its annual audited consolidated financial statements. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of such interim results.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The results for the condensed consolidated statement of operations are not necessarily indicative of results to be expected for the year ending December 31, 2018 or for any future interim period. The condensed consolidated balance sheet at June 30, 2018 has been derived from unaudited financial statements; however, it does not include all of the information and notes required by U.S. GAAP for complete financial statements. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2017, and notes thereto included in the Company&#8217;s annual report on Form 10-K filed on March 23, 2018.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6643462608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LIQUIDITY AND FINANCIAL CONDITION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_LiquidityAndFinancialConditionTextBlock', window );">LIQUIDITY AND FINANCIAL CONDITION</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 3: LIQUIDITY AND FINANCIAL CONDITION</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s activities since inception have consisted principally of acquiring product and technology rights, raising capital, and performing research and development. Successful completion of the Company&#8217;s development programs and, ultimately, the attainment of profitable operations are dependent on future events, including, among other things, its ability to access potential markets; secure financing, develop a customer base; attract, retain and motivate qualified personnel; and develop strategic alliances and collaborations. From inception, the Company has been funded by a combination of equity and debt financings.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company expects to continue to incur substantial losses over the next several years during its development phase. To fully execute its business plan, the Company will need to complete certain research and development activities and clinical studies. Further, the Company&#8217;s product candidates will require regulatory approval prior to commercialization. These activities may span many years and require substantial expenditures to complete and may ultimately be unsuccessful. Any delays in completing these activities could adversely impact the Company. The Company plans to meet its capital requirements primarily through issuances of debt and equity securities and, in the longer term, revenue from product sales.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2018, the Company had cash of approximately $7.8 million. Historically, the Company had net losses and negative cash flows from operations. Management intends to continue its research efforts and to finance operations of the Company through debt and/or equity financings. Management plans to seek additional debt and/or equity financing through private or public offerings. There can be no assurance that the Company will be successful in obtaining additional financing on favorable terms, or at all. The Company has no sources of revenue to provide incoming cash flows to sustain its future operations. The Company&#8217;s ability to pursue its planned business activities is dependent upon successful efforts to raise additional capital. These factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_LiquidityAndFinancialConditionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liquidity and financial condition text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_LiquidityAndFinancialConditionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753918736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 4: SIGNIFICANT ACCOUNTING POLICIES</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">There have been no material changes in the Company&#8217;s significant accounting policies to those previously disclosed in the Company&#8217;s annual report on Form 10-K, which was filed with the SEC on March 23, 2018.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">New Accounting Pronouncement</div></div><div style="font-weight:bold;display:inline;">s</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-weight:bold;display:inline;">Recent Accounting Pronouncements Adopted in the Year</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Compensation-Stock Compensation</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In May 2017, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2017-09, Compensation&#8212;Stock Compensation (Topic 718): Scope of Modification Accounting, which clarifies when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions. It is effective prospectively for the annual period beginning after December 15, 2017 and interim periods within that annual period. Early adoption is permitted. The Company adopted ASU 2017-09 on January 1, 2018; the adoption of ASU 2017-09 did not have a material impact on its financial condition or results of operations, as the Company has not had any modifications to share-based payment awards. However, if the Company does have a modification to an award in the future, it will follow the guidance in ASU 2017-09.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Revenue from Contracts with Customers</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In May 2014, the FASB issued ASU No. 2014-09, &#8220;Revenue from Contracts with Customers (Topic 606)&#8221; (ASU 2014-09) as modified by ASU No. 2015-14, &#8220;Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date,&#8221; ASU 2016-08, &#8220;Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net),&#8221; ASU No. 2016-10, &#8220;Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing,&#8221; and ASU No. 2016-12, &#8220;Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.&#8221; The revenue recognition principle in ASU 2014-09 is that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, new and enhanced disclosures will be required. Companies may adopt the new standard either using the full retrospective approach, a modified retrospective approach with practical expedients, or a cumulative effect upon adoption approach. The Company adopted the new standard effective January 1, 2018, using the modified retrospective approach. The only impact of the adoption of ASU 2014-09 was to reclassify the Company's grant income as revenue.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recent Accounting Pronouncements Not Yet Adopted</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Accounting for Certain Financial Instruments with Down Round Features</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On July 13, 2017, the FASB has issued a two-part ASU, No. 2017-11, (i). Accounting for Certain Financial Instruments with Down Round Features and (ii) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests With a Scope Exception.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The ASU is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 and the interim periods within that annual period. Early adoption is permitted. The Company will be evaluating the impact of adopting this standard on the consolidated financial statements and disclosures.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Improvements to Nonemployee Share-Based Payment Accounting</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In June 2018, the FASB issued ASU 2018-07 &#8220;Improvements to Nonemployee Share-Based Payment Accounting&#8221;, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than an entity&#8217;s adoption date of Topic 606. The Company is currently evaluating the impact of the new standard on its consolidated financial statements.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753919696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 5: NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Basic loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted loss per common share is computed similarly to basic loss per common share except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the computation of net loss per share:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%;"><tr><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Numerator:</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 48%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Net loss</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(4,812,797</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;">)</div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(1,893,377</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(8,009,283</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;">)</div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(4,313,262</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;">)</div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Denominator:</div></div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Weighted average common shares outstanding</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">11,838,371</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">8,576,634</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">11,233,755</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">8,503,521</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net loss per share data:</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Basic and Diluted</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(0.41</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;">)</div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(0.22</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(0.71</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;">)</div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(0.51</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr></table></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;">&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following securities, rounded to the thousand, were not included in the diluted net loss per share calculation because their effect was anti-dilutive for the periods presented:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in auto 0in 0px; width: 96%;;text-align:left;"><tr><td style="border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></div></td><td style="border-top: 0px none; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: 0px none; padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Common stock options</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">439,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">455,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Common stock purchase warrants</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">4,871,000</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">6,544,000</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Potentially dilutive securities</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">5,310,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="padding: 0in 0in 2.5pt; background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">6,999,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6757004576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_DerivativesAndFairValueAbstract', window );"><strong>Derivatives and Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;">&#160;</div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="text-transform: uppercase; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 6: WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS</div></div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company&#8217;s common stock purchase warrants that are categorized within Level 3 of the fair value hierarchy for the six months ended June 30, 2018 and 2017 is as follows:</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 80%; border-spacing: 0px; margin: 0in auto 0in 0px;;text-align:left;"><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px; vertical-align: bottom;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="width: 1255px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Stock price</td><td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">$</td><td style="width: 216px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">9.43</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="width: 17px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">$</td><td style="width: 215px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">3.88</td><td style="width: 17px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:white"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Exercise price</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">$</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">8.67</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">$</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1.20</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Contractual term (years)</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1.32</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1.03</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:white"><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Volatility (annual)</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">83</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">78</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Risk-free rate</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td></tr><tr style="vertical-align:bottom; background-color:white"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Dividend yield (per share)</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">0</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">0</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td></tr></table><div style="clear:both;"></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management&#8217;s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuations.</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Financial Liabilities Measured at Fair Value on a Recurring Basis</div></div></div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Warrant liability:</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 99%; border-spacing: 0px;"><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="14" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measured at June 30, 2018</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Quoted prices in active</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Significant other</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Significant</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">markets</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">observable inputs</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">unobservable inputs</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 1)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2018</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="width: 755px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">Warrant liability</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">-</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">-</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">147,000</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 226px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">147,000</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr></table><div style="clear: both; background: none;"></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 99%; border-spacing: 0px;"><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="14" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measured at December 31, 2017</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Quoted prices in active</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Significant other</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Significant</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">markets</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">observable inputs</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">unobservable inputs</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 1)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2017</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="width: 755px; text-align: justify; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">Warrant liability</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">-</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">-</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">9,000</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 226px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">9,000</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr></table><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The fair value accounting standards define fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is determined based upon assumptions that market participants would use in pricing an asset or liability. Fair value measurements are rated on a three-tier hierarchy as follows:</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"><tr style="vertical-align:top"><td style="width: 24px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 24px; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"><div style="font-family: symbol; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#183;</div></td><td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 1 inputs: Quoted prices (unadjusted) for identical assets or liabilities in active markets;</div></td></tr></table><div style="clear: both; background: none;"></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"><tr style="vertical-align:top"><td style="width: 24px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 24px; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"><div style="font-family: symbol; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#183;</div></td><td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 2 inputs: Inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly; and</div></td></tr></table><div style="clear: both; background: none;"></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"><tr style="vertical-align:top"><td style="width: 24px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 24px; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"><div style="font-family: symbol; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#183;</div></td><td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 3 inputs: Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions.</div></td></tr></table><div style="clear: both; background: none;"></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">There were no transfers between Level 1, 2 or 3 during the six months ended June 30, 2018.</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table presents changes in Level 3 liabilities measured at fair value for the six months ended June 30, 2018:</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 69%; border-spacing: 0px;"><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Warrant</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Liability</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="width: 1083px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">Balance - December 31, 2017</td><td style="width: 40px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 13px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 158px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">9,000</td><td style="width: 26px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:white"><td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt; padding-top: 0px;">Change in fair value of warrant liability</td><td style="padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="border-bottom: 1pt solid black; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="border-bottom: 1pt solid black; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">138,000</td><td style="padding-bottom: 1pt; text-align: left; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="padding-bottom: 2.5pt; padding-left: 0px; padding-top: 0px;">Balance &#8211; June 30, 2018</td><td style="padding-bottom: 2.5pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="border-bottom: 2.5pt double black; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="border-bottom: 2.5pt double black; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">147,000</td><td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0px; padding-top: 0px;">&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_DerivativesAndFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_DerivativesAndFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753919696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 7: STOCKHOLDERS&#8217; EQUITY</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018 Common Stock Transactions</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Common Stock Purchase Agreement</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On May 14, 2018, the Company&#8217;s largest stockholder Eastern Capital Limited entered into a Common Stock Purchase Agreement with the Company pursuant to which it purchased 1,300,000 shares of common stock at a price per share of $2.40 providing gross proceeds to the Company of $3.12 million.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Exercise and Repricing of Warrants Held by Existing Institutional Investors </div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On May 14, 2018, certain institutional holders of outstanding warrants entered into Warrant Exercise Agreements with the Company that provide for an amendment to the exercise price of the warrants being exercised at $2.50 per share. Upon closing of the Warrant Exercise Agreements, such institutional holders immediately exercised warrants for 782,505 shares of common stock providing aggregate proceeds to the Company of approximately $2.0 million.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The fair value relating to the modification of exercise prices on the repriced and exercised warrants was treated as deemed dividend on the statement of stockholders&#8217; equity of $728,000.</div></div><div>&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A weighted average summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company&#8217;s common stock purchase warrants that are included in the modification is as follows:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in auto 0in 0px; width: 60%;;text-align:left;"><tr><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted Average Inputs</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Before</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">After</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Modification</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Modification</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 64%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 15%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">9.93</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 15%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2.50</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Contractual term (years)</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2.37</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2.37</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Volatility (annual)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">79</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">79</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1.5</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1.5</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield (per share)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">0</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">0</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr></table><div style="clear:both;"></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Exercise of Stock Warrants</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During June 2018, shareholders exercised 782,800 shares of common stock pursuant to stock warrants providing aggregate proceeds to the Company of approximately $2.3 million. <div style="letter-spacing: 0px; top: 0px;;display:inline;">118,425</div> of the stock warrants exercised were exercised on a cashless basis, resulting in a cancellation of 83,130 stock warrants.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Exercise of Stock Options</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In January 2018, 10,416 shares of common stock were issued pursuant to stock option exercises at an exercise price equal to $1.74 per share.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Consulting Arrangements</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the six months ended June 30, 2018, the Company issued 132,825 shares of common stock as part of consulting agreements. The fair value of the common stock of approximately $644,000 was recognized as stock-based compensation, $563,000 in general and administrative expenses and $81,000 in research and development expenses.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Share Purchase Warrants</div></div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A summary of the Company&#8217;s share purchase warrants as of June 30, 2018 and changes during the period is presented below:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%;;text-align:left;"><tr><td style="border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted Average</div></div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of</div></div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted Average</div></div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Remaining Contractual</div></div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Intrinsic</div></div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exercise Price</div></div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life (in years)</div></div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance - January 1, 2018</div></div></div></td><td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6,520,000</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6.11</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3.16</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,739,000</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Issued</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Cashless exercised</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(118,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">4.01</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Exercised for cash</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(1,447,000</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2.95</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Expired or Cancelled</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(84,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">4.01</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance - June 30, 2018</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4,871,000</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="padding: 0in 0in 2.5pt; background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5.94</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="padding: 0in 0in 2.5pt; background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2.76</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="padding: 0in 0in 2.5pt; background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">20,417,000</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6756938480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-transform: uppercase; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 8: STOCK-BASED COMPENSATION</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company recorded approximately $960,000 and $271,000 of stock-based compensation expense for the three months ended June 30, 2018 and 2017, respectively. The Company recorded approximately $1,096,000 and $647,000 of stock-based compensation expense for the six months ended June 30, 2018 and 2017, respectively.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">At June 30, 2018, the total stock-based compensation cost related to unvested awards not yet recognized was $159,000. The expected weighted average period compensation costs to be recognized was 0.48 years. Future option grants will impact the compensation expense recognized.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$596,000 and $364,000 of stock-based compensation expenses for the three months ended June 30, 2018 were included in general and administrative expenses and research and development expenses, respectively, on the condensed consolidated statements of operations.</div></div><div>&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$629,000 and $467,000 of stock-based compensation expenses for the six months ended June 30, 2018 were included in general and administrative expenses and research and development expenses, respectively, on the condensed consolidated statements of operations.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208855<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753919696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GRANT INCOME<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_GrantIncomeAbstract', window );"><strong>Grant Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_GrantIncomeTextBlock', window );">GRANT INCOME</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-size: 10pt; text-transform: uppercase; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 9:&#160;</div><div style="font-weight:bold;display:inline;">grant income</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the six months ended June 30, 2018, the Company received $0.2 million of a grant awarded to Mayo Foundation from the U.S. Department of Defense for the Phase II Clinical Trial of TPIV200. The grant compensated the Company for clinical supplies manufactured and provided by the Company for the clinical study. In accordance with Accounting Standards Update No. 2014-09, &#8220;Revenue from Contracts with Customers (Topic 606)&#8221; issued by the Financial Accounting Standards Board, the Company recorded the $0.2 million of grant income as revenue.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_GrantIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grant Income (Abstract)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_GrantIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_GrantIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of grant income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_GrantIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6656598704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">New Accounting Pronouncement</div></div><div style="font-weight:bold;display:inline;">s</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-weight:bold;display:inline;">Recent Accounting Pronouncements Adopted in the Year</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Compensation-Stock Compensation</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In May 2017, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2017-09, Compensation&#8212;Stock Compensation (Topic 718): Scope of Modification Accounting, which clarifies when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions. It is effective prospectively for the annual period beginning after December 15, 2017 and interim periods within that annual period. Early adoption is permitted. The Company adopted ASU 2017-09 on January 1, 2018; the adoption of ASU 2017-09 did not have a material impact on its financial condition or results of operations, as the Company has not had any modifications to share-based payment awards. However, if the Company does have a modification to an award in the future, it will follow the guidance in ASU 2017-09.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Revenue from Contracts with Customers</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In May 2014, the FASB issued ASU No. 2014-09, &#8220;Revenue from Contracts with Customers (Topic 606)&#8221; (ASU 2014-09) as modified by ASU No. 2015-14, &#8220;Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date,&#8221; ASU 2016-08, &#8220;Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net),&#8221; ASU No. 2016-10, &#8220;Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing,&#8221; and ASU No. 2016-12, &#8220;Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.&#8221; The revenue recognition principle in ASU 2014-09 is that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, new and enhanced disclosures will be required. Companies may adopt the new standard either using the full retrospective approach, a modified retrospective approach with practical expedients, or a cumulative effect upon adoption approach. The Company adopted the new standard effective January 1, 2018, using the modified retrospective approach. The only impact of the adoption of ASU 2014-09 was to reclassify the Company's grant income as revenue.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recent Accounting Pronouncements Not Yet Adopted</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Accounting for Certain Financial Instruments with Down Round Features</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On July 13, 2017, the FASB has issued a two-part ASU, No. 2017-11, (i). Accounting for Certain Financial Instruments with Down Round Features and (ii) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests With a Scope Exception.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The ASU is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 and the interim periods within that annual period. Early adoption is permitted. The Company will be evaluating the impact of adopting this standard on the consolidated financial statements and disclosures.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Improvements to Nonemployee Share-Based Payment Accounting</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In June 2018, the FASB issued ASU 2018-07 &#8220;Improvements to Nonemployee Share-Based Payment Accounting&#8221;, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than an entity&#8217;s adoption date of Topic 606. The Company is currently evaluating the impact of the new standard on its consolidated financial statements.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755868496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the computation of net loss per share:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%;"><tr><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Numerator:</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 48%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Net loss</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(4,812,797</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;">)</div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(1,893,377</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(8,009,283</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;">)</div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(4,313,262</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;">)</div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Denominator:</div></div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Weighted average common shares outstanding</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">11,838,371</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">8,576,634</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">11,233,755</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">8,503,521</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net loss per share data:</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Basic and Diluted</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(0.41</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;">)</div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(0.22</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(0.71</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;">)</div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(0.51</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr></table></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_NetLossPerShareTableTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;">&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following securities, rounded to the thousand, were not included in the diluted net loss per share calculation because their effect was anti-dilutive for the periods presented:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in auto 0in 0px; width: 96%;;text-align:left;"><tr><td style="border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></div></td><td style="border-top: 0px none; padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: 0px none; padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 74%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Common stock options</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">439,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">455,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Common stock purchase warrants</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">4,871,000</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">6,544,000</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Potentially dilutive securities</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">5,310,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="padding: 0in 0in 2.5pt; background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">6,999,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_NetLossPerShareTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Loss Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_NetLossPerShareTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755892976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_DerivativesAndFairValueAbstract', window );"><strong>Derivatives and Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ValuationMethodology', window );">Valuation Methodology</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company&#8217;s common stock purchase warrants that are categorized within Level 3 of the fair value hierarchy for the six months ended June 30, 2018 and 2017 is as follows:</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 80%; border-spacing: 0px; margin: 0in auto 0in 0px;;text-align:left;"><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px; vertical-align: bottom;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px; vertical-align: bottom;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="width: 1255px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Stock price</td><td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">$</td><td style="width: 216px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">9.43</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="width: 17px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">$</td><td style="width: 215px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">3.88</td><td style="width: 17px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:white"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Exercise price</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">$</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">8.67</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">$</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1.20</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Contractual term (years)</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1.32</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1.03</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:white"><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Volatility (annual)</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">83</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">78</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Risk-free rate</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">1</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td></tr><tr style="vertical-align:bottom; background-color:white"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">Dividend yield (per share)</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">0</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">&#160;</td><td style="text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">0</td><td style="text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px; vertical-align: bottom;">%</td></tr></table><div style="clear:both;"></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis', window );">Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Warrant liability:</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 99%; border-spacing: 0px;"><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="14" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measured at June 30, 2018</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Quoted prices in active</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Significant other</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Significant</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">markets</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">observable inputs</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">unobservable inputs</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 1)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2018</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="width: 755px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">Warrant liability</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">-</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">-</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">147,000</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 226px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">147,000</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr></table><div style="clear: both; background: none;"></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 99%; border-spacing: 0px;"><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="14" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measured at December 31, 2017</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Quoted prices in active</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Significant other</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Significant</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">markets</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">observable inputs</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">unobservable inputs</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 1)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2017</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="width: 755px; text-align: justify; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">Warrant liability</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">-</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">-</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 227px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">9,000</td><td style="width: 19px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 18px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 226px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">9,000</td><td style="width: 18px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_MeasuredAtFairValue', window );">Schedule of Changes in Level 3 Liabilities Measured at Fair Value</a></td>
<td class="text"><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table presents changes in Level 3 liabilities measured at fair value for the six months ended June 30, 2018:</div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify; background: none;"><div style="text-decoration: none; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; width: 69%; border-spacing: 0px;"><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td colspan="2" style="font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Warrant</div></div></td><td style="font-weight: normal; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom"><td style="padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="font-weight: normal; padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td colspan="2" style="border-bottom: 1pt solid black; font-weight: normal; text-align: center; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">Liability</div></div></td><td style="padding-bottom: 1pt; font-weight: normal; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="width: 1083px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">Balance - December 31, 2017</td><td style="width: 40px; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="width: 13px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="width: 158px; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">9,000</td><td style="width: 26px; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:white"><td style="text-align: left; padding-bottom: 1pt; padding-left: 9pt; padding-top: 0px;">Change in fair value of warrant liability</td><td style="padding-bottom: 1pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="border-bottom: 1pt solid black; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">&#160;</td><td style="border-bottom: 1pt solid black; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">138,000</td><td style="padding-bottom: 1pt; text-align: left; padding-left: 0px; padding-top: 0px;">&#160;</td></tr><tr style="vertical-align:bottom; background-color:#cceeff"><td style="padding-bottom: 2.5pt; padding-left: 0px; padding-top: 0px;">Balance &#8211; June 30, 2018</td><td style="padding-bottom: 2.5pt; padding-left: 0px; padding-top: 0px;">&#160;</td><td style="border-bottom: 2.5pt double black; text-align: left; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">$</td><td style="border-bottom: 2.5pt double black; text-align: right; padding-left: 0px; padding-top: 0px; padding-bottom: 0px;">147,000</td><td style="padding-bottom: 2.5pt; text-align: left; padding-left: 0px; padding-top: 0px;">&#160;</td></tr></table><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_DerivativesAndFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_DerivativesAndFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial assets and liabilities measured at fair value on recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_FinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_MeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_MeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ValuationMethodology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ValuationMethodology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6756915776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ValuationMethodologyTableTextBlock', window );">Schedule of weighted average valuation methodology</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A weighted average summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company&#8217;s common stock purchase warrants that are included in the modification is as follows:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in auto 0in 0px; width: 60%;;text-align:left;"><tr><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted Average Inputs</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Before</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">After</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Modification</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Modification</div></div></div></td><td style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 64%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 15%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">9.93</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 15%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2.50</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Contractual term (years)</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2.37</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2.37</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Volatility (annual)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">79</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">79</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1.5</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">1.5</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: justify; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield (per share)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">0</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">0</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; padding: 0pt 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_SharePurchaseWarrantsTableTextBlock', window );">Schedule of share purchase warrants</a></td>
<td class="text"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A summary of the Company&#8217;s share purchase warrants as of June 30, 2018 and changes during the period is presented below:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%;;text-align:left;"><tr><td style="border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted Average</div></div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of</div></div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted Average</div></div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Remaining Contractual</div></div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Intrinsic</div></div></div></div></td><td style="padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exercise Price</div></div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life (in years)</div></div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: center; margin-right: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value</div></div></div></div></td><td style="padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 48%; font-size: 10pt; line-height: 10pt;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance - January 1, 2018</div></div></div></td><td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6,520,000</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6.11</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3.16</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; font-size: 10pt; line-height: 10pt; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,739,000</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; font-size: 10pt; line-height: 10pt; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Issued</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Cashless exercised</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(118,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">4.01</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Exercised for cash</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(1,447,000</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2.95</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Expired or Cancelled</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(84,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">4.01</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; vertical-align: bottom; padding: 0in 0in 1pt;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px 0px 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-right: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance - June 30, 2018</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 2.5pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4,871,000</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="padding: 0in 0in 2.5pt; background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5.94</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="padding: 0in 0in 2.5pt; background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2.76</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="padding: 0in 0in 2.5pt; background-color: rgb(255, 255, 255); width: 1%; vertical-align: bottom;"><div style="font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; text-align: left; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; text-align: right; margin-right: 0in; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">20,417,000</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; font-size: 10pt; line-height: 10pt; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_SharePurchaseWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_SharePurchaseWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ValuationMethodologyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ValuationMethodologyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755993856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LIQUIDITY AND FINANCIAL CONDITION - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6764421312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER - Computation of income (loss) per share (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (4,812,797)<span></span>
</td>
<td class="num">$ (1,893,377)<span></span>
</td>
<td class="num">$ (8,009,283)<span></span>
</td>
<td class="num">$ (4,313,262)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding</a></td>
<td class="nump">11,838,371<span></span>
</td>
<td class="nump">8,576,634<span></span>
</td>
<td class="nump">11,233,755<span></span>
</td>
<td class="nump">8,503,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net loss per share data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and Diluted</a></td>
<td class="num">$ (0.41)<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (0.71)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToParentDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToParentDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755948528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER - Potentially Dilutive Securities (Detail) - shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityShares', window );">Common stock options</a></td>
<td class="nump">439,000<span></span>
</td>
<td class="nump">455,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_CommonStockWarrantsEquityTreatment', window );">Common stock purchase warrants</a></td>
<td class="nump">4,871,000<span></span>
</td>
<td class="nump">6,544,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="nump">5,310,000<span></span>
</td>
<td class="nump">6,999,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_CommonStockWarrantsEquityTreatment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock warrants - equity treatment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_CommonStockWarrantsEquityTreatment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)(2),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6445032&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6764161808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS - Conversion Option - Valuation Methodology (Detail) - Share Purchase Warrants [Member]<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember', window );">Measurement Input, Share Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price</a></td>
<td class="nump">$ 9.43<span></span>
</td>
<td class="nump">$ 3.88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember', window );">Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">8.67<span></span>
</td>
<td class="nump">1.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember', window );">Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and Rights Outstanding, Term</a></td>
<td class="text">1 year 3 months 25 days<span></span>
</td>
<td class="text">1 year 11 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember', window );">Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember', window );">Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6763942336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS - Conversion Option - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted prices in active markets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Warrant liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant other observable inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Warrant liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant other unobservable inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Warrant liability</a></td>
<td class="nump">147,000<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Warrant liability</a></td>
<td class="nump">$ 147,000<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109247956&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6760994128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS - Conversion Option - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Detail)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance</a></td>
<td class="nump">$ 9,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair value of warrant liability</a></td>
<td class="nump">138,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance</a></td>
<td class="nump">$ 147,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6766884480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY -  Weighted average summary of quantitative information (Detail) - Share Purchase Warrants [Member]<br></strong></div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember', window );">Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">8.67<span></span>
</td>
<td class="nump">1.20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember', window );">Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and Rights Outstanding, Term</a></td>
<td class="text">1 year 3 months 25 days<span></span>
</td>
<td class="text">1 year 11 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember', window );">Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember', window );">Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsBeforeModificationMember', window );">Weighted Average Inputs Before Modification [Member] | Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">9.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsBeforeModificationMember', window );">Weighted Average Inputs Before Modification [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and Rights Outstanding, Term</a></td>
<td class="text">2 years 4 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsBeforeModificationMember', window );">Weighted Average Inputs Before Modification [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsBeforeModificationMember', window );">Weighted Average Inputs Before Modification [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsBeforeModificationMember', window );">Weighted Average Inputs Before Modification [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsAfterModificationMember', window );">Weighted Average Inputs After Modification [Member] | Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsAfterModificationMember', window );">Weighted Average Inputs After Modification [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and Rights Outstanding, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 13 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsAfterModificationMember', window );">Weighted Average Inputs After Modification [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsAfterModificationMember', window );">Weighted Average Inputs After Modification [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsAfterModificationMember', window );">Weighted Average Inputs After Modification [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and Rights Outstanding, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=tpiv_SharePurchaseWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsBeforeModificationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsBeforeModificationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsAfterModificationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=tpiv_WeightedAverageInputsAfterModificationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6764114576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY- Summary of the Company's share purchase warrants (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Warrants, Beginning balance</a></td>
<td class="nump">6,520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_NumberOfWarrantIssued', window );">Number of Warrants, Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_NumberOfWarrantsCashlessExercised', window );">Number of Warrant of Cashless exercised</a></td>
<td class="num">(118,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_NumberOfWarrantExercisedForCash', window );">Number of Warrant Exercised for cash</a></td>
<td class="num">(1,447,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_NumberOfWarrantExpiredOrCancelled', window );">Number of Warrant Expired or Cancelled</a></td>
<td class="num">(84,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of Warrants, Ending balance</a></td>
<td class="nump">4,871,000<span></span>
</td>
<td class="nump">6,520,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Beginning Balance</a></td>
<td class="nump">$ 6.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Cashless exercised</a></td>
<td class="nump">4.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash', window );">Weighted Average Exercise Price, Exercised for cash</a></td>
<td class="nump">2.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Expired or Cancelled</a></td>
<td class="nump">4.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Ending Balance</a></td>
<td class="nump">$ 5.94<span></span>
</td>
<td class="nump">$ 6.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife', window );">Weighted Average Remaining Contractual Life, Outstanding (in years)</a></td>
<td class="text">2 years 9 months 4 days<span></span>
</td>
<td class="text">3 years 1 month 28 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue', window );">Total Intrinsic Value</a></td>
<td class="nump">$ 20,417,000<span></span>
</td>
<td class="nump">$ 1,739,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding class of warrant or right.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ClassOfWarrantOrRightOutStandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or rights outstanding issued weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ClassOfWarrantOrRightsOutStandingIssuedWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Rights Outstanding Weighted Average Exercise Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right outstanding issued weighted average remaining life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ClassOfWarrantOrRightsOutStandingWeightedAverageRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or rights outstanding cashless exercised weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ClassOfWarrantOrRightsOutstandingCashlessExercisedWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or rights outstanding exercised weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ClassOfWarrantOrRightsOutstandingExercisedWeightedAverageExercisedForCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or rights outstanding expired or Cancelled weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ClassOfWarrantOrRightsOutstandingExpiredOrCancelledWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_NumberOfWarrantExercisedForCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_NumberOfWarrantExercisedForCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_NumberOfWarrantExpiredOrCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants expired or cancelled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_NumberOfWarrantExpiredOrCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_NumberOfWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_NumberOfWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_NumberOfWarrantsCashlessExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants cashless exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_NumberOfWarrantsCashlessExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6766353040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 14, 2018</div></th>
<th class="th"><div>Jan. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems', window );"><strong>Common Stock Capital Shares Reserved For Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">$ 3,120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="nump">782,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">782,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">782,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from Warrant Exercises</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,261,085<span></span>
</td>
<td class="nump">$ 638,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ExerciseOfWarrantsAmount', window );">Exercise Of Warrants Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,261,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_NonCashExcerciseOfWarrantsAmount', window );">Non Cash Excercise Of Warrants Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_NumberOfWarrantExpiredOrCancelled', window );">Number Of Warrant Expired or Cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(84,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,826,837<span></span>
</td>
<td class="nump">$ 1,202,725<span></span>
</td>
<td class="nump">$ 3,426,387<span></span>
</td>
<td class="nump">$ 2,191,817<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ArrangementsAxis=tpiv_ConsultingArrangementsMember', window );">Consulting Arrangements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems', window );"><strong>Common Stock Capital Shares Reserved For Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated Share-based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">644,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 563,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems', window );"><strong>Common Stock Capital Shares Reserved For Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ExerciseOfWarrantsAmount', window );">Exercise Of Warrants Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 728,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=tpiv_EasternCapitalLimitedMember', window );">Eastern Capital Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems', window );"><strong>Common Stock Capital Shares Reserved For Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 2.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems', window );"><strong>Common Stock Capital Shares Reserved For Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_tpiv_ExerciseOfWarrantsAmount', window );">Exercise Of Warrants Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock Capital Shares Reserved For Future Issuance [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_CommonStockCapitalSharesReservedForFutureIssuanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ExerciseOfWarrantsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of warrants amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ExerciseOfWarrantsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_NonCashExcerciseOfWarrantsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of warrant exercised of non cash amount transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_NonCashExcerciseOfWarrantsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_NumberOfWarrantExpiredOrCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants expired or cancelled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_NumberOfWarrantExpiredOrCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tpiv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tpiv_ArrangementsAxis=tpiv_ConsultingArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tpiv_ArrangementsAxis=tpiv_ConsultingArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=tpiv_EasternCapitalLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=tpiv_EasternCapitalLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6756340256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">$ 960,000<span></span>
</td>
<td class="nump">$ 271,000<span></span>
</td>
<td class="nump">$ 1,096,472<span></span>
</td>
<td class="nump">$ 647,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</a></td>
<td class="nump">159,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 159,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">364,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 467,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="nump">$ 596,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 629,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753973184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GRANT INCOME - Additional Information (Detail) - Grant [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="nump">$ 205,994<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 205,994<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member', window );">Accounting Standards Update 2014-09 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>44
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MT:*C!+SFP+II8CB.?0L7P 0CC#9]%U#/Q%+]$ULZP$[),9DY-0Q#/2Q++N_
MX?WYZ;6L6QF72#J%^54R@HX!U^P\^6UY_[!Y9-VBX7=5D\]JPV]%P\7UZF-R
M_>%W$;9>FZWYQ\9GP:Z%7_^B^P)02P,$%     @ 48@)39E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M/!.\"T3_M5IBD@)M(WV9A=FT=V?/=+12[SYRF(&',3,@#CT"3Q!H1 !M>Q3
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M8[5+%]^X='MWXCLU2KVSW:UR]\UP[!D:UAS&(UUT.E>N_@%02P,$%     @
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MI1PH?5.#;Z>-ZRLB4I*C4"FP?-S(CI2ERB0Y_G9)W7Y-%?CX_I']BRY>%G/
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MFXWSKXWQ@%)V-[A"+3ZPQ5%0^V!^0-M.:S8YWO3S"V++,R[^ %!+ P04
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MV&HH:'PXOL&SG<=L-KP9EA_$UF]<_@)02P,$%     @ 48@)3>-$:A&U 0
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MT/AP_(!G.X_9;'@S+#^(K=^X_ M02P,$%     @ 48@)309FFD:T 0  T@,
M !D   !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL?5/;;MLP#/T501]0)4K2
M%H%MH&E1;, &!!VV/2LV;0O5Q9/DN/O[4;+K>9NQ%TFD> X/*2H;K'OU+4 @
M;UH9G],VA.[(F"];T,+?V X,WM36:1'0= WSG0-1)9!6C&\VMTP+:6B1)=_9
M%9GM@Y(&SH[X7FOA?IY V2&G6_KN>)%-&Z*#%5DG&O@"X6MW=FBQF:62&HR7
MUA '=4X?ML?3/L:G@&\2!K\XDUC)Q=K7:'RL<KJ)@D!!&2*#P.T*CZ!4)$(9
M/R9..J>,P.7YG?TYU8ZU7(2'1ZN^RRJT.;VGI():]"J\V.$#3/4<*)F*_P17
M4!@>E6".TBJ?5E+V/E@]L: 4+=[&79JT#^/-@4^P=0"? 'P&W*<\;$R4E#^)
M((K,V8&XL?>=B$^\/7+L31F=J17I#L5[]%Z++3]D[!J)IIC3&,.7,7,$0_8Y
M!5]+<>+_P/DZ?+>J<)?@NS\4WJX3[%<)]HE@_]\2UV+N_DK"%CW5X)HT39Z4
MMC=IDA?>>6 ?TB.RW^'CM'\6KI'&DXL-^+*I_[6U 5#*Y@9'J,4/-AL*ZA"/
M=WAVXYB-1K#=](/8_(V+7U!+ P04    " !1B E-D]EC!K4!  #2 P  &0
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M47^3*BD-V%2B.UMP8Y^*Q>!0&;?=V[V:!F8RC.SGMX L#U+^!U!+ P04
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M_.W'.VJT=N"M;&[\F'7^$2Z!@,:%[;W?FVD4I\#I?GYE9'GJY1]02P,$%
M  @ 48@)3<//H+R; 0  6P,  !D   !X;"]W;W)K<VAE971S+W-H965T,C N
M>&UL;9/;;J,P$(9?Q?(#Q&!Z4@1(3:MJ5]I*45>[O79@"%9]8&TGM&^_8T-0
M4N4&>\;_?'.P*4?K/GP/$,BG5L97M ]A6#/FFQZT\"L[@,&3SCHM IINS_S@
M0+0I2"O&L^R.:2$-K<ODV[JZM(>@I(&M(_Z@M7!?&U!VK&A.3XXWN>]#=+"Z
M',0>?D/X,VP=6FRAM%*#\=(:XJ"KZ&.^WA11GP1_)8S^;$]B)SMK/Z+QLZUH
M%@L"!4V(!('+$9Y J0C",O[-3+JDC('G^Q/])?6.O>R$AR>KWF4;^HH^4-)"
M)PXJO-GQ!\S]W%(R-_\+CJ!0'BO!'(U5/GU)<_#!ZIF"I6CQ.:W2I'6<^:>P
MZP%\#N!+ )]ZF1*ERI]%$'7I[$C<-/M!Q"O.UQQGTT1G&D4ZP^(]>H]U?I>5
M[!A!LV8S:?B%)E\T#/E+$GXU"4^ X@+ KP.*JX B 6XN ,6W*B=-GB612:+[
MU<.W+.QL+O'9O0JWE\:3G0TXXC2(SMH ",Q6>)<]OO3%4-"%N+W'O9ON>S*"
M'>:GS);_J?X/4$L#!!0    ( %&("4V=N^G<?@(  -T'   9    >&PO=V]R
M:W-H965T<R]S:&5E=#(Q+GAM;(U578^;,!#\*XCW'MC&X$0DTN6C:J56BJYJ
M^^PD3D 'F-I.<OWWM0WAB..F?0GV9F9V=S#>_,+%JRP84\%;735R%A9*M=,H
MDKN"U50^\98U^I\#%S55>BN.D6P%HWM+JJL(QG$:U;1LPGEN8QLQS_E)567#
M-B*0I[JFXO>"5?PR"T%X#;R4QT*90#3/6WIDWYCZWFZ$WD6#RKZL62-+W@2"
M'6;A,YBNB<%;P(^27>1H'9A.MIR_FLWG_2R,34&L8CME%*A^G-F25941TF7\
MZC7#(:4ACM=7]8^V=]W+EDJVY-7/<J^*64C"8,\.]%2I%W[YQ/I^<!CTS7]A
M9U9IN*E$Y]CQ2MK?8'>2BM>]BBZEIF_=LVSL\]+K7VE^ NP)<"#HW(\(J">@
M=T+RD)#TA.1_,^">@)T,4=>[-7-%%9WG@E\"T1V'EII3!Z98OZZ="=JW8__3
M?DH=/<]!FN31V0CUF$6'@2,,)K>0U3T$#(A(%S!4 7U5+. ='=XF6-XC\,2I
MX9\BZX<B-V4BKUG(\M&-6=@OD'@%$BN0C 2RV#&[@V06TEC(AX0 F$TRQQ$/
M$) )0ID#7'F )(XGD"#''E]J!!!,H;]'[.T1>TQ*_0*I5R"],PFD3D^+#H-'
MI0) $$$9<%RZ!Q*<I2ERSOC*)PBUF1@[)OD$8X3A7\Y[YFTQ\WA$_ +$*T \
M'CG?PZ+#3,:O,WY*7(.\*.A\.2LORC5[[45AUYEH=#?53!SMH)#!CI\:94P9
M18=9] S-W>;$%V"Z!)[X2L^N;M2\RW>#[RL5Q[*1P98K?:/:>^_ N6*Z>%UH
M&!1ZU@Z;BAV4669Z+;J)TVT4;_MA&@T3??X'4$L#!!0    ( %&("4U0[-7I
M P(  $D%   9    >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;'U4[8Z;,!!\
M%<0#G/ER<D2 =,FI:J56BJ[J];<#FX#.QM0VX?KVM0WA"-#[@[W+S.X,V)MT
M7+S)$D Y[XS6,G5+I9H=0C(O@1'YP!NH]9LS%XPH'8H+DHT 4E@2HRCPO UB
MI*K=++&YH\@2WBI:U7 4CFP9(^+O'BCO4M=W;XF7ZE(JDT!9TI +_ 3UJSD*
M':&Q2E$QJ&7%:T? .76?_-T!&[P%O%;0R<G>,4Y.G+^9X%N1NIX1!!1R92H0
MO5SA )2:0EK&GZ&F.[8TQ.G^5OV+]:Z]G(B$ Z>_JT*5J?OH.@6<24O5"^^^
MPN 'N\Y@_CM<@6JX4:)[Y)Q*^W3R5BK.ABI:"B/O_5K5=NV&^C?:.B$8",%(
M\/&GA' @A!^$R)KOE5FKST21+!&\<T3_LQIBSH2_"_7'S$W2?CO[3KN5.GO-
M_*V7H*LI-&#V/2:88D8$TM7'%L%:BWVPH ?W#0Y+!([7.X2K)D++C^Y,^#,3
M/09;3&TQ41A[WLSK806&\11V)R=:E1.MR)E9WD?+/H];?ZEGB=O@*/JO(+PJ
M"*\("F>"\*(1#HV>N: E;A/'\5(0FIQ !N)B+ZMT<M[6ROSK27:<!T^!.<&S
M_%[/B?Y:?Y3IA\P/(BY5+9T35_I^V%-\YER!END]:(6EGFMC0.&LS':K]Z*_
MW7V@>#,,+C1.S^P?4$L#!!0    ( %&("4W/^@M9:0(  &,)   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(S+GAM;)56;:^:,!C]*X0?8"GOW"#)KLNR)5MB
M[K+M<]4JY!;*VBIW_WYM0:+X8/2+M.4\A_,<.;1YQ\6[+"E5SD?-&KET2Z7:
M%X3DMJ0UD0O>TD;?V7-1$Z6GXH!D*RC9V:*:(=_S8E23JG&+W*ZM19'SHV)5
M0]?"D<>Z)N+?*V6\6[K8/2^\58=2F054Y"TYT)]4_6K70L_0R+*K:MK(BC>.
MH/NE^PF_K'!F"BSB=T4[>3%V3"L;SM_-Y-MNZ7I&$65TJPP%T9<375'&#)/6
M\7<@=<=GFL++\9G]BVU>-[,ADJXX^U/M5+ET4]?9T3TY,O7&NZ]T:"ARG:'[
M[_1$F88;)?H96\ZD_76V1ZEX/;!H*37YZ*]58Z_=P'\N@PO\H< ?"_SP;D$P
M% 23 M0KLZU^)HH4N>"=(_I_JR7FI< O@39S:Q:M=_:>[E;JU5.!DS!')T,T
M8%Y[C'^%B:XQ*P@3CQBD-8Q"?%"(;PG"*X($)@A @L 2!%<$*4P0@@0AH"";
M6-%C,HMI+"9;A,'$BUM0L$AGI$2@E.A62NK!!#%($#]N1@(2)( "/#&CQV!\
MT6BZB).)&P *+WQ82PIJ20$M,P092) ][@;VX)AX@(9@FA,(%$Z# H&B&3$S
MF<4 Q4S8,)PV[#]A"9PW'#SPB@R@Z/(5F<8%P,Q*@9.+@>BF,Q\/#"<.1T\8
M F<.QX\8$M\TBZ=^W(-<"X&SBZ'PSO4"1PZG3]@!APYGC]B1W?3J3>VX!^F%
MH(O=SAP_?A!QJ!KI;+C2&Z?=WO:<*ZKIO(4F*O6)9YPPNE=FF.BQZ+?]?J)X
M.QQIT'BN*OX#4$L#!!0    ( %&("4U55##.( (  #L'   9    >&PO=V]R
M:W-H965T<R]S:&5E=#(T+GAM;)55[6Z;,!1]%<0#U!B33Q&D-M6T29L4=5KW
MVTEN JK!S'9"]_:S#4$DN4VS/[&O.>=P[B&VTT:J-YT#F."]%)5>A+DQ]9P0
MO<FAY/I!UE#9)SNI2FYLJ?9$UPKXUI-*0>(H&I.2%U68I7YMI;)4'HPH*EBI
M0!_*DJN_3R!DLPAI>%IX*?:Y<0LD2VN^AY]@?M4K92O2JVR+$BI=R"I0L%N$
MCW2^I,P1/.*U@$8/YH%K92WEFRN^;1=AY!R!@(UQ$MP.1UB"$$[)^OC3B8;]
M.QUQ.#^I?_'-VV;67,-2BM_%UN2+<!H&6]CQ@S OLOD*74.C,.BZ_PY'$!;N
MG-AW;*30_C?8'+219:=BK93\O1V+RH]-IW^BX82X(\0]@28W":PCL L":9WY
M5I^YX5FJ9!.H]FO5W/TIZ)S9,#=NT6?GG]ENM5T]9G0Z2\G1"768IQ83#S#Q
M.6*)($8]A%@#O8L8=1%[?C)T,8MP 88*,"_ S@0H+I"@ LF5 \8N8F@A$P^I
M/"2ZB.$6XLS#"/4P0E*(<8$Q*C"^/X4)*C#Y/(46,KJ1PBW$F8<IZF&*I,!P
M@1DJ,+L_!1KAFR+Z/(<.,VR3)I,HNDP#P<V&J',_'VQ2BF22?""![S :_T<J
M^!ZC[(Y4V-46P%.YQB&ID,$IYJZ5'USMBTH':VGL@>B/K9V4!JQB]& 3SNU-
MUA<"=L9-)W:NVN.\+8RLNZN*]/=E]@]02P,$%     @ 48@)30$(7/+? 0
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MW9F]])/C RWZZ5' \\M4_ 502P,$%     @ 48@)3>QPKH5E P  EA$  !D
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M,C<N>&ULC99=;]L@%(;_BN7[Q09_5TFD)-.T29M4=>IV31.26+6-!R3I_OT
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MX*-0RT2N63> NHV@;3];P3#@\[]02P,$%     @ 48@)33A,ON@4 @  ]@4
M !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&ULC53M;ILP%'T5Q /40'#3
M1(#4?%2;M$E1IVV_'7(34&W,;"=T;S]_E2:$I<V/8%_..?>>:W.SCHL760&H
MX)711N9AI50[1TB6%3 B[W@+C7ZSYX(1I;?B@&0K@.PLB5&41-$]8J1NPB*S
ML8TH,GY4M&Y@(P)Y9(R(OPN@O,O#.'P+/->'2ID *K*6'. 'J)_M1N@=ZE5V
M-8-&UKP)!.SS\#&>K['!6\"O&CIYM@Z,DRWG+V;S=9>'D2D(*)3**!#].,$2
M*#5"NHP_7C/L4QKB^?I-_<EZUUZV1,*2T]_U3E5Y^! &.]B3(U7/O/L"W@\.
M V_^&YR :KBI1.<H.97V/RB/4G'F570IC+RZ9]W89^?>3%-/&R<DGI#TA!C?
M)$P\8?).N)TA]83TLQFP)^!!!N2\VV:NB")%)G@7"'<=6F)N73S'^KA*$[2G
M8]_I?DH=/14)GF;H9(0\9N$PR1D&/UQ"5M>0N$<@74!?13)6Q2*YHB>7"9;7
M"#P;U/"AR/JFR$69D]%F32P_O6C6H!,+AYE:3.,P$9[-TH&?:U@TL/,YH?4M
MH0M+Z:BE=,32?WJ"1P7PQSU9X1$KYC?(@\XN+0-QL!-$!B4_-LH<R5FT'U*/
MB;GT@_@BGB_CD?A*#S4W@][EW43\3L2A;F2PY4I_:O:#V'.N0%<?W>GR*SV$
M^PV%O3++J5X+-XK<1O'63UG4C_KB'U!+ P04    " !1B E-X&!K.!TB  #F
MFP  %    'AL+W-H87)E9%-T<FEN9W,N>&UL[5U9<]M(DGZ>_145/=YI*8*B
M>>AVCR,HB;(Y(U%JD7+OQ,0^@$")Q#0(T#@DJV-^_.9152A<)&5[=GLV%!UM
M240=65697QZ5"?Z4)*G(0O]S)L^C+$S__$/OL/.#^+(,PN3//RS2='7Z]FWB
M+N322=K12H;PY"&*ETX*?\;SM\DJEHZ7+*1,E\';7J=S^';I^.$/[W]*_/<_
MI>\O(C=;RC 5@] 3PS#UTV<Q"GD$/PK%GD@63BR3G]ZF[W]ZBWVXWZ&XCL)T
MD4 ?3WKEIW_)PK;H=UJBU^D>EQ\.LGE;='KU#PT]-A%_O_)#*4:I7";_W=AA
M^KR2Y8?=SM[/E>FAM4<]+@-G7G[ZX 1)91@SQZV,_0CWR1,73EIIIY?]'W_X
MP]JU7?J)ZP3B;]*)Q25\6-G=<DLU;VW;GWOE3]0QWLFYGZ2Q \.,G66%V.G@
M=G1]?3\>BM'XO-TPQCD0$0,!(SCE+^*O\KG<[CR+X_*2FK9G;Z_;V^MW&Z:Z
M] ,9BW/H-X_BRCR3I1/@\SNYBN+4#^?B/%JNG+#2<!H['CZ>/"]G45!Y>COZ
MU+34:+D$7INDD?MK2TR(Z\5-EB:I$^*(E97?C"^&X\GP0L!ODYNKT<5@"G^<
M#:X&X_.AF'P<#J<3D)_[R878>;-;.6+I J]T20J.FG;521*9)J>5QTZR*']V
M&\N5XWM"?@$02(!TH%IXL%N)GU9X9AJE<%AN89;Z-O7/-'V![\S\P$]]625R
MX+H(6(E8.<_.+)!$D..Z<28]NV.YWR].3#RKFU1.^#:.EGZ2 ).(,*IR67%M
M:R;BAFL:G-]<7X^FU\,QG.-@3.<\'8T_#,?GH^&DU!@1^319.:[\\P\ N8F,
M'^4/[T6%C9&[%E'@R3CY4<C/&:RO>KS,B0ESXIM.N]/IPB[&XM$),MD2^]WV
MD5CZ08#8R/ LG"Q=1+'_F_1:HMMO'YKGN.O=CO6!Z@ [B >!CZ.<R>&\1?0@
M ,BDP6]J ^PJES,00,VR+0&CK*2;^H\RJ)S1P/-\A&[88.3*/3\4KK/R8<-K
MV"1;9@&(/;+K@^_Z:?U!)35;M_%(B?9M>DX 8:'Y0( </4C@'8^10/S]FM9=
MT3NE=BWQ"0^G8=BSK8?=#E5V;AWD[H5,?4#=74"9-^)M@Z;.9Z9]R!EI4\,*
M9[WU9.+/0SRJ=2RK.S9.5-<XGV6;ULR\V[2,F@&\O-[Z0<NMU@S8<':3*?Q@
M%+FY%#>WP[O!= 0-FG5#?VOCJJ(Y[N2C#+,:.&;1B-7C\M.;E8P=4JM:?U0&
MN -0<V)WH10+2'VT0ANEW.Z##"6:# 3WWM(/R0A!F*@G*:I,76YW%26)> #4
MUVVCL+H $(98^*$;+:7842/M5J%UX81S">W$@^,K]D3 >RHIG1IM<"%G*9"(
ME&9^LB#S; ZF=+G=6,(P0''3YP+6P-S9$F=.XKN,KWZ0U<C5+]*?+Q :G4=8
M.5 >9H3"0+*KN'TCGW^@E34!#C_EC7LI0R,_3Z8WYW_]>'-U,;R;_"B&/]^/
MIG\#S@9]PRPLD85%P2%H9GSBB :Q7H^;EL*Y13-H%((I20JGN8NE>2Y8\S2V
M/7,")W3AQ 9+-&J$DXJU!IQI3W;DQN8C@!YL;Y\K8U(H5K'_"#2*50#&!7*=
M)N(;!R'*:NT3$#.2,>!V&;M^ OL#OA@H\&31-/?F?FNF4\+W\OG6=MQF0FP9
MR,0:8,L)ZSHV3[@W<Y V.!2$)0*PM?/4MJ\=_K* 8N "Q+X+/0V=8,[YH9?Q
MF6_!U&L=]RI3KVV^E3H\'TP^BLNKFU_6J$-T=\!9CYZ4%LB5U0#-SWKWXTZZ
M4>@"EG,( 78GU "<1O0[GJ'(<*-!0'(MY#2/R=HC^2KUT72P:^:P:"(OC!3%
M5[M<3=IUO,U6;#J22S\$UMAP)."XN5)ZJHO?!%=(M&'@>NS"XX-NT0.89CBI
M&R55)[4XG194[)<4A/D[#:? KW%[5W'TZ*,NG#V+![-=S5N,'4$MQQ)81I#_
M5'7ZZ1A #F=R[H<AC@?DK"A8U-14HL/7U&B2K58![3$Z7.Y">EE 2PRC<(]6
M44=YY: W@F5EK8/I_=VP:!Y7++QX[H3^;PH-SV&KH\#W6+J196[1ZP;"M;@K
MEH2%3.!#6E0B_CZ8H37JIA4-/XZ Q;JG8NRD64QKOC'&II@ZJ]%RB4[Q* 0U
MO@/&IOC3'X][O<X[%8:BO[KO!*@?]>!)JL]V6\(18_GH> YP5KR*>%2RN?@O
MEKONR0F8!SZ(N9CY0(V["*,@FC\37, 4H-O<+*%#ALY(3H1&K[-Z%NB(PTK]
MW_ I#(7T628ZK@;X(WHD,QS.'EC58W28@[6N4,D>4F;@63+@/ * ^"$@$JI6
M'#@%EDSUL("Q1&1;W(>!_RML'!GBJI,PJT O.%T _X7 %=%3\ R^@1<C4^"0
MX"2D.5 [:GF20@RP_Z!RS G\"%2M0)8<\$1F\,.#H9+49T..1W-E$,"?L1XE
M>4[@_%'N9+A0W(OM'K+0U7/^ZE-X<;J'G7GAT[V%#-!8SS^"(8"D-"*4 -[V
M8?O$RF8\W/QL&9E. 6"DF@\41@Q*:1Z2H8ICT=)M&BMAV+/!9$1Z\O9N. &=
M2:)18=V;Z5#T3LF;H/!-012F, F<!O,0DI*%3@;&,NDA,,Y#UDA:G-"&,I*3
MY)*S  \$<(;7"ZX]\RP.''L$XT]^NJ 5.:R%<"J ;A@(("4A1@.W$ _>=8$!
MN3^VOP^)&))2(G^P!'!R';&C).F^/6F+#X/!K18H8D4_3*'9TJ+6MZX,\+16
M68PJ)D6%SUP&LI^Y+-+PV26T%GA%0*T',; \H-TQDG GY\A0.-)D[[_P$QQ@
M(MTLSN-*PR\NNY/HH8 ZP]::YLGPW%!+,39>:^* >SJC<W*8615^Z%T%C4>*
M/LS0A<[/:?WIM-'?P=&B%8@2<_32"<%A9'V9?A\>B.5#(-T4N1K$]Q]90C
M"A2[@INO%%"(IX"Q!@S"DJ14VGH2&2B4+B" $S_3@3IL5*U*.)YD(.GZL.%9
M%N!ZD:O5'P:8&I9B%D!XE8,ZVK" =X8*'W@3C&7@/$))LJ=Y N"5F20#RDV5
MCX'S/>-EA^2X:3D^>HR:@%:%P)V13M&+8-W+:VB@><:FMJ"+.V5I6Q'9!3 /
MR2+L(]#JL4V2'VK=Z;T3B^@)=$(,.B857@2LAJL' 0TR5 9PIHK-RW*$478\
M_,^9'[/]8B22_2W@JT""^JQGS0H O83EDD64!1YN/]YCDAT4A?_0P&TP9_-
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MX\.- <1'D,&340K'/L]:_9UK&7*#^%AQJT-$: USEMCYB:79LA6&X_*MT&P
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M]$SA#I"H# !H;1(#=PU0T1(4GJN>KLGTJ-F2MABE2'3.S2#Q>3:;"18H4.*
MC77+XCS H'G\H'O \0.RDHI1GH3 BI@4)<D>KRV&3DR!<&9Z) B>+/T4^+IH
M/#B*V8'_-,^AC/W%@>' ]%<AIW=,LQX.(ZE6>_ ?2(J;19;,"R.R9K<:9;95
MCF&RC9.288I_V^S"ADP3$\*)?#31J:)!29$J3;3-?R@)H>(0A0)L'%& B^#I
M(<+X.SW23(Q-K6U!I+&,^/,H)(7,QR;.E:N=6-"Q7P,=,)Z"@WV" P47VPVM
M4.&P<[BK;Y%V%(4XVB[N,B^<]8\UV\$>DO.ULYUBVHN,T6%60C,T\H#YVRU-
MCJ+F<*]S_"VSW>I(D4#7+@,,GR,#G*N L&*3G3S%6\_Q(<9K>]5I+-/= F5J
M+P[WNIUOH6Z$AJ__0!'*6PY#$;_<@%,QU^$?D.\K'S031JX,$71[4""D]RV$
MC.F&;(_UPVB)OH&V0^B:$VUVC" ,P1T'BP%CK)H2CHKSC/9=D[F'L;@?>0LA
M1P&3D)P&KP*NJO=OTG93P#_PE2>.=07) V>BS2/$.4 )S'KV714<,(NCF!2&
MPU!GT6SJ'B$QH5MS_-B3U1X^4B19,:&9^C!@S2_U#0P#-MJ<%6+H;D2[*\K2
M0S>?K@(QZ9@M4PIJ:"=0*[.V0B$=*6&;3.M%8\%)GRPZOIQE'*(839HK%7-I
MV3(P)KV&)LP=*W/0TAPT>Y="Y:UA']9@1>O)#%2O1*KD&ZDO*926M:0--/-4
MK/N-7=F@CHCST)I';U(JQ?]L@_Z/B9A;>8F(@(H-M[ ,P0,"<S U%J+5$MGD
M7$7L<A-^1/>"W)FV_B)Z"L4==/+$I70XWG4#ZC:#U77[K;(!B6I/I].+]"G:
M6SG@PL!B6[F1V(4MW?%WV]^)&N3@'=_?Q7H8G1:C=QQK=1[P1EWF^(Y37>-Q
M8R@IP-H@3\HEA2WJ9X:Q-&GC*%21%:J4T9%,_;AAV#%F!@#<@0;&M8[0*@+K
M+Q&_X)H<9?X.OZB(,O,/,DC!+'O(PSHF9B$U%?CP@>N.*'#96F]_(3H4FV\R
MZ+CT@:_$OK]1I\%&HH'LZ%BH)3X\!GT,HQAQ55?)FZ^\*!2=HUN[J$Q ^.",
MY'(51,]2<D[?WAF99K?*-+-X=11R+#./8Y8-('RRUSG2BN_KYU+*3/L_"6Q(
MP Y0*;L S[_&HE38P8'Z,)^6&8;U Y6%& 61NSLDM,LH,<)DS$:.ARWR2<J#
M/^F+2@?LA=".4A3"T-L0;095EZ>Z8I$C$47IL#EZ(T.?K!61EPS5ZZSE=)"M
M+,68$HP5^+2Y3IA;&7G41W<F-QOVW!A"15F!L55%%U[8- E,1;,IIV9S_D0E
MBC:<BJN;R43<#N_$Y./@;B@&M[=7H_/!V=503&\$UH;=C/D19[]7 W&U -@<
M]*LO(:-XW@%8A2^G2)47F*(#NV* =A0V-TO9J?#\1Y^"LB9+5D6ZGKZB D'?
MO#'S:VM> Z0J==B"+A!]/R F0]-OS6(DJ1&&8[]D7^:WJQY.3$8FMN-KILC%
MBT5P.?DA")5U\6-B=9'E ^!M)*)>,6GU21(9.@V=HPVP8QRB4I=QNK4*7T<F
M.8PT)J7X8IA=IS3@+E2SETWYR*F8^%\*E4+5#\S]4S%_A((5^6]C4/HQZO!3
M8:I4WHB=_=8Q>#)')T=B%__LMHY/^JW^D?KSN-4!5[=WW.<_]UM],(UZASWX
M\T*&>(W!(U9*6)K9!HRDX_XQ3-$5QZV#H\/687\?/^SU^ZVC@P/\L--O'?2Z
MHEI,@PCBG%8K:I"V3GN_RU1VVKV>_NW(?': OQ6/).>"EH@COM?6(3;PD!*Z
M$Z1#MVX;3!S"4W-7#TT PKHZM6PF72=+I$H.5*8\&L9X8;)G.%)'HS1<JPPI
MZ=5P0,TY%\KB=(G&?O\$SJ\C]@\.Z&>AT2J+7;PDSU-X@16.NM3PL'6POT^_
MW6K!HO!^57H.@",ZJL_)"4]7J6\:W-WA#<75:' VNC))*H/1G?@TN+H?BNLA
MJ.0[KA>H5F31W1],RPJ=BB&H#/.E("LH6>80F/4E](@!F 3+)3I,(*"?,=70
M3]DMLU.HR Y0Q;+(0TI[P9.E!%[R."V&+!+K8B4+HQE21]#@@P4.IY#I"I>Z
M"Q1W_0F:2+[+%?98:JD5_Q7F*XB^5J%6;<,"=#=>KN0AT00XKES:5:H5)J[C
M#$<6J.1T+1!QI)Q*5T >3]K[??C1;Q\?@WN@LNSUP^/VX1'\Z+9['1--0>,;
M8[QBARR777C:[\$_G;[X%*&DT87B#IOINP( ZS_%T3'\<^<GO^X]Q&"08@Z,
MZ,)'^/\%JD),DW_V)6B('2.[NZ(#C_%_QHI8\J4DWBHO5WF"$-YZR2?8&F )
M4 !D)&$A!J=3_$.Q@8I<*"O0)"=$H96YF=M)>,.?V%X>6-<S?5FJ/N(D).')
MQ(W]F53*#34QNYUTZXI)!#ILSH"&M[EF>)U^H</#2#OC$L7O->MBWHJQHZZL
M>NMKZ:"SX>$=N"6/&)1 SUTEA'*F<CZ"7;&]M$:PJVQ""O'K$50.+6TIBB"Q
M\TQBM-=R>Z3QEHH)E1D9_)4W#9P*JY[*IJ/(M#]GD4I\<_F2U&%S?&*)+]L-
M]B<JMTO4B'6-J%N$P/P[+*'=7?U;S_S6WRU15UD5R,N>^K^[?T0PG/_6L.!*
M:N3O;M%5"M<M_$0MFW].BR!GN93YS2?%4(K-E -J!3*?\N145U(B+J6Q8'IT
MR$5;E)>"!:DH:SIFZE@T<G049)-P@IHXKK(.TB>\F><]Q'+ZU,?P.275#A)R
M1ULV@93!@4CH4XX' 0L'!BV X@2(ZI!J+1D7&^$Q<XU#O@Q#<[N&:W+WE.M9
M2%S3!8#K7HK^7ZY(;*WPIS]VC_OOE/[I*C8X+?':3A9R!H?T5.8_1>I=\W82
MFSB_P)PFG[(P4<],-**?+9.E"<O]7.+SW+!35+9R56IQL H!>^#GN^BC4H&"
M_HNO" HT] T-]S6"@*LT87!VBF!M:4!I3I2I0>>')J\.D^B$O:+/I2+H%+OG
MA$_TAS&@:/&$SI-2YJSAT\2PH%EZ#PGHV_[=>GN@WM-1!FQB)YKH;=E"%6QG
MBIP:0+@RPJ8J6 $2JO"AP6';5P1@*/B8>NA125MWWY7P.,?:2I)/3>G\^A?&
M#/D2G&("7Q-'.#HMU.LK\T)7[1.YA6K[:0Y'2?')K38P!W.0<3),;OB*%&\D
M*]F.QI !=WZ.41#KG2QBZ(!LQWG!_A6X_2B#DD(FRG]V-LYOXFTF,=2J_V$A
M\5-C&7O SOT.^R?:%2T7HH*4*\LS]]^@T9M>>[^C<O:0J>=T/;G2]:'*3=14
M8(=^N]O+,SJ-58NH<"<UUD+#7[2U_A$MS]DS-%5E-1B;]]-,I=R-PD<J0TNJ
MFZX3DOU"!\5!=']O.=QY ;V]U5IN#)UFCY/J)A,8ZOQ%+GC) Y9Z+V31CE?V
MJIE])OGU'SIZ B/"'A]T\FUOBWM49&C3J:W" =80VM)U0W6[X"^7TO,YV3:?
MU9"#JS@Z[K4..@=-K)$?OC.?8T9C*M<Q0"F_M]?NY-Q0,D9B&:C09F3=N^59
M,<6M3+1]:TK_Z6ZSNB:Z;L/"34D)/WA-0W>?RM71Y6EVJ93]VB2-%#H+!WCZ
MJ$?H!Z9(-4;X;^@6ET,XA7TO.;,FI#50ZV4[0IQ)= K%@ +FA;2NPA\5K_:D
M?8(N+[%\HU?;:_>/^)\ZK_;H!+W:DQJOMGV ?BW]NX5G.[3JVAEI#29=L-*W
MKH&HKQ:JG.E0=HZ;8=6&Y6(E_C>+53\7JRX0N-\[J%G0C;*$1WD"%2^GVVGM
M=P^;R'Z2>19H=0GJ&D-O0B)44D7QJ.5G.M9(O.FVC_9M>,,D&"R?P#<HX&;,
M%=Y>;&MI%4L#%)W=/IQ$KQ'%''I)5\J?F_D= Z(5<-*Y=86(8N4<#E6 \(FN
M[54>"<%.TOAVDS<'AWWJ!.(W;WR#5/'MAF^.N[I+8_F-[M!6+RTQ=H-AZT(0
MKS;=F3I6H:/I57G:J+6,9)5 Z%NQ6PY6U&#)V-RO5![=R:6J1K!1@E^C-8(/
M0-OY;KXRP_JWQ'Q7_H,4.[!9"E X,I.;Q*7D#XST]CK*;SYL=[L"K)A#-&=;
M1RIX/&(NVU/_G5?>\R!V4 RQZ:[8;W>ZU&Q8>5D/WBWL*R,9@>[D0#5<<48I
MOA8TQ()Z'/%XOSR@M83"8>1!ZS?BH'VR#R,?X0)Z*.=K3/*]LP&_M>;Z=CB>
MU);<7YAK=<J4L)-\[R2_4NH<7R*BWI6C6/Y6W_5N> W%L3+3:P@IW(JB<,6(
M!"4!/#GD<R,AZ:D]T!J]1ORTE.2O>$#'?9LP;_$MD.VMJ -R3@YS^@[5P;^$
MOBV#T&7J!FD=9J;YZR7KYL:7P;!5QN&=C&QO7!8EKIK,> OI$/C>= ].V#Z:
M+JS:\8JII*"A,J5.=RL-VVGO'[, 8^6@*@6B3G-EZ&%6B54R5[N/^:!M0%[[
M-/J'^]N>1K(]N[#NM"RL;2%^(ZX7C[AE)<>L?15 *9,9=N&P=Y+OPO[AUCR9
M;,N4O_L]J+P9D&["1F. GV']6P-'G)VW <U.3HO)?%]ITI@0ZYM.VSC37-O
MPY,\LHR"2XRO]\A"]7X@4^-%+RZXP#=MF#?88(Z<C2VWI.5'(W&N2W6GE">/
MR2FWHT\]+=(\J6$)E5BIJ2759FI]\;5*G$,:9E@?QT$MK'>W7@I5[LY5$5:Y
M\#.GLI9>N;*N;N6[)J6_O *J<H"L#_##\B$VI7N^L.I.[.CBNLI;Y-85A=6\
M?.NU@NRU@NRU@NRU@NRU@NRU@NRU@NRU@NRU@NRU@NRU@NRU@NRU@NRU@NRU
M@NRU@NRU@NRU@NP[5Y"!$8? 5PU=3:PWL<.6X9XF:&&R&&SQ-3*OY4:_MW*C
MNK?]T_<<F6/=KG#EM6KI]UZUU"C5GTS"TW6>\%1Y;=R_8R[5:XG1-Y<85;[H
M)[\NR+\+YBL+;[9"EM?BG-?BG/^3XIQUQL]YM5Y@LPQLQ>ZO90HO*E/8RE2M
MY+K4JJ6JQGM-)_[_DDZ\CCL:TBJWDM;7G,W7G,WMOSX#)K&^'G1D@<;.!7YG
M0H!^&<8A.1VED@Q2^);#==]12$%-_ 7KM " .-?S"NM(1ZE<)M5O>]:]:$=E
MWNM[1!/V2"HLGUY_.R[Z=KN6<V=VH?$;&'./O?H.AMSWWOCEM8VN^.;ORF5_
MN_J-E!L"'U^W;[:/>*%]1.O+GZP-J__.[3KG=6V;33#X?H/;^FT>*G(*OJR&
MOL&*RR/@LUK_U%Y[4T9]TY?H%N2H^0O+"]]OW=SL.B\\9H6IOY>4D;.)",LW
MLD9(6I:3A/PTCD+CS[2LK9CB%]GXGS.Y7K M?W,+NDN@WT2ZV6"J&Z2OT1$W
MN1"U1&7HK>96F<E3M Z^>FKL7>[4Y2];ZFOKMW< 4OQ<.4C5#)15W=,:DGF7
M++.EB>J:OFC.B$LT9\P+N>[0KGG!$&;'C/VS=H3O(8K?T_O? NZ;W$GM,!KG
M;\T;>5J%U_&L$Y6*CUHUR8V/N;ESG45O'-,U8/"O/+YO=F'-F564"%Y]6Y7#
M:'>1>*[=<F5\U7_U\!8NY58>XIZHQN*W<>2^0<%L<*0*7I,>0_RS"IO;(_)W
MG' ;&.ZIJ[5]#:G=?BUH?C^ZML;:[S?E2R'Z7W (6R)[P\0U#ON_E-N^8KZM
M=/[WFNZ;>>C%,WXO%OKZG=V.@^J $V"O-K;Q8W-48[-&[_8*%VXU_IV.7Y@O
M13\SU_>S>G51UXFC"QM;DB+<_*W@E6[5,,0V?:H1B6V6,N1+XH;%5SBF*,/V
M]C5HVXTCU._EAFY;;.O&B3?O\B8BMMGSS63P 6R[??6!-@R@M6Q7Q8JF-6G7
M$ZU=]VN5:U\UZW(ST3NN;58.\=7=13193IO"58UR;K\+IN)7.^A7=^L?%EZN
MHU_$,^% S1V'73W\2BY==#I2WYVXA1>L(HZJ[.^6PJK*5P<QPTHK:E'90#4[
M=]=:I"D]8NU<G[A^I'FJ1C.Z985VK0#0N4-QS=ES;I/J'M7(C7Y_!25PEY&L
MTMQ(P8WU.J !I3[7O&%:A1N_N-MWXO7<O P@[^P:U NK!G7(-:A5=JI_G463
M(AP$0>12<I5=+U\H?6J8:2(I/;0E/ECEM(-B.6U3URW84SU%()RH;+^&V$CC
MVII>;]5H%#3M@+63R'HU;Q80@R<JNU2O.,FAG/Q-7MO73)=\PWRMZIU($>FW
M?0?#M^!BTR(K9V423/FP&]D1$[/UBP!H$Y)B"1^]_H$2R;'F\<[4V_^O3]A2
MQT L?)=7=)0).3!1NGJ7\@5RUBSFFV"DL:-=B[X5'WPHB&0S8]16UQ2+:UI8
MY\[?ZDWA-RR+%5/G2P7#UI1_ZIJ%ZOK>)DGZ_G\ 4$L#!!0    ( %&("4VL
M-G:L6P(  /\,   -    >&PO<W1Y;&5S+GAM;-676V_3,!3'OXKE(K1):$E:
MVC&61())DY  35H?>)O<Q$DL^1(<IZ3[]/B22QO4P0I#[4MS?([/[_P=.^E)
M6*D-Q?<%Q@HTC/(J@H52Y7O/JY(",U1=B!)S'<F$9$CIH<R]JI08I95)8M2;
M^O["8XAP&(>\9K=,52 1-5<1G/<NX/)O1(HC^'#V^GLMU/4KX*Z3-Y.)_W!^
M/?:?V< Y!([Q*8U@L'@+O3^'7OC^?K )CN#S9\*?8H_0B^>AGR"/P)=[P -H
M3^([D^BU6Q:'F>##SLV@<V@R8ABL$8W@#:)D)8G)RA C=./<4^-(!!42*'UD
M=.7 >*I'%P[<R)RFEL,(%]+6=A7<[ZJ=/@IT(R.04-H+G$+GB,,2*84EO]4#
M.]DZ?PF!UEYN2JTPEV@33.=P2+ 7760E9(IE7R: G2L.*<Z,'$GRPER5*#T3
M5$HP;:0$Y8(CJZ'+: V-33"E]^91^Y;ML)L,N#EF2WP(C(K.U*MNS6'7?"MY
MF^;8V]C905Q0DK50'VN]'&['YLSA.XDSTMAQD_4"-!V5)=U\H"3G#+O%_+9@
M<&#!.$1='5 (21XUSQR51#NPA&"-I2+)MN>'1.42-ZH[3DUVJ.;I"6K^U_<Y
MQQQ+1+=%Z[-_S'?Y/RN>7?Z]9/M6&0L^KKOZTA+-?_L)B)R?@LC%*8@\@<=F
M=G7\&DTG][(BO;;%V.IC=KJ8W@M6-:&*\%9N0=(4.SVFC8S@5].?TIU>8FAF
M-%ZAE?X:V>'KW!1GJ*;JSBS1!B,XV)^-\&#1SUKVB @.]A><DII=V8+#)T_\
M$U!+ P04    " !1B E-XN7V@>L"   H%   #P   'AL+W=O<FMB;V]K+GAM
M;,686V^;,!2 _XK%R[:'CMBY]**FD@-N:XT""Z15'VEP&E0N$9!V_?<S9-F.
MJNQH+UZ> &/,)]O'GWTNWZKZY:FJ7LB/(B^;J;5NV\V%;3?+M2J2YFNU4:5^
MLZKJ(FGU8_UL-YM:)6FS5JHM<IL-!A.[2++2NKK<MQ76]M5E=W.?J;?F3WGW
M2))EF[VJ.'F:6@-+U[-!Q;[1_75'=%'_"U.U6F5+Y5;+;:'*=@=5JSQILZIL
MUMFFL4B9%&IJ[:L07J9$E&W6OA-9[IK2=2W2_UJF4XOJ^S9I]3>O69,]Y<HB
M]46F7]0RI1VX.4@G\%WA1\(E^BX*/.GR6#_,N,=]1Q  R1!(=DS((8 <(I##
MHT!&L;[<"1] CA#(T3$AQP!RC$".CPDY 9 3!')B%M+G\6(N2'!-@E#,>2PU
M*B [1<A.S9+->"2C#BR<BTCX<<\&T,X0M#.S:)[\OI"NC!\)]UUR+7T=OY)[
MW3CK4@D@SQ'(<[.0D;SQY;5TN!\3[CC!PH^E?T-"/1$=*> @TP&V< \,3T 1
M$R^((J*G'XENN9Z,/ PU(Y]Y@L00$_6+8<$\\/F\ZTE/\IGT?@\]EW-RS[T%
MQ,0,0PTK)HH#Y]MMX+EB'GTB0D_3^!&R86*AALW2LYWHL.Y7Q+M0KXT?8YIB
M3J&&I7+3#[#T-9N 3)A"J&&'H$%,H4,H)A%JVB)8$--3B(D9A1I6"AK$] QB
M8G:AAO5R*(C)9[W_SU7S!4)B=J&&]8(ZD W@CAO3"SNF7AB%F)A>F&&]X)@,
M8J('&,-Z00.(P1,,PTS##)L&QQQ!3$PXS+!P<$QXBF&8@YAI!QU:CDX(>5#9
M\[I5$!-S$#/LH$.8)R3:%D52OY,*8F(.8H8=])?>Y&F:?4BG,,Q!['\XZ,!F
M[1<JQ,0LQ Q;".[90"\F^2Y%!5,JF(6&N[S:/IF6JE56JM37OVAT^3+)EV%-
MNLMN@S\:=^I=;?/<T65!Z55)G_[JVMAG[JY^ E!+ P04    " !1B E-5: L
MZ6P!   ?$P  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSQ=@];H-
M$(;AJU@<P,L,_HV,JS1NDUQ@!6M YD^[&\6^?0A-L&3OI$!?&A "S;S5 ^+P
M9FKMJZYU9=6[Q;6I6Y=&I??]BU(N*TVCW;+K33O<.7>VT7ZXM(7J=7;1A5$<
MQQMEIS.BXV$Z<W'*T\B><HH6']H6QJ>1NM;JJ[,75QKCG1I/M!P6#(_<>O.7
M]=WY7&7FM<L^&]/Z!Q6_"R+U.(C#00P/2L)!"3QH%0Y:P8/6X: U/&@3#MK
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M<U!+ 0(4 Q0    ( %&("4UF\PM@@@   +$    0              "  >D
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 48@)32]DF(KO    *P(
M !$              ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ 48@)39E<G",0!@  G"<  !,              ( !MP(  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " !1B E-,ZC00&,"   5"   &
M        @ 'X"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ 48@)3:549?]- P  8PX  !@              ( !D0L  'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( %&("4W!J)4ZH@(  $H+   8
M              "  10/  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"
M% ,4    " !1B E-7:?W^Z@#  !6#P  &               @ 'L$0  >&PO
M=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ 48@)3?@0GV!O P
M/0X  !@              ( !RA4  'AL+W=O<FMS:&5E=',O<VAE970U+GAM
M;%!+ 0(4 Q0    ( %&("4T%;^QEB@,  /P-   8              "  6\9
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " !1B E-=J&V
M,; !  #2 P  &               @ $O'0  >&PO=V]R:W-H965T<R]S:&5E
M=#<N>&UL4$L! A0#%     @ 48@)34&V,2BP 0  T@,  !@
M ( !%1\  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( %&(
M"4WM>5HXM $  -(#   8              "  ?L@  !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6Q02P$"% ,4    " !1B E-XT1J$;4!  #2 P  &0
M        @ 'E(@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0
M   ( %&("4T&9II&M $  -(#   9              "  =$D  !X;"]W;W)K
M<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ 48@)39/98P:U 0  T@,
M !D              ( !O"8  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q0
M2P$"% ,4    " !1B E-5.C[?[,!  #2 P  &0              @ &H*
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( %&("4T:KS/%
MM $  -(#   9              "  9(J  !X;"]W;W)K<VAE971S+W-H965T
M,30N>&UL4$L! A0#%     @ 48@)30,?PBRT 0  T@,  !D
M ( !?2P  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " !1
MB E-LV8\:[4!  #2 P  &0              @ %H+@  >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( %&("4T%M >9Q $  #<$   9
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M970R,2YX;6Q02P$"% ,4    " !1B E-4.S5Z0,"  !)!0  &0
M    @ '1.@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (
M %&("4W/^@M9:0(  &,)   9              "  0L]  !X;"]W;W)K<VAE
M971S+W-H965T,C,N>&UL4$L! A0#%     @ 48@)3554,,X@ @  .P<  !D
M             ( !JS\  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"
M% ,4    " !1B E- 0A<\M\!  "E!   &0              @ $"0@  >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( %&("4WL<*Z%90,
M )81   9              "  1A$  !X;"]W;W)K<VAE971S+W-H965T,C8N
M>&UL4$L! A0#%     @ 48@)39#;34NS @  ^0D  !D              ( !
MM$<  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " !1B E-
MR =JFGD#  !X#P  &0              @ &>2@  >&PO=V]R:W-H965T<R]S
M:&5E=#(X+GAM;%!+ 0(4 Q0    ( %&("4TTY4;B:P(  .P'   9
M      "  4Y.  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%
M  @ 48@)33A,ON@4 @  ]@4  !D              ( !\%   'AL+W=O<FMS
M:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " !1B E-X&!K.!TB  #FFP
M%               @ $[4P  >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4
M    " !1B E-K#9VK%L"  #_#   #0              @ &*=0  >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( %&("4WBY?:!ZP(  "@4   /
M  "  1!X  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !1B E-5: LZ6P!
M   ?$P  &@              @ $H>P  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " !1B E-:89[.(@!  #4$P  $P
M@ ',?   6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     )P G (,*  "%?@
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.10.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>68</ContextCount>
  <ElementCount>120</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>25</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>1001 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/CondensedConsolidatedStatementOfStockholdersEquity</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007 - Disclosure - NATURE OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/NatureOfOperations</Role>
      <ShortName>NATURE OF OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1008 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/BasisOfPresentation</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1009 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/LiquidityAndFinancialCondition</Role>
      <ShortName>LIQUIDITY AND FINANCIAL CONDITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>1010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/SignificantAccountingPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>1011 - Disclosure - NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholder</Role>
      <ShortName>NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>1012 - Disclosure - WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurements</Role>
      <ShortName>WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>1013 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/StockholdersEquity</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>1014 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/StockBasedCompensation</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>1015 - Disclosure - GRANT INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/GrantIncome</Role>
      <ShortName>GRANT INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>1016 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>1017 - Disclosure - NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderTables</Role>
      <ShortName>NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholder</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>1018 - Disclosure - WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsTables</Role>
      <ShortName>WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurements</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>1019 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/StockholdersEquityTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.tapimmune.com/role/StockholdersEquity</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>1020 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/LiquidityAndFinancialConditionAdditionalInformationDetail</Role>
      <ShortName>LIQUIDITY AND FINANCIAL CONDITION - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>1021 - Disclosure - NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER - Computation of income (loss) per share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderComputationOfIncomeLossPerShareDetail</Role>
      <ShortName>NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER - Computation of income (loss) per share (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>1022 - Disclosure - NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER - Potentially Dilutive Securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/NetLossPerShareApplicableToCommonShareholderPotentiallyDilutiveSecuritiesDetail</Role>
      <ShortName>NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDER - Potentially Dilutive Securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>1023 - Disclosure - WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS - Conversion Option - Valuation Methodology (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionValuationMethodologyDetail</Role>
      <ShortName>WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS - Conversion Option - Valuation Methodology (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>1024 - Disclosure - WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS - Conversion Option - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail</Role>
      <ShortName>WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS - Conversion Option - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>1025 - Disclosure - WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS - Conversion Option - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/WarrantLiabilityAndFairValueMeasurementsConversionOptionScheduleOfChangesInLevel3LiabilitiesMeasuredAtFairValueDetail</Role>
      <ShortName>WARRANT LIABILITY AND FAIR VALUE MEASUREMENTS - Conversion Option - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>1026 - Disclosure - STOCKHOLDERS' EQUITY -  Weighted average summary of quantitative information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/StockholdersEquityWeightedAverageSummaryOfQuantitativeInformationDetail</Role>
      <ShortName>STOCKHOLDERS' EQUITY -  Weighted average summary of quantitative information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>1027 - Disclosure - STOCKHOLDERS' EQUITY- Summary of the Company's share purchase warrants (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/StockholdersEquitySummaryOfTheCompanySSharePurchaseWarrantsDetail</Role>
      <ShortName>STOCKHOLDERS' EQUITY- Summary of the Company's share purchase warrants (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>1028 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/StockholdersEquityAdditionalInformationDetail</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>1029 - Disclosure - STOCK-BASED COMPENSATION - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/StockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>STOCK-BASED COMPENSATION - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="tpiv-20180630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>1030 - Disclosure - GRANT INCOME - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tapimmune.com/role/GrantIncomeAdditionalInformationDetail</Role>
      <ShortName>GRANT INCOME - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>tpiv-20180630.xml</File>
    <File>tpiv-20180630.xsd</File>
    <File>tpiv-20180630_cal.xml</File>
    <File>tpiv-20180630_def.xml</File>
    <File>tpiv-20180630_lab.xml</File>
    <File>tpiv-20180630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2018-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>50
<FILENAME>0001144204-18-043366-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001144204-18-043366-xbrl.zip
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M\CQ\D]&.0!X_<=Y/WNEP^:C&,_HBXY57>P9J_O=S"LJ![\T "WR;B.WYDQ+
MA^G:<8+C/#F3:@;<B0Y3\^;,'_3%^R-I]?HVPEM]UO5$Y_T13O_C>)*?O$I
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M/Y7V8BT)/M9?@>5!X:Z#;MWX,5QAWS\+J9X?"E=AT:%<!MZ,-2P\<D%#"=^
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M@(%H$2]\+8_02:$AP>+P@#G<YCC*)M,,<"X!/)U)*1<IJJK-9(; 10,?CX6
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M^B)KT.PA?-@(?A9A(_/JD12B(\Y:V,$LN;;X!**HVM'GQ'\K2D ^G-?]$;O
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MPR]OH[;+L FAEQ>_&74+<K7)+CEAUSX*/?0MP0\?QKV3.#QWG !]R7 I^5'
MU'!0?MZ!0ME'((R]1_A!;ZC ?$N%U2T'/=->]!*N&_M=Q1C1KTV7=\*NN >5
MQ2XH"@3?]"S N#F:0,,CY@DXC'&''N_?.!3G#9@>K@N<AS+'Q4%'I)\W+5/Y
MU-,=: LX[M"!3GIKJ@==P7[W4V)VN8RJ %3![VFXJ&7WJ2"$$?G=?1'/PJO$
MV(D+-5T8X%CH-/YP)C@10B)*WE$+]U"$'P8+.JYMNR_JJQC$^&BJ6\CO)WM;
MK,$LN;W=/M&^ [7A!##Y,=AZ":]XH,]"O<LNH9_=GO!RKW*4$3$T_6GZ%V7Z
M#^EV/8-N@]V-J'-=4><4Q<XUBV,&W=2:;U.$G+V)+#J6^A9924@4PE645*V-
M8Q1KE5K/@/5UA(?)%A'1O$HXY$>@5)6T6)%4S6.MO6JMMYX%M*P/U0)'DH%D
M%T](GN!E:9G)DL:;.]%W/46QXSI^ V(KXY=NA/]V0L*H;YK'NK:JE->X"0V
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M(IY8#&@>* XG&2[!KTSP([9+;)?8[IXH8V*[Q';W$MAOVA5-.ZU4VS6B&X6
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MA+WQNR*4^+_:U:IV?NGV^MP9))_HY\SUT@^\B-1W;RN,LQOQS$T. GK]"$M
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MAPV?'=TM7</#N.9%X'?=\%;[B0;/UJOK:? D>\1@N-X8"X;/%GV51H[3@$W
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M@CS\*W0H4>'<C)W?\F/B-7SB48-:CW#,;U)+(>"HS;9&N4.BDRAS=28>X/W
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M-[-VF0'38IU,7<9'%M1F;EZUVKS,S$1$%'YI>OR^T8 57QCS1\NDYL>7'S#
M%\X7R]$=MI)R!J8]0@'(]_B25BIVJ@.U(VE=24H5@.KVU.5%Z=I#=0!WU7Y?
MD:5UO8@BY3H&?.3*N]:]('YR"S'SF:VN\T6W/,Z25\,;.O$L@YK3'M"_<,S0
MX!4GAR>YAOSL*MVVK":(JL7.K;M=!S85!3"^);?G\])?W%JPF5FU'F)@[1SG
MKVIFE!D\/>"+Z[$/Y0*@KIQ6)>9JC"!*[,U:46XM_^7#*V_ZNX=Y>ZO)X:7V
M]K0%UF:MJ*#8HD:H6!K]Z8$(R>NV:B._G>Y.57KI4KZN4QM5^)QP916^>@BU
M7E=>N<(GQYZ9_PW]@ V??^N6M$Z+!8!4<5JD]O8TY?'*7M0\!-5F4;;;FB9%
M3Y0QJ9C5V^E+CT4;C6IS.%O%.Z?X0F[P@1R^Q^20V;^05*QK)A$R;FF]W.1#
M:6\"[MQ-J'?'.33MF *ZI24GL^L;F5?=R6A05G 5^IQJD_557$ZU.S58NMSK
MA/=S8FFE 5AKJK@TYNQ'AI:-P5IV5Q^.9:<KEXKK)'/I2"BM?KOJ2%0U>95!
MR&J\U4"QSKI]+:!8S?!M\5]EY;;(;7:WA-?EO\Q9;N@8:C#+M'A#2ZC;7ZUA
M0;@KDN"':^6?_J7V:4VORNS9OH.=16UXJK!]N%;_D2^5WC8\K-2+?*-/_*W<
M_)#2SL6HG8I1^T[6JFW=5*7Y><-JYLPYD%H3XP"%3Q0M[ZN*5IA'4UOO/NM^
M0+U$V7RUQA8,9:0436I]I0^Z_=D)0"+FA>$"WM72WI79NJ9#V<F/>8<JF]A>
MV<0%ZQ7EF.GDIO"7828C3X^UHP^JK%1"S+PM2SOGZ0Y::L!)V!3DN<[H_N-+
M,@F4I%L^"ME4*(U"80IT>TI;:B_IJZN;MTU/<UMW5IM" $][2V<0UO,TO3B2
MF04KP&%N+F%5'+;9/L ,<RTR8=5=4C#4%3>YQ*=)][/Q=+IN7SA^X(6L?ZO0
MUJ>F/Q?MIYKVAK;M&M WF\735:";X&&>L=J5=U@Y?FBS-<0S9L$#[\_CKOWV
M^N)G^M4*.PSFI]^JV3['=R#]P)8_J0-UU3YSS#-S#(45AA<^\4A+O:VX:EZK
MMQU-F^?'2K;/;U_UJ>X9(W;A 'VDMCOALR-E3E9;$*_7R79'G7-RH<F5Y4[T
M.G0W\8;M @:LO$=H;6>++P"1JZNDG!>9)<$+QW#']&MVDIQ=KM*K=EG#DIUQ
MO;ZJ=KMSRWZS[ZQJC"K)N]JX*&ULNB+"%L4:W-CI7L1C*$E]I:<N<*.\*TI/
M;D'O8SF^97!)F.NN<QM+%LTN9BM+5^W/ZN9JAM1F?V515G0Q@R9W-W&@UHML
M*NY /#,,ID;@;-PNW3/]'Q,34 ;O:E(_#;[4##;P(70#L\^"7'/@H3'CX(VN
MWIE)PMJNX>&,-G)M$\R)DB>?H-GEC_G8;V.S9D?1,G5HSL15'<C&/./ =K=9
M=B6EU^WF5F8W<JAH']7VJ5+N=.1VIZ=DM]*6NU*V$YH[L7C"<4MKY( L)7T1
M;]EFYVE3XIBY^=I+JONAQXVX<"9AD".9W Z8C&O9$\Q-?::=S1YX^S+A%'%7
M>#5\Y6&ZRTSA\7/['^G0]>BE:UI#R^!-2OJ$A;2=&?-)F)OWZ;?Z*;BL,JKU
M16,A?W4%C<;9,*!>S<&8GX3;33"*EED7I 8/PD_7AB&P8>3V*#G8A$A_U]%8
MR,'YU! E&K4GAQ#!*)QH+T^-&\O_]<6C,"0P&-0/;F 8]R@_9"C7K?:N8U(X
M[5Z>($+%I/8L$2(DN6F/I>)J0@T8FD\6VP\.W[A?:3(_![.;B"R<'"@26 )%
M9!NE9,L!N:7>.,]42YK<LB"PDS4N'=BF#.U25C]5&VCFXV:#N[#A+D?X3@=W
M362O.;;)E1ILS];G9Z/*"B0,K+3.5L326P L^_KU[93KN3"PLI6U\+*V8J_U
MVHWOXF:UU^IT=US8BO?RB#-SL'@ Y9:R:V60VV @7+>_N)#W=CUWM7@SC @-
M^I*FNK?K 5QQ*G9'#=SB491W/8@KSJ#B(!8-XIH"_96[)+%;S=S6+C%;3?':
MP^)=O,*TA]!UR/^HETK[M3JZXOVTPG1T?#RD2UE><3R>[SW;&C#P<8]9$S)[
M>1S9^L'R74V1NP-X]]W)_%MP[,GL' 5GC)=5\R>-GD5OKWQ6GB1EYV1OKGS&
M^;WHLP-,3@3S'_@6CJ%M#EQO@Z$J. =[^1-UW+'E%)^\^I!E3G.2]24S%K;E
M_!H,73=PW(!^A2?DF;_DN>QF[J,@F Q.3IZ>GEKL8RW7>SA1)$D]86^?L ./
MXN,# //[(T@18$YJ'I&3U'>Q_W[X?U!+ P04    " !1B E-M,3WT24,   5
M;0  $0   '1P:78M,C Q.# V,S N>'-D[5S=<^(X$G^_JOL?=+SL[ ,A##L?
M24UFRP$R0RW!+&9V]NKJ:DNQ!:C&R!Y)SB1U=?_[M60;#/[ !H>9.O*2&$O=
M_>L/M5NRY'>_/BQ==$^XH!Z[:K3/SAN(,-MS*)M?-0(Y:[YM_/K^[W][]X]F
M\P-AA&-)''3WB'I8XBG']A<14Z/.V3F"?^<732.8!T(V7YZWWZ)_M=N7YV\N
M.V_^C?YCW/X7]:TI:J)OW[Z=.<!":A9GMK=L-I4882_($B.)^9S($5X2X6.;
M7#464OJ7K98BD]BGRV7 B*)J*1GGKSL*MDN6A,D;CR][9(8#5UXUO@;8I3-*
MG 8"/9FXE#Z]+\5-=]_H^:USYO$Y=#EOM_Z\'5H::<S7I>S+1N^'.^[&_3LM
MU7R'!8F[/Z3Z1]S;%Q<7+=VZZ@J,: %KRH3$S";)_HY<$20[OVJ%C6L4!7S_
M'"9 !*(YQ]A?=9]A<:>[1@W:<,WS=K/3CDEL+V"2/VX"$<0^FWOWK:A1D;W9
M(@LXAP#,HXM:,P@=0K-IH"$#'GFP%]G]54L& 67W1,ALDK!-$74VB1BFMLBF
MT4T9>@AJ9Q- @^K>WNP.#I"//A&9KM$M&;H(Z?,<(="20> 0GQ-;C?W<B+EH
M86YSSR6 P)9-\N"[F&'I\<<;^+TRB,=8L,QFXDC>4HA;T*D)O0BG]HIN-]$F
M@> R;1*XF51.)1S,F =I"/*7_N7[E,T\=:G&X*729PK<D;KX-!D4I ZM>L^S
M Y6$#.;TF:3R<0#<^%+S;R *UBOLL9+KD!EE5*-J0[Z!A!G3)2^!!PJ9H 27
M=ZUM%C'70!#'9._U-?A3  ]-H49Z1!5UR:)8,RS7W\:N';CY EH;%M[;Y%V/
M.80!5[@0GDL=%:77V%4YT5H0(D5H^!+]<LS_$FQN@:5(9/^N.>KU1U:_IZXL
M<SCH&5/X<6T,C5&WCZR/_?[4>O;"EG7'&#*W7!!) 5)9EVP2Y?BGLX]_T(L-
MWC\_^XLX*R,*<V;ZJM8#%$7#)X<@QT^_E/.3-85_M_T1^,B\0>:X/S&F ^CP
M[*&$P<V9)3W[R\)S':B^^U\#> B4<50F78Z_7E7TEW*7-36[OWTTA[W^Q/H)
M]7__-)C^\]EQFR.EB\7BQO6^E1U9Z_XYCGJ]S\#J&M9'=#,T/Y_:P!IA&7"2
MSG 9]W/L_4858538KB>  GZ,C.FG2?^DT]4U%A1B=9S0)S1K5D..7=]NV_7:
ML 8Z6,>3O@6!JRU[8H8=4DC2#J1IJ/9O*(/:B&)7Y0RZMO&./CGFOM@V]W
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M::LC0&.DJM2*L$+)A31:U"D3JB<:E>G9[&="YPL)#@4CXSFQ@N42\T=S]GN
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M/!AU?E3ZUOYXJ -FC=81D=B5"W(D;T?'=[%1=;!/$$=;,B=$I6>XW_68UCW
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MD?H@&,&19NL<$>WRS1A BIJGK7^Y[JZX(%&"XSBEH(D(M$1@8RKX#FAO5$Y
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M3U (.;<,;OO=K\^V>J#L[L1WYT?S'/PB58L*=+':@;)LY]SS=F@?_]7!^W\
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M>+-9THTT6X"QAAI:X(Y+?M\Q4HL_@5C&Q]""HUC<=U8V3;9,"]Z$=3G/'7"
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MI0$GRF3^#'TY$^U*(T1$6B_H85B8,SG*!>&^A"E]#NQ^2.@UBXBMO5_>Y@6
M1G:9D1IG7][^0N)GX..<E,ESUJS3NF=\UC\:]!P]UR4]XM/@57% YT@1VWV/
M80[Y,BM!-C:%T"?CZ=6?&?([DC+8Y3 9*\SE=@V"*MWX(-L9TJZZ"K>#=M&8
M-Z$H'"F5%IRP#F!SY,'4MK2[D,*G68'6FY@4ZTSZ8I!OF%(/[W7,YK>)X$JW
M%K\"K+:HV7@4(TEA!G"@>!,X,1/RR]M<WH04H*#AVQ5Y(:EB]=5K %![D&(
M9[4UT9 W@1G<C=ZZ^,IYVJ@=T(&CXPCM5=B$+ 7=^HB]B>) 8]V7%1N!?M6J
MC1 #,A.7G;F4#'=/?^E>KP4X41-PM1B3"G9%&+V)^N!)VF_%87^&#_42K5,.
MES#Z$^K!$_6@%8D',X"H#G*G)"YA]">L8VY*+KQD.O]QYE[7<G')FP#HJ'&2
MK5VF9@ 5H1S^GHPL)/<?AMDS*2^SIN?*#TB07GAI<D=,L-X4[(J:SH&(O&+0
M0WF:G2>3ZD1#7 E (%PZTE$L?WRID&SWD8+=U$B]O@<1-DK"N#0K0'GCN^^:
ME*?7=^0.M) JB6E:.@K7D'CCB;? BR\[>8L$^>Q77[ V?B35\-<L?RQ)\4(G
MBL8ROB,PJ4=@6S2>Z^5 BYD!HWKFS,GW0+>H7H'VRZE#=?AW,F"(40#Q%HSY
M/+[,H@*: XNV^;^#+F?T?= YJE-C\UVPA7KDAQ+N=UML.FZRODZ2<*V\>7!?
MCT9A\7;S]-<:M)A4DR-7Y!<RWW/6HGY_OW^$X!##R5RT?WJ >E]Q8W3RIYI6
MVO)F<^@V>Q& ?=\I;MIWC24->;/U;)OPFNKAT(WO'#?1C)Q@@18L^HL0MKFV
M4\0<>A#;(B**RZH2C3<;71<)0@ZQ@TR4ZM=G;066-[M'-[SYXEQR1:#*T^1!
MAAXW^4 .?;Z>?"CT%YK \R;(:Q/Y0 Y1PW4M\BE$YTVPUN;2@1RB>FNMD2H'
MZ$T %T:6B$-49ZCU82M!Z4^,%T;6%T<;V4WSK('2GS PKJM?L>L4UFEV[1YD
M)C7:=JKA^).DARNK[IDXKU:#$3NGJ)H" ^I6@/F3><<5>;[L/]VQJ,SY8>0#
M$N3\6#F^:XXIOY"GO"#?\SAY2J+)NR.R+"!&C3!TN.GL=$;0,FL=8-I(LF-"
MWN )5N".W G:8)@<I7A'H$Z%TD:J'9_3E[$>ZL;;X\YPT8.D2-BS0>KL9+9B
MN+P)M)2JGD^;'): +@07CDVZ?#%17/&F-%",7#6;24K&YG94#[=\)'#6+ATX
M@C/]S;T7OAX8-HL$>Q@2BC;,WNZY4+;SA7#0_,&^D8]*T,&O:\KDS*0IS\)R
MF)*RG!Y@Q*)NKJS(WJSJH79VB>(X/5T?D3<A35UB6$X1,JEI$Z*0VV+4"6;D
MD95;2DPG'F0P$U$EYU4(QYL8H:Y781@@[)QB:GU+_40\/-Y$!MDAR#MSV193
M*CL9(2:(ZT99"!@U=<TN5&W6$]3S:>-%3AN3A5@@/3.0O36O:_HUA1LA?7O4
M7=_<6T%A(4A'3]4SZ_(B+ZC%J:GTU6J-X*B7$SJI7XC'0GB-@ CNL*-QZ_>3
M<==TB17G[5)DEX@L"TTS!?10KQ28$6H3LX78&U/2IY/MK",*!%6-4VL?8,KH
MHV9QL=0!6B.W$9O3=O"OR'A'J,;@]VD6R#I,KY*G]C. 9OM,%[A!E):G 5/@
M-@)W=)?B<4+OT$ GS"*2IMH6T'I%)OW)]EI#$D0V(G/:3LYK+CFKBW.KKS1Z
MV2+#RQ%\&S$_[=?LU=[JI%^8?89I!C=<P?KZW0J_P_@AT<YY9G+"DI)D91*)
MTIJT:*7!M47G&BWA.8P<,K41[.RY5)WUY'0[W$86T2IBC# .;@=QG#3R=,C;
M(>IW^6B49^R;9R!+%:;L2+B\(S11"MM_7-1571"Z5:5SW)7D=+9CBT'OR(HW
M*<_H>OWU-6KXG1]?#D9YG?%R7VC5HUWD\!!E]VE%L3P35Q>RA>-=6QU0=*[;
MH;6@Y^AR#_?DUQ697;!O]^GQ0U+1O+&7,,N_)#'LEA4GQ]SRH @WFU.M(^/N
M#'+/421(O3E-7I.1INI:?$[F(?]*,U>IGU8P; E&DJ--JO8AM(0?34)U('IS
M+HU*M2_'V9O@W,,3;GJ3\>9I0,V+9[:\J"9I7GE0DQL##'62%B/U)M7%@G1E
MDT8IG/_R '\JPXAU1^5U7,.60 _HD[28'SZAK2!ZDP,#E6IO)ND-<.[AZT;W
M]6.9Q$E8O-V'=,W1BL,4U0&,;@[K,2=K!5IO4F0L2'<=CN"/"WU0:5VI*P<]
M5S=&]0,XY4P(Z--$YD\.C T0Z<NDZY!1Y=4HA*L*EUF4C\C<R3UY8%,QW4IJ
M@>6/F&W1T82KQ.M/7@R!J,I1*JT'O1<[)Z.2 B/F%F'YDQ;#&7>^3*ZN2+2;
M%</GZ_F](\3'CUR9LVK$-DZ]?;H+WCMR%*E@Z=X^4SJ?+0D@?W)C6&/)EYG3
M/EW*.1/![;,PMR@=.VME82'P\ X_&QA\:@0(_,E[<95GSQ4I1N?D42<'.Z\X
MX'<3)8VY8(F!VLAYX88[Y13(KP!=$CO#C%C;>NPL E&DQ-A.?GQ9H^P1I5J;
M^MO_B.F1FZA&+^QX/EH!E=OXO.DG1R&I-IXWI:H6V!L") )BMC"I \#Q93*T
MR)!R-L3+[F I6W(/,U6RH]E0@59 I2]I'SHEX^U]<I2GWD(:Y5Z[[+L,DH S
M!/^&$\Y\F3I=D*><0VU$_7-EF%[Q$$R.>A4!^?L)##:!+&#+6:*)J03"L:1;
M%3H=5BYY$_V:,K,(3L"-LWP05KG!GNPV0Y)JVCO "":I'TORSYKZLE]H7)K:
ML2BHP6X&]1%S[#D,[Y+!%5")X1-9EU0=#B2JT^!#3\FG4+XV92N@!*1AY+ET
M0!KV;.J6/>4L:NPJ*:=X2Q)]?,Y?]F*2- S"'U:)@Y^"*_(<ILT-"\%DR2G%
MQ#]X/Y<59! %S!B[1HR945P66BW2"(QUG4"FP75=<^46*-K8<;$A16//3)TU
MKIQ\;"2:_!J6%2FRR?B\2D9)16)Y0GU)E49RE"1YPF[+L:%U$ ATCA ;<9%D
M,#DF- %#616UQNTU08WF0CWB$R^.S&857 &5"'$5+#K\B13TDLX]H$VB)'N^
M>>( **DM4O+_27T_U>)G&BUBAP*H*.9W#"=Z$/0FA$B/[>U-V&NS=]U*M=8?
M(KAK)BXF93S>4KD&#^IKQ4Y&/;\G\*$+*+21L&;IHJ?D7&&U')/M'46>R$$*
M"+"1$G/QFW)W]'K)1CZL$U*YRA3J70$@4+"-Y)(6%(R]NMC3M')9L)*T,<]*
M^ 9,DHMRR/> LCJ-['BIRB3]EG>>HH-$H'V$F TV>3:9V\_K J2^)462Q\T\
MVOP.LVBS[!%YA*))0XTF4-)>.\A8UE$'@MZ \A*L!, U^<G^J74OF#70>,-1
M[EA@L;^.7< Z@D-HL7^R_*$@./M-1K2H3H/OW8UL)5P!G1AI3_C]D&7_[3"&
ME^LWN%$2ZFY^" N@"RC'R(\BFWK8/]XP,:7/?K9O+.A]0O'18TWF$B4(,M1A
M1,=04;^$(!F]20A[C.:&_()1^N5M7N8V?&/>JI]A$:\@*R^S!KQAUFX<08+>
M,4I.?M>+SX85*.C'"*%!W "UZ7,F]R2"T5DEI#P+Z8,%7]ZF.9^G*=--HYCU
M6VZ.]M[;$FA+*8(.A!"F=%OD$2%Q>0'J6WF-3M8[9-4:E"A>:8?4:R$6\&K#
M53?]F&Z.>U'YQG'N*,\03FY[)50!+3;\>6Y?T3ITE%81ZQ$";<P"QA!\@(.4
M-4YBOJ$!&."/,@M/KX'&W_7>C#-#[ +6,7Q]T!UA7_.-9& #IH,L'L0C8*2L
M"A#\A:A9UVN@0?Y>)N.6V 6L(_CZ*&Q0WQ!$/B<O),W'+!>0DFQIO0;G>_/G
MZD$64#OU^VWHB:7UW:&-9Y8LY[NXDKRV)"X,^U$4C]I$#M$+/?R"(*P;US?W
M\1V5TD2NK76)+3Z9L_T958X1XUJD),GIY /QYEVCSBDY3M!S=,LU+?6GK"'Q
MYL4B"[Q@!\@X($@9*8.P3:,>78U+KDOE #EB1A3SV8PCO#>/_K3WP\]19?%M
M&F8TM[OZJJ2#ST'7QLZ_S6'8]K&'"K\W#Q&]DQ[ER_R/WK54JP;"AG\JI&+1
M6"P&FD/,$6.^9JS+[LT31-I#<ZTO8:?U7E>J7/F+@GOS;E ']?LRI[7G09F7
M&R$HQ<$K,<>(:0G,YRHE%.]?].GZB,@Q]@N(2@J,F%N$]>X?[SE&SX+@FD3E
MI(G@H=$[;%*_8&G4#JP@*$'<!L.MR]'<$DI_WOJ1GCDI"=:H#8!1(M8ZTZJ-
MS9\7?OB[3./].<!"O?]L>+HDP>#1LSZC<9J_$3*YB\47^CK/7DA)PV3IIK]\
MR*LP7?SWL[RLKO/J[Z2Z(U'^G"7_DL;5._LF*-=1AE 7'<2Q&OQY@\@9T":&
M^R(O)C_1<CV,CL<5!&A N:OK66^4Z$;Q+I/[D)%O-#2Q68G?49Q(']K%2,+4
M-E2$R>MF93>-%IFJ3A%AL"RW5S$C95$M, 9_6V4+?J(![G$=53?3*]@"MY.H
M*"#O[??]<S?-"%EB3XG"562("17SG#I$G)U#6KZ!@^534BI9R(D$B:O0$!1B
ML!U&#ACR,#;DFU9FK852#124JQ=Z@X"_%/$0^!,?8C4,D<WJ_IW#\A<;?3C>
MQ%YTC7MC@!SM="R$)$[US>=)@L>;R 4[!&&O/\Z84JU""#NA0?R/NJQ8_ QL
M?*_)ST$4T5N*-'U"D6?PQTB::K!5.U0=)Z?;8I5W@^A-8 6-@+IY&L2-+$K#
M@U>\ 85]&-R.!SZG4I3^Q&#8X\Z7N75#)"K/AA&"-.9(8?K)8NJ>_'4<PT0$
MY0_W3Y7L:M5O\*-L%K3&EF"*-8+F3^S&'7DA64UH%H:S/*N*,*I^)-7P#+IX
M/B+%91:E=4SS2Y8E@?_BA_!5>B9LW!K5R>D^RI7=UC[*+C 5D1X<?_P>E>$Q
M+,F?_A]02P,$%     @ 48@)39)X.>C/,P  [^8" !4   !T<&EV+3(P,3@P
M-C,P7VQA8BYX;6S=?7MOY#B2Y]]WP'T'7N\!TPW8]5S,;#=F9I%E9]7DC<OI
ML5W3-V@L&G**:6L[+65+2E=Y%OO=CP^]^59*#%8#BYWJ-(.*('\1#)+!B#_^
M^Y?''7K">9%DZ9^^>?WBU3<(IYLL3M+[/WUS*+>G__;-O__Y?_W//_[OT],/
M.,5Y5.(8W3VC\ZB,;O-H\TM14Z.W+UXA\C^OOC]='.X/17GZYM7K?T,_O7[]
MPZL__/#V#_^!_FOQ\;_1\N86G:+/GS^_B$D7)>OBQ29[/#VEG]DEZ2]W48$1
M82LM_O3-0UGN?WCYDC;_<I?O7F3Y_<LWKUZ]?5DW_(:W_.%+D?1:?WY;MWW]
M\O]]O+C9/.#'Z#1)BS)*-RT5[49&]_K[[[]_R?Y*FA;)#P6CO\@V4<D&RL@7
M4K:@_W5:-SNE/YV^?G/Z]O6++T7\#1V#/-OA:[Q%[/,_E,][_*=OBN1QOZ-L
ML]\><KR5\[#+\Y>4_F6*[^E4T?Z_I_V__CWM_U^JGR^B.[S[!M&6GZY72G&^
M[_55$;WTQ.,5SI,L7J;CF!U2^^7ZIHSR\@B^N_2^.+_-RF@WBN<NI2]N+_&X
M\6WIO(TK,8]XW+AV**?DMA0Y=1[,WBCNZ+\OR/=[G.$O)4YC'->\44J-Y60=
M,XO+NLPVO<YVU/1F>5_.<I\\L57FU>_?OF*2T%]^/L\VAT><EHN4&( R*9]7
MZ3;+'YGI7MP5=,TIZXX8ZZS[GQUH6ZE[3.:XR [Y!CM)S,>QSTUTY\(-6<L(
M)5VP<7KZZ>:;/]=DB- A3H@ZE.BGFO8__LB_WXBSR/O#'N6;FC?R3X,\58N7
MFXPLL?ORM"?:-L\>G<>Y8B5S'I())RBN/LB^$,1$V:@&E:D@0C&!"KQY<9\]
MO8QQ\I*J"_T'TYO35Z\KS^-?R$^-%!T6;J.[UKITE$7?W(-^&/A5CG1O>%EK
M$"6P&>X:]S9C;8N)&A+;J+AC3!^*T_LHVG-<X%U9U+\, 5+]_#/Q34I,63G;
M146QWMZ4V>:7Q9>DD*#$@L8#5&PX'^*%-4'9%K%&1!%),P$H1W-<=E9X?VS[
MP+<U6FJ06T/%']*[')QGCU$BF/^.H++&'K$MY=6$#MX0"-93<NP3T6I4#*&L
MAH3/%9SXY7A%5$IFG\TD<"MYEV^[U9Q2($82TI(NC+]A61<&?W:PW))^#>#@
M33R#H>)+.?GT[] 3W1T[V<1V!VZVB5R0+\7T:^]WT;UB)@=M/$WED+/A7#9_
M1[0!U&1*QZ\[F]+!FUTOFS/,<^(2&11TT-:SI@XY5:HL;TBVNC&]00#77ND(
MR]18.KRS ^!]4FRBW3]PE+\GOY@6<*&U9Q"(W"IAP)LBVA:QQM! 4(RT# J*
M8?8$!@Y$>SCTVH, HL^Q"1*5@0@(%)(15\-",MRS 8.?%U[C^X2>$:;E9?2H
M6B7D33W!0<'G$ G5\6?;#M&&4!C0#6YW^G4C._/,GQ'4Y=%NE<;XRU_QLW;J
MA;9>YU[D5#'Y54/$6B+2%';Z%2,LSK]B>&<#P-DASWM+D=Y)5#?W! ,-O\*)
M#V_:<Q&@W473<'<!81KKF8W"^V2'\S/RO?LLUYN$04NO!F'(I<(<L&:H;@=K
M"Z0#*UH"Z:C.-N>W>40CM6Z>'^\R8<0K]@=M/,WSD+/A#%=_1[P!U-1*QZ\[
MJ=+!FWM=SQX?LY2=&M\\1&1BUH>2AJU11O2+O);0[XJOET&U_#,J?M9_@C@A
MZE ">P,6\R)Q#2PF!>#R=KU]GZ11NDG(GB4K$D-HC!LYQ)6N7IXAWAHR>K74
M$**:$CA 9LQD*:]1+68* 'ZJL!)50PA(J4))6O HXD>.9M$M+& TGR!8ED:X
MZ*?=(SYQGN!B<46ZQ,2-CYG9_H@?[W"N ZN.RB=RM=P+\&"MT0(U[>M+=DX"
M!>MYA?"*>3.:! 4P0\FW-KP;I0T**N_:H.)> :1W06K#;$+XUP8MFN3:H(42
M@.]RH0FHT36&\&$N-$$T'?_@0ATYX]F9.9YA$*]&P(32LQ$ X0_!BZ+ 96&Q
MS1LV](A<@4<A8H0UT.S0_ #6S.?-S?+V!A*<\ND> E,^U[Y!69V:6V-3:.\=
MHB+'<J2>H/I&(PS(FOFN^8U8^Q_@(:P AQS)"F1XC!J/B@<-?OF??4:&<WZ$
M628_ P5^>V1H+SRG'<,6BDITA^^3-*57%MD6\6YGXK9]M#R65YS&:BZ]QLIW
M=$&(CN\H@C_M)'N)?93$RR][G!:X,A8:=56T]ZB_*HZ'DU^U0U7#9MV!47)7
MKC%O6*"(8#?&>WI4#1( 9@64(9:U* 'RI6Q]*#C?R>PS38_=3JJ"T4RR? =H
MTW.3@O&2K+PC*&@:,0D 1B4*(<&G1%TH:-/#S#^^+I+H+MDE)3T]3_E!X4.V
MB\E2M?SUD)3/%CM+^RX\8M1!KB%@.J1L5>4$X-O08R1:+=ZM+E:WJ^4-6ER>
MHYO;]=E?_[*^.%]>W_P.+?_V:77[#TC5< 7A4'E<$0BB7O9'-3HB&!4R'WYT
M&H=S<N,D0<WTKB4"/<,Q0T>C!N"G.8O-)CND97$5/=.0!**6Y)?\@&.129US
MX]*+3P_(23K!3:JH447.5IFJ R13)*!SSVF$W'>$C"HA.SH&ZI*Y@U3PV]P1
MZD\)SW&>/$5E\H2=M$Y/YE'-#/P+;^*:YHT6/<^G0T\XO\O,6N0HPX]1SMYP
MU1H"$KWO@I^A0MB QY\&7&8EKG73#'QI:X]XEW,[A AK5:\=X/BVX_F*8"LI
MBBQ_1FD&\R#) A)#+&OP +F%<-HZ &\9++<*,&=&5NSV3RT#\5SL[7$(5KC#
M@QUVH4"K1RLX2)7H# ^5%G $"#'('A^3DD:3T7.BLRPMD_0>IQL]+K54/@,2
MM-P+QQEM:[;UZK4'"F!P$V#]\>/J]N/R\I8?6IZM+V]7EQ^6EV>K)6A\F 6*
MA#M[,X3".?(_XJ@_J"-^ZZ-]<+MNR[Y@[)D018?T=PA+10KI-'_L*3Y$Z/J(
MZ[! +L"<+HAN>A"J+KP699DG=X>2G=Z5&=EQSGVH;[GE/$(TKAV@Y_KNUULA
M76@Y+1? "X25376 /LPZX; RV*P$1S/M$!IJQ?J[:$=+"YV@Q2,]28<+#IV"
M6UA#8F] 0 )(.X_1_A[M#KIW[-+6?H-')=Q*@C"[SP5/$&MX@E9%<<#3ASE;
M+H_'\ X<.:I"B"1N5 4/OZ<)5882$YS%II[/#09\R@X+V@0R0:#8GNN"<_U_
M7KUX]>HUVD<Y>N("_.OK%W] C\EN1U.3%#PK3G0H'[(\^2>.3]#KMR]^W_R=
M[J1>O^K\4!$D;!38G[,V PV*6';]_WM(,7K[Z@2QDGVTS3G>L'>VZ.UK]NL?
M3A#I98\W]$9L![HO4^%5=E@A ZO'X)$X9@E7HMU5E,2K]"S:)\2_T06*J"A\
M!H4HN19B(YJ6B#9%28JJQD"1'F,XIX'[IX3SC9QSKW$<>KP(,1MZL/C#^34N
MHR3%\3+*Z0NI8K'9'!X/.UK#[AQODTVB.V>P(?:(?BM9AG"JB5!-A;[MT*&*
M\#L8K1@E49?]F+>"U Q[A V5Q!Y>4'L(GA:.>RG66XD^$=B.8L"[T3FO<OK-
MY)+9ODP;(P#SSBHO*IS=A0P[^DV&##BPR->GM[2F!-8!?8)+E2)HDEO":8.M
M*%PE,MC\G([(LE$.T R=G5W+592O<Y8X)F8;F"N<,P;M-NAJ:I@]NT8:_3:>
M$*(L1YR4;^IIF0BN0@%LZ]T%XXI3;<R;C7X@>VH3ZC3;;!/D0+2(Z_2B.2^Q
MTQZ1"D9K)-SKM:5:6%H*N!@99Q%Z>A$I)0!2#!60- JA0A&@(ACW&4H*2 50
M.N@R\,]VY#L.^2;>>ZB'WV 8$&-$.]36PC%MOAT9).;U;K@<^'/N)]P](P<Y
M>DH0R);")>&_"YR@MMLC]A.V'8!MOAV<;V$/[G=C,6([/DHXKDE!["K<X*??
MFH>SMY =&5AM+TR$P"=86@]==8 %O<\X0A#%;N-EC(OD/J5 "T=W;/<>=A#S
MIRNK=),]XB;YL478L9+"HW:HN1ZBB;=$G<S4052.,0S[$#6&,??IPQ?L94F5
M2,\F5[6:Q*OOKN1;]'>+ZB53W1@\O8P#]^L]SB/ZZ*=)V @:@V["B^B=Z\'B
M,V2BP$38!\+,.7["NVQ/-:_B2QLMH:7S&BBAET",D>#MJ_"RAJ+6 ZC@B".D
MB%L*V. ("RR)<1$60/*G#Q]P2BS+CN:=B1^3E%53IJ&&9HTP4GK4";,40SQ5
M%#QU4H\&5B^.DR3JT4#JAB6NAMIA"2I_^M$LO/72I=$(25N/.B#C5.U&U(U@
MWB39\,J?)&6"XP.):B4:ACA60@$ N7R7<9$55MCMMH9 ;X];-7ZK#>"WM.$,
M\9U.(-:R3']&%$DUE+,T# B+L%""6,2$SPQ<:=;GHU(IBSVJ!:W7[%QF2<1<
M72U-@_F*[#OP#>P8B=;E \Y14HE2&?7O0'>SUA 3\WM9X@LB9>.'*$FIRJ[3
M]K=+;)>W44D+DKQ1+8DZ@^,)HE35^H"R%'7_1(CATSG:2W7V0/X+TU<^VRBI
MKI?HZ['/@UR/P-F;K*&G3OEHP)W'50>75F[3H)W/U63 H;!RX++O) 65E,"&
M^QWY$]"Z!L7=GA"1.6%>XH=#$M-4 2'R:9O;<R1_7A=_F:8+"[U,S3T>TA&S
M6-!/8V(9EU^HNW%(B@=Z<+C>GN,[W:)N0>OSH,Y"$N& J[^0]ZGH.DCIH" ^
M1B#Z,\)],>Y)/]/)\#V7(<7W]#H=4@:O9XZV:B*<.MKJB#^5KY]-UN$V[Z(B
MV= [@V1W*+71+D9*C^INEF*(J^8A;Q,0=H(8%;^^XG10RNXN3KW"T9J0/.3%
MASA63HZ[,$;&?2J[I8(,5=U2._PI^H\XN7\@7UX0#$;W^/) LW^LMXRY3@RK
MO?Z/[="C61@MLU#MH.H(53TAWA5U"L2'G@$9DND'(*H&(&T&8%,%> <5VGT<
MVH?*?!S4?0:=/.'T8!56)3;U&EHB\"G&8? F :3Q=. 6]'A9-?MB9(A\ZKWC
M]#T1@>:8IDS\F)0/9X>B)'O?G&R!=P>J4+38)/F_^#;Z8H:R6V_^T>XHK0)B
M_(JO[@=])AVANJ<3U/2%ZLX0Z0U8<8X4_ ,[>^87.0&HUQC0*C1P#&+]+R86
MBPC(XJ$QP] KA3+*)%<P"+%,F):'HQ%7Y&4';>2_AD@C/_U\E6?Q85.N\QN<
M/R4;O/B2R!"G;NH!>1H^)?6C:#/F^U<MB0=#VH(\%S -<#WUIM'U @&63)]_
MNSC/'J,DU>- UMXO&*0<6R&"MX;&A'K$)<!0#[?'^PGJ"GQD>4MU-Q'=5C[O
M''K<R=V8G_C?01\/2491.*@6A]!GZO[JG1+988\K;&%%[S7!OYU$8L[_^MD9
M/6B2%0 (XSF:TXR)2=\=I@L A9R1L^QQGZ6L,)+<0[&D@T"=0@+A2H1#JFVG
M\%S\7!O,Q3V(7N@PI-0''8 \7A#VN5!Z9H;V/B\#%1R;$*-TRSS=DTW-MM=;
M,AU*A+LQ'41 $@H9?4I)6YC404K_LILO2.EF^D'R9.P")0/2^\9**(#7'3"B
MV$ '7X- "9=!)8+3MA(!,-:/% 2MS(+XU (K9%G6*8#2CF%&>*-:J @ JQ(H
M\2-6(H#%OS7CDGH)02!>CQ93M0%WC)?[Y(DA]]7OW[YBN*6__+S\@O--4N#U
M]D?^VJ+@A=LDL#6T]X!:$\>"RUHU1>LMJAO/54:/%K-($T-@NZL W$WY7+..
M*\H8;;,<;:+B ;+.GA5^:B#[ T^<$86O'QE,":+V15*!(M;Z17?8/1X1V27<
M!<NR:TA/.W,R79?ZFWI&FUJ6\R1NM"^\>0R;7L^=+/+ZPB;S90:5?_S\D).5
M](I- LO\R/ZVWK,7[+72:_7+O2_?Q7T=)94O/[P3Q'M!O)NF"")O4O6%FLY
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M#K0*#"V"8'4T.+9'GP>%HZ46MA:=1!%U7S1O%-]<G2#6'[L&JGHD2S8KIQ&
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MUA;1QF15)LU!T6L:>Z'PCF'@85%SGCU&B;"Y-XA;$P$CI^'=%CN<(#CT].?
M!C_]"8!#$'^OER<;_!'3>T(''(FD@&B2R&'$5'43@!@9^HD3!H4MU>R8$*::
M&CB<+;_@?),4(Z$FI09$FUP:"\#5A %C3C-3)MAII@D2>7N\H0GW</XX G@B
M,2CN)+)8P8[3(4H8*.I4LV0&G6J*X##'%.#OV8[L-<C^Y-D9=@IZ0.2I)+(
M'S=U+6V0^-/.F F"VNF"0^%U4OSR/L>X+AAZ'97N2Z^N$T \:F6S "6E1[2#
MMAPN[2)(;)KGT010\R3"K\_GR5,2XS0>A5)=)P&LUU+97-;MNH-P06J>1MN%
M7#V'7_V5Q(7% ^OY/_WU7TU<:)YX3WC0?J%^$OY5WU' #]]OX+)"T&5/%Q:"
M(GM\6%/%>1%.K^D;@^YK@J$UUU@XMVY\/JMQDT]X8U*'P5$%X1WTW]$(*SSH
M6Y,1DRD\-1DQDV' E9X6C(0H)PT$EI4<SE"D=*&BKSLW+HCK3HS'C$[-6;L&
M3]U&/G,S=7E3)/JD?X7Q;O3<\8!O&7=>DS\)LRMD>!*F=NK4L\K=L)D$--6L
M<J>K3#&KV-?."T</ L#FDI5OP[V"9WSNV$GFP&,=:YPG3Q&->VYSS6_;'R]Q
M:5/3W:$3G]6I7603TR#4[4Y0-]"7/@X-(U#7?>J$<LO.\P9PHE6T#!7OHAU]
M=W_S@&GII W3SG?/;8.S+&7LTHB5=\]_P?$]<;/.<9'<IWQ7:AMB.\-'(4ZQ
MYA@[]0%,@3J?HX_"V0<1^R*J/WF"[IX[[5#]V2I@*H@(V]_*L(&<6LVFK\KS
MJMF4%6(97J7$XC+?H_@0)2G-)M7P>8UWC,GB(=D;@F_'=@BR/#O*/%2EJB7J
M-E6$[?HQ)!"2P7@>8]"J]D+&0-6?CDH8,<8R:V@\:IJ.<SO(*>*8_:C3;.S[
MU!DC>H9J880.@"]>\60,=U 10/C 0YXU%X@U>&#.=8[A/(0("SU*E-Z;%"(
MV'[WW+*4X)P(__#,JJ49/"W;#B"P;Y))]Z*Y(0!UI;R( J(E5GA3:HT5V "T
MJ!N#(7)H])<<^X'0*4L)=<M,"T=0O\JK2" ZYH)&I:JY0!% XUBP0L%T_[6]
M8R:C@M F*?<Z6\X)3JI"IJ]#\=6LY/C;(:/!L>R2F%5CC3;L,.\QRG^AV4.^
MK83Z+@CE40-+J2IJ5,$JQIM1BO$F$,5X,T(QW@2H&&HY;I+[--DFFR@M458^
MT,S.=P7.GUC]@X3U4"O'F^"4XXV[<KP)23G>CE*.MX$HQ]L1RO$V0.50RR$J
MQR%5JL?;X-3CK;MZO(52C\Y%4L/7A<4;" ,=R*6*7 )UF$/1C7,(X"V!#TE@
M+DTTV%+?C6B %4RT4/U>X'E\K%"GBW BA;IRJ6'7)/Y[[D<,?<AI+OGFC]#:
MY"QA%:F&=BH) @IZ$A#H&/(DP _ -3MOZDP[)>>4DD$X9W+^-8=''8) 0NML
MYD+IR&@FPF,YTUU4%.MMI;OKG#T^,(6_Z8A\EC'5\2XD]J:-:8[FVDQE.7]
M$D)0E'D6A.*?QBD QI"-.VPBA,:2SHW4X"D01])N6JR !>A*RH[7?TS*AT^=
MO2W?$EYC.C!D5>9Q$->]!Z?-@LWZ<KQ9FN![P#=04XR8[MRD^P+T,_D6ZGZL
M.E5!@\]UGUZS+YZTSN],-:7WQ('+XILRRLLQEUYSC&(5B#J3J,LT#EQ0Z/N^
MR6R)S;W@9(8D?/NKD.**P7*5;G+2'3['_']GL,>.W_\*[+/KB$YLKW7F^@1Q
M+E#-!OJV9D0X9SYZ?"WKD4$-\]D#^2]ZW(ZV=,"?V-:5^(F?0SH>\:K54UG&
M42H-O TR! 5J:* W/XIX.<V^!S#\;TX)P/=LND _(X" \6^,Y--20>N ,J1-
M@R'04+VYI0#7!7TLG@68CDAB,2A S9>H=WB;Y?AC%K.K=[I,Z=-:.';B*]&%
MJVS&RNN5#\F[0-T^Y@NJL"G6&8*@WM)FC$)L+Y$&'%RM4FM,-IM1-9M5E,P=
MG\W'3A_.%3]=K,AB2\S[D49$V0>H#5%+9JM9K(?0+8A7,6'MAP&K9O/A ZCC
MK<>(F1P8CXC-Y!RVX_) 66D<G.(L*AYVN"CJ A6QRF!8$/JR$C8R#$>:TZ#U
MMDV'5),UI4=B$&-PA#1=OWO;RH-5\GC3>FN4]53=+\2L]/NXR6FJ?V^$J0&J
M_BW=WG021;INLWNDT'OMOAS66]63;OY/R O#$4()AH"F]<'W24JK1J,[Z)O!
MB21:LL8J<<!/%"3Z8W6L(%&>Z5;V55$<K%?SNC'0"M[P:ERU$6\:PD)M8KJ'
M8#G;4.MQ'QNZ-7@&8(Q9=RW&NEEK$]9V)G^Y6???9SGU!2SU2R0#TC0)_V:=
M:XC0EJR9U)<)0?_L1<E<1('2216R=-HY*ZS&Z*G3G#0:.]XI5BBM=+6E^=!O
MJN66VY/!YKU7HU&EV)-T[4OYIQD'N2/=L0_KO)-(']4N3;7F(>&TJE_I$\24
MS#,P!DG!O8 )U:)GE4+3"2O+-:=N=&)UR"J3<]W(6F^_\E'0Y^'Q7VT)>>*&
MV<UAS4]CMA72FKR="3\ ;AI'C(F;@6Q T/HB2L,QH\=E3OP_YQ 9365 CMKD
MZF-G/$%UYS@3.ID.&0UIXSJ"V])ZV1B(>HUIZ CYO4X'?8AV%\EVO']IW3^X
M)74?D;&>IF!-FF^@SD<0_4J8[N;X(7(0O7?.C;Y-4O2,H[P 2>,QBRZY.:40
MBC2-9WJL0DFLJI5WFC?0VI'N9SMAVR>T^B-9& B"=COK,VP9(=@IFT0&FW,V
M1D8GI2$,XZ3-7IS,31RXTS85RO3G;;-";-R)F]/<=,[<FLG9U)3>]IO"+?JD
M)W$COP+N+XT=G9';3S'\Y>LZJIMJN(9"_X^^T"&%U<RC6&[;43BMFF9/.HUV
M&3>F8L0/^ ZUW94/EXQ9S*_K9X*QO\[C8S3 F>+\3_2/O)O@28X!CQPODP4.
MRI&<2;U<SP3!=&NJD\%)=,SB?%"B8Y"&N'O!1';K25HD&U5"F5&]@)I1G736
M;NK@%KGN9Z:$+C'>)FE"P?SAD,04([-)?)N5T<XD$*PA,\+3;*?\8'.\&7*9
ML7:NFB0,/2=/982@;ANF"6$)W$^SE-WQ,J'NU;L'9A$@/LMX&*]@VSARL Q3
M,()7X>: Z::F4_ZC[D1"]2)GL0#JV\0^/H!>[BQ_/23ELT6:WF%#CZ]R!!Z'
M,\ ;!))Z5SZBPY<;\N$\9DW/'A^S]*;,-K^<1?N$N(0W#Q&9C6M,,Q>QF(CW
MA_*08QJ 1@V0*I?N4;UY6\7'2BLH+^L(L9Y0U17B?:&Z,T1Z0[P[5/<'4^@]
M;-G]+6%'8;V_=L$#W6[1"G'2_2U3MTFYP^OMBBRE3TE\B$PU317M/2Y:*HZ%
MW3MM1S=[;4O0A&73\^US\=7B9+@&:T$"B&V:<K!;-?LV6Z8E\1:,*<N<>X+4
M!Z.40\3U*J*7&>+-@?.:>1<+5)OLD&G4,SM8>M1 \H'U=D%W;_<LZ:=I=9&W
M]ZE-"HX%*TW:42/=:8G(?A1=9NEIU/GMEORSH,4\R83 +C_^!?.J43JD"7JC
M@YD_[>@P4"S2F(QP9X"[XVLLP^C<DT>-<I=R",EN#Q98!%VV0I'6I^Z-Q/%0
M*T>"V)^^WASNBB1.HOSY)J+K+MOJ&58T#8U''=1Q+A05C?CV@V]D(9>LJ;GV
MJ1-&K S1;P2*1YRW#%Q&C^2?'>4S;I5LB'TBWT86 YA %Y09!?"J#]:8$A3#
M&E#^-&25;K)'?%-&)5N<+C*>]-&P%FBI/.J$GGLQIH*V1DUS5+</P,I:S,,0
M3A:3 (XCHY$UT,%C26F9-&@*P$I9S8<EHJ!LTT66WI.5Y?$<WY5THVLP2O+F
M'A&DX'<('-KLE+9#M.$)8N<4\!9(-]I#H.B&&@X?1F.C(@#$B-*\R%$2@&71
MC[H)*9,5M)"&Z-3Q,@I+84L(&F@XD,$AF6P3+01G3-RFQAPB)IN7N4"C-!_V
MI$$ Q[UD3A<Z@!;&=8KLX3.=U7&-L;C0E)(^NL=@0ZDN=,6G1T>77*AK4\][
M@O&5#$*XP56"%AP78#6/"LP39.45!1Y/5BG//%'A^8'6M>25+#GSE_@S^Y/V
M.L&R Y\GK+8R"8>4; *KK*.<M"HJ>U)-YPDB]+Q% 7IXZ31MP@&FTYQY!"-C
M@#/&(N4)7^PW'?[4-#XAI^%<0!DW#+SQ2?5"F;3G$ -%E6G\!2"9!A_<D+%W
M>4?8L2$]O!D3)'*Q8E7I[:"-F'S*+&V8?+X\F[!W48%CXA3L<5KPL_Q.(,&[
MY[;-5?3,@GT^1WF\WK-0@GJK4ZQ2+I'C TTH1GP;6Y]C++7@IW>T=]1E ?4B
M9>Z>4;=AQ0=BC)R@BI5VRU[0<NVUGCH^(?6^2'A'N'3E\0YOX#);=>:V&UJ$
M/BD37)Q%-!_%N^>Z3DS]Q%%C&([N&;I(E],H.)R=M3GNVIX1[YKJ<MUYFXLG
MN#)2[OBPJC+E#@Z/$:L[UCF.Y09A^87^4[=.VG;@,S[55B8A4+,F1,H5JB(&
M#<YTFC(A)M-IOCPZ?GA'^KS_@%.R?.P6:;R('Y,TH8]^R^0)FX%HVX%/1\M6
M)L%!XH0GJ")E4<-]XA"0Z#9G@@OB-&'@.^'N7OU]EM_@_(EX-J./]B0=P>^-
MU3*..>JK_DK+1]0]!;A=-LRKT]F?<E+]AK3C7P_$6U\^T2A[<[R0DL)S.+N<
M:P%X34O$FNK"AHYFVY >UYW[9524.$^;2XZ+Y#&A_@9DE7A+Y,C"VS6P 46\
M.:9=30.+>G4 N!SW 01"&<?? CGC0BN+&CP%WKRXSYY>QCCAN"'_&,*%_/3S
M!;Z/=OP!K<(H2EMY@(2<.R$8CK9HGCV#13=IAK*>:\TXSC:[AJ?_8A-/\VIX
MU1[ *W;5Z'5G<^R[<T4$4;425@MAM0XJG\6:27S% .GY_AK6>]OA[\6F^!I[
MJ^"347,@:PT3,_(^2:-TDT2[54HVNP>++ I*"H_.BIKKX8 W+5';-(# ?L.P
M#[T4PYA[3+E!7\=M<4Z?4/-])=EUKK<2_@KJ2A7R/YDSXDSZ&9\)/J8='QLT
MA_%*?PY@"(DU9D"%/]6I[E>,V38&[3R"=\BAD"JWNF8+X8! .II#P$B'\@@_
ML9=#0O.<16SGRR.4<*C-  +\*D4UH#UW;];1M/+Q7$>5MIDHYWNW7_UC&%E+
M"-@I%Z\^\*#?M*@'5@F^&4;5&7Y6HSM5O8$L+0Z[DBRRW<[U^V(]C;_',5K.
MQ9C_NGD_Z@M\9VPS X-G&YZ&W_)AQA33 +,Q9O%E%C=6@W8^0TL&' H6@?X]
ME)?LTN$4XD%D8_DUQ/NVC*?Q%9D$FDK&?.\SR^>^BMA=[7@IR@1P.(>PUYT3
M)]/%QII!XD^SZN\;;&F_F4<D#_@;(I#^&=&_!V!(94,Y!(UL'/U/MM$  IHN
MH]'I3'D %L?.5D!KN5T0G3G?K&,_P051JCU<AUA*V-W'45,Z+K@2+/$J?=5-
MAN6!,':.G_ NV],UM.+*"%8K:H\0M9-&S&;/J1@@.W0U&H, H\-$#2'H,$L>
MBW@][G?9,\95@*;<U;O,TB=<T+=,U)\K6-70[M_/LJ*\S,I_X/(:;[+[-/DG
MCC5PG?&;/DN+S3ARPO:C^E8=-ZQ\CW&"FB_RS4IQTG^O03](VI3H&9>H_29H
MU;.Y(2@44)L;?[\!]>51W.^SO/J)MGL-H=,*1GX+BJX:8^_:?U(]56!/$SK,
M_":M@A;9WDR%%M8>3YCC_SP4)3O#(;Q<XL^+S28[I/3\^RK/4O+/C?:J>60_
M/D^H'2443K!;>J8>--5%VP7J]Q' V<RH&14.P<=,I_>B2W'&GMX;MT?RYOY+
M+@WY518FJAH&<>RC&VM%U2'I0'NT:0U6655F:I(_[>.HQ*3]O[[ZWEQJR([>
MIPVSE$BP7:V=:@@1IT24]/35]T%LJIUF3+!5#M/%9;P@W?#_(O^@7M2?_S]0
M2P,$%     @ 48@)33W[9T\2*0  +:P" !4   !T<&EV+3(P,3@P-C,P7W!R
M92YX;6SM7?MOXSB2_OV ^Q]RO3^G.W;>@YU=N//H"RX=9SN9G5L<#H(BT;9N
M9,FC1SK9P_WO1U)^2#:?$N6B- TL=KK=),6OON*KJEC\\U_?YN'!*TK2((Y^
M_C#X>/3A $5>[ ?1].</>38YO/CPU[_\Z[_\^=\.#[^@""5NAOR#E_>#:S=S
MGQ/7^RU=U3XX_GAT@/]S='DXRJ=YFAT.CP87!_\U&/QT=/[3\?E_'_SOZ.O_
M'=P\/1\<'GS__OVCCYO(:!,?O7A^>$@^$P;1;R]NB@YPMZ+TYP^S+%O\].D3
M*?[VDH0?XV3Z:7AT=/QI5?!#4?*GMS2HE/Y^O"H[^/2?7^^?O!F:NX=!E&9N
MY&UJD698]0:7EY>?Z+_BHFGP4TKKW\>>FU%!2?MUP"U!_G:X*G9(?CH<# ^/
M!Q_?4O\#D4$2A^@;FAS0S_^4O2_0SQ_28+X(2;?I;[,$37[^D"V"5RKCH[/C
M(U+[3]>QE\]1E(TB_R;*@NS]+IK$R9SV^<,!:?>7;W>5SF?N(IC/\P@1"CZ1
M$I_$C7QJUL.K./)1E"(?_R&-P\ G^O39#0DI3S.$LE2YGRI-M=[;1S?!HIJA
M+/#<T&#7M]IM \<3'GV($)V.)^,%&=F8X(;BY[79:O_'DZ<L]GZ;Q:&/9Z*;
MWW.LLX9@L)MNFXTK-YW=AO%W@V24FFS8^P<WRQ-42V5851OVYK.;!AC>8X)2
M#%1OHF/6;=B?^P#KB(^U!,^>MT&$!W3@AH2=0*MKLF8:]O(IF$;!!$\M>);W
MO#C'TWPT?<1ZXP5(G4Y)*TWU#&7W<9H^HN1IAB?#T6*!&W9?0O0<7\7S>1S1
MGXN1J:Z!6HTV1/"KFR18-O>!^Q*$2R[=(/F[&^;H*W)3/!;HZ%3NO7J#3?6C
M_GS:PGQ)F\2#E<QN\P6>YO2&.:]ZPUY](53<X:WR'"EWI5*GS3%L=BR#C.EG
M\KO&VE*CZ3V-;TTDNLT:'^N:_>4WT.I:.O*+_[IAZ7QRC3(W4-^'-_C"'D<"
MF;;R8G\RGA2S1[FN)N86OKQ'63S&&=9]S%+X?AV$>1:\HB?DY0DF"J4M2D+I
MNWN:3[""+DTNXP6AAA2@''U%V2SVXS">OFN*HHU/ TEC/8Y':8H/TKC:J@G,
MU+*B/\K6;8VCT3?"9((7/'HBV)/HC/432,[$HN;G(3[.7<W<:(K2N^@>O:+P
M6 QC3])MV#OC:^JO*)C.\)E\A'OI3M%3/I^[R?MX\K?<)38VETPH]=<Q8]\S
MCGO]X><9(JN)&[T_T6GU,4^\&=Z4+PG6'74&OF0<JXD=B6:KK9RLC.'0:]G<
M><P$ -7F:*\7)1/2/>YDI?OH#6\=?.2O )#F&]G@J9\D]BH?"8EG(DYD0B*_
M.*+&1R\I<<EDJX9"]P6%M'E'N:XSN#@_/;U<RD:IIT0:*18']92DR/LXC5\_
M^2CX1'I/_D!A'!X-EGZ2/^&?UGTI=8&>/!A]%Q4ONGO!H'*45+ON)MZJ;?S'
M'1ZK;IYEB4\+:LD_]&9!N%:!21+/ZPIUV:%8 UB>XH[&BT*'/QS$"9Y=?OXP
M^'" P4Y0@I? ^T)47# 4"96G+JLK4B=N^D+;R]/#J>LN"F91F*6K7[8I7O[L
MK,W85Z&;IDN+_.@M2!D\2^L4,CF'(5N)K"J_ZH#8) \[0G(9UG4\=X-(P.YN
MX4(*9S"TJG/$YE8 ATWJ\5Y(-3$?X\40W6&AL,:JK$HAA-/.#%5E/&Q23^PF
M]1FW*R&1%"$@3P8#JTC;98!/7 4#FZA3.XD:X>[[!,)MZ$XY3%7*%#"'G:.*
M#8+-U9F=7*V0/Z(DB/&>S[_&*X=D=%7*4MC#[@XS-A@VA^=V<W@;I)X;_@.Y
MR2W^1;;0;94NH'=O#,K@L)F\Z *3A6JJ<UDJ7\ _[CB;+$!L/B_MY+,X0W]#
MTX <G:/LP9WS)E=640KZ&.@LT8!%(1:.">#(9@:OL P28G3ST=M_H'<AA5ME
M"]QV'?/5.>2!X9"X'T..-HE7>9)4E@CQ/H=7G*(_[=ZD*L7#87,_%IN:0_(V
M"%%RA5%,XT0\("LE"\Q )M;&PY$-A4.?I;:9Y\0E5SJ>WN<O<<@AKE*&2N7D
MJ'.4L4%PR++4YK)<!8H8%&(5I'[,=)QGY/8*@2=>"P45"XET=F%40<;ANI'9
MYM.VAZ\5KY_"C18HW\MXLHY7>8S30.(JU*GN' \!?4H\AR&[H',,M _1%JC$
MB[1!8\@WF*$D1?=]<! >GUA"\88C79<@@6#('0C):U.?X#&0[TB-(&5?X#'7
M9:2]UP0=I2@)4#IZ7'680OR*YB\H$8U3?BWG!,AN*N&*,UHE0 PY!>$9_ER+
M868MYP1XN:W!,!^((6^B%2OMO<"OSR_L0%E5ZZ^MU;X;<C)"4KB,-I?OW:L%
M'2ACJH01-GV,OAOR+<)3M[0K*C.X5=XY!C+#";@1D<CJOB'O(NC>UDUGHMTL
M_F?G!/@DPB> LW====J0MQ"2'[R*+]S OWDCL>MH*0,!8<SRS@GP"42703X*
M4_Y#:^9/U7G3.0'>L^ARN-M[4V[#+,[<$)0[*6D.E&F[&5N.P&ZM;[(!I*ET
MNVX4^8S+3/)=BVH3SO%EAW:D6JA,N18A)]L28/4=*[^2 ^6*K$6@5 =8Z$SY
M*$&7V")W2/KHOI,3-I84_B7)D;^+7327J[?BG  ?9R2D<F9]38"F7)J0JG&-
MDN"5WCO6T@51-><$> FH1;X4$8=M;3/3*TI>8C"^'^(,K11<3C.CM'-JSY2O
MSBX/"(=4;0,4+*E:0Y>AWJ= 5Q8:4<K!P6%4WPQEQWY=C4CG%-CIUI1!"H!#
MG;Z%"I Z$@L59#3Y"=X_7,4T8QN*/#&5@EH.5)!M(VIE@#AQ$)TR7-4Z1PN.
M*"?VS,)USU(2=!S6M4U>L*MMU95,$Q2)3=#;I9U3\& F(4U<*S03"(=4;0,9
M+*FE&%89H]M%':C;\(WH9*+@<*EMXH+E<I,9Z-$-_+OHRET$F<N*KY?4<.!S
M5]1@5@2&0W"GK%G?2(ZG"/DW;A+A744Z\KQ\GH<D*OL:30(O$*V_\LH.5!Z:
M1J0KXN+PWRF3%2N7M<9^RX&Z\=2(7PX.#I_ZL4]VG':9^\X&7BGGU!Y3I '_
M!!\C1P_T ZFV]<"6*S;5EU=Z>-]F,+R F$KK7;@9#&WQ\DI%RIM.=_'\N'.S
MG1_M&-C4SV))PB<;Q(]K-U@.P.8E"46<4RH'R(^;-XSK# /H>Y \MCAC5@;E
MQ^4;IF2 C8=U2!9 ^7'_!LL!V'M78YW=ZGT/KN!4512?-\8)1>M3\^CJ.1)E
M2S^O 2PO<',QFT,5L[\850]N\U3A%NDL1GDVBY/@GYLSK93][8I8/N"FY/JL
ML]'TX+X/"^9=FN;:3!>5L%S ;<=-62XCZ<>-H1V(XHP]BC6QA,#MR$VYWH'3
MA_M$)<=FC45<H386E2W6+R7FE2&9NI%DC2=?8_D6U'(&T+<<:O/-AF+L2I,=
MHUQQV>;4P"*QQ3!6C]TRC#Y<4=),L*=2#0O'EA-V/8YWL)BZE<28J@$]?FLI
MI977Z/>L@,7S8NN^*#CX.#6<P87V<UN /KU+X%5.*$4U-]XE?W7KR(M+ACUX
ME[:L;26"M#UXE_S0X8ZPVMAY=VF+S9#-CKKS[M)<VCPS7*9)5N(1_VV;0_P3
M/CS'?NYE^.R$DM? 0YP!R2OJ#(>#(]N<Z;M#4=I]R">R&A%'(Z<*0"EW_ G+
M%S( FDVEQ'!Y% "!?$:K^8Q*'X*5.E)+I0K<0,< -4;8LR@+ ^2S6A;X2R]M
M.<VI[VJV>@_YII:)"/Q7%.5()5_A=E&LPD>#,UOR=6^QPN:0"\&0 PS67+I$
M=XN%1*YI$H"_!MGL*D\S?!I+\*$LS(G=@:1$PO_SG]TW.=TZK17B! YJX7(L
M5(E:, TYU:S0&M'$O2I2  <^O]3C=]-W4XXQ:-=(2O<?RTR"*O,WKPJ>,#LU
MB8MQ&,O%!WHM+D58@C,,\AJK;Q@OB'"6>(7C5% /BP<X;D5,'&_X2B'UP0?V
M!44H<4.2I\J?!Q%]8) D,))S+JF)100<QU*'=250??"0+5TCT70E'0'3.V6Q
M&(#C5NIPRX%A+#D?X/7'-;3"_W$?ITI\;DIC40#'HS1B=!N(L:QZ@)P^Q%%<
MQ;<4C<*.2UH7BPD\?XC.UDL1D*G\>G9D4_SB!A'1Z7&T^>T!J:54Y-1U,$98
MWA699*N!(KY^9.0C$%."$6&4-V]$8'F0SHH;J]?H1:0(TKKD5'IQ!.S9;:0+
MZA!-I?,#SKJ),J75O5(.CX<N<\S TH<$?ZL$*ZO0V<]N&GCDH!F$>28,0)34
MQ"*RQ:VAM*PKP3&5YP]V^/Z*@ND,8QKA;KA3]) 39]QX0F&70O/45:%>@UBD
MG;*Y-4'98JI &P(<EU$QU3PW<%E-:J:R5*B/V3P%]#!KQD .CVRYI2>7J<3A
M7 +4I\0FA22NXODBCDB@L&IH)*L>EHXMU_5*;$EXY0/I09*3+7#24$EF>2P-
M6V[F\<GB[*GX>'J0\:1TK4$:N;53UAD.@*T? G)X/D<FAAZD->&D&)6R*JR'
MI0-\WM5F6 %/#_*;;.<6E=+,KH#E 7S U>97!*0'*4^:!F(.CVRY"*V^?]KJ
M?0]2EC3-ASL<V&=5H-SPF&0C,!2-N4!)$).#>I)!\:EVG[ER^W<XL,\E*.)P
MI^^&HB*;L)<M@E?*R='9\1%EA/SB/%(7%7H,7:^XES@GC\0QB!&4)NZ,C@PS
M%130T9"*3/%R?? +4X1#6RYJZ?-4!=&/?!YTOB^FBNL\P;NP1SK&:?X2^F]C
MBC"]>4.)%Z3B.5.W+3PYV7+S4GUQU =H*AK22DTI%AM#JB)H#(O2%NMQ$UV1
M(H0-H>3,_:L^CB>_N@FY,9>*UVE>>3)Y7D*?4S56 "D.4R&2/IH$$35V?,D#
MGR3F;X4UX9K-*4Z#18:=&'M*,&#?%>90M>SJ>'+EIK,0I<))5%*#[E L3)_'
M(TP!B:GHQ5:&&;__DK.F1FTJ">B'9(UPRD1E*BRQ&;][V%$O0WE(W,*<Q'I1
M"NMNJ9F-X5V$+6[7YGMJ <)^A"Z*=XE,^%\2<91CW2:Q6#NQ9IC!:2Q8$M1/
M^#]Y6CP#_!QSG&7+B5AJ[]1NJYB[.S75U,?8CT#+FG'2 UO<4$HD,SIO*MJQ
MTVZH;MA=90A,/8=<>#)N(K]+7JAA)_;__+Z;>O^829X-<<=I<=ZY#>/O>\^K
M6HIM7?=!+\QXIQIF[1ABIJL973RTQ4G+%:4D>**$XT>:U4T.S.'0%B=1B2 )
ME6P0?^PTJT/H!_0D[+ IY0&Q*LWJ_F/3K'$(J(_)K=Y;E6ZUSEF.+#*/2?P:
MX#W,Y_=?\*;D+EKG?1AY6?!:/&NMD!1!NS$L0@N/_D-N@&)=A#V(+ZYYZH=^
M"+,N8TI6 ?[3F-HNI;)XX)P.%=/6-^3%D1>$J(+Z.38W8;3Q.4P?L/W9K,JU
M)Z,>1%5C&23(3=$U*OY[5TI6<A^X+T%(<0M44+$%/-:!3P_MZ0%;[[0$TX-7
M)O5]JARO(O0;HOM6%)$<>O V9>M)@HZA$\CL6V'4I=(XA/VRT)\(38F!U9I%
M:BVXI;=0[?4JQ4:P]( ];68W0+K(^Y F>!?S8X(6;N#+L\;*JN*)&?C(K4NH
MJEJP<#:.F:_.(,]6Z<3(\T@4<?KHOA/K%<FIZWE)CB'5W/JJ-.B QX2VI3_J
MZ/N0GUA]DC9B\<."Z]6JI(N\#TF0.9AO@\C%6T8SQF)!8UB0%@:?:!N+I0BM
MO%F 47@(^2EY384$8Q#[Y'A22IZ"I\O510FR%%>O//*BUINU6IP3@+V!=5FN
MZHQ):9BZY0 ;95@6QA+T*OA?M"*)JA42 M[]FM$7+;C]R-9<AJI[3U1:UQF>
M0*?M;DTO!(!-W7ZP<"/+$)R1W0@6''3"9Z.:HHN\#^FA*6 :_;E]"A2%(G$K
M8<%8>!>9OS&5(3%U30&:8@F9&*PMD63*M!5]-G43 3Z-DAI-MD3DZM#$#0WI
MX"V#?+$(J0#<<!62?!=-XF1>,*$0'J[6 EZG++R;P*=:"Y:I:PN@R6&7(!_B
MR,-_O(M>44JM79'/V#!<!ZD7QFF>J+RHU+1I+&3H15A'&_AS1W,A<#1-V]9H
M.//7$M0X><3KS?(OS_C$FN*.XZ[>ND%"KVN/)]_0(@D\M#9VC-*[R,_%IB0S
MK1=G9NB7VHQH </ 9%A&'#W3-E2:US,BP9LW3R_;D*P>S=8#_N9FB[JAAI[#
MN@GSXGXNWSVX&1;(>++TU<31WB_9C9.I&P7_I!_?W  DBA3YCR6XX\F24S?<
M7 Y46$N-M(_WL.< UIQ=<@16FYW"N-/ WFF#LN<8;#B@#=WU QN6Y(6A=#PI
MR^C'N&3JQNG1_L?EDIUEC 1>9 0P=\HZX#FG#$J>/2HYF-MZU6<_0_(^^#T/
M?/*HT7IW@8\V<52D/-GWZ'S&$#Z'Q TJ'VD[93$=6I?0.7M+L4367^5M,16K
MX\X"F[PX\F/L&[4@=7LX/ 73*)@$'MX4;\;Y(YY*/.)<VO=5K9T>J%RXXE9R
MA@!V19$\16-)KP$'V,HO%CK'LJB,K.O;O@>4D;L JP=*1XL%!DGB+Y_C9>0+
M^;G(X;/O,48.V7&4X7Z&]'%=/._@T[;:\_""B@[ 8XM?@RA.\"R]ZLO&,J R
MT!1J.\#7GN0B9X\T16A='V9+8\XJE)FNUBMSWU?D$KQTKZL^Q#@[I,TMP;3\
M#<&@4:GF7.Q_R'"ZI#)>9%4=( NSJJC90T4%5=?'B0TO_F[WX"'.5#QHXHK.
M^MT^<"QZ:X]R&P[\BP!2 CB[/2V(O1ABNS>M]SV[KZ5+0ZS7_?B&0G+3ZRI.
MEQG_7TA/']UW52-?LX:=]1MA-LKB<[G+2@MALY8=Z(=]#)#)64L-"*;;UI0O
M-$$RO6+>>--9:DNVT604):[-P3H3F:%^2&V!K+*T)U Q4%+Q,*Q_0A"=7ZA$
M1IC>V/T G$D/Z'NI1TD<X3\6L26%6-^+_U=98'2;<J"S'TNHX/A\ZZ#L^O#3
ML0S2](U['XMMV0=!\B5[,^3G(=Z.K-[17@F>N#8]?."_#L*<Y$"@%*@<W.JU
MZ$ G8%8@AW.,:P"XO<':*)2N.@2EU,LK.=!9F+795<1D*"FS]09BW9EVOV;B
MH5;(&J=OI$DJV*\HF\5^',93UC,9W+(.5 9*91$Q-)P+I*U39A.&UH$&HS1%
M&<%9RM&RU%9_E&T"FO&YVLL3\KP3#=3AL=FT70<J]583YHV -C3]&=421M]Y
MQ#.*.E#91IIPR<-A*,T\5.#-CGT<9K_?EFN&&$P@@JWKOY%R-#@%OSNK)%*>
MPX6)Y\=S*>6W++!,;+EX6Z5)PBD7RA_\W10B!5N>P.%RQ.96 *<G#Z@44QCQ
M!,41=2$ICEM6O4(VMCRLH35VA7"Z_=3*%C3I$&:6+V1ARP.[0K;83(M1&7HG
M!7HPW]=]#0E+P;8'D92&[2X&0\^B:#.I8=)1LV;*:U+,9^"Q1UPJ%(T]'%"&
M7@DQ;)BF5MC'//%F;HI6%Y75"%6H6H"W,14)EU$=5(9>ZP S58NO'&U>Y"XE
MW[A&F1N$^[87D OUN(_T7CWN\JL;*L:0B2LZ9Q"AG&OG%KMS4A."2GT'>AI5
M$+S,]R>#]\/(L#GUG4$;D919T[4YG/'3M'6$Z:;VAC-K;0UGW TM!T:W;0QL
MU58YHTAJ.F?0]L&&PU<%7[>-#ML+67:%MX;O033E></4*CIGP,=4%>;XG$N
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MJQ82 C96*!"HQCP7G2&[A"7\W[P5[\'74P%&[4).P/$4QK1 !-!0A)4UBK!
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M!V^@EG"EQ94 =_/+,_Y3BA=2HO;2JX6:+6$)0L\+?&+9FE +80]>-GW*7]+
M#]SD_<DE$Z-2I#:O#I8*D$>KI?E!@K0'3Y66<#VX<_S'DJY+MPORRLX .B&D
MA$(.[XK >O!6Z5V$C^!H8ZE8/N$GF0($M?"6"8CREB8!*=9N)R'CP),.?F$]
M/#R <U5)6=,BNXRJVWG)VLG[.3@%HKNMA5^.M@^/CIK)##HXM<7.SF>+3;,
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M]=#264\*'"5J9/[<8WKU7?^2/2G6KX/4"^,4$SF>E+M(<_.27J=92NEY*3G
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M-C,P+GAM;%!+ 0(4 Q0    ( %&("4VTQ/?1)0P  !5M   1
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M  !T<&EV+3(P,3@P-C,P7W!R92YX;6Q02P4&      8 !@"* 0  1A<!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
